Subject Accession	Species	Race	Race Specify	Ethnicity	Strain	Gender	Age Event	Age Event Specify	Subject Age	Age Unit	Subject Phenotype	ARM Accession	ARM Name	Study Accession	Study Brief Title	Biosample Accession	Biosample Description	Biosample Name	Biosample Type	Biosample Subtype	Study Time Collected	Study Time Collected Unit	Study Time T0 Event	Study Time T0 Event Specify	Biosample Treatment	Planned Visit Accession	Planned Visit Name	Experiment Accession	Expsample Accession	Expsample Description	Expsample Result Schema	Expsample Treatement	Reagent Accession	Reagent Name	Reagent Reporter Name	File Info ID	File Detail	File Name	Original File Name
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752350			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003779		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	578466	Flow cytometry result	Panel_P13_A10_P13_110191_PBMC_10112011_A10.578466.fcs	Panel_P13_A10_P13_110191_PBMC_10112011_A10.fcs
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752350			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004116		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578824	Flow cytometry result	Panel_P9_A1_P9_110191_PBMC_10112011_A01.578824.fcs	Panel_P9_A1_P9_110191_PBMC_10112011_A01.fcs
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752350			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004392		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579100	Flow cytometry result	Panel_P2_A7_P2_110191_PBMC_10112011_A07.579100.fcs	Panel_P2_A7_P2_110191_PBMC_10112011_A07.fcs
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752350			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004562		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579270	Flow cytometry result	Panel_L2_A4_L2_110191_PBMC_10112011_A04.579270.fcs	Panel_L2_A4_L2_110191_PBMC_10112011_A04.fcs
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752350			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004668		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579376	Flow cytometry result	Panel_L1_A1_L1_110191_PBMC_10112011_A01.579376.fcs	Panel_L1_A1_L1_110191_PBMC_10112011_A01.fcs
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752350			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005215		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579923	Flow cytometry result	Panel_L3_A7_L3_110191_PBMC_10112011_A07.579923.fcs	Panel_L3_A7_L3_110191_PBMC_10112011_A07.fcs
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752350			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005258		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579966	Flow cytometry result	Panel_L5_MonoNKDC_A4_L5_110191_PBMC_10112011_A04.579966.fcs	Panel_L5_MonoNKDC_A4_L5_110191_PBMC_10112011_A04.fcs
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752350			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005261		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579969	Flow cytometry result	Panel_P10_A4_P10_110191_PBMC_10112011_A04.579969.fcs	Panel_P10_A4_P10_110191_PBMC_10112011_A04.fcs
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752350			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005392		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	580100	Flow cytometry result	Panel_P1_A10_P1_110191_PBMC_10112011_A10.580100.fcs	Panel_P1_A10_P1_110191_PBMC_10112011_A10.fcs
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752350			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005596		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	580304	Flow cytometry result	Panel_L4_B_Cells_A1_L4_110191_PBMC_10112011_A01.580304.fcs	Panel_L4_B_Cells_A1_L4_110191_PBMC_10112011_A01.fcs
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752351			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003893		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	578597	Flow cytometry result	Panel_P2_B7_P2_110191_PBMC_10132011_B07.578597.fcs	Panel_P2_B7_P2_110191_PBMC_10132011_B07.fcs
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752351			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003944		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	578650	Flow cytometry result	Panel_L4_B_Cells_B1_L4_110191_PBMC_10132011_B01.578650.fcs	Panel_L4_B_Cells_B1_L4_110191_PBMC_10132011_B01.fcs
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752351			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004271		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	578979	Flow cytometry result	Panel_L2_B4_L2_110191_PBMC_10132011_B04.578979.fcs	Panel_L2_B4_L2_110191_PBMC_10132011_B04.fcs
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752351			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004337		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579045	Flow cytometry result	Panel_L1_B1_L1_110191_PBMC_10132011_B01.579045.fcs	Panel_L1_B1_L1_110191_PBMC_10132011_B01.fcs
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752351			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004357		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579065	Flow cytometry result	Panel_P13_B10_P13_110191_PBMC_10132011_B10.579065.fcs	Panel_P13_B10_P13_110191_PBMC_10132011_B10.fcs
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752351			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004545		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579253	Flow cytometry result	Panel_L5_MonoNKDC_B4_L5_110191_PBMC_10132011_B04.579253.fcs	Panel_L5_MonoNKDC_B4_L5_110191_PBMC_10132011_B04.fcs
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752351			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005175		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579883	Flow cytometry result	Panel_L3_B7_L3_110191_PBMC_10132011_B07.579883.fcs	Panel_L3_B7_L3_110191_PBMC_10132011_B07.fcs
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752351			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005432		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580140	Flow cytometry result	Panel_P10_B4_P10_110191_PBMC_10132011_B04.580140.fcs	Panel_P10_B4_P10_110191_PBMC_10132011_B04.fcs
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752351			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005461		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	580169	Flow cytometry result	Panel_P1_B10_P1_110191_PBMC_10132011_B10.580169.fcs	Panel_P1_B10_P1_110191_PBMC_10132011_B10.fcs
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752351			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005466		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580174	Flow cytometry result	Panel_P9_B1_P9_110191_PBMC_10132011_B01.580174.fcs	Panel_P9_B1_P9_110191_PBMC_10132011_B01.fcs
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752352			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003950		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	578656	Flow cytometry result	Panel_L1_C1_L1_110191_PBMC_10182011_C01.578656.fcs	Panel_L1_C1_L1_110191_PBMC_10182011_C01.fcs
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752352			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003951		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578657	Flow cytometry result	Panel_P10_C4_P10_110191_PBMC_10182011_C04.578657.fcs	Panel_P10_C4_P10_110191_PBMC_10182011_C04.fcs
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752352			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004073		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	578781	Flow cytometry result	Panel_P1_C10_P1_110191_PBMC_10182011_C10.578781.fcs	Panel_P1_C10_P1_110191_PBMC_10182011_C10.fcs
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752352			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004563		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579271	Flow cytometry result	Panel_P13_C10_P13_110191_PBMC_10182011_C10.579271.fcs	Panel_P13_C10_P13_110191_PBMC_10182011_C10.fcs
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752352			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004763		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579471	Flow cytometry result	Panel_L5_MonoNKDC_C4_L5_110191_PBMC_10182011_C04.579471.fcs	Panel_L5_MonoNKDC_C4_L5_110191_PBMC_10182011_C04.fcs
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752352			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004846		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579554	Flow cytometry result	Panel_L3_C7_L3_110191_PBMC_10182011_C07.579554.fcs	Panel_L3_C7_L3_110191_PBMC_10182011_C07.fcs
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752352			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005057		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579765	Flow cytometry result	Panel_L4_B_Cells_C1_L4_110191_PBMC_10182011_C01.579765.fcs	Panel_L4_B_Cells_C1_L4_110191_PBMC_10182011_C01.fcs
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752352			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005455		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	580163	Flow cytometry result	Panel_L2_C4_L2_110191_PBMC_10182011_C04.580163.fcs	Panel_L2_C4_L2_110191_PBMC_10182011_C04.fcs
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752352			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005541		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580249	Flow cytometry result	Panel_P9_C1_P9_110191_PBMC_10182011_C01.580249.fcs	Panel_P9_C1_P9_110191_PBMC_10182011_C01.fcs
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752352			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005614		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	580322	Flow cytometry result	Panel_P2_C7_P2_110191_PBMC_10182011_C07.580322.fcs	Panel_P2_C7_P2_110191_PBMC_10182011_C07.fcs
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752353			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003647		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	578274	Flow cytometry result	Panel_L4_B_Cells_D1_L4_110191_PBMC_11082011_D01.578274.fcs	Panel_L4_B_Cells_D1_L4_110191_PBMC_11082011_D01.fcs
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752353			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004276		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	578984	Flow cytometry result	Panel_L1_D1_L1_110191_PBMC_11082011_D01.578984.fcs	Panel_L1_D1_L1_110191_PBMC_11082011_D01.fcs
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752353			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004501		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579209	Flow cytometry result	Panel_P2_D7_P2_110191_PBMC_11082011_D07.579209.fcs	Panel_P2_D7_P2_110191_PBMC_11082011_D07.fcs
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752353			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004613		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579321	Flow cytometry result	Panel_P9_D1_P9_110191_PBMC_11082011_D01.579321.fcs	Panel_P9_D1_P9_110191_PBMC_11082011_D01.fcs
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752353			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004631		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579339	Flow cytometry result	Panel_L2_D4_L2_110191_PBMC_11082011_D04.579339.fcs	Panel_L2_D4_L2_110191_PBMC_11082011_D04.fcs
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752353			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004742		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579450	Flow cytometry result	Panel_P13_D10_P13_110191_PBMC_11082011_D10.579450.fcs	Panel_P13_D10_P13_110191_PBMC_11082011_D10.fcs
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752353			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004824		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579532	Flow cytometry result	Panel_P1_D10_P1_110191_PBMC_11082011_D10.579532.fcs	Panel_P1_D10_P1_110191_PBMC_11082011_D10.fcs
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752353			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005251		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579959	Flow cytometry result	Panel_P10_D4_P10_110191_PBMC_11082011_D04.579959.fcs	Panel_P10_D4_P10_110191_PBMC_11082011_D04.fcs
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752353			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005376		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	580084	Flow cytometry result	Panel_L3_D7_L3_110191_PBMC_11082011_D07.580084.fcs	Panel_L3_D7_L3_110191_PBMC_11082011_D07.fcs
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752353			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005410		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	580118	Flow cytometry result	Panel_L5_MonoNKDC_D4_L5_110191_PBMC_11082011_D04.580118.fcs	Panel_L5_MonoNKDC_D4_L5_110191_PBMC_11082011_D04.fcs
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689463			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003674		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	578321	Flow cytometry result	Panel_L3_A8_L3_110192_PBMC_10112011_A08.578321.fcs	Panel_L3_A8_L3_110192_PBMC_10112011_A08.fcs
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689463			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003747		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	578427	Flow cytometry result	Panel_L5_MonoNKDC_A5_L5_110192_PBMC_10112011_A05.578427.fcs	Panel_L5_MonoNKDC_A5_L5_110192_PBMC_10112011_A05.fcs
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689463			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004021		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	578729	Flow cytometry result	Panel_L2_A5_L2_110192_PBMC_10112011_A05.578729.fcs	Panel_L2_A5_L2_110192_PBMC_10112011_A05.fcs
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689463			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004057		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	578765	Flow cytometry result	Panel_P13_A11_P13_110192_PBMC_10112011_A11.578765.fcs	Panel_P13_A11_P13_110192_PBMC_10112011_A11.fcs
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689463			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004143		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	578851	Flow cytometry result	Panel_L1_A2_L1_110192_PBMC_10112011_A02.578851.fcs	Panel_L1_A2_L1_110192_PBMC_10112011_A02.fcs
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689463			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004581		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579289	Flow cytometry result	Panel_P9_A2_P9_110192_PBMC_10112011_A02.579289.fcs	Panel_P9_A2_P9_110192_PBMC_10112011_A02.fcs
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689463			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004598		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579306	Flow cytometry result	Panel_P10_A5_P10_110192_PBMC_10112011_A05.579306.fcs	Panel_P10_A5_P10_110192_PBMC_10112011_A05.fcs
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689463			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005091		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579799	Flow cytometry result	Panel_L4_B_Cells_A2_L4_110192_PBMC_10112011_A02.579799.fcs	Panel_L4_B_Cells_A2_L4_110192_PBMC_10112011_A02.fcs
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689463			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005208		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579916	Flow cytometry result	Panel_P2_A8_P2_110192_PBMC_10112011_A08.579916.fcs	Panel_P2_A8_P2_110192_PBMC_10112011_A08.fcs
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689463			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005476		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	580184	Flow cytometry result	Panel_P1_A11_P1_110192_PBMC_10112011_A11.580184.fcs	Panel_P1_A11_P1_110192_PBMC_10112011_A11.fcs
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689464			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004209		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	578917	Flow cytometry result	Panel_L5_MonoNKDC_B5_L5_110192_PBMC_10132011_B05.578917.fcs	Panel_L5_MonoNKDC_B5_L5_110192_PBMC_10132011_B05.fcs
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689464			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004251		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	578959	Flow cytometry result	Panel_L2_B5_L2_110192_PBMC_10132011_B05.578959.fcs	Panel_L2_B5_L2_110192_PBMC_10132011_B05.fcs
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689464			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004348		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579056	Flow cytometry result	Panel_L1_B2_L1_110192_PBMC_10132011_B02.579056.fcs	Panel_L1_B2_L1_110192_PBMC_10132011_B02.fcs
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689464			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004399		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579107	Flow cytometry result	Panel_P10_B5_P10_110192_PBMC_10132011_B05.579107.fcs	Panel_P10_B5_P10_110192_PBMC_10132011_B05.fcs
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689464			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004455		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579163	Flow cytometry result	Panel_L3_B8_L3_110192_PBMC_10132011_B08.579163.fcs	Panel_L3_B8_L3_110192_PBMC_10132011_B08.fcs
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689464			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004551		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579259	Flow cytometry result	Panel_P13_B11_P13_110192_PBMC_10132011_B11.579259.fcs	Panel_P13_B11_P13_110192_PBMC_10132011_B11.fcs
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689464			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004557		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579265	Flow cytometry result	Panel_P1_B11_P1_110192_PBMC_10132011_B11.579265.fcs	Panel_P1_B11_P1_110192_PBMC_10132011_B11.fcs
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689464			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004980		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579688	Flow cytometry result	Panel_L4_B_Cells_B2_L4_110192_PBMC_10132011_B02.579688.fcs	Panel_L4_B_Cells_B2_L4_110192_PBMC_10132011_B02.fcs
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689464			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005080		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579788	Flow cytometry result	Panel_P2_B8_P2_110192_PBMC_10132011_B08.579788.fcs	Panel_P2_B8_P2_110192_PBMC_10132011_B08.fcs
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689464			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005535		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580243	Flow cytometry result	Panel_P9_B2_P9_110192_PBMC_10132011_B02.580243.fcs	Panel_P9_B2_P9_110192_PBMC_10132011_B02.fcs
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689465			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004018		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	578726	Flow cytometry result	Panel_P1_C11_P1_110192_PBMC_10182011_C11.578726.fcs	Panel_P1_C11_P1_110192_PBMC_10182011_C11.fcs
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689465			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004072		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	578780	Flow cytometry result	Panel_L3_C8_L3_110192_PBMC_10182011_C08.578780.fcs	Panel_L3_C8_L3_110192_PBMC_10182011_C08.fcs
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689465			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004240		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578948	Flow cytometry result	Panel_P10_C5_P10_110192_PBMC_10182011_C05.578948.fcs	Panel_P10_C5_P10_110192_PBMC_10182011_C05.fcs
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689465			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004300		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579008	Flow cytometry result	Panel_P13_C11_P13_110192_PBMC_10182011_C11.579008.fcs	Panel_P13_C11_P13_110192_PBMC_10182011_C11.fcs
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689465			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004518		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579226	Flow cytometry result	Panel_P2_C8_P2_110192_PBMC_10182011_C08.579226.fcs	Panel_P2_C8_P2_110192_PBMC_10182011_C08.fcs
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689465			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004590		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579298	Flow cytometry result	Panel_L1_C2_L1_110192_PBMC_10182011_C02.579298.fcs	Panel_L1_C2_L1_110192_PBMC_10182011_C02.fcs
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689465			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004787		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579495	Flow cytometry result	Panel_L5_MonoNKDC_C5_L5_110192_PBMC_10182011_C05.579495.fcs	Panel_L5_MonoNKDC_C5_L5_110192_PBMC_10182011_C05.fcs
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689465			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004893		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579601	Flow cytometry result	Panel_L2_C5_L2_110192_PBMC_10182011_C05.579601.fcs	Panel_L2_C5_L2_110192_PBMC_10182011_C05.fcs
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689465			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005529		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580237	Flow cytometry result	Panel_P9_C2_P9_110192_PBMC_10182011_C02.580237.fcs	Panel_P9_C2_P9_110192_PBMC_10182011_C02.fcs
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689465			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005592		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	580300	Flow cytometry result	Panel_L4_B_Cells_C2_L4_110192_PBMC_10182011_C02.580300.fcs	Panel_L4_B_Cells_C2_L4_110192_PBMC_10182011_C02.fcs
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689466			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003760		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578443	Flow cytometry result	Panel_P10_D5_P10_110192_PBMC_11082011_D05.578443.fcs	Panel_P10_D5_P10_110192_PBMC_11082011_D05.fcs
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689466			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003761		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	578444	Flow cytometry result	Panel_P13_D11_P13_110192_PBMC_11082011_D11.578444.fcs	Panel_P13_D11_P13_110192_PBMC_11082011_D11.fcs
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689466			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004341		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579049	Flow cytometry result	Panel_L2_D5_L2_110192_PBMC_11082011_D05.579049.fcs	Panel_L2_D5_L2_110192_PBMC_11082011_D05.fcs
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689466			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004639		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579347	Flow cytometry result	Panel_L3_D8_L3_110192_PBMC_11082011_D08.579347.fcs	Panel_L3_D8_L3_110192_PBMC_11082011_D08.fcs
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689466			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004808		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579516	Flow cytometry result	Panel_P2_D8_P2_110192_PBMC_11082011_D08.579516.fcs	Panel_P2_D8_P2_110192_PBMC_11082011_D08.fcs
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689466			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004820		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579528	Flow cytometry result	Panel_P9_D2_P9_110192_PBMC_11082011_D02.579528.fcs	Panel_P9_D2_P9_110192_PBMC_11082011_D02.fcs
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689466			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005514		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	580222	Flow cytometry result	Panel_L1_D2_L1_110192_PBMC_11082011_D02.580222.fcs	Panel_L1_D2_L1_110192_PBMC_11082011_D02.fcs
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689466			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005517		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	580225	Flow cytometry result	Panel_L5_MonoNKDC_D5_L5_110192_PBMC_11082011_D05.580225.fcs	Panel_L5_MonoNKDC_D5_L5_110192_PBMC_11082011_D05.fcs
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689466			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005594		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	580302	Flow cytometry result	Panel_L4_B_Cells_D2_L4_110192_PBMC_11082011_D02.580302.fcs	Panel_L4_B_Cells_D2_L4_110192_PBMC_11082011_D02.fcs
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689466			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005640		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	580348	Flow cytometry result	Panel_P1_D11_P1_110192_PBMC_11082011_D11.580348.fcs	Panel_P1_D11_P1_110192_PBMC_11082011_D11.fcs
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752355			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003874		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	578576	Flow cytometry result	Panel_P1_E10_P1_110193_PBMC_10112011_E10.578576.fcs	Panel_P1_E10_P1_110193_PBMC_10112011_E10.fcs
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752355			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004312		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579020	Flow cytometry result	Panel_L2_E4_L2_110193_PBMC_10112011_E04.579020.fcs	Panel_L2_E4_L2_110193_PBMC_10112011_E04.fcs
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752355			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004509		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579217	Flow cytometry result	Panel_L5_MonoNKDC_E4_L5_110193_PBMC_10112011_E04.579217.fcs	Panel_L5_MonoNKDC_E4_L5_110193_PBMC_10112011_E04.fcs
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752355			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005125		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579833	Flow cytometry result	Panel_L4_B_Cells_E1_L4_110193_PBMC_10112011_E01.579833.fcs	Panel_L4_B_Cells_E1_L4_110193_PBMC_10112011_E01.fcs
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752355			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005155		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579863	Flow cytometry result	Panel_P2_E7_P2_110193_PBMC_10112011_E07.579863.fcs	Panel_P2_E7_P2_110193_PBMC_10112011_E07.fcs
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752355			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005166		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579874	Flow cytometry result	Panel_L3_E7_L3_110193_PBMC_10112011_E07.579874.fcs	Panel_L3_E7_L3_110193_PBMC_10112011_E07.fcs
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752355			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005179		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579887	Flow cytometry result	Panel_P13_E10_P13_110193_PBMC_10112011_E10.579887.fcs	Panel_P13_E10_P13_110193_PBMC_10112011_E10.fcs
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752355			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005402		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580110	Flow cytometry result	Panel_P10_E4_P10_110193_PBMC_10112011_E04.580110.fcs	Panel_P10_E4_P10_110193_PBMC_10112011_E04.fcs
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752355			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005544		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	580252	Flow cytometry result	Panel_L1_E1_L1_110193_PBMC_10112011_E01.580252.fcs	Panel_L1_E1_L1_110193_PBMC_10112011_E01.fcs
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752355			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005679		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580387	Flow cytometry result	Panel_P9_E1_P9_110193_PBMC_10112011_E01.580387.fcs	Panel_P9_E1_P9_110193_PBMC_10112011_E01.fcs
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752356			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003683		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	578334	Flow cytometry result	Panel_L1_F1_L1_110193_PBMC_10132011_F01.578334.fcs	Panel_L1_F1_L1_110193_PBMC_10132011_F01.fcs
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752356			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003925		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	578630	Flow cytometry result	Panel_L2_F4_L2_110193_PBMC_10132011_F04.578630.fcs	Panel_L2_F4_L2_110193_PBMC_10132011_F04.fcs
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752356			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003971		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578679	Flow cytometry result	Panel_P10_F4_P10_110193_PBMC_10132011_F04.578679.fcs	Panel_P10_F4_P10_110193_PBMC_10132011_F04.fcs
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752356			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004010		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	578718	Flow cytometry result	Panel_L5_MonoNKDC_F4_L5_110193_PBMC_10132011_F04.578718.fcs	Panel_L5_MonoNKDC_F4_L5_110193_PBMC_10132011_F04.fcs
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752356			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004051		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	578759	Flow cytometry result	Panel_L3_F7_L3_110193_PBMC_10132011_F07.578759.fcs	Panel_L3_F7_L3_110193_PBMC_10132011_F07.fcs
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752356			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004152		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	578860	Flow cytometry result	Panel_P1_F10_P1_110193_PBMC_10132011_F10.578860.fcs	Panel_P1_F10_P1_110193_PBMC_10132011_F10.fcs
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752356			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004363		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579071	Flow cytometry result	Panel_P2_F7_P2_110193_PBMC_10132011_F07.579071.fcs	Panel_P2_F7_P2_110193_PBMC_10132011_F07.fcs
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752356			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004671		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579379	Flow cytometry result	Panel_L4_B_Cells_F1_L4_110193_PBMC_10132011_F01.579379.fcs	Panel_L4_B_Cells_F1_L4_110193_PBMC_10132011_F01.fcs
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752356			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005393		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580101	Flow cytometry result	Panel_P9_F1_P9_110193_PBMC_10132011_F01.580101.fcs	Panel_P9_F1_P9_110193_PBMC_10132011_F01.fcs
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752356			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005534		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	580242	Flow cytometry result	Panel_P13_F10_P13_110193_PBMC_10132011_F10.580242.fcs	Panel_P13_F10_P13_110193_PBMC_10132011_F10.fcs
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752357			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003994		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	578702	Flow cytometry result	Panel_L3_G7_L3_110193_PBMC_10182011_G07.578702.fcs	Panel_L3_G7_L3_110193_PBMC_10182011_G07.fcs
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752357			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004614		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579322	Flow cytometry result	Panel_P1_G10_P1_110193_PBMC_10182011_G10.579322.fcs	Panel_P1_G10_P1_110193_PBMC_10182011_G10.fcs
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752357			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004726		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579434	Flow cytometry result	Panel_L2_G4_L2_110193_PBMC_10182011_G04.579434.fcs	Panel_L2_G4_L2_110193_PBMC_10182011_G04.fcs
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752357			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004728		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579436	Flow cytometry result	Panel_L1_G1_L1_110193_PBMC_10182011_G01.579436.fcs	Panel_L1_G1_L1_110193_PBMC_10182011_G01.fcs
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752357			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004795		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579503	Flow cytometry result	Panel_P13_G10_P13_110193_PBMC_10182011_G10.579503.fcs	Panel_P13_G10_P13_110193_PBMC_10182011_G10.fcs
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752357			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005012		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579720	Flow cytometry result	Panel_P2_G7_P2_110193_PBMC_10182011_G07.579720.fcs	Panel_P2_G7_P2_110193_PBMC_10182011_G07.fcs
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752357			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005136		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579844	Flow cytometry result	Panel_P9_G1_P9_110193_PBMC_10182011_G01.579844.fcs	Panel_P9_G1_P9_110193_PBMC_10182011_G01.fcs
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752357			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005274		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579982	Flow cytometry result	Panel_L4_B_Cells_G1_L4_110193_PBMC_10182011_G01.579982.fcs	Panel_L4_B_Cells_G1_L4_110193_PBMC_10182011_G01.fcs
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752357			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005618		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580326	Flow cytometry result	Panel_P10_G4_P10_110193_PBMC_10182011_G04.580326.fcs	Panel_P10_G4_P10_110193_PBMC_10182011_G04.fcs
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752357			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005686		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	580394	Flow cytometry result	Panel_L5_MonoNKDC_G4_L5_110193_PBMC_10182011_G04.580394.fcs	Panel_L5_MonoNKDC_G4_L5_110193_PBMC_10182011_G04.fcs
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752358			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003772		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	578457	Flow cytometry result	Panel_L5_MonoNKDC_H4_L5_110193_PBMC_11082011_H04.578457.fcs	Panel_L5_MonoNKDC_H4_L5_110193_PBMC_11082011_H04.fcs
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752358			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004002		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	578710	Flow cytometry result	Panel_P13_H10_P13_110193_PBMC_11082011_H10.578710.fcs	Panel_P13_H10_P13_110193_PBMC_11082011_H10.fcs
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752358			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004154		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	578862	Flow cytometry result	Panel_P2_H7_P2_110193_PBMC_11082011_H07.578862.fcs	Panel_P2_H7_P2_110193_PBMC_11082011_H07.fcs
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752358			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004217		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	578925	Flow cytometry result	Panel_L3_H7_L3_110193_PBMC_11082011_H07.578925.fcs	Panel_L3_H7_L3_110193_PBMC_11082011_H07.fcs
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752358			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004277		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578985	Flow cytometry result	Panel_P10_H4_P10_110193_PBMC_11082011_H04.578985.fcs	Panel_P10_H4_P10_110193_PBMC_11082011_H04.fcs
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752358			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004688		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579396	Flow cytometry result	Panel_L2_H4_L2_110193_PBMC_11082011_H04.579396.fcs	Panel_L2_H4_L2_110193_PBMC_11082011_H04.fcs
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752358			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004720		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579428	Flow cytometry result	Panel_L4_B_Cells_H1_L4_110193_PBMC_11082011_H01.579428.fcs	Panel_L4_B_Cells_H1_L4_110193_PBMC_11082011_H01.fcs
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752358			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005026		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579734	Flow cytometry result	Panel_P1_H10_P1_110193_PBMC_11082011_H10.579734.fcs	Panel_P1_H10_P1_110193_PBMC_11082011_H10.fcs
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752358			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005506		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	580214	Flow cytometry result	Panel_L1_H1_L1_110193_PBMC_11082011_H01.580214.fcs	Panel_L1_H1_L1_110193_PBMC_11082011_H01.fcs
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752358			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005553		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580261	Flow cytometry result	Panel_P9_H1_P9_110193_PBMC_11082011_H01.580261.fcs	Panel_P9_H1_P9_110193_PBMC_11082011_H01.fcs
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689467			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003686		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	578338	Flow cytometry result	Panel_L2_A4_L2_110194_PBMC_10112011_A04.578338.fcs	Panel_L2_A4_L2_110194_PBMC_10112011_A04.fcs
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689467			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003792		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	578484	Flow cytometry result	Panel_L4_B_Cells_A1_L4_110194_PBMC_10112011_A01.578484.fcs	Panel_L4_B_Cells_A1_L4_110194_PBMC_10112011_A01.fcs
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689467			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003922		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	578627	Flow cytometry result	Panel_L3_A7_L3_110194_PBMC_10112011_A07.578627.fcs	Panel_L3_A7_L3_110194_PBMC_10112011_A07.fcs
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689467			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004055		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578763	Flow cytometry result	Panel_P9_A1_P9_110194_PBMC_10112011_A01.578763.fcs	Panel_P9_A1_P9_110194_PBMC_10112011_A01.fcs
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689467			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004070		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	578778	Flow cytometry result	Panel_P13_A10_P13_110194_PBMC_10112011_A10.578778.fcs	Panel_P13_A10_P13_110194_PBMC_10112011_A10.fcs
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689467			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004456		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579164	Flow cytometry result	Panel_P1_A10_P1_110194_PBMC_10112011_A10.579164.fcs	Panel_P1_A10_P1_110194_PBMC_10112011_A10.fcs
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689467			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004548		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579256	Flow cytometry result	Panel_P2_A7_P2_110194_PBMC_10112011_A07.579256.fcs	Panel_P2_A7_P2_110194_PBMC_10112011_A07.fcs
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689467			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004559		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579267	Flow cytometry result	Panel_L5_MonoNKDC_A4_L5_110194_PBMC_10112011_A04.579267.fcs	Panel_L5_MonoNKDC_A4_L5_110194_PBMC_10112011_A04.fcs
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689467			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005516		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580224	Flow cytometry result	Panel_P10_A4_P10_110194_PBMC_10112011_A04.580224.fcs	Panel_P10_A4_P10_110194_PBMC_10112011_A04.fcs
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689467			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005519		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	580227	Flow cytometry result	Panel_L1_A1_L1_110194_PBMC_10112011_A01.580227.fcs	Panel_L1_A1_L1_110194_PBMC_10112011_A01.fcs
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689468			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003929		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578634	Flow cytometry result	Panel_P9_B1_P9_110194_PBMC_10132011_B01.578634.fcs	Panel_P9_B1_P9_110194_PBMC_10132011_B01.fcs
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689468			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004104		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	578812	Flow cytometry result	Panel_L4_B_Cells_B1_L4_110194_PBMC_10132011_B01.578812.fcs	Panel_L4_B_Cells_B1_L4_110194_PBMC_10132011_B01.fcs
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689468			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004222		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	578930	Flow cytometry result	Panel_P1_B10_P1_110194_PBMC_10132011_B10.578930.fcs	Panel_P1_B10_P1_110194_PBMC_10132011_B10.fcs
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689468			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004492		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579200	Flow cytometry result	Panel_L5_MonoNKDC_B4_L5_110194_PBMC_10132011_B04.579200.fcs	Panel_L5_MonoNKDC_B4_L5_110194_PBMC_10132011_B04.fcs
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689468			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004840		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579548	Flow cytometry result	Panel_P10_B4_P10_110194_PBMC_10132011_B04.579548.fcs	Panel_P10_B4_P10_110194_PBMC_10132011_B04.fcs
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689468			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004999		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579707	Flow cytometry result	Panel_L2_B4_L2_110194_PBMC_10132011_B04.579707.fcs	Panel_L2_B4_L2_110194_PBMC_10132011_B04.fcs
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689468			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005011		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579719	Flow cytometry result	Panel_L1_B1_L1_110194_PBMC_10132011_B01.579719.fcs	Panel_L1_B1_L1_110194_PBMC_10132011_B01.fcs
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689468			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005315		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	580023	Flow cytometry result	Panel_L3_B7_L3_110194_PBMC_10132011_B07.580023.fcs	Panel_L3_B7_L3_110194_PBMC_10132011_B07.fcs
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689468			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005360		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	580068	Flow cytometry result	Panel_P13_B10_P13_110194_PBMC_10132011_B10.580068.fcs	Panel_P13_B10_P13_110194_PBMC_10132011_B10.fcs
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689468			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005566		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	580274	Flow cytometry result	Panel_P2_B7_P2_110194_PBMC_10132011_B07.580274.fcs	Panel_P2_B7_P2_110194_PBMC_10132011_B07.fcs
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689469			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003780		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	578467	Flow cytometry result	Panel_L2_C4_L2_110194_PBMC_10182011_C04.578467.fcs	Panel_L2_C4_L2_110194_PBMC_10182011_C04.fcs
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689469			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003966		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	578674	Flow cytometry result	Panel_P1_C10_P1_110194_PBMC_10182011_C10.578674.fcs	Panel_P1_C10_P1_110194_PBMC_10182011_C10.fcs
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689469			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004149		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578857	Flow cytometry result	Panel_P9_C1_P9_110194_PBMC_10182011_C01.578857.fcs	Panel_P9_C1_P9_110194_PBMC_10182011_C01.fcs
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689469			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004443		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579151	Flow cytometry result	Panel_L1_C1_L1_110194_PBMC_10182011_C01.579151.fcs	Panel_L1_C1_L1_110194_PBMC_10182011_C01.fcs
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689469			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004656		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579364	Flow cytometry result	Panel_P10_C4_P10_110194_PBMC_10182011_C04.579364.fcs	Panel_P10_C4_P10_110194_PBMC_10182011_C04.fcs
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689469			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004784		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579492	Flow cytometry result	Panel_P13_C10_P13_110194_PBMC_10182011_C10.579492.fcs	Panel_P13_C10_P13_110194_PBMC_10182011_C10.fcs
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689469			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004908		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579616	Flow cytometry result	Panel_L5_MonoNKDC_C4_L5_110194_PBMC_10182011_C04.579616.fcs	Panel_L5_MonoNKDC_C4_L5_110194_PBMC_10182011_C04.fcs
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689469			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005030		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579738	Flow cytometry result	Panel_P2_C7_P2_110194_PBMC_10182011_C07.579738.fcs	Panel_P2_C7_P2_110194_PBMC_10182011_C07.fcs
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689469			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005445		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	580153	Flow cytometry result	Panel_L4_B_Cells_C1_L4_110194_PBMC_10182011_C01.580153.fcs	Panel_L4_B_Cells_C1_L4_110194_PBMC_10182011_C01.fcs
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689469			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005648		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	580356	Flow cytometry result	Panel_L3_C7_L3_110194_PBMC_10182011_C07.580356.fcs	Panel_L3_C7_L3_110194_PBMC_10182011_C07.fcs
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689470			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003664		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	578304	Flow cytometry result	Panel_L4_B_Cells_D1_L4_110194_PBMC_11082011_D01.578304.fcs	Panel_L4_B_Cells_D1_L4_110194_PBMC_11082011_D01.fcs
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689470			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003752		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	578434	Flow cytometry result	Panel_L5_MonoNKDC_D4_L5_110194_PBMC_11082011_D04.578434.fcs	Panel_L5_MonoNKDC_D4_L5_110194_PBMC_11082011_D04.fcs
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689470			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003825		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	578523	Flow cytometry result	Panel_L1_D1_L1_110194_PBMC_11082011_D01.578523.fcs	Panel_L1_D1_L1_110194_PBMC_11082011_D01.fcs
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689470			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003942		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	578648	Flow cytometry result	Panel_L3_D7_L3_110194_PBMC_11082011_D07.578648.fcs	Panel_L3_D7_L3_110194_PBMC_11082011_D07.fcs
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689470			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004175		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578883	Flow cytometry result	Panel_P9_D1_P9_110194_PBMC_11082011_D01.578883.fcs	Panel_P9_D1_P9_110194_PBMC_11082011_D01.fcs
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689470			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004344		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579052	Flow cytometry result	Panel_L2_D4_L2_110194_PBMC_11082011_D04.579052.fcs	Panel_L2_D4_L2_110194_PBMC_11082011_D04.fcs
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689470			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004844		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579552	Flow cytometry result	Panel_P13_D10_P13_110194_PBMC_11082011_D10.579552.fcs	Panel_P13_D10_P13_110194_PBMC_11082011_D10.fcs
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689470			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005162		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579870	Flow cytometry result	Panel_P1_D10_P1_110194_PBMC_11082011_D10.579870.fcs	Panel_P1_D10_P1_110194_PBMC_11082011_D10.fcs
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689470			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005474		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	580182	Flow cytometry result	Panel_P2_D7_P2_110194_PBMC_11082011_D07.580182.fcs	Panel_P2_D7_P2_110194_PBMC_11082011_D07.fcs
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689470			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005607		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580315	Flow cytometry result	Panel_P10_D4_P10_110194_PBMC_11082011_D04.580315.fcs	Panel_P10_D4_P10_110194_PBMC_11082011_D04.fcs
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689471			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003706		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	578372	Flow cytometry result	Panel_L2_E4_L2_110195_PBMC_10112011_E04.578372.fcs	Panel_L2_E4_L2_110195_PBMC_10112011_E04.fcs
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689471			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003837		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	578535	Flow cytometry result	Panel_L3_E7_L3_110195_PBMC_10112011_E07.578535.fcs	Panel_L3_E7_L3_110195_PBMC_10112011_E07.fcs
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689471			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003917		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	578622	Flow cytometry result	Panel_P1_E10_P1_110195_PBMC_10112011_E10.578622.fcs	Panel_P1_E10_P1_110195_PBMC_10112011_E10.fcs
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689471			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004316		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579024	Flow cytometry result	Panel_P13_E10_P13_110195_PBMC_10112011_E10.579024.fcs	Panel_P13_E10_P13_110195_PBMC_10112011_E10.fcs
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689471			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004387		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579095	Flow cytometry result	Panel_L4_B_Cells_E1_L4_110195_PBMC_10112011_E01.579095.fcs	Panel_L4_B_Cells_E1_L4_110195_PBMC_10112011_E01.fcs
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689471			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004679		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579387	Flow cytometry result	Panel_L1_E1_L1_110195_PBMC_10112011_E01.579387.fcs	Panel_L1_E1_L1_110195_PBMC_10112011_E01.fcs
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689471			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004837		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579545	Flow cytometry result	Panel_P9_E1_P9_110195_PBMC_10112011_E01.579545.fcs	Panel_P9_E1_P9_110195_PBMC_10112011_E01.fcs
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689471			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005114		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579822	Flow cytometry result	Panel_L5_MonoNKDC_E4_L5_110195_PBMC_10112011_E04.579822.fcs	Panel_L5_MonoNKDC_E4_L5_110195_PBMC_10112011_E04.fcs
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689471			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005163		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579871	Flow cytometry result	Panel_P10_E4_P10_110195_PBMC_10112011_E04.579871.fcs	Panel_P10_E4_P10_110195_PBMC_10112011_E04.fcs
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689471			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005425		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	580133	Flow cytometry result	Panel_P2_E7_P2_110195_PBMC_10112011_E07.580133.fcs	Panel_P2_E7_P2_110195_PBMC_10112011_E07.fcs
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689472			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003707		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	578373	Flow cytometry result	Panel_L4_B_Cells_F1_L4_110195_PBMC_10132011_F01.578373.fcs	Panel_L4_B_Cells_F1_L4_110195_PBMC_10132011_F01.fcs
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689472			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003749		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	578430	Flow cytometry result	Panel_P2_F7_P2_110195_PBMC_10132011_F07.578430.fcs	Panel_P2_F7_P2_110195_PBMC_10132011_F07.fcs
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689472			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003797		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	578490	Flow cytometry result	Panel_L2_F4_L2_110195_PBMC_10132011_F04.578490.fcs	Panel_L2_F4_L2_110195_PBMC_10132011_F04.fcs
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689472			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003907		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	578611	Flow cytometry result	Panel_L3_F7_L3_110195_PBMC_10132011_F07.578611.fcs	Panel_L3_F7_L3_110195_PBMC_10132011_F07.fcs
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689472			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004084		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578792	Flow cytometry result	Panel_P10_F4_P10_110195_PBMC_10132011_F04.578792.fcs	Panel_P10_F4_P10_110195_PBMC_10132011_F04.fcs
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689472			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004565		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579273	Flow cytometry result	Panel_L1_F1_L1_110195_PBMC_10132011_F01.579273.fcs	Panel_L1_F1_L1_110195_PBMC_10132011_F01.fcs
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689472			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005088		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579796	Flow cytometry result	Panel_P13_F10_P13_110195_PBMC_10132011_F10.579796.fcs	Panel_P13_F10_P13_110195_PBMC_10132011_F10.fcs
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689472			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005411		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580119	Flow cytometry result	Panel_P9_F1_P9_110195_PBMC_10132011_F01.580119.fcs	Panel_P9_F1_P9_110195_PBMC_10132011_F01.fcs
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689472			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005428		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	580136	Flow cytometry result	Panel_L5_MonoNKDC_F4_L5_110195_PBMC_10132011_F04.580136.fcs	Panel_L5_MonoNKDC_F4_L5_110195_PBMC_10132011_F04.fcs
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689472			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005678		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	580386	Flow cytometry result	Panel_P1_F10_P1_110195_PBMC_10132011_F10.580386.fcs	Panel_P1_F10_P1_110195_PBMC_10132011_F10.fcs
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689473			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003781		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	578468	Flow cytometry result	Panel_L1_G1_L1_110195_PBMC_10182011_G01.578468.fcs	Panel_L1_G1_L1_110195_PBMC_10182011_G01.fcs
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689473			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003930		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	578635	Flow cytometry result	Panel_P1_G10_P1_110195_PBMC_10182011_G10.578635.fcs	Panel_P1_G10_P1_110195_PBMC_10182011_G10.fcs
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689473			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003991		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	578699	Flow cytometry result	Panel_P13_G10_P13_110195_PBMC_10182011_G10.578699.fcs	Panel_P13_G10_P13_110195_PBMC_10182011_G10.fcs
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689473			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004042		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	578750	Flow cytometry result	Panel_L2_G4_L2_110195_PBMC_10182011_G04.578750.fcs	Panel_L2_G4_L2_110195_PBMC_10182011_G04.fcs
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689473			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004127		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	578835	Flow cytometry result	Panel_L4_B_Cells_G1_L4_110195_PBMC_10182011_G01.578835.fcs	Panel_L4_B_Cells_G1_L4_110195_PBMC_10182011_G01.fcs
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689473			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004426		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579134	Flow cytometry result	Panel_P2_G7_P2_110195_PBMC_10182011_G07.579134.fcs	Panel_P2_G7_P2_110195_PBMC_10182011_G07.fcs
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689473			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004542		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579250	Flow cytometry result	Panel_L3_G7_L3_110195_PBMC_10182011_G07.579250.fcs	Panel_L3_G7_L3_110195_PBMC_10182011_G07.fcs
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689473			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005332		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580040	Flow cytometry result	Panel_P9_G1_P9_110195_PBMC_10182011_G01.580040.fcs	Panel_P9_G1_P9_110195_PBMC_10182011_G01.fcs
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689473			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005569		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580277	Flow cytometry result	Panel_P10_G4_P10_110195_PBMC_10182011_G04.580277.fcs	Panel_P10_G4_P10_110195_PBMC_10182011_G04.fcs
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689473			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005621		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	580329	Flow cytometry result	Panel_L5_MonoNKDC_G4_L5_110195_PBMC_10182011_G04.580329.fcs	Panel_L5_MonoNKDC_G4_L5_110195_PBMC_10182011_G04.fcs
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689474			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003798		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	578491	Flow cytometry result	Panel_L4_B_Cells_H1_L4_110195_PBMC_11082011_H01.578491.fcs	Panel_L4_B_Cells_H1_L4_110195_PBMC_11082011_H01.fcs
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689474			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003997		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	578705	Flow cytometry result	Panel_L2_H4_L2_110195_PBMC_11082011_H04.578705.fcs	Panel_L2_H4_L2_110195_PBMC_11082011_H04.fcs
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689474			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004307		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579015	Flow cytometry result	Panel_P9_H1_P9_110195_PBMC_11082011_H01.579015.fcs	Panel_P9_H1_P9_110195_PBMC_11082011_H01.fcs
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689474			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004410		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579118	Flow cytometry result	Panel_L1_H1_L1_110195_PBMC_11082011_H01.579118.fcs	Panel_L1_H1_L1_110195_PBMC_11082011_H01.fcs
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689474			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004514		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579222	Flow cytometry result	Panel_P10_H4_P10_110195_PBMC_11082011_H04.579222.fcs	Panel_P10_H4_P10_110195_PBMC_11082011_H04.fcs
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689474			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004528		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579236	Flow cytometry result	Panel_P1_H10_P1_110195_PBMC_11082011_H10.579236.fcs	Panel_P1_H10_P1_110195_PBMC_11082011_H10.fcs
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689474			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004678		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579386	Flow cytometry result	Panel_L3_H7_L3_110195_PBMC_11082011_H07.579386.fcs	Panel_L3_H7_L3_110195_PBMC_11082011_H07.fcs
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689474			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005018		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579726	Flow cytometry result	Panel_L5_MonoNKDC_H4_L5_110195_PBMC_11082011_H04.579726.fcs	Panel_L5_MonoNKDC_H4_L5_110195_PBMC_11082011_H04.fcs
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689474			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005223		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579931	Flow cytometry result	Panel_P2_H7_P2_110195_PBMC_11082011_H07.579931.fcs	Panel_P2_H7_P2_110195_PBMC_11082011_H07.fcs
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689474			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005291		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579999	Flow cytometry result	Panel_P13_H10_P13_110195_PBMC_11082011_H10.579999.fcs	Panel_P13_H10_P13_110195_PBMC_11082011_H10.fcs
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689475			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003768		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	578452	Flow cytometry result	Panel_L5_MonoNKDC_A5_L5_110196_PBMC_10112011_A05.578452.fcs	Panel_L5_MonoNKDC_A5_L5_110196_PBMC_10112011_A05.fcs
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689475			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004005		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	578713	Flow cytometry result	Panel_P2_A8_P2_110196_PBMC_10112011_A08.578713.fcs	Panel_P2_A8_P2_110196_PBMC_10112011_A08.fcs
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689475			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004125		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	578833	Flow cytometry result	Panel_L1_A2_L1_110196_PBMC_10112011_A02.578833.fcs	Panel_L1_A2_L1_110196_PBMC_10112011_A02.fcs
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689475			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004323		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579031	Flow cytometry result	Panel_L2_A5_L2_110196_PBMC_10112011_A05.579031.fcs	Panel_L2_A5_L2_110196_PBMC_10112011_A05.fcs
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689475			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004435		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579143	Flow cytometry result	Panel_L4_B_Cells_A2_L4_110196_PBMC_10112011_A02.579143.fcs	Panel_L4_B_Cells_A2_L4_110196_PBMC_10112011_A02.fcs
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689475			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004479		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579187	Flow cytometry result	Panel_P9_A2_P9_110196_PBMC_10112011_A02.579187.fcs	Panel_P9_A2_P9_110196_PBMC_10112011_A02.fcs
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689475			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004616		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579324	Flow cytometry result	Panel_P10_A5_P10_110196_PBMC_10112011_A05.579324.fcs	Panel_P10_A5_P10_110196_PBMC_10112011_A05.fcs
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689475			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005051		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579759	Flow cytometry result	Panel_L3_A8_L3_110196_PBMC_10112011_A08.579759.fcs	Panel_L3_A8_L3_110196_PBMC_10112011_A08.fcs
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689475			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005184		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579892	Flow cytometry result	Panel_P1_A11_P1_110196_PBMC_10112011_A11.579892.fcs	Panel_P1_A11_P1_110196_PBMC_10112011_A11.fcs
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689475			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005638		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	580346	Flow cytometry result	Panel_P13_A11_P13_110196_PBMC_10112011_A11.580346.fcs	Panel_P13_A11_P13_110196_PBMC_10112011_A11.fcs
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689476			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003691		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	578347	Flow cytometry result	Panel_L1_B2_L1_110196_PBMC_10132011_B02.578347.fcs	Panel_L1_B2_L1_110196_PBMC_10132011_B02.fcs
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689476			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003969		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	578677	Flow cytometry result	Panel_L3_B8_L3_110196_PBMC_10132011_B08.578677.fcs	Panel_L3_B8_L3_110196_PBMC_10132011_B08.fcs
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689476			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004352		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579060	Flow cytometry result	Panel_P2_B8_P2_110196_PBMC_10132011_B08.579060.fcs	Panel_P2_B8_P2_110196_PBMC_10132011_B08.fcs
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689476			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004356		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579064	Flow cytometry result	Panel_L4_B_Cells_B2_L4_110196_PBMC_10132011_B02.579064.fcs	Panel_L4_B_Cells_B2_L4_110196_PBMC_10132011_B02.fcs
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689476			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004536		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579244	Flow cytometry result	Panel_P1_B11_P1_110196_PBMC_10132011_B11.579244.fcs	Panel_P1_B11_P1_110196_PBMC_10132011_B11.fcs
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689476			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004636		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579344	Flow cytometry result	Panel_L2_B5_L2_110196_PBMC_10132011_B05.579344.fcs	Panel_L2_B5_L2_110196_PBMC_10132011_B05.fcs
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689476			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004694		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579402	Flow cytometry result	Panel_P13_B11_P13_110196_PBMC_10132011_B11.579402.fcs	Panel_P13_B11_P13_110196_PBMC_10132011_B11.fcs
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689476			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005317		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580025	Flow cytometry result	Panel_P10_B5_P10_110196_PBMC_10132011_B05.580025.fcs	Panel_P10_B5_P10_110196_PBMC_10132011_B05.fcs
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689476			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005373		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580081	Flow cytometry result	Panel_P9_B2_P9_110196_PBMC_10132011_B02.580081.fcs	Panel_P9_B2_P9_110196_PBMC_10132011_B02.fcs
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689476			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005492		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	580200	Flow cytometry result	Panel_L5_MonoNKDC_B5_L5_110196_PBMC_10132011_B05.580200.fcs	Panel_L5_MonoNKDC_B5_L5_110196_PBMC_10132011_B05.fcs
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689477			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003685		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	578336	Flow cytometry result	Panel_P1_C11_P1_110196_PBMC_10182011_C11.578336.fcs	Panel_P1_C11_P1_110196_PBMC_10182011_C11.fcs
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689477			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003775		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	578462	Flow cytometry result	Panel_L2_C5_L2_110196_PBMC_10182011_C05.578462.fcs	Panel_L2_C5_L2_110196_PBMC_10182011_C05.fcs
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689477			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003784		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578471	Flow cytometry result	Panel_P9_C2_P9_110196_PBMC_10182011_C02.578471.fcs	Panel_P9_C2_P9_110196_PBMC_10182011_C02.fcs
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689477			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003940		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578645	Flow cytometry result	Panel_P10_C5_P10_110196_PBMC_10182011_C05.578645.fcs	Panel_P10_C5_P10_110196_PBMC_10182011_C05.fcs
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689477			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003977		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	578685	Flow cytometry result	Panel_L4_B_Cells_C2_L4_110196_PBMC_10182011_C02.578685.fcs	Panel_L4_B_Cells_C2_L4_110196_PBMC_10182011_C02.fcs
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689477			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004704		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579412	Flow cytometry result	Panel_P13_C11_P13_110196_PBMC_10182011_C11.579412.fcs	Panel_P13_C11_P13_110196_PBMC_10182011_C11.fcs
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689477			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004973		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579681	Flow cytometry result	Panel_L1_C2_L1_110196_PBMC_10182011_C02.579681.fcs	Panel_L1_C2_L1_110196_PBMC_10182011_C02.fcs
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689477			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004974		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579682	Flow cytometry result	Panel_L5_MonoNKDC_C5_L5_110196_PBMC_10182011_C05.579682.fcs	Panel_L5_MonoNKDC_C5_L5_110196_PBMC_10182011_C05.fcs
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689477			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005073		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579781	Flow cytometry result	Panel_P2_C8_P2_110196_PBMC_10182011_C08.579781.fcs	Panel_P2_C8_P2_110196_PBMC_10182011_C08.fcs
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689477			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005109		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579817	Flow cytometry result	Panel_L3_C8_L3_110196_PBMC_10182011_C08.579817.fcs	Panel_L3_C8_L3_110196_PBMC_10182011_C08.fcs
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689478			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003952		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	578659	Flow cytometry result	Panel_P2_D8_P2_110196_PBMC_11082011_D08.578659.fcs	Panel_P2_D8_P2_110196_PBMC_11082011_D08.fcs
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689478			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004233		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	578941	Flow cytometry result	Panel_L4_B_Cells_D2_L4_110196_PBMC_11082011_D02.578941.fcs	Panel_L4_B_Cells_D2_L4_110196_PBMC_11082011_D02.fcs
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689478			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004470		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579178	Flow cytometry result	Panel_L2_D5_L2_110196_PBMC_11082011_D05.579178.fcs	Panel_L2_D5_L2_110196_PBMC_11082011_D05.fcs
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689478			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004580		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579288	Flow cytometry result	Panel_L1_D2_L1_110196_PBMC_11082011_D02.579288.fcs	Panel_L1_D2_L1_110196_PBMC_11082011_D02.fcs
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689478			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004743		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579451	Flow cytometry result	Panel_P10_D5_P10_110196_PBMC_11082011_D05.579451.fcs	Panel_P10_D5_P10_110196_PBMC_11082011_D05.fcs
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689478			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004819		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579527	Flow cytometry result	Panel_L5_MonoNKDC_D5_L5_110196_PBMC_11082011_D05.579527.fcs	Panel_L5_MonoNKDC_D5_L5_110196_PBMC_11082011_D05.fcs
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689478			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005072		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579780	Flow cytometry result	Panel_P9_D2_P9_110196_PBMC_11082011_D02.579780.fcs	Panel_P9_D2_P9_110196_PBMC_11082011_D02.fcs
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689478			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005092		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579800	Flow cytometry result	Panel_P1_D11_P1_110196_PBMC_11082011_D11.579800.fcs	Panel_P1_D11_P1_110196_PBMC_11082011_D11.fcs
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689478			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005266		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579974	Flow cytometry result	Panel_L3_D8_L3_110196_PBMC_11082011_D08.579974.fcs	Panel_L3_D8_L3_110196_PBMC_11082011_D08.fcs
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689478			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005311		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	580019	Flow cytometry result	Panel_P13_D11_P13_110196_PBMC_11082011_D11.580019.fcs	Panel_P13_D11_P13_110196_PBMC_11082011_D11.fcs
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752359			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004074		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	578782	Flow cytometry result	Panel_L2_A5_L2_110197_PBMC_10112011_A05.578782.fcs	Panel_L2_A5_L2_110197_PBMC_10112011_A05.fcs
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752359			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004082		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	578790	Flow cytometry result	Panel_L3_A8_L3_110197_PBMC_10112011_A08.578790.fcs	Panel_L3_A8_L3_110197_PBMC_10112011_A08.fcs
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752359			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004366		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579074	Flow cytometry result	Panel_L4_B_Cells_A2_L4_110197_PBMC_10112011_A02.579074.fcs	Panel_L4_B_Cells_A2_L4_110197_PBMC_10112011_A02.fcs
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752359			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004372		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579080	Flow cytometry result	Panel_P1_A11_P1_110197_PBMC_10112011_A11.579080.fcs	Panel_P1_A11_P1_110197_PBMC_10112011_A11.fcs
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752359			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004560		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579268	Flow cytometry result	Panel_P10_A5_P10_110197_PBMC_10112011_A05.579268.fcs	Panel_P10_A5_P10_110197_PBMC_10112011_A05.fcs
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752359			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004739		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579447	Flow cytometry result	Panel_L1_A2_L1_110197_PBMC_10112011_A02.579447.fcs	Panel_L1_A2_L1_110197_PBMC_10112011_A02.fcs
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752359			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004911		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579619	Flow cytometry result	Panel_P2_A8_P2_110197_PBMC_10112011_A08.579619.fcs	Panel_P2_A8_P2_110197_PBMC_10112011_A08.fcs
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752359			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004932		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579640	Flow cytometry result	Panel_P9_A2_P9_110197_PBMC_10112011_A02.579640.fcs	Panel_P9_A2_P9_110197_PBMC_10112011_A02.fcs
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752359			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005260		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579968	Flow cytometry result	Panel_P13_A11_P13_110197_PBMC_10112011_A11.579968.fcs	Panel_P13_A11_P13_110197_PBMC_10112011_A11.fcs
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752359			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005295		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	580003	Flow cytometry result	Panel_L5_MonoNKDC_A5_L5_110197_PBMC_10112011_A05.580003.fcs	Panel_L5_MonoNKDC_A5_L5_110197_PBMC_10112011_A05.fcs
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752360			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003847		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	578547	Flow cytometry result	Panel_P2_B8_P2_110197_PBMC_10132011_B08.578547.fcs	Panel_P2_B8_P2_110197_PBMC_10132011_B08.fcs
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752360			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004050		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	578758	Flow cytometry result	Panel_P1_B11_P1_110197_PBMC_10132011_B11.578758.fcs	Panel_P1_B11_P1_110197_PBMC_10132011_B11.fcs
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752360			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004120		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	578828	Flow cytometry result	Panel_L5_MonoNKDC_B5_L5_110197_PBMC_10132011_B05.578828.fcs	Panel_L5_MonoNKDC_B5_L5_110197_PBMC_10132011_B05.fcs
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752360			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004211		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	578919	Flow cytometry result	Panel_P13_B11_P13_110197_PBMC_10132011_B11.578919.fcs	Panel_P13_B11_P13_110197_PBMC_10132011_B11.fcs
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752360			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004224		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	578932	Flow cytometry result	Panel_L3_B8_L3_110197_PBMC_10132011_B08.578932.fcs	Panel_L3_B8_L3_110197_PBMC_10132011_B08.fcs
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752360			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004891		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579599	Flow cytometry result	Panel_P10_B5_P10_110197_PBMC_10132011_B05.579599.fcs	Panel_P10_B5_P10_110197_PBMC_10132011_B05.fcs
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752360			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004898		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579606	Flow cytometry result	Panel_L4_B_Cells_B2_L4_110197_PBMC_10132011_B02.579606.fcs	Panel_L4_B_Cells_B2_L4_110197_PBMC_10132011_B02.fcs
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752360			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004964		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579672	Flow cytometry result	Panel_L1_B2_L1_110197_PBMC_10132011_B02.579672.fcs	Panel_L1_B2_L1_110197_PBMC_10132011_B02.fcs
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752360			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005305		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	580013	Flow cytometry result	Panel_L2_B5_L2_110197_PBMC_10132011_B05.580013.fcs	Panel_L2_B5_L2_110197_PBMC_10132011_B05.fcs
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752360			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005690		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580398	Flow cytometry result	Panel_P9_B2_P9_110197_PBMC_10132011_B02.580398.fcs	Panel_P9_B2_P9_110197_PBMC_10132011_B02.fcs
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752361			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003865		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	578567	Flow cytometry result	Panel_L1_C2_L1_110197_PBMC_10182011_C02.578567.fcs	Panel_L1_C2_L1_110197_PBMC_10182011_C02.fcs
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752361			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003873		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	578575	Flow cytometry result	Panel_L5_MonoNKDC_C5_L5_110197_PBMC_10182011_C05.578575.fcs	Panel_L5_MonoNKDC_C5_L5_110197_PBMC_10182011_C05.fcs
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752361			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004142		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	578850	Flow cytometry result	Panel_L2_C5_L2_110197_PBMC_10182011_C05.578850.fcs	Panel_L2_C5_L2_110197_PBMC_10182011_C05.fcs
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752361			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004287		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578995	Flow cytometry result	Panel_P10_C5_P10_110197_PBMC_10182011_C05.578995.fcs	Panel_P10_C5_P10_110197_PBMC_10182011_C05.fcs
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752361			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004343		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579051	Flow cytometry result	Panel_L3_C8_L3_110197_PBMC_10182011_C08.579051.fcs	Panel_L3_C8_L3_110197_PBMC_10182011_C08.fcs
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752361			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004497		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579205	Flow cytometry result	Panel_P13_C11_P13_110197_PBMC_10182011_C11.579205.fcs	Panel_P13_C11_P13_110197_PBMC_10182011_C11.fcs
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752361			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004653		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579361	Flow cytometry result	Panel_L4_B_Cells_C2_L4_110197_PBMC_10182011_C02.579361.fcs	Panel_L4_B_Cells_C2_L4_110197_PBMC_10182011_C02.fcs
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752361			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004776		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579484	Flow cytometry result	Panel_P9_C2_P9_110197_PBMC_10182011_C02.579484.fcs	Panel_P9_C2_P9_110197_PBMC_10182011_C02.fcs
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752361			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004883		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579591	Flow cytometry result	Panel_P2_C8_P2_110197_PBMC_10182011_C08.579591.fcs	Panel_P2_C8_P2_110197_PBMC_10182011_C08.fcs
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752361			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005673		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	580381	Flow cytometry result	Panel_P1_C11_P1_110197_PBMC_10182011_C11.580381.fcs	Panel_P1_C11_P1_110197_PBMC_10182011_C11.fcs
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752362			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004390		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579098	Flow cytometry result	Panel_L4_B_Cells_D2_L4_110197_PBMC_11082011_D02.579098.fcs	Panel_L4_B_Cells_D2_L4_110197_PBMC_11082011_D02.fcs
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752362			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004425		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579133	Flow cytometry result	Panel_P13_D11_P13_110197_PBMC_11082011_D11.579133.fcs	Panel_P13_D11_P13_110197_PBMC_11082011_D11.fcs
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752362			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004487		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579195	Flow cytometry result	Panel_P1_D11_P1_110197_PBMC_11082011_D11.579195.fcs	Panel_P1_D11_P1_110197_PBMC_11082011_D11.fcs
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752362			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004513		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579221	Flow cytometry result	Panel_L5_MonoNKDC_D5_L5_110197_PBMC_11082011_D05.579221.fcs	Panel_L5_MonoNKDC_D5_L5_110197_PBMC_11082011_D05.fcs
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752362			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004760		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579468	Flow cytometry result	Panel_L2_D5_L2_110197_PBMC_11082011_D05.579468.fcs	Panel_L2_D5_L2_110197_PBMC_11082011_D05.fcs
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752362			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004959		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579667	Flow cytometry result	Panel_P10_D5_P10_110197_PBMC_11082011_D05.579667.fcs	Panel_P10_D5_P10_110197_PBMC_11082011_D05.fcs
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752362			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005090		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579798	Flow cytometry result	Panel_P2_D8_P2_110197_PBMC_11082011_D08.579798.fcs	Panel_P2_D8_P2_110197_PBMC_11082011_D08.fcs
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752362			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005133		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579841	Flow cytometry result	Panel_L3_D8_L3_110197_PBMC_11082011_D08.579841.fcs	Panel_L3_D8_L3_110197_PBMC_11082011_D08.fcs
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752362			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005599		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	580307	Flow cytometry result	Panel_L1_D2_L1_110197_PBMC_11082011_D02.580307.fcs	Panel_L1_D2_L1_110197_PBMC_11082011_D02.fcs
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752362			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005653		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580361	Flow cytometry result	Panel_P9_D2_P9_110197_PBMC_11082011_D02.580361.fcs	Panel_P9_D2_P9_110197_PBMC_11082011_D02.fcs
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689479			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004047		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	578755	Flow cytometry result	Panel_L2_E5_L2_110198_PBMC_10112011_E05.578755.fcs	Panel_L2_E5_L2_110198_PBMC_10112011_E05.fcs
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689479			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004099		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	578807	Flow cytometry result	Panel_L4_B_Cells_E2_L4_110198_PBMC_10112011_E02.578807.fcs	Panel_L4_B_Cells_E2_L4_110198_PBMC_10112011_E02.fcs
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689479			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004361		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579069	Flow cytometry result	Panel_L1_E2_L1_110198_PBMC_10112011_E02.579069.fcs	Panel_L1_E2_L1_110198_PBMC_10112011_E02.fcs
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689479			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004467		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579175	Flow cytometry result	Panel_P13_E11_P13_110198_PBMC_10112011_E11.579175.fcs	Panel_P13_E11_P13_110198_PBMC_10112011_E11.fcs
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689479			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004667		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579375	Flow cytometry result	Panel_P2_E8_P2_110198_PBMC_10112011_E08.579375.fcs	Panel_P2_E8_P2_110198_PBMC_10112011_E08.fcs
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689479			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004848		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579556	Flow cytometry result	Panel_L3_E8_L3_110198_PBMC_10112011_E08.579556.fcs	Panel_L3_E8_L3_110198_PBMC_10112011_E08.fcs
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689479			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005058		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579766	Flow cytometry result	Panel_P9_E2_P9_110198_PBMC_10112011_E02.579766.fcs	Panel_P9_E2_P9_110198_PBMC_10112011_E02.fcs
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689479			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005138		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579846	Flow cytometry result	Panel_P10_E5_P10_110198_PBMC_10112011_E05.579846.fcs	Panel_P10_E5_P10_110198_PBMC_10112011_E05.fcs
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689479			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005145		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579853	Flow cytometry result	Panel_P1_E11_P1_110198_PBMC_10112011_E11.579853.fcs	Panel_P1_E11_P1_110198_PBMC_10112011_E11.fcs
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689479			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005643		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	580351	Flow cytometry result	Panel_L5_MonoNKDC_E5_L5_110198_PBMC_10112011_E05.580351.fcs	Panel_L5_MonoNKDC_E5_L5_110198_PBMC_10112011_E05.fcs
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689480			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003832		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	578530	Flow cytometry result	Panel_L1_F2_L1_110198_PBMC_10132011_F02.578530.fcs	Panel_L1_F2_L1_110198_PBMC_10132011_F02.fcs
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689480			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003923		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	578628	Flow cytometry result	Panel_L4_B_Cells_F2_L4_110198_PBMC_10132011_F02.578628.fcs	Panel_L4_B_Cells_F2_L4_110198_PBMC_10132011_F02.fcs
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689480			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004223		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	578931	Flow cytometry result	Panel_L2_F5_L2_110198_PBMC_10132011_F05.578931.fcs	Panel_L2_F5_L2_110198_PBMC_10132011_F05.fcs
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689480			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004375		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579083	Flow cytometry result	Panel_P13_F11_P13_110198_PBMC_10132011_F11.579083.fcs	Panel_P13_F11_P13_110198_PBMC_10132011_F11.fcs
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689480			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004564		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579272	Flow cytometry result	Panel_P9_F2_P9_110198_PBMC_10132011_F02.579272.fcs	Panel_P9_F2_P9_110198_PBMC_10132011_F02.fcs
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689480			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004618		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579326	Flow cytometry result	Panel_L3_F8_L3_110198_PBMC_10132011_F08.579326.fcs	Panel_L3_F8_L3_110198_PBMC_10132011_F08.fcs
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689480			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004713		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579421	Flow cytometry result	Panel_P10_F5_P10_110198_PBMC_10132011_F05.579421.fcs	Panel_P10_F5_P10_110198_PBMC_10132011_F05.fcs
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689480			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004802		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579510	Flow cytometry result	Panel_L5_MonoNKDC_F5_L5_110198_PBMC_10132011_F05.579510.fcs	Panel_L5_MonoNKDC_F5_L5_110198_PBMC_10132011_F05.fcs
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689480			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004850		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579558	Flow cytometry result	Panel_P1_F11_P1_110198_PBMC_10132011_F11.579558.fcs	Panel_P1_F11_P1_110198_PBMC_10132011_F11.fcs
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689480			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004926		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579634	Flow cytometry result	Panel_P2_F8_P2_110198_PBMC_10132011_F08.579634.fcs	Panel_P2_F8_P2_110198_PBMC_10132011_F08.fcs
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689481			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003844		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	578544	Flow cytometry result	Panel_L4_B_Cells_G2_L4_110198_PBMC_10182011_G02.578544.fcs	Panel_L4_B_Cells_G2_L4_110198_PBMC_10182011_G02.fcs
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689481			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004015		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	578723	Flow cytometry result	Panel_L2_G5_L2_110198_PBMC_10182011_G05.578723.fcs	Panel_L2_G5_L2_110198_PBMC_10182011_G05.fcs
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689481			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004146		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	578854	Flow cytometry result	Panel_L3_G8_L3_110198_PBMC_10182011_G08.578854.fcs	Panel_L3_G8_L3_110198_PBMC_10182011_G08.fcs
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689481			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004236		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578944	Flow cytometry result	Panel_P10_G5_P10_110198_PBMC_10182011_G05.578944.fcs	Panel_P10_G5_P10_110198_PBMC_10182011_G05.fcs
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689481			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004283		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	578991	Flow cytometry result	Panel_L5_MonoNKDC_G5_L5_110198_PBMC_10182011_G05.578991.fcs	Panel_L5_MonoNKDC_G5_L5_110198_PBMC_10182011_G05.fcs
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689481			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004328		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579036	Flow cytometry result	Panel_L1_G2_L1_110198_PBMC_10182011_G02.579036.fcs	Panel_L1_G2_L1_110198_PBMC_10182011_G02.fcs
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689481			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004379		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579087	Flow cytometry result	Panel_P2_G8_P2_110198_PBMC_10182011_G08.579087.fcs	Panel_P2_G8_P2_110198_PBMC_10182011_G08.fcs
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689481			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004416		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579124	Flow cytometry result	Panel_P1_G11_P1_110198_PBMC_10182011_G11.579124.fcs	Panel_P1_G11_P1_110198_PBMC_10182011_G11.fcs
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689481			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004422		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579130	Flow cytometry result	Panel_P13_G11_P13_110198_PBMC_10182011_G11.579130.fcs	Panel_P13_G11_P13_110198_PBMC_10182011_G11.fcs
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689481			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004654		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579362	Flow cytometry result	Panel_P9_G2_P9_110198_PBMC_10182011_G02.579362.fcs	Panel_P9_G2_P9_110198_PBMC_10182011_G02.fcs
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689482			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003719		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	578390	Flow cytometry result	Panel_L5_MonoNKDC_H5_L5_110198_PBMC_11082011_H05.578390.fcs	Panel_L5_MonoNKDC_H5_L5_110198_PBMC_11082011_H05.fcs
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689482			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003926		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	578631	Flow cytometry result	Panel_L1_H2_L1_110198_PBMC_11082011_H02.578631.fcs	Panel_L1_H2_L1_110198_PBMC_11082011_H02.fcs
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689482			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004397		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579105	Flow cytometry result	Panel_P9_H2_P9_110198_PBMC_11082011_H02.579105.fcs	Panel_P9_H2_P9_110198_PBMC_11082011_H02.fcs
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689482			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004464		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579172	Flow cytometry result	Panel_L3_H8_L3_110198_PBMC_11082011_H08.579172.fcs	Panel_L3_H8_L3_110198_PBMC_11082011_H08.fcs
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689482			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004661		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579369	Flow cytometry result	Panel_P13_H11_P13_110198_PBMC_11082011_H11.579369.fcs	Panel_P13_H11_P13_110198_PBMC_11082011_H11.fcs
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689482			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004761		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579469	Flow cytometry result	Panel_P2_H8_P2_110198_PBMC_11082011_H08.579469.fcs	Panel_P2_H8_P2_110198_PBMC_11082011_H08.fcs
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689482			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004933		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579641	Flow cytometry result	Panel_P1_H11_P1_110198_PBMC_11082011_H11.579641.fcs	Panel_P1_H11_P1_110198_PBMC_11082011_H11.fcs
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689482			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005022		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579730	Flow cytometry result	Panel_P10_H5_P10_110198_PBMC_11082011_H05.579730.fcs	Panel_P10_H5_P10_110198_PBMC_11082011_H05.fcs
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689482			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005578		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	580286	Flow cytometry result	Panel_L4_B_Cells_H2_L4_110198_PBMC_11082011_H02.580286.fcs	Panel_L4_B_Cells_H2_L4_110198_PBMC_11082011_H02.fcs
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689482			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005602		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	580310	Flow cytometry result	Panel_L2_H5_L2_110198_PBMC_11082011_H05.580310.fcs	Panel_L2_H5_L2_110198_PBMC_11082011_H05.fcs
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689483			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003862		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	578564	Flow cytometry result	Panel_L3_A9_L3_110199_PBMC_10112011_A09.578564.fcs	Panel_L3_A9_L3_110199_PBMC_10112011_A09.fcs
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689483			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004075		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	578783	Flow cytometry result	Panel_P13_A12_P13_110199_PBMC_10112011_A12.578783.fcs	Panel_P13_A12_P13_110199_PBMC_10112011_A12.fcs
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689483			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004208		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	578916	Flow cytometry result	Panel_L4_B_Cells_A3_L4_110199_PBMC_10112011_A03.578916.fcs	Panel_L4_B_Cells_A3_L4_110199_PBMC_10112011_A03.fcs
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689483			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004768		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579476	Flow cytometry result	Panel_L5_MonoNKDC_A6_L5_110199_PBMC_10112011_A06.579476.fcs	Panel_L5_MonoNKDC_A6_L5_110199_PBMC_10112011_A06.fcs
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689483			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004834		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579542	Flow cytometry result	Panel_P2_A9_P2_110199_PBMC_10112011_A09.579542.fcs	Panel_P2_A9_P2_110199_PBMC_10112011_A09.fcs
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689483			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004942		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579650	Flow cytometry result	Panel_P1_A12_P1_110199_PBMC_10112011_A12.579650.fcs	Panel_P1_A12_P1_110199_PBMC_10112011_A12.fcs
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689483			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004963		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579671	Flow cytometry result	Panel_L1_A3_L1_110199_PBMC_10112011_A03.579671.fcs	Panel_L1_A3_L1_110199_PBMC_10112011_A03.fcs
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689483			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005111		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579819	Flow cytometry result	Panel_P9_A3_P9_110199_PBMC_10112011_A03.579819.fcs	Panel_P9_A3_P9_110199_PBMC_10112011_A03.fcs
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689483			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005188		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579896	Flow cytometry result	Panel_P10_A6_P10_110199_PBMC_10112011_A06.579896.fcs	Panel_P10_A6_P10_110199_PBMC_10112011_A06.fcs
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689483			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005253		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579961	Flow cytometry result	Panel_L2_A6_L2_110199_PBMC_10112011_A06.579961.fcs	Panel_L2_A6_L2_110199_PBMC_10112011_A06.fcs
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689484			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003662		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	578300	Flow cytometry result	Panel_P13_B12_P13_110199_PBMC_10132011_B12.578300.fcs	Panel_P13_B12_P13_110199_PBMC_10132011_B12.fcs
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689484			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004100		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	578808	Flow cytometry result	Panel_L4_B_Cells_B3_L4_110199_PBMC_10132011_B03.578808.fcs	Panel_L4_B_Cells_B3_L4_110199_PBMC_10132011_B03.fcs
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689484			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004232		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	578940	Flow cytometry result	Panel_P2_B9_P2_110199_PBMC_10132011_B09.578940.fcs	Panel_P2_B9_P2_110199_PBMC_10132011_B09.fcs
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689484			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004294		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579002	Flow cytometry result	Panel_L2_B6_L2_110199_PBMC_10132011_B06.579002.fcs	Panel_L2_B6_L2_110199_PBMC_10132011_B06.fcs
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689484			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004350		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579058	Flow cytometry result	Panel_L5_MonoNKDC_B6_L5_110199_PBMC_10132011_B06.579058.fcs	Panel_L5_MonoNKDC_B6_L5_110199_PBMC_10132011_B06.fcs
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689484			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004396		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579104	Flow cytometry result	Panel_P10_B6_P10_110199_PBMC_10132011_B06.579104.fcs	Panel_P10_B6_P10_110199_PBMC_10132011_B06.fcs
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689484			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005036		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579744	Flow cytometry result	Panel_P9_B3_P9_110199_PBMC_10132011_B03.579744.fcs	Panel_P9_B3_P9_110199_PBMC_10132011_B03.fcs
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689484			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005098		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579806	Flow cytometry result	Panel_P1_B12_P1_110199_PBMC_10132011_B12.579806.fcs	Panel_P1_B12_P1_110199_PBMC_10132011_B12.fcs
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689484			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005349		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	580057	Flow cytometry result	Panel_L3_B9_L3_110199_PBMC_10132011_B09.580057.fcs	Panel_L3_B9_L3_110199_PBMC_10132011_B09.fcs
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689484			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005628		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	580336	Flow cytometry result	Panel_L1_B3_L1_110199_PBMC_10132011_B03.580336.fcs	Panel_L1_B3_L1_110199_PBMC_10132011_B03.fcs
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689485			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003722		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	578395	Flow cytometry result	Panel_L2_C6_L2_110199_PBMC_10182011_C06.578395.fcs	Panel_L2_C6_L2_110199_PBMC_10182011_C06.fcs
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689485			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003939		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578644	Flow cytometry result	Panel_P9_C3_P9_110199_PBMC_10182011_C03.578644.fcs	Panel_P9_C3_P9_110199_PBMC_10182011_C03.fcs
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689485			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004508		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579216	Flow cytometry result	Panel_P10_C6_P10_110199_PBMC_10182011_C06.579216.fcs	Panel_P10_C6_P10_110199_PBMC_10182011_C06.fcs
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689485			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004628		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579336	Flow cytometry result	Panel_L4_B_Cells_C3_L4_110199_PBMC_10182011_C03.579336.fcs	Panel_L4_B_Cells_C3_L4_110199_PBMC_10182011_C03.fcs
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689485			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005095		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579803	Flow cytometry result	Panel_P13_C12_P13_110199_PBMC_10182011_C12.579803.fcs	Panel_P13_C12_P13_110199_PBMC_10182011_C12.fcs
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689485			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005171		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579879	Flow cytometry result	Panel_P1_C12_P1_110199_PBMC_10182011_C12.579879.fcs	Panel_P1_C12_P1_110199_PBMC_10182011_C12.fcs
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689485			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005338		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	580046	Flow cytometry result	Panel_L3_C9_L3_110199_PBMC_10182011_C09.580046.fcs	Panel_L3_C9_L3_110199_PBMC_10182011_C09.fcs
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689485			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005398		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	580106	Flow cytometry result	Panel_P2_C9_P2_110199_PBMC_10182011_C09.580106.fcs	Panel_P2_C9_P2_110199_PBMC_10182011_C09.fcs
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689485			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005440		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	580148	Flow cytometry result	Panel_L5_MonoNKDC_C6_L5_110199_PBMC_10182011_C06.580148.fcs	Panel_L5_MonoNKDC_C6_L5_110199_PBMC_10182011_C06.fcs
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689485			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005467		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	580175	Flow cytometry result	Panel_L1_C3_L1_110199_PBMC_10182011_C03.580175.fcs	Panel_L1_C3_L1_110199_PBMC_10182011_C03.fcs
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689486			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003989		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	578697	Flow cytometry result	Panel_L1_D3_L1_110199_PBMC_11082011_D03.578697.fcs	Panel_L1_D3_L1_110199_PBMC_11082011_D03.fcs
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689486			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004004		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	578712	Flow cytometry result	Panel_L2_D6_L2_110199_PBMC_11082011_D06.578712.fcs	Panel_L2_D6_L2_110199_PBMC_11082011_D06.fcs
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689486			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004167		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	578875	Flow cytometry result	Panel_L4_B_Cells_D3_L4_110199_PBMC_11082011_D03.578875.fcs	Panel_L4_B_Cells_D3_L4_110199_PBMC_11082011_D03.fcs
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689486			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004325		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579033	Flow cytometry result	Panel_L5_MonoNKDC_D6_L5_110199_PBMC_11082011_D06.579033.fcs	Panel_L5_MonoNKDC_D6_L5_110199_PBMC_11082011_D06.fcs
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689486			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004624		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579332	Flow cytometry result	Panel_P2_D9_P2_110199_PBMC_11082011_D09.579332.fcs	Panel_P2_D9_P2_110199_PBMC_11082011_D09.fcs
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689486			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004796		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579504	Flow cytometry result	Panel_P13_D12_P13_110199_PBMC_11082011_D12.579504.fcs	Panel_P13_D12_P13_110199_PBMC_11082011_D12.fcs
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689486			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005038		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579746	Flow cytometry result	Panel_P10_D6_P10_110199_PBMC_11082011_D06.579746.fcs	Panel_P10_D6_P10_110199_PBMC_11082011_D06.fcs
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689486			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005107		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579815	Flow cytometry result	Panel_L3_D9_L3_110199_PBMC_11082011_D09.579815.fcs	Panel_L3_D9_L3_110199_PBMC_11082011_D09.fcs
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689486			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005150		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579858	Flow cytometry result	Panel_P9_D3_P9_110199_PBMC_11082011_D03.579858.fcs	Panel_P9_D3_P9_110199_PBMC_11082011_D03.fcs
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689486			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005615		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	580323	Flow cytometry result	Panel_P1_D12_P1_110199_PBMC_11082011_D12.580323.fcs	Panel_P1_D12_P1_110199_PBMC_11082011_D12.fcs
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752363			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003694		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578352	Flow cytometry result	Panel_P9_E2_P9_110200_PBMC_10112011_E02.578352.fcs	Panel_P9_E2_P9_110200_PBMC_10112011_E02.fcs
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752363			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003960		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	578667	Flow cytometry result	Panel_P1_E11_P1_110200_PBMC_10112011_E11.578667.fcs	Panel_P1_E11_P1_110200_PBMC_10112011_E11.fcs
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752363			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003992		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	578700	Flow cytometry result	Panel_L2_E5_L2_110200_PBMC_10112011_E05.578700.fcs	Panel_L2_E5_L2_110200_PBMC_10112011_E05.fcs
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752363			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004278		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	578986	Flow cytometry result	Panel_P2_E8_P2_110200_PBMC_10112011_E08.578986.fcs	Panel_P2_E8_P2_110200_PBMC_10112011_E08.fcs
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752363			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004324		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579032	Flow cytometry result	Panel_L1_E2_L1_110200_PBMC_10112011_E02.579032.fcs	Panel_L1_E2_L1_110200_PBMC_10112011_E02.fcs
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752363			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004619		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579327	Flow cytometry result	Panel_L5_MonoNKDC_E5_L5_110200_PBMC_10112011_E05.579327.fcs	Panel_L5_MonoNKDC_E5_L5_110200_PBMC_10112011_E05.fcs
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752363			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004657		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579365	Flow cytometry result	Panel_L3_E8_L3_110200_PBMC_10112011_E08.579365.fcs	Panel_L3_E8_L3_110200_PBMC_10112011_E08.fcs
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752363			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004923		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579631	Flow cytometry result	Panel_P13_E11_P13_110200_PBMC_10112011_E11.579631.fcs	Panel_P13_E11_P13_110200_PBMC_10112011_E11.fcs
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752363			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004975		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579683	Flow cytometry result	Panel_P10_E5_P10_110200_PBMC_10112011_E05.579683.fcs	Panel_P10_E5_P10_110200_PBMC_10112011_E05.fcs
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752363			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005207		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579915	Flow cytometry result	Panel_L4_B_Cells_E2_L4_110200_PBMC_10112011_E02.579915.fcs	Panel_L4_B_Cells_E2_L4_110200_PBMC_10112011_E02.fcs
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752364			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003710		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	578378	Flow cytometry result	Panel_L4_B_Cells_F2_L4_110200_PBMC_10132011_F02.578378.fcs	Panel_L4_B_Cells_F2_L4_110200_PBMC_10132011_F02.fcs
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752364			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003877		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	578580	Flow cytometry result	Panel_L3_F8_L3_110200_PBMC_10132011_F08.578580.fcs	Panel_L3_F8_L3_110200_PBMC_10132011_F08.fcs
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752364			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003965		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	578673	Flow cytometry result	Panel_P13_F11_P13_110200_PBMC_10132011_F11.578673.fcs	Panel_P13_F11_P13_110200_PBMC_10132011_F11.fcs
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752364			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003970		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	578678	Flow cytometry result	Panel_P2_F8_P2_110200_PBMC_10132011_F08.578678.fcs	Panel_P2_F8_P2_110200_PBMC_10132011_F08.fcs
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752364			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004007		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	578715	Flow cytometry result	Panel_L5_MonoNKDC_F5_L5_110200_PBMC_10132011_F05.578715.fcs	Panel_L5_MonoNKDC_F5_L5_110200_PBMC_10132011_F05.fcs
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752364			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004043		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578751	Flow cytometry result	Panel_P9_F2_P9_110200_PBMC_10132011_F02.578751.fcs	Panel_P9_F2_P9_110200_PBMC_10132011_F02.fcs
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752364			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004188		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	578896	Flow cytometry result	Panel_L1_F2_L1_110200_PBMC_10132011_F02.578896.fcs	Panel_L1_F2_L1_110200_PBMC_10132011_F02.fcs
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752364			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004582		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579290	Flow cytometry result	Panel_P10_F5_P10_110200_PBMC_10132011_F05.579290.fcs	Panel_P10_F5_P10_110200_PBMC_10132011_F05.fcs
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752364			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005176		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579884	Flow cytometry result	Panel_P1_F11_P1_110200_PBMC_10132011_F11.579884.fcs	Panel_P1_F11_P1_110200_PBMC_10132011_F11.fcs
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752364			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005417		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	580125	Flow cytometry result	Panel_L2_F5_L2_110200_PBMC_10132011_F05.580125.fcs	Panel_L2_F5_L2_110200_PBMC_10132011_F05.fcs
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752365			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003993		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	578701	Flow cytometry result	Panel_P13_G11_P13_110200_PBMC_10182011_G11.578701.fcs	Panel_P13_G11_P13_110200_PBMC_10182011_G11.fcs
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752365			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004114		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578822	Flow cytometry result	Panel_P9_G2_P9_110200_PBMC_10182011_G02.578822.fcs	Panel_P9_G2_P9_110200_PBMC_10182011_G02.fcs
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752365			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004136		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	578844	Flow cytometry result	Panel_P2_G8_P2_110200_PBMC_10182011_G08.578844.fcs	Panel_P2_G8_P2_110200_PBMC_10182011_G08.fcs
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752365			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004216		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	578924	Flow cytometry result	Panel_L5_MonoNKDC_G5_L5_110200_PBMC_10182011_G05.578924.fcs	Panel_L5_MonoNKDC_G5_L5_110200_PBMC_10182011_G05.fcs
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752365			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004575		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579283	Flow cytometry result	Panel_P1_G11_P1_110200_PBMC_10182011_G11.579283.fcs	Panel_P1_G11_P1_110200_PBMC_10182011_G11.fcs
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752365			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004807		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579515	Flow cytometry result	Panel_P10_G5_P10_110200_PBMC_10182011_G05.579515.fcs	Panel_P10_G5_P10_110200_PBMC_10182011_G05.fcs
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752365			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004943		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579651	Flow cytometry result	Panel_L1_G2_L1_110200_PBMC_10182011_G02.579651.fcs	Panel_L1_G2_L1_110200_PBMC_10182011_G02.fcs
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752365			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004970		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579678	Flow cytometry result	Panel_L4_B_Cells_G2_L4_110200_PBMC_10182011_G02.579678.fcs	Panel_L4_B_Cells_G2_L4_110200_PBMC_10182011_G02.fcs
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752365			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005396		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	580104	Flow cytometry result	Panel_L3_G8_L3_110200_PBMC_10182011_G08.580104.fcs	Panel_L3_G8_L3_110200_PBMC_10182011_G08.fcs
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752365			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005421		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	580129	Flow cytometry result	Panel_L2_G5_L2_110200_PBMC_10182011_G05.580129.fcs	Panel_L2_G5_L2_110200_PBMC_10182011_G05.fcs
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752366			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003652		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	578282	Flow cytometry result	Panel_L1_H2_L1_110200_PBMC_11082011_H02.578282.fcs	Panel_L1_H2_L1_110200_PBMC_11082011_H02.fcs
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752366			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004003		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	578711	Flow cytometry result	Panel_L5_MonoNKDC_H5_L5_110200_PBMC_11082011_H05.578711.fcs	Panel_L5_MonoNKDC_H5_L5_110200_PBMC_11082011_H05.fcs
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752366			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004391		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579099	Flow cytometry result	Panel_L3_H8_L3_110200_PBMC_11082011_H08.579099.fcs	Panel_L3_H8_L3_110200_PBMC_11082011_H08.fcs
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752366			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004458		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579166	Flow cytometry result	Panel_P13_H11_P13_110200_PBMC_11082011_H11.579166.fcs	Panel_P13_H11_P13_110200_PBMC_11082011_H11.fcs
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752366			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004953		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579661	Flow cytometry result	Panel_L4_B_Cells_H2_L4_110200_PBMC_11082011_H02.579661.fcs	Panel_L4_B_Cells_H2_L4_110200_PBMC_11082011_H02.fcs
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752366			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005061		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579769	Flow cytometry result	Panel_P1_H11_P1_110200_PBMC_11082011_H11.579769.fcs	Panel_P1_H11_P1_110200_PBMC_11082011_H11.fcs
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752366			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005067		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579775	Flow cytometry result	Panel_P9_H2_P9_110200_PBMC_11082011_H02.579775.fcs	Panel_P9_H2_P9_110200_PBMC_11082011_H02.fcs
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752366			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005282		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579990	Flow cytometry result	Panel_P2_H8_P2_110200_PBMC_11082011_H08.579990.fcs	Panel_P2_H8_P2_110200_PBMC_11082011_H08.fcs
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752366			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005498		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	580206	Flow cytometry result	Panel_L2_H5_L2_110200_PBMC_11082011_H05.580206.fcs	Panel_L2_H5_L2_110200_PBMC_11082011_H05.fcs
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752366			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005507		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580215	Flow cytometry result	Panel_P10_H5_P10_110200_PBMC_11082011_H05.580215.fcs	Panel_P10_H5_P10_110200_PBMC_11082011_H05.fcs
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689487			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003801		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	578495	Flow cytometry result	Panel_L3_H9_L3_110201_PBMC_10112011_H09.578495.fcs	Panel_L3_H9_L3_110201_PBMC_10112011_H09.fcs
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689487			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003921		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578626	Flow cytometry result	Panel_P10_H6_P10_110201_PBMC_10112011_H06.578626.fcs	Panel_P10_H6_P10_110201_PBMC_10112011_H06.fcs
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689487			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004412		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579120	Flow cytometry result	Panel_L1_H3_L1_110201_PBMC_10112011_H03.579120.fcs	Panel_L1_H3_L1_110201_PBMC_10112011_H03.fcs
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689487			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004457		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579165	Flow cytometry result	Panel_P9_H3_P9_110201_PBMC_10112011_H03.579165.fcs	Panel_P9_H3_P9_110201_PBMC_10112011_H03.fcs
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689487			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004712		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579420	Flow cytometry result	Panel_P2_H9_P2_110201_PBMC_10112011_H09.579420.fcs	Panel_P2_H9_P2_110201_PBMC_10112011_H09.fcs
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689487			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004948		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579656	Flow cytometry result	Panel_P1_H12_P1_110201_PBMC_10112011_H12.579656.fcs	Panel_P1_H12_P1_110201_PBMC_10112011_H12.fcs
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689487			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005135		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579843	Flow cytometry result	Panel_L4_B_Cells_H3_L4_110201_PBMC_10112011_H03.579843.fcs	Panel_L4_B_Cells_H3_L4_110201_PBMC_10112011_H03.fcs
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689487			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005448		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	580156	Flow cytometry result	Panel_L2_H6_L2_110201_PBMC_10112011_H06.580156.fcs	Panel_L2_H6_L2_110201_PBMC_10112011_H06.fcs
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689487			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005538		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	580246	Flow cytometry result	Panel_L5_MonoNKDC_H6_L5_110201_PBMC_10112011_H06.580246.fcs	Panel_L5_MonoNKDC_H6_L5_110201_PBMC_10112011_H06.fcs
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689487			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005559		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	580267	Flow cytometry result	Panel_P13_H12_P13_110201_PBMC_10112011_H12.580267.fcs	Panel_P13_H12_P13_110201_PBMC_10112011_H12.fcs
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689488			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004466		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579174	Flow cytometry result	Panel_L2_G6_L2_110201_PBMC_10132011_G06.579174.fcs	Panel_L2_G6_L2_110201_PBMC_10132011_G06.fcs
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689488			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004533		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579241	Flow cytometry result	Panel_P9_G3_P9_110201_PBMC_10132011_G03.579241.fcs	Panel_P9_G3_P9_110201_PBMC_10132011_G03.fcs
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689488			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004833		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579541	Flow cytometry result	Panel_P10_G6_P10_110201_PBMC_10132011_G06.579541.fcs	Panel_P10_G6_P10_110201_PBMC_10132011_G06.fcs
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689488			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004882		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579590	Flow cytometry result	Panel_L1_G3_L1_110201_PBMC_10132011_G03.579590.fcs	Panel_L1_G3_L1_110201_PBMC_10132011_G03.fcs
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689488			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004993		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579701	Flow cytometry result	Panel_L3_G9_L3_110201_PBMC_10132011_G09.579701.fcs	Panel_L3_G9_L3_110201_PBMC_10132011_G09.fcs
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689488			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005363		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	580071	Flow cytometry result	Panel_P2_G9_P2_110201_PBMC_10132011_G09.580071.fcs	Panel_P2_G9_P2_110201_PBMC_10132011_G09.fcs
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689488			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005403		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	580111	Flow cytometry result	Panel_L4_B_Cells_G3_L4_110201_PBMC_10132011_G03.580111.fcs	Panel_L4_B_Cells_G3_L4_110201_PBMC_10132011_G03.fcs
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689488			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005654		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	580362	Flow cytometry result	Panel_L5_MonoNKDC_G6_L5_110201_PBMC_10132011_G06.580362.fcs	Panel_L5_MonoNKDC_G6_L5_110201_PBMC_10132011_G06.fcs
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689488			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005660		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	580368	Flow cytometry result	Panel_P13_G12_P13_110201_PBMC_10132011_G12.580368.fcs	Panel_P13_G12_P13_110201_PBMC_10132011_G12.fcs
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689488			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005671		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	580379	Flow cytometry result	Panel_P1_G12_P1_110201_PBMC_10132011_G12.580379.fcs	Panel_P1_G12_P1_110201_PBMC_10132011_G12.fcs
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689489			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003938		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	578643	Flow cytometry result	Panel_L2_F6_L2_110201_PBMC_10182011_F06.578643.fcs	Panel_L2_F6_L2_110201_PBMC_10182011_F06.fcs
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689489			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003981		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578689	Flow cytometry result	Panel_P9_F3_P9_110201_PBMC_10182011_F03.578689.fcs	Panel_P9_F3_P9_110201_PBMC_10182011_F03.fcs
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689489			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004150		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	578858	Flow cytometry result	Panel_P1_F12_P1_110201_PBMC_10182011_F12.578858.fcs	Panel_P1_F12_P1_110201_PBMC_10182011_F12.fcs
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689489			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004284		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	578992	Flow cytometry result	Panel_P13_F12_P13_110201_PBMC_10182011_F12.578992.fcs	Panel_P13_F12_P13_110201_PBMC_10182011_F12.fcs
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689489			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004423		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579131	Flow cytometry result	Panel_P10_F6_P10_110201_PBMC_10182011_F06.579131.fcs	Panel_P10_F6_P10_110201_PBMC_10182011_F06.fcs
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689489			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004431		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579139	Flow cytometry result	Panel_L4_B_Cells_F3_L4_110201_PBMC_10182011_F03.579139.fcs	Panel_L4_B_Cells_F3_L4_110201_PBMC_10182011_F03.fcs
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689489			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004507		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579215	Flow cytometry result	Panel_P2_F9_P2_110201_PBMC_10182011_F09.579215.fcs	Panel_P2_F9_P2_110201_PBMC_10182011_F09.fcs
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689489			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005205		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579913	Flow cytometry result	Panel_L3_F9_L3_110201_PBMC_10182011_F09.579913.fcs	Panel_L3_F9_L3_110201_PBMC_10182011_F09.fcs
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689489			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005242		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579950	Flow cytometry result	Panel_L1_F3_L1_110201_PBMC_10182011_F03.579950.fcs	Panel_L1_F3_L1_110201_PBMC_10182011_F03.fcs
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689489			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005626		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	580334	Flow cytometry result	Panel_L5_MonoNKDC_F6_L5_110201_PBMC_10182011_F06.580334.fcs	Panel_L5_MonoNKDC_F6_L5_110201_PBMC_10182011_F06.fcs
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689490			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003799		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	578492	Flow cytometry result	Panel_L3_E9_L3_110201_PBMC_11082011_E09.578492.fcs	Panel_L3_E9_L3_110201_PBMC_11082011_E09.fcs
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689490			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004094		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	578802	Flow cytometry result	Panel_P1_E12_P1_110201_PBMC_11082011_E12.578802.fcs	Panel_P1_E12_P1_110201_PBMC_11082011_E12.fcs
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689490			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004250		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	578958	Flow cytometry result	Panel_P2_E9_P2_110201_PBMC_11082011_E09.578958.fcs	Panel_P2_E9_P2_110201_PBMC_11082011_E09.fcs
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689490			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004593		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579301	Flow cytometry result	Panel_L2_E6_L2_110201_PBMC_11082011_E06.579301.fcs	Panel_L2_E6_L2_110201_PBMC_11082011_E06.fcs
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689490			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005099		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579807	Flow cytometry result	Panel_P10_E6_P10_110201_PBMC_11082011_E06.579807.fcs	Panel_P10_E6_P10_110201_PBMC_11082011_E06.fcs
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689490			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005102		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579810	Flow cytometry result	Panel_L1_E3_L1_110201_PBMC_11082011_E03.579810.fcs	Panel_L1_E3_L1_110201_PBMC_11082011_E03.fcs
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689490			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005252		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579960	Flow cytometry result	Panel_P13_E12_P13_110201_PBMC_11082011_E12.579960.fcs	Panel_P13_E12_P13_110201_PBMC_11082011_E12.fcs
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689490			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005347		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580055	Flow cytometry result	Panel_P9_E3_P9_110201_PBMC_11082011_E03.580055.fcs	Panel_P9_E3_P9_110201_PBMC_11082011_E03.fcs
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689490			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005486		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	580194	Flow cytometry result	Panel_L5_MonoNKDC_E6_L5_110201_PBMC_11082011_E06.580194.fcs	Panel_L5_MonoNKDC_E6_L5_110201_PBMC_11082011_E06.fcs
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689490			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005695		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	580403	Flow cytometry result	Panel_L4_B_Cells_E3_L4_110201_PBMC_11082011_E03.580403.fcs	Panel_L4_B_Cells_E3_L4_110201_PBMC_11082011_E03.fcs
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689491			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003741		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	578421	Flow cytometry result	Panel_L4_B_Cells_D3_L4_110202_PBMC_10112011_D03.578421.fcs	Panel_L4_B_Cells_D3_L4_110202_PBMC_10112011_D03.fcs
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689491			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003827		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578525	Flow cytometry result	Panel_P9_D3_P9_110202_PBMC_10112011_D03.578525.fcs	Panel_P9_D3_P9_110202_PBMC_10112011_D03.fcs
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689491			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003839		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	578538	Flow cytometry result	Panel_L2_D6_L2_110202_PBMC_10112011_D06.578538.fcs	Panel_L2_D6_L2_110202_PBMC_10112011_D06.fcs
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689491			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004317		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579025	Flow cytometry result	Panel_P2_D9_P2_110202_PBMC_10112011_D09.579025.fcs	Panel_P2_D9_P2_110202_PBMC_10112011_D09.fcs
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689491			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004692		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579400	Flow cytometry result	Panel_P10_D6_P10_110202_PBMC_10112011_D06.579400.fcs	Panel_P10_D6_P10_110202_PBMC_10112011_D06.fcs
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689491			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004751		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579459	Flow cytometry result	Panel_L3_D9_L3_110202_PBMC_10112011_D09.579459.fcs	Panel_L3_D9_L3_110202_PBMC_10112011_D09.fcs
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689491			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004849		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579557	Flow cytometry result	Panel_P13_D12_P13_110202_PBMC_10112011_D12.579557.fcs	Panel_P13_D12_P13_110202_PBMC_10112011_D12.fcs
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689491			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005074		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579782	Flow cytometry result	Panel_L1_D3_L1_110202_PBMC_10112011_D03.579782.fcs	Panel_L1_D3_L1_110202_PBMC_10112011_D03.fcs
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689491			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005528		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	580236	Flow cytometry result	Panel_L5_MonoNKDC_D6_L5_110202_PBMC_10112011_D06.580236.fcs	Panel_L5_MonoNKDC_D6_L5_110202_PBMC_10112011_D06.fcs
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689491			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005677		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	580385	Flow cytometry result	Panel_P1_D12_P1_110202_PBMC_10112011_D12.580385.fcs	Panel_P1_D12_P1_110202_PBMC_10112011_D12.fcs
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689492			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003736		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578415	Flow cytometry result	Panel_P9_C3_P9_110202_PBMC_10132011_C03.578415.fcs	Panel_P9_C3_P9_110202_PBMC_10132011_C03.fcs
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689492			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004358		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579066	Flow cytometry result	Panel_L5_MonoNKDC_C6_L5_110202_PBMC_10132011_C06.579066.fcs	Panel_L5_MonoNKDC_C6_L5_110202_PBMC_10132011_C06.fcs
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689492			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004403		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579111	Flow cytometry result	Panel_P2_C9_P2_110202_PBMC_10132011_C09.579111.fcs	Panel_P2_C9_P2_110202_PBMC_10132011_C09.fcs
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689492			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004773		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579481	Flow cytometry result	Panel_P1_C12_P1_110202_PBMC_10132011_C12.579481.fcs	Panel_P1_C12_P1_110202_PBMC_10132011_C12.fcs
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689492			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004857		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579565	Flow cytometry result	Panel_L1_C3_L1_110202_PBMC_10132011_C03.579565.fcs	Panel_L1_C3_L1_110202_PBMC_10132011_C03.fcs
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689492			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004874		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579582	Flow cytometry result	Panel_P13_C12_P13_110202_PBMC_10132011_C12.579582.fcs	Panel_P13_C12_P13_110202_PBMC_10132011_C12.fcs
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689492			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005081		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579789	Flow cytometry result	Panel_P10_C6_P10_110202_PBMC_10132011_C06.579789.fcs	Panel_P10_C6_P10_110202_PBMC_10132011_C06.fcs
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689492			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005234		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579942	Flow cytometry result	Panel_L2_C6_L2_110202_PBMC_10132011_C06.579942.fcs	Panel_L2_C6_L2_110202_PBMC_10132011_C06.fcs
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689492			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005384		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	580092	Flow cytometry result	Panel_L3_C9_L3_110202_PBMC_10132011_C09.580092.fcs	Panel_L3_C9_L3_110202_PBMC_10132011_C09.fcs
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689492			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005539		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	580247	Flow cytometry result	Panel_L4_B_Cells_C3_L4_110202_PBMC_10132011_C03.580247.fcs	Panel_L4_B_Cells_C3_L4_110202_PBMC_10132011_C03.fcs
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689493			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003656		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578289	Flow cytometry result	Panel_P9_B3_P9_110202_PBMC_10182011_B03.578289.fcs	Panel_P9_B3_P9_110202_PBMC_10182011_B03.fcs
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689493			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003756		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	578439	Flow cytometry result	Panel_P1_B12_P1_110202_PBMC_10182011_B12.578439.fcs	Panel_P1_B12_P1_110202_PBMC_10182011_B12.fcs
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689493			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003888		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578592	Flow cytometry result	Panel_P10_B6_P10_110202_PBMC_10182011_B06.578592.fcs	Panel_P10_B6_P10_110202_PBMC_10182011_B06.fcs
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689493			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003935		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	578640	Flow cytometry result	Panel_L1_B3_L1_110202_PBMC_10182011_B03.578640.fcs	Panel_L1_B3_L1_110202_PBMC_10182011_B03.fcs
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689493			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004454		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579162	Flow cytometry result	Panel_L5_MonoNKDC_B6_L5_110202_PBMC_10182011_B06.579162.fcs	Panel_L5_MonoNKDC_B6_L5_110202_PBMC_10182011_B06.fcs
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689493			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004605		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579313	Flow cytometry result	Panel_L4_B_Cells_B3_L4_110202_PBMC_10182011_B03.579313.fcs	Panel_L4_B_Cells_B3_L4_110202_PBMC_10182011_B03.fcs
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689493			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004831		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579539	Flow cytometry result	Panel_L2_B6_L2_110202_PBMC_10182011_B06.579539.fcs	Panel_L2_B6_L2_110202_PBMC_10182011_B06.fcs
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689493			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004863		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579571	Flow cytometry result	Panel_L3_B9_L3_110202_PBMC_10182011_B09.579571.fcs	Panel_L3_B9_L3_110202_PBMC_10182011_B09.fcs
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689493			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005017		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579725	Flow cytometry result	Panel_P13_B12_P13_110202_PBMC_10182011_B12.579725.fcs	Panel_P13_B12_P13_110202_PBMC_10182011_B12.fcs
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689493			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005586		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	580294	Flow cytometry result	Panel_P2_B9_P2_110202_PBMC_10182011_B09.580294.fcs	Panel_P2_B9_P2_110202_PBMC_10182011_B09.fcs
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689494			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004083		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	578791	Flow cytometry result	Panel_P1_A12_P1_110202_PBMC_11082011_A12.578791.fcs	Panel_P1_A12_P1_110202_PBMC_11082011_A12.fcs
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689494			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004303		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579011	Flow cytometry result	Panel_L4_B_Cells_A3_L4_110202_PBMC_11082011_A03.579011.fcs	Panel_L4_B_Cells_A3_L4_110202_PBMC_11082011_A03.fcs
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689494			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004449		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579157	Flow cytometry result	Panel_P2_A9_P2_110202_PBMC_11082011_A09.579157.fcs	Panel_P2_A9_P2_110202_PBMC_11082011_A09.fcs
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689494			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004566		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579274	Flow cytometry result	Panel_L5_MonoNKDC_A6_L5_110202_PBMC_11082011_A06.579274.fcs	Panel_L5_MonoNKDC_A6_L5_110202_PBMC_11082011_A06.fcs
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689494			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004576		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579284	Flow cytometry result	Panel_P10_A6_P10_110202_PBMC_11082011_A06.579284.fcs	Panel_P10_A6_P10_110202_PBMC_11082011_A06.fcs
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689494			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004925		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579633	Flow cytometry result	Panel_L1_A3_L1_110202_PBMC_11082011_A03.579633.fcs	Panel_L1_A3_L1_110202_PBMC_11082011_A03.fcs
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689494			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004927		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579635	Flow cytometry result	Panel_P13_A12_P13_110202_PBMC_11082011_A12.579635.fcs	Panel_P13_A12_P13_110202_PBMC_11082011_A12.fcs
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689494			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005042		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579750	Flow cytometry result	Panel_L3_A9_L3_110202_PBMC_11082011_A09.579750.fcs	Panel_L3_A9_L3_110202_PBMC_11082011_A09.fcs
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689494			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005308		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	580016	Flow cytometry result	Panel_L2_A6_L2_110202_PBMC_11082011_A06.580016.fcs	Panel_L2_A6_L2_110202_PBMC_11082011_A06.fcs
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689494			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005434		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580142	Flow cytometry result	Panel_P9_A3_P9_110202_PBMC_11082011_A03.580142.fcs	Panel_P9_A3_P9_110202_PBMC_11082011_A03.fcs
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752367			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003858		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	578559	Flow cytometry result	Panel_L3_A9_L3_110203_PBMC_10112011_A09.578559.fcs	Panel_L3_A9_L3_110203_PBMC_10112011_A09.fcs
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752367			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004351		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579059	Flow cytometry result	Panel_P13_A12_P13_110203_PBMC_10112011_A12.579059.fcs	Panel_P13_A12_P13_110203_PBMC_10112011_A12.fcs
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752367			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004451		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579159	Flow cytometry result	Panel_P9_A3_P9_110203_PBMC_10112011_A03.579159.fcs	Panel_P9_A3_P9_110203_PBMC_10112011_A03.fcs
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752367			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004506		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579214	Flow cytometry result	Panel_P1_A12_P1_110203_PBMC_10112011_A12.579214.fcs	Panel_P1_A12_P1_110203_PBMC_10112011_A12.fcs
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752367			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004622		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579330	Flow cytometry result	Panel_L2_A6_L2_110203_PBMC_10112011_A06.579330.fcs	Panel_L2_A6_L2_110203_PBMC_10112011_A06.fcs
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752367			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004777		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579485	Flow cytometry result	Panel_P2_A9_P2_110203_PBMC_10112011_A09.579485.fcs	Panel_P2_A9_P2_110203_PBMC_10112011_A09.fcs
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752367			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005066		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579774	Flow cytometry result	Panel_L4_B_Cells_A3_L4_110203_PBMC_10112011_A03.579774.fcs	Panel_L4_B_Cells_A3_L4_110203_PBMC_10112011_A03.fcs
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752367			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005358		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	580066	Flow cytometry result	Panel_L5_MonoNKDC_A6_L5_110203_PBMC_10112011_A06.580066.fcs	Panel_L5_MonoNKDC_A6_L5_110203_PBMC_10112011_A06.fcs
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752367			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005483		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	580191	Flow cytometry result	Panel_L1_A3_L1_110203_PBMC_10112011_A03.580191.fcs	Panel_L1_A3_L1_110203_PBMC_10112011_A03.fcs
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752367			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005521		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580229	Flow cytometry result	Panel_P10_A6_P10_110203_PBMC_10112011_A06.580229.fcs	Panel_P10_A6_P10_110203_PBMC_10112011_A06.fcs
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752368			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003677		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	578325	Flow cytometry result	Panel_P13_B12_P13_110203_PBMC_10132011_B12.578325.fcs	Panel_P13_B12_P13_110203_PBMC_10132011_B12.fcs
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752368			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004253		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	578961	Flow cytometry result	Panel_L5_MonoNKDC_B6_L5_110203_PBMC_10132011_B06.578961.fcs	Panel_L5_MonoNKDC_B6_L5_110203_PBMC_10132011_B06.fcs
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752368			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004766		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579474	Flow cytometry result	Panel_L1_B3_L1_110203_PBMC_10132011_B03.579474.fcs	Panel_L1_B3_L1_110203_PBMC_10132011_B03.fcs
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752368			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004827		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579535	Flow cytometry result	Panel_P1_B12_P1_110203_PBMC_10132011_B12.579535.fcs	Panel_P1_B12_P1_110203_PBMC_10132011_B12.fcs
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752368			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005001		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579709	Flow cytometry result	Panel_L4_B_Cells_B3_L4_110203_PBMC_10132011_B03.579709.fcs	Panel_L4_B_Cells_B3_L4_110203_PBMC_10132011_B03.fcs
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752368			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005348		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	580056	Flow cytometry result	Panel_L2_B6_L2_110203_PBMC_10132011_B06.580056.fcs	Panel_L2_B6_L2_110203_PBMC_10132011_B06.fcs
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752368			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005451		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	580159	Flow cytometry result	Panel_P2_B9_P2_110203_PBMC_10132011_B09.580159.fcs	Panel_P2_B9_P2_110203_PBMC_10132011_B09.fcs
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752368			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005490		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	580198	Flow cytometry result	Panel_L3_B9_L3_110203_PBMC_10132011_B09.580198.fcs	Panel_L3_B9_L3_110203_PBMC_10132011_B09.fcs
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752368			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005582		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580290	Flow cytometry result	Panel_P9_B3_P9_110203_PBMC_10132011_B03.580290.fcs	Panel_P9_B3_P9_110203_PBMC_10132011_B03.fcs
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752368			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005604		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580312	Flow cytometry result	Panel_P10_B6_P10_110203_PBMC_10132011_B06.580312.fcs	Panel_P10_B6_P10_110203_PBMC_10132011_B06.fcs
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752369			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004076		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	578784	Flow cytometry result	Panel_L5_MonoNKDC_C6_L5_110203_PBMC_10182011_C06.578784.fcs	Panel_L5_MonoNKDC_C6_L5_110203_PBMC_10182011_C06.fcs
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752369			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004199		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	578907	Flow cytometry result	Panel_L1_C3_L1_110203_PBMC_10182011_C03.578907.fcs	Panel_L1_C3_L1_110203_PBMC_10182011_C03.fcs
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752369			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004468		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579176	Flow cytometry result	Panel_P1_C12_P1_110203_PBMC_10182011_C12.579176.fcs	Panel_P1_C12_P1_110203_PBMC_10182011_C12.fcs
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752369			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004471		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579179	Flow cytometry result	Panel_L4_B_Cells_C3_L4_110203_PBMC_10182011_C03.579179.fcs	Panel_L4_B_Cells_C3_L4_110203_PBMC_10182011_C03.fcs
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752369			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005008		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579716	Flow cytometry result	Panel_L3_C9_L3_110203_PBMC_10182011_C09.579716.fcs	Panel_L3_C9_L3_110203_PBMC_10182011_C09.fcs
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752369			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005292		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	580000	Flow cytometry result	Panel_L2_C6_L2_110203_PBMC_10182011_C06.580000.fcs	Panel_L2_C6_L2_110203_PBMC_10182011_C06.fcs
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752369			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005342		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580050	Flow cytometry result	Panel_P10_C6_P10_110203_PBMC_10182011_C06.580050.fcs	Panel_P10_C6_P10_110203_PBMC_10182011_C06.fcs
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752369			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005419		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	580127	Flow cytometry result	Panel_P13_C12_P13_110203_PBMC_10182011_C12.580127.fcs	Panel_P13_C12_P13_110203_PBMC_10182011_C12.fcs
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752369			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005515		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580223	Flow cytometry result	Panel_P9_C3_P9_110203_PBMC_10182011_C03.580223.fcs	Panel_P9_C3_P9_110203_PBMC_10182011_C03.fcs
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752369			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005520		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	580228	Flow cytometry result	Panel_P2_C9_P2_110203_PBMC_10182011_C09.580228.fcs	Panel_P2_C9_P2_110203_PBMC_10182011_C09.fcs
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752370			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003842		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	578541	Flow cytometry result	Panel_L2_D6_L2_110203_PBMC_11082011_D06.578541.fcs	Panel_L2_D6_L2_110203_PBMC_11082011_D06.fcs
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752370			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004147		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	578855	Flow cytometry result	Panel_P2_D9_P2_110203_PBMC_11082011_D09.578855.fcs	Panel_P2_D9_P2_110203_PBMC_11082011_D09.fcs
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752370			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004178		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	578886	Flow cytometry result	Panel_P13_D12_P13_110203_PBMC_11082011_D12.578886.fcs	Panel_P13_D12_P13_110203_PBMC_11082011_D12.fcs
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752370			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004388		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579096	Flow cytometry result	Panel_P1_D12_P1_110203_PBMC_11082011_D12.579096.fcs	Panel_P1_D12_P1_110203_PBMC_11082011_D12.fcs
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752370			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004851		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579559	Flow cytometry result	Panel_L1_D3_L1_110203_PBMC_11082011_D03.579559.fcs	Panel_L1_D3_L1_110203_PBMC_11082011_D03.fcs
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752370			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004935		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579643	Flow cytometry result	Panel_P10_D6_P10_110203_PBMC_11082011_D06.579643.fcs	Panel_P10_D6_P10_110203_PBMC_11082011_D06.fcs
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752370			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005123		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579831	Flow cytometry result	Panel_P9_D3_P9_110203_PBMC_11082011_D03.579831.fcs	Panel_P9_D3_P9_110203_PBMC_11082011_D03.fcs
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752370			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005351		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	580059	Flow cytometry result	Panel_L4_B_Cells_D3_L4_110203_PBMC_11082011_D03.580059.fcs	Panel_L4_B_Cells_D3_L4_110203_PBMC_11082011_D03.fcs
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752370			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005408		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	580116	Flow cytometry result	Panel_L5_MonoNKDC_D6_L5_110203_PBMC_11082011_D06.580116.fcs	Panel_L5_MonoNKDC_D6_L5_110203_PBMC_11082011_D06.fcs
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752370			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005570		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	580278	Flow cytometry result	Panel_L3_D9_L3_110203_PBMC_11082011_D09.580278.fcs	Panel_L3_D9_L3_110203_PBMC_11082011_D09.fcs
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689495			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003661		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	578298	Flow cytometry result	Panel_L5_MonoNKDC_H5_L5_110204_PBMC_10112011_H05.578298.fcs	Panel_L5_MonoNKDC_H5_L5_110204_PBMC_10112011_H05.fcs
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689495			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003892		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	578596	Flow cytometry result	Panel_L3_H8_L3_110204_PBMC_10112011_H08.578596.fcs	Panel_L3_H8_L3_110204_PBMC_10112011_H08.fcs
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689495			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003902		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	578606	Flow cytometry result	Panel_P2_H8_P2_110204_PBMC_10112011_H08.578606.fcs	Panel_P2_H8_P2_110204_PBMC_10112011_H08.fcs
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689495			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003996		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	578704	Flow cytometry result	Panel_P13_H11_P13_110204_PBMC_10112011_H11.578704.fcs	Panel_P13_H11_P13_110204_PBMC_10112011_H11.fcs
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689495			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004173		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	578881	Flow cytometry result	Panel_P1_H11_P1_110204_PBMC_10112011_H11.578881.fcs	Panel_P1_H11_P1_110204_PBMC_10112011_H11.fcs
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689495			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004315		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579023	Flow cytometry result	Panel_L1_H2_L1_110204_PBMC_10112011_H02.579023.fcs	Panel_L1_H2_L1_110204_PBMC_10112011_H02.fcs
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689495			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004355		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579063	Flow cytometry result	Panel_P9_H2_P9_110204_PBMC_10112011_H02.579063.fcs	Panel_P9_H2_P9_110204_PBMC_10112011_H02.fcs
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689495			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004573		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579281	Flow cytometry result	Panel_L4_B_Cells_H2_L4_110204_PBMC_10112011_H02.579281.fcs	Panel_L4_B_Cells_H2_L4_110204_PBMC_10112011_H02.fcs
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689495			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004912		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579620	Flow cytometry result	Panel_P10_H5_P10_110204_PBMC_10112011_H05.579620.fcs	Panel_P10_H5_P10_110204_PBMC_10112011_H05.fcs
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689495			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005503		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	580211	Flow cytometry result	Panel_L2_H5_L2_110204_PBMC_10112011_H05.580211.fcs	Panel_L2_H5_L2_110204_PBMC_10112011_H05.fcs
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689496			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003755		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	578438	Flow cytometry result	Panel_L4_B_Cells_G2_L4_110204_PBMC_10132011_G02.578438.fcs	Panel_L4_B_Cells_G2_L4_110204_PBMC_10132011_G02.fcs
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689496			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004012		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578720	Flow cytometry result	Panel_P9_G2_P9_110204_PBMC_10132011_G02.578720.fcs	Panel_P9_G2_P9_110204_PBMC_10132011_G02.fcs
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689496			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004014		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	578722	Flow cytometry result	Panel_L2_G5_L2_110204_PBMC_10132011_G05.578722.fcs	Panel_L2_G5_L2_110204_PBMC_10132011_G05.fcs
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689496			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004314		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579022	Flow cytometry result	Panel_P10_G5_P10_110204_PBMC_10132011_G05.579022.fcs	Panel_P10_G5_P10_110204_PBMC_10132011_G05.fcs
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689496			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004617		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579325	Flow cytometry result	Panel_P1_G11_P1_110204_PBMC_10132011_G11.579325.fcs	Panel_P1_G11_P1_110204_PBMC_10132011_G11.fcs
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689496			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004947		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579655	Flow cytometry result	Panel_P13_G11_P13_110204_PBMC_10132011_G11.579655.fcs	Panel_P13_G11_P13_110204_PBMC_10132011_G11.fcs
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689496			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005206		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579914	Flow cytometry result	Panel_L5_MonoNKDC_G5_L5_110204_PBMC_10132011_G05.579914.fcs	Panel_L5_MonoNKDC_G5_L5_110204_PBMC_10132011_G05.fcs
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689496			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005460		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	580168	Flow cytometry result	Panel_L3_G8_L3_110204_PBMC_10132011_G08.580168.fcs	Panel_L3_G8_L3_110204_PBMC_10132011_G08.fcs
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689496			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005580		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	580288	Flow cytometry result	Panel_L1_G2_L1_110204_PBMC_10132011_G02.580288.fcs	Panel_L1_G2_L1_110204_PBMC_10132011_G02.fcs
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689496			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005697		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	580405	Flow cytometry result	Panel_P2_G8_P2_110204_PBMC_10132011_G08.580405.fcs	Panel_P2_G8_P2_110204_PBMC_10132011_G08.fcs
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689497			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003753		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	578435	Flow cytometry result	Panel_L2_F5_L2_110204_PBMC_10182011_F05.578435.fcs	Panel_L2_F5_L2_110204_PBMC_10182011_F05.fcs
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689497			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003778		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	578465	Flow cytometry result	Panel_L3_F8_L3_110204_PBMC_10182011_F08.578465.fcs	Panel_L3_F8_L3_110204_PBMC_10182011_F08.fcs
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689497			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003934		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578639	Flow cytometry result	Panel_P10_F5_P10_110204_PBMC_10182011_F05.578639.fcs	Panel_P10_F5_P10_110204_PBMC_10182011_F05.fcs
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689497			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004132		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	578840	Flow cytometry result	Panel_P2_F8_P2_110204_PBMC_10182011_F08.578840.fcs	Panel_P2_F8_P2_110204_PBMC_10182011_F08.fcs
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689497			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004162		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	578870	Flow cytometry result	Panel_L4_B_Cells_F2_L4_110204_PBMC_10182011_F02.578870.fcs	Panel_L4_B_Cells_F2_L4_110204_PBMC_10182011_F02.fcs
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689497			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004711		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579419	Flow cytometry result	Panel_L5_MonoNKDC_F5_L5_110204_PBMC_10182011_F05.579419.fcs	Panel_L5_MonoNKDC_F5_L5_110204_PBMC_10182011_F05.fcs
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689497			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004733		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579441	Flow cytometry result	Panel_P13_F11_P13_110204_PBMC_10182011_F11.579441.fcs	Panel_P13_F11_P13_110204_PBMC_10182011_F11.fcs
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689497			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004986		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579694	Flow cytometry result	Panel_L1_F2_L1_110204_PBMC_10182011_F02.579694.fcs	Panel_L1_F2_L1_110204_PBMC_10182011_F02.fcs
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689497			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005239		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579947	Flow cytometry result	Panel_P9_F2_P9_110204_PBMC_10182011_F02.579947.fcs	Panel_P9_F2_P9_110204_PBMC_10182011_F02.fcs
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689497			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005511		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	580219	Flow cytometry result	Panel_P1_F11_P1_110204_PBMC_10182011_F11.580219.fcs	Panel_P1_F11_P1_110204_PBMC_10182011_F11.fcs
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689498			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004195		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	578903	Flow cytometry result	Panel_L5_MonoNKDC_E5_L5_110204_PBMC_11082011_E05.578903.fcs	Panel_L5_MonoNKDC_E5_L5_110204_PBMC_11082011_E05.fcs
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689498			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004320		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579028	Flow cytometry result	Panel_P10_E5_P10_110204_PBMC_11082011_E05.579028.fcs	Panel_P10_E5_P10_110204_PBMC_11082011_E05.fcs
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689498			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004475		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579183	Flow cytometry result	Panel_P1_E11_P1_110204_PBMC_11082011_E11.579183.fcs	Panel_P1_E11_P1_110204_PBMC_11082011_E11.fcs
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689498			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004944		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579652	Flow cytometry result	Panel_P9_E2_P9_110204_PBMC_11082011_E02.579652.fcs	Panel_P9_E2_P9_110204_PBMC_11082011_E02.fcs
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689498			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005032		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579740	Flow cytometry result	Panel_L4_B_Cells_E2_L4_110204_PBMC_11082011_E02.579740.fcs	Panel_L4_B_Cells_E2_L4_110204_PBMC_11082011_E02.fcs
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689498			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005078		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579786	Flow cytometry result	Panel_P13_E11_P13_110204_PBMC_11082011_E11.579786.fcs	Panel_P13_E11_P13_110204_PBMC_11082011_E11.fcs
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689498			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005270		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579978	Flow cytometry result	Panel_P2_E8_P2_110204_PBMC_11082011_E08.579978.fcs	Panel_P2_E8_P2_110204_PBMC_11082011_E08.fcs
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689498			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005423		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	580131	Flow cytometry result	Panel_L3_E8_L3_110204_PBMC_11082011_E08.580131.fcs	Panel_L3_E8_L3_110204_PBMC_11082011_E08.fcs
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689498			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005532		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	580240	Flow cytometry result	Panel_L1_E2_L1_110204_PBMC_11082011_E02.580240.fcs	Panel_L1_E2_L1_110204_PBMC_11082011_E02.fcs
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689498			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005573		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	580281	Flow cytometry result	Panel_L2_E5_L2_110204_PBMC_11082011_E05.580281.fcs	Panel_L2_E5_L2_110204_PBMC_11082011_E05.fcs
SUB120432	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752371			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003705		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	578371	Flow cytometry result	Panel_L1_E3_L1_110206_PBMC_10112011_E03.578371.fcs	Panel_L1_E3_L1_110206_PBMC_10112011_E03.fcs
SUB120432	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752371			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003738		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	578417	Flow cytometry result	Panel_P13_E12_P13_110206_PBMC_10112011_E12.578417.fcs	Panel_P13_E12_P13_110206_PBMC_10112011_E12.fcs
SUB120432	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752371			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004023		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	578731	Flow cytometry result	Panel_L4_B_Cells_E3_L4_110206_PBMC_10112011_E03.578731.fcs	Panel_L4_B_Cells_E3_L4_110206_PBMC_10112011_E03.fcs
SUB120432	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752371			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004111		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578819	Flow cytometry result	Panel_P10_E6_P10_110206_PBMC_10112011_E06.578819.fcs	Panel_P10_E6_P10_110206_PBMC_10112011_E06.fcs
SUB120432	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752371			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004180		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	578888	Flow cytometry result	Panel_L2_E6_L2_110206_PBMC_10112011_E06.578888.fcs	Panel_L2_E6_L2_110206_PBMC_10112011_E06.fcs
SUB120432	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752371			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004526		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579234	Flow cytometry result	Panel_P2_E9_P2_110206_PBMC_10112011_E09.579234.fcs	Panel_P2_E9_P2_110206_PBMC_10112011_E09.fcs
SUB120432	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752371			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005019		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579727	Flow cytometry result	Panel_P9_E3_P9_110206_PBMC_10112011_E03.579727.fcs	Panel_P9_E3_P9_110206_PBMC_10112011_E03.fcs
SUB120432	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752371			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005216		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579924	Flow cytometry result	Panel_L5_MonoNKDC_E6_L5_110206_PBMC_10112011_E06.579924.fcs	Panel_L5_MonoNKDC_E6_L5_110206_PBMC_10112011_E06.fcs
SUB120432	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752371			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005531		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	580239	Flow cytometry result	Panel_L3_E9_L3_110206_PBMC_10112011_E09.580239.fcs	Panel_L3_E9_L3_110206_PBMC_10112011_E09.fcs
SUB120432	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752371			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005561		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	580269	Flow cytometry result	Panel_P1_E12_P1_110206_PBMC_10112011_E12.580269.fcs	Panel_P1_E12_P1_110206_PBMC_10112011_E12.fcs
SUB120432	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752372			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003987		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	578695	Flow cytometry result	Panel_P1_F12_P1_110206_PBMC_10132011_F12.578695.fcs	Panel_P1_F12_P1_110206_PBMC_10132011_F12.fcs
SUB120432	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752372			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004184		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	578892	Flow cytometry result	Panel_P2_F9_P2_110206_PBMC_10132011_F09.578892.fcs	Panel_P2_F9_P2_110206_PBMC_10132011_F09.fcs
SUB120432	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752372			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004309		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579017	Flow cytometry result	Panel_L3_F9_L3_110206_PBMC_10132011_F09.579017.fcs	Panel_L3_F9_L3_110206_PBMC_10132011_F09.fcs
SUB120432	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752372			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004424		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579132	Flow cytometry result	Panel_P10_F6_P10_110206_PBMC_10132011_F06.579132.fcs	Panel_P10_F6_P10_110206_PBMC_10132011_F06.fcs
SUB120432	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752372			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004981		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579689	Flow cytometry result	Panel_L1_F3_L1_110206_PBMC_10132011_F03.579689.fcs	Panel_L1_F3_L1_110206_PBMC_10132011_F03.fcs
SUB120432	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752372			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005151		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579859	Flow cytometry result	Panel_L4_B_Cells_F3_L4_110206_PBMC_10132011_F03.579859.fcs	Panel_L4_B_Cells_F3_L4_110206_PBMC_10132011_F03.fcs
SUB120432	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752372			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005194		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579902	Flow cytometry result	Panel_P9_F3_P9_110206_PBMC_10132011_F03.579902.fcs	Panel_P9_F3_P9_110206_PBMC_10132011_F03.fcs
SUB120432	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752372			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005406		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	580114	Flow cytometry result	Panel_L2_F6_L2_110206_PBMC_10132011_F06.580114.fcs	Panel_L2_F6_L2_110206_PBMC_10132011_F06.fcs
SUB120432	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752372			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005663		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	580371	Flow cytometry result	Panel_P13_F12_P13_110206_PBMC_10132011_F12.580371.fcs	Panel_P13_F12_P13_110206_PBMC_10132011_F12.fcs
SUB120432	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752372			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005696		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	580404	Flow cytometry result	Panel_L5_MonoNKDC_F6_L5_110206_PBMC_10132011_F06.580404.fcs	Panel_L5_MonoNKDC_F6_L5_110206_PBMC_10132011_F06.fcs
SUB120432	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752373			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004226		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578934	Flow cytometry result	Panel_P9_G3_P9_110206_PBMC_10182011_G03.578934.fcs	Panel_P9_G3_P9_110206_PBMC_10182011_G03.fcs
SUB120432	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752373			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004377		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579085	Flow cytometry result	Panel_L3_G9_L3_110206_PBMC_10182011_G09.579085.fcs	Panel_L3_G9_L3_110206_PBMC_10182011_G09.fcs
SUB120432	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752373			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004427		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579135	Flow cytometry result	Panel_P2_G9_P2_110206_PBMC_10182011_G09.579135.fcs	Panel_P2_G9_P2_110206_PBMC_10182011_G09.fcs
SUB120432	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752373			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004574		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579282	Flow cytometry result	Panel_P10_G6_P10_110206_PBMC_10182011_G06.579282.fcs	Panel_P10_G6_P10_110206_PBMC_10182011_G06.fcs
SUB120432	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752373			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004675		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579383	Flow cytometry result	Panel_L1_G3_L1_110206_PBMC_10182011_G03.579383.fcs	Panel_L1_G3_L1_110206_PBMC_10182011_G03.fcs
SUB120432	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752373			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004791		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579499	Flow cytometry result	Panel_L4_B_Cells_G3_L4_110206_PBMC_10182011_G03.579499.fcs	Panel_L4_B_Cells_G3_L4_110206_PBMC_10182011_G03.fcs
SUB120432	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752373			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004921		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579629	Flow cytometry result	Panel_P13_G12_P13_110206_PBMC_10182011_G12.579629.fcs	Panel_P13_G12_P13_110206_PBMC_10182011_G12.fcs
SUB120432	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752373			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005152		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579860	Flow cytometry result	Panel_P1_G12_P1_110206_PBMC_10182011_G12.579860.fcs	Panel_P1_G12_P1_110206_PBMC_10182011_G12.fcs
SUB120432	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752373			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005201		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579909	Flow cytometry result	Panel_L5_MonoNKDC_G6_L5_110206_PBMC_10182011_G06.579909.fcs	Panel_L5_MonoNKDC_G6_L5_110206_PBMC_10182011_G06.fcs
SUB120432	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752373			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005442		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	580150	Flow cytometry result	Panel_L2_G6_L2_110206_PBMC_10182011_G06.580150.fcs	Panel_L2_G6_L2_110206_PBMC_10182011_G06.fcs
SUB120433	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752374			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004871		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579579	Flow cytometry result	Panel_L2_D4_L2_110207_PBMC_10112011_D04.579579.fcs	Panel_L2_D4_L2_110207_PBMC_10112011_D04.fcs
SUB120433	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752374			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005023		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579731	Flow cytometry result	Panel_P2_D7_P2_110207_PBMC_10112011_D07.579731.fcs	Panel_P2_D7_P2_110207_PBMC_10112011_D07.fcs
SUB120433	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752374			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005100		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579808	Flow cytometry result	Panel_P1_D10_P1_110207_PBMC_10112011_D10.579808.fcs	Panel_P1_D10_P1_110207_PBMC_10112011_D10.fcs
SUB120433	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752374			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005203		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579911	Flow cytometry result	Panel_P10_D4_P10_110207_PBMC_10112011_D04.579911.fcs	Panel_P10_D4_P10_110207_PBMC_10112011_D04.fcs
SUB120433	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752374			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005224		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579932	Flow cytometry result	Panel_P13_D10_P13_110207_PBMC_10112011_D10.579932.fcs	Panel_P13_D10_P13_110207_PBMC_10112011_D10.fcs
SUB120433	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752374			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005278		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579986	Flow cytometry result	Panel_L5_MonoNKDC_D4_L5_110207_PBMC_10112011_D04.579986.fcs	Panel_L5_MonoNKDC_D4_L5_110207_PBMC_10112011_D04.fcs
SUB120433	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752374			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005333		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	580041	Flow cytometry result	Panel_L4_B_Cells_D1_L4_110207_PBMC_10112011_D01.580041.fcs	Panel_L4_B_Cells_D1_L4_110207_PBMC_10112011_D01.fcs
SUB120433	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752374			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005395		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	580103	Flow cytometry result	Panel_L3_D7_L3_110207_PBMC_10112011_D07.580103.fcs	Panel_L3_D7_L3_110207_PBMC_10112011_D07.fcs
SUB120433	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752374			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005481		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	580189	Flow cytometry result	Panel_L1_D1_L1_110207_PBMC_10112011_D01.580189.fcs	Panel_L1_D1_L1_110207_PBMC_10112011_D01.fcs
SUB120433	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752374			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005550		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580258	Flow cytometry result	Panel_P9_D1_P9_110207_PBMC_10112011_D01.580258.fcs	Panel_P9_D1_P9_110207_PBMC_10112011_D01.fcs
SUB120433	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752375			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003762		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	578445	Flow cytometry result	Panel_P1_C10_P1_110207_PBMC_10132011_C10.578445.fcs	Panel_P1_C10_P1_110207_PBMC_10132011_C10.fcs
SUB120433	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752375			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003765		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	578448	Flow cytometry result	Panel_P2_C7_P2_110207_PBMC_10132011_C07.578448.fcs	Panel_P2_C7_P2_110207_PBMC_10132011_C07.fcs
SUB120433	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752375			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003943		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	578649	Flow cytometry result	Panel_L3_C7_L3_110207_PBMC_10132011_C07.578649.fcs	Panel_L3_C7_L3_110207_PBMC_10132011_C07.fcs
SUB120433	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752375			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003961		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	578668	Flow cytometry result	Panel_P13_C10_P13_110207_PBMC_10132011_C10.578668.fcs	Panel_P13_C10_P13_110207_PBMC_10132011_C10.fcs
SUB120433	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752375			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004546		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579254	Flow cytometry result	Panel_L4_B_Cells_C1_L4_110207_PBMC_10132011_C01.579254.fcs	Panel_L4_B_Cells_C1_L4_110207_PBMC_10132011_C01.fcs
SUB120433	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752375			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004747		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579455	Flow cytometry result	Panel_L1_C1_L1_110207_PBMC_10132011_C01.579455.fcs	Panel_L1_C1_L1_110207_PBMC_10132011_C01.fcs
SUB120433	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752375			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004900		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579608	Flow cytometry result	Panel_L2_C4_L2_110207_PBMC_10132011_C04.579608.fcs	Panel_L2_C4_L2_110207_PBMC_10132011_C04.fcs
SUB120433	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752375			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005337		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	580045	Flow cytometry result	Panel_L5_MonoNKDC_C4_L5_110207_PBMC_10132011_C04.580045.fcs	Panel_L5_MonoNKDC_C4_L5_110207_PBMC_10132011_C04.fcs
SUB120433	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752375			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005651		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580359	Flow cytometry result	Panel_P10_C4_P10_110207_PBMC_10132011_C04.580359.fcs	Panel_P10_C4_P10_110207_PBMC_10132011_C04.fcs
SUB120433	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752375			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005688		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580396	Flow cytometry result	Panel_P9_C1_P9_110207_PBMC_10132011_C01.580396.fcs	Panel_P9_C1_P9_110207_PBMC_10132011_C01.fcs
SUB120433	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752376			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003740		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	578419	Flow cytometry result	Panel_L4_B_Cells_B1_L4_110207_PBMC_10182011_B01.578419.fcs	Panel_L4_B_Cells_B1_L4_110207_PBMC_10182011_B01.fcs
SUB120433	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752376			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004652		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579360	Flow cytometry result	Panel_P2_B7_P2_110207_PBMC_10182011_B07.579360.fcs	Panel_P2_B7_P2_110207_PBMC_10182011_B07.fcs
SUB120433	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752376			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004703		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579411	Flow cytometry result	Panel_L5_MonoNKDC_B4_L5_110207_PBMC_10182011_B04.579411.fcs	Panel_L5_MonoNKDC_B4_L5_110207_PBMC_10182011_B04.fcs
SUB120433	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752376			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004852		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579560	Flow cytometry result	Panel_P10_B4_P10_110207_PBMC_10182011_B04.579560.fcs	Panel_P10_B4_P10_110207_PBMC_10182011_B04.fcs
SUB120433	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752376			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004860		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579568	Flow cytometry result	Panel_L3_B7_L3_110207_PBMC_10182011_B07.579568.fcs	Panel_L3_B7_L3_110207_PBMC_10182011_B07.fcs
SUB120433	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752376			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005004		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579712	Flow cytometry result	Panel_P9_B1_P9_110207_PBMC_10182011_B01.579712.fcs	Panel_P9_B1_P9_110207_PBMC_10182011_B01.fcs
SUB120433	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752376			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005027		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579735	Flow cytometry result	Panel_P1_B10_P1_110207_PBMC_10182011_B10.579735.fcs	Panel_P1_B10_P1_110207_PBMC_10182011_B10.fcs
SUB120433	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752376			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005217		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579925	Flow cytometry result	Panel_P13_B10_P13_110207_PBMC_10182011_B10.579925.fcs	Panel_P13_B10_P13_110207_PBMC_10182011_B10.fcs
SUB120433	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752376			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005457		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	580165	Flow cytometry result	Panel_L2_B4_L2_110207_PBMC_10182011_B04.580165.fcs	Panel_L2_B4_L2_110207_PBMC_10182011_B04.fcs
SUB120433	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752376			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005512		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	580220	Flow cytometry result	Panel_L1_B1_L1_110207_PBMC_10182011_B01.580220.fcs	Panel_L1_B1_L1_110207_PBMC_10182011_B01.fcs
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689499			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003748		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	578428	Flow cytometry result	Panel_P2_D8_P2_110209_PBMC_10112011_D08.578428.fcs	Panel_P2_D8_P2_110209_PBMC_10112011_D08.fcs
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689499			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004008		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	578716	Flow cytometry result	Panel_P13_D11_P13_110209_PBMC_10112011_D11.578716.fcs	Panel_P13_D11_P13_110209_PBMC_10112011_D11.fcs
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689499			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004406		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579114	Flow cytometry result	Panel_L5_MonoNKDC_D5_L5_110209_PBMC_10112011_D05.579114.fcs	Panel_L5_MonoNKDC_D5_L5_110209_PBMC_10112011_D05.fcs
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689499			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004499		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579207	Flow cytometry result	Panel_L2_D5_L2_110209_PBMC_10112011_D05.579207.fcs	Panel_L2_D5_L2_110209_PBMC_10112011_D05.fcs
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689499			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004583		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579291	Flow cytometry result	Panel_L1_D2_L1_110209_PBMC_10112011_D02.579291.fcs	Panel_L1_D2_L1_110209_PBMC_10112011_D02.fcs
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689499			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004856		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579564	Flow cytometry result	Panel_P9_D2_P9_110209_PBMC_10112011_D02.579564.fcs	Panel_P9_D2_P9_110209_PBMC_10112011_D02.fcs
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689499			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005196		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579904	Flow cytometry result	Panel_L4_B_Cells_D2_L4_110209_PBMC_10112011_D02.579904.fcs	Panel_L4_B_Cells_D2_L4_110209_PBMC_10112011_D02.fcs
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689499			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005218		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579926	Flow cytometry result	Panel_L3_D8_L3_110209_PBMC_10112011_D08.579926.fcs	Panel_L3_D8_L3_110209_PBMC_10112011_D08.fcs
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689499			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005346		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580054	Flow cytometry result	Panel_P10_D5_P10_110209_PBMC_10112011_D05.580054.fcs	Panel_P10_D5_P10_110209_PBMC_10112011_D05.fcs
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689499			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005482		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	580190	Flow cytometry result	Panel_P1_D11_P1_110209_PBMC_10112011_D11.580190.fcs	Panel_P1_D11_P1_110209_PBMC_10112011_D11.fcs
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689500			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003910		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578614	Flow cytometry result	Panel_P10_C5_P10_110209_PBMC_10132011_C05.578614.fcs	Panel_P10_C5_P10_110209_PBMC_10132011_C05.fcs
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689500			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003974		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	578682	Flow cytometry result	Panel_L5_MonoNKDC_C5_L5_110209_PBMC_10132011_C05.578682.fcs	Panel_L5_MonoNKDC_C5_L5_110209_PBMC_10132011_C05.fcs
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689500			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004196		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	578904	Flow cytometry result	Panel_L4_B_Cells_C2_L4_110209_PBMC_10132011_C02.578904.fcs	Panel_L4_B_Cells_C2_L4_110209_PBMC_10132011_C02.fcs
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689500			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004595		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579303	Flow cytometry result	Panel_P9_C2_P9_110209_PBMC_10132011_C02.579303.fcs	Panel_P9_C2_P9_110209_PBMC_10132011_C02.fcs
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689500			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004621		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579329	Flow cytometry result	Panel_L3_C8_L3_110209_PBMC_10132011_C08.579329.fcs	Panel_L3_C8_L3_110209_PBMC_10132011_C08.fcs
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689500			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004658		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579366	Flow cytometry result	Panel_P13_C11_P13_110209_PBMC_10132011_C11.579366.fcs	Panel_P13_C11_P13_110209_PBMC_10132011_C11.fcs
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689500			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004749		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579457	Flow cytometry result	Panel_P2_C8_P2_110209_PBMC_10132011_C08.579457.fcs	Panel_P2_C8_P2_110209_PBMC_10132011_C08.fcs
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689500			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004832		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579540	Flow cytometry result	Panel_L2_C5_L2_110209_PBMC_10132011_C05.579540.fcs	Panel_L2_C5_L2_110209_PBMC_10132011_C05.fcs
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689500			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005127		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579835	Flow cytometry result	Panel_P1_C11_P1_110209_PBMC_10132011_C11.579835.fcs	Panel_P1_C11_P1_110209_PBMC_10132011_C11.fcs
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689500			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005597		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	580305	Flow cytometry result	Panel_L1_C2_L1_110209_PBMC_10132011_C02.580305.fcs	Panel_L1_C2_L1_110209_PBMC_10132011_C02.fcs
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689501			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003673		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	578319	Flow cytometry result	Panel_L3_B8_L3_110209_PBMC_10182011_B08.578319.fcs	Panel_L3_B8_L3_110209_PBMC_10182011_B08.fcs
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689501			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003916		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	578620	Flow cytometry result	Panel_L1_B2_L1_110209_PBMC_10182011_B02.578620.fcs	Panel_L1_B2_L1_110209_PBMC_10182011_B02.fcs
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689501			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003983		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	578691	Flow cytometry result	Panel_L4_B_Cells_B2_L4_110209_PBMC_10182011_B02.578691.fcs	Panel_L4_B_Cells_B2_L4_110209_PBMC_10182011_B02.fcs
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689501			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004028		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	578736	Flow cytometry result	Panel_P2_B8_P2_110209_PBMC_10182011_B08.578736.fcs	Panel_P2_B8_P2_110209_PBMC_10182011_B08.fcs
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689501			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004130		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	578838	Flow cytometry result	Panel_L2_B5_L2_110209_PBMC_10182011_B05.578838.fcs	Panel_L2_B5_L2_110209_PBMC_10182011_B05.fcs
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689501			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004554		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579262	Flow cytometry result	Panel_P10_B5_P10_110209_PBMC_10182011_B05.579262.fcs	Panel_P10_B5_P10_110209_PBMC_10182011_B05.fcs
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689501			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004676		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579384	Flow cytometry result	Panel_P1_B11_P1_110209_PBMC_10182011_B11.579384.fcs	Panel_P1_B11_P1_110209_PBMC_10182011_B11.fcs
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689501			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004690		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579398	Flow cytometry result	Panel_L5_MonoNKDC_B5_L5_110209_PBMC_10182011_B05.579398.fcs	Panel_L5_MonoNKDC_B5_L5_110209_PBMC_10182011_B05.fcs
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689501			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004698		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579406	Flow cytometry result	Panel_P13_B11_P13_110209_PBMC_10182011_B11.579406.fcs	Panel_P13_B11_P13_110209_PBMC_10182011_B11.fcs
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689501			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004718		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579426	Flow cytometry result	Panel_P9_B2_P9_110209_PBMC_10182011_B02.579426.fcs	Panel_P9_B2_P9_110209_PBMC_10182011_B02.fcs
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689502			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003737		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	578416	Flow cytometry result	Panel_L5_MonoNKDC_A5_L5_110209_PBMC_11082011_A05.578416.fcs	Panel_L5_MonoNKDC_A5_L5_110209_PBMC_11082011_A05.fcs
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689502			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003958		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578665	Flow cytometry result	Panel_P9_A2_P9_110209_PBMC_11082011_A02.578665.fcs	Panel_P9_A2_P9_110209_PBMC_11082011_A02.fcs
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689502			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004156		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	578864	Flow cytometry result	Panel_L4_B_Cells_A2_L4_110209_PBMC_11082011_A02.578864.fcs	Panel_L4_B_Cells_A2_L4_110209_PBMC_11082011_A02.fcs
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689502			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004177		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	578885	Flow cytometry result	Panel_P2_A8_P2_110209_PBMC_11082011_A08.578885.fcs	Panel_P2_A8_P2_110209_PBMC_11082011_A08.fcs
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689502			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004237		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	578945	Flow cytometry result	Panel_L2_A5_L2_110209_PBMC_11082011_A05.578945.fcs	Panel_L2_A5_L2_110209_PBMC_11082011_A05.fcs
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689502			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004264		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	578972	Flow cytometry result	Panel_L3_A8_L3_110209_PBMC_11082011_A08.578972.fcs	Panel_L3_A8_L3_110209_PBMC_11082011_A08.fcs
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689502			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004523		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579231	Flow cytometry result	Panel_P1_A11_P1_110209_PBMC_11082011_A11.579231.fcs	Panel_P1_A11_P1_110209_PBMC_11082011_A11.fcs
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689502			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004649		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579357	Flow cytometry result	Panel_P10_A5_P10_110209_PBMC_11082011_A05.579357.fcs	Panel_P10_A5_P10_110209_PBMC_11082011_A05.fcs
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689502			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004917		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579625	Flow cytometry result	Panel_P13_A11_P13_110209_PBMC_11082011_A11.579625.fcs	Panel_P13_A11_P13_110209_PBMC_11082011_A11.fcs
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689502			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005662		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	580370	Flow cytometry result	Panel_L1_A2_L1_110209_PBMC_11082011_A02.580370.fcs	Panel_L1_A2_L1_110209_PBMC_11082011_A02.fcs
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689503			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004155		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578863	Flow cytometry result	Panel_P9_H1_P9_110210_PBMC_10112011_H01.578863.fcs	Panel_P9_H1_P9_110210_PBMC_10112011_H01.fcs
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689503			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004485		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579193	Flow cytometry result	Panel_L2_H4_L2_110210_PBMC_10112011_H04.579193.fcs	Panel_L2_H4_L2_110210_PBMC_10112011_H04.fcs
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689503			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004524		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579232	Flow cytometry result	Panel_P10_H4_P10_110210_PBMC_10112011_H04.579232.fcs	Panel_P10_H4_P10_110210_PBMC_10112011_H04.fcs
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689503			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004659		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579367	Flow cytometry result	Panel_L5_MonoNKDC_H4_L5_110210_PBMC_10112011_H04.579367.fcs	Panel_L5_MonoNKDC_H4_L5_110210_PBMC_10112011_H04.fcs
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689503			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004665		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579373	Flow cytometry result	Panel_L4_B_Cells_H1_L4_110210_PBMC_10112011_H01.579373.fcs	Panel_L4_B_Cells_H1_L4_110210_PBMC_10112011_H01.fcs
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689503			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004913		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579621	Flow cytometry result	Panel_P1_H10_P1_110210_PBMC_10112011_H10.579621.fcs	Panel_P1_H10_P1_110210_PBMC_10112011_H10.fcs
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689503			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005126		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579834	Flow cytometry result	Panel_P2_H7_P2_110210_PBMC_10112011_H07.579834.fcs	Panel_P2_H7_P2_110210_PBMC_10112011_H07.fcs
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689503			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005499		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	580207	Flow cytometry result	Panel_L1_H1_L1_110210_PBMC_10112011_H01.580207.fcs	Panel_L1_H1_L1_110210_PBMC_10112011_H01.fcs
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689503			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005598		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	580306	Flow cytometry result	Panel_P13_H10_P13_110210_PBMC_10112011_H10.580306.fcs	Panel_P13_H10_P13_110210_PBMC_10112011_H10.fcs
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689503			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005608		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	580316	Flow cytometry result	Panel_L3_H7_L3_110210_PBMC_10112011_H07.580316.fcs	Panel_L3_H7_L3_110210_PBMC_10112011_H07.fcs
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689504			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003723		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	578396	Flow cytometry result	Panel_P1_G10_P1_110210_PBMC_10132011_G10.578396.fcs	Panel_P1_G10_P1_110210_PBMC_10132011_G10.fcs
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689504			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004049		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578757	Flow cytometry result	Panel_P9_G1_P9_110210_PBMC_10132011_G01.578757.fcs	Panel_P9_G1_P9_110210_PBMC_10132011_G01.fcs
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689504			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004135		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	578843	Flow cytometry result	Panel_L3_G7_L3_110210_PBMC_10132011_G07.578843.fcs	Panel_L3_G7_L3_110210_PBMC_10132011_G07.fcs
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689504			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004354		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579062	Flow cytometry result	Panel_L2_G4_L2_110210_PBMC_10132011_G04.579062.fcs	Panel_L2_G4_L2_110210_PBMC_10132011_G04.fcs
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689504			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004634		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579342	Flow cytometry result	Panel_P13_G10_P13_110210_PBMC_10132011_G10.579342.fcs	Panel_P13_G10_P13_110210_PBMC_10132011_G10.fcs
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689504			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004822		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579530	Flow cytometry result	Panel_L1_G1_L1_110210_PBMC_10132011_G01.579530.fcs	Panel_L1_G1_L1_110210_PBMC_10132011_G01.fcs
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689504			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004906		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579614	Flow cytometry result	Panel_L4_B_Cells_G1_L4_110210_PBMC_10132011_G01.579614.fcs	Panel_L4_B_Cells_G1_L4_110210_PBMC_10132011_G01.fcs
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689504			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005002		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579710	Flow cytometry result	Panel_P2_G7_P2_110210_PBMC_10132011_G07.579710.fcs	Panel_P2_G7_P2_110210_PBMC_10132011_G07.fcs
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689504			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005149		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579857	Flow cytometry result	Panel_P10_G4_P10_110210_PBMC_10132011_G04.579857.fcs	Panel_P10_G4_P10_110210_PBMC_10132011_G04.fcs
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689504			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005405		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	580113	Flow cytometry result	Panel_L5_MonoNKDC_G4_L5_110210_PBMC_10132011_G04.580113.fcs	Panel_L5_MonoNKDC_G4_L5_110210_PBMC_10132011_G04.fcs
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689505			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003880		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578583	Flow cytometry result	Panel_P10_F4_P10_110210_PBMC_10182011_F04.578583.fcs	Panel_P10_F4_P10_110210_PBMC_10182011_F04.fcs
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689505			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004159		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	578867	Flow cytometry result	Panel_L3_F7_L3_110210_PBMC_10182011_F07.578867.fcs	Panel_L3_F7_L3_110210_PBMC_10182011_F07.fcs
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689505			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004194		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	578902	Flow cytometry result	Panel_P13_F10_P13_110210_PBMC_10182011_F10.578902.fcs	Panel_P13_F10_P13_110210_PBMC_10182011_F10.fcs
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689505			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004248		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	578956	Flow cytometry result	Panel_L4_B_Cells_F1_L4_110210_PBMC_10182011_F01.578956.fcs	Panel_L4_B_Cells_F1_L4_110210_PBMC_10182011_F01.fcs
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689505			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004295		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579003	Flow cytometry result	Panel_L5_MonoNKDC_F4_L5_110210_PBMC_10182011_F04.579003.fcs	Panel_L5_MonoNKDC_F4_L5_110210_PBMC_10182011_F04.fcs
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689505			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004655		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579363	Flow cytometry result	Panel_P9_F1_P9_110210_PBMC_10182011_F01.579363.fcs	Panel_P9_F1_P9_110210_PBMC_10182011_F01.fcs
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689505			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004731		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579439	Flow cytometry result	Panel_P1_F10_P1_110210_PBMC_10182011_F10.579439.fcs	Panel_P1_F10_P1_110210_PBMC_10182011_F10.fcs
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689505			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004895		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579603	Flow cytometry result	Panel_L2_F4_L2_110210_PBMC_10182011_F04.579603.fcs	Panel_L2_F4_L2_110210_PBMC_10182011_F04.fcs
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689505			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005379		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	580087	Flow cytometry result	Panel_P2_F7_P2_110210_PBMC_10182011_F07.580087.fcs	Panel_P2_F7_P2_110210_PBMC_10182011_F07.fcs
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689505			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005562		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	580270	Flow cytometry result	Panel_L1_F1_L1_110210_PBMC_10182011_F01.580270.fcs	Panel_L1_F1_L1_110210_PBMC_10182011_F01.fcs
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689506			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003867		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	578569	Flow cytometry result	Panel_L2_E4_L2_110210_PBMC_11082011_E04.578569.fcs	Panel_L2_E4_L2_110210_PBMC_11082011_E04.fcs
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689506			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003878		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	578581	Flow cytometry result	Panel_P1_E10_P1_110210_PBMC_11082011_E10.578581.fcs	Panel_P1_E10_P1_110210_PBMC_11082011_E10.fcs
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689506			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003995		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	578703	Flow cytometry result	Panel_P2_E7_P2_110210_PBMC_11082011_E07.578703.fcs	Panel_P2_E7_P2_110210_PBMC_11082011_E07.fcs
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689506			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004308		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579016	Flow cytometry result	Panel_L1_E1_L1_110210_PBMC_11082011_E01.579016.fcs	Panel_L1_E1_L1_110210_PBMC_11082011_E01.fcs
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689506			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004674		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579382	Flow cytometry result	Panel_L3_E7_L3_110210_PBMC_11082011_E07.579382.fcs	Panel_L3_E7_L3_110210_PBMC_11082011_E07.fcs
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689506			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005156		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579864	Flow cytometry result	Panel_P10_E4_P10_110210_PBMC_11082011_E04.579864.fcs	Panel_P10_E4_P10_110210_PBMC_11082011_E04.fcs
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689506			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005174		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579882	Flow cytometry result	Panel_P9_E1_P9_110210_PBMC_11082011_E01.579882.fcs	Panel_P9_E1_P9_110210_PBMC_11082011_E01.fcs
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689506			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005190		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579898	Flow cytometry result	Panel_L5_MonoNKDC_E4_L5_110210_PBMC_11082011_E04.579898.fcs	Panel_L5_MonoNKDC_E4_L5_110210_PBMC_11082011_E04.fcs
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689506			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005195		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579903	Flow cytometry result	Panel_P13_E10_P13_110210_PBMC_11082011_E10.579903.fcs	Panel_P13_E10_P13_110210_PBMC_11082011_E10.fcs
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689506			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005574		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	580282	Flow cytometry result	Panel_L4_B_Cells_E1_L4_110210_PBMC_11082011_E01.580282.fcs	Panel_L4_B_Cells_E1_L4_110210_PBMC_11082011_E01.fcs
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689507			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003697		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	578357	Flow cytometry result	Panel_L1_A1_L1_110211_PBMC_10112011_A01.578357.fcs	Panel_L1_A1_L1_110211_PBMC_10112011_A01.fcs
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689507			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003785		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	578473	Flow cytometry result	Panel_P13_A10_P13_110211_PBMC_10112011_A10.578473.fcs	Panel_P13_A10_P13_110211_PBMC_10112011_A10.fcs
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689507			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003937		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	578642	Flow cytometry result	Panel_P1_A10_P1_110211_PBMC_10112011_A10.578642.fcs	Panel_P1_A10_P1_110211_PBMC_10112011_A10.fcs
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689507			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004274		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	578982	Flow cytometry result	Panel_P2_A7_P2_110211_PBMC_10112011_A07.578982.fcs	Panel_P2_A7_P2_110211_PBMC_10112011_A07.fcs
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689507			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004633		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579341	Flow cytometry result	Panel_L3_A7_L3_110211_PBMC_10112011_A07.579341.fcs	Panel_L3_A7_L3_110211_PBMC_10112011_A07.fcs
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689507			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004663		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579371	Flow cytometry result	Panel_P9_A1_P9_110211_PBMC_10112011_A01.579371.fcs	Panel_P9_A1_P9_110211_PBMC_10112011_A01.fcs
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689507			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005157		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579865	Flow cytometry result	Panel_L5_MonoNKDC_A4_L5_110211_PBMC_10112011_A04.579865.fcs	Panel_L5_MonoNKDC_A4_L5_110211_PBMC_10112011_A04.fcs
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689507			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005219		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579927	Flow cytometry result	Panel_P10_A4_P10_110211_PBMC_10112011_A04.579927.fcs	Panel_P10_A4_P10_110211_PBMC_10112011_A04.fcs
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689507			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005221		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579929	Flow cytometry result	Panel_L4_B_Cells_A1_L4_110211_PBMC_10112011_A01.579929.fcs	Panel_L4_B_Cells_A1_L4_110211_PBMC_10112011_A01.fcs
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689507			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005636		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	580344	Flow cytometry result	Panel_L2_A4_L2_110211_PBMC_10112011_A04.580344.fcs	Panel_L2_A4_L2_110211_PBMC_10112011_A04.fcs
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689508			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003696		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	578356	Flow cytometry result	Panel_L5_MonoNKDC_B4_L5_110211_PBMC_10132011_B04.578356.fcs	Panel_L5_MonoNKDC_B4_L5_110211_PBMC_10132011_B04.fcs
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689508			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003884		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	578588	Flow cytometry result	Panel_L4_B_Cells_B1_L4_110211_PBMC_10132011_B01.578588.fcs	Panel_L4_B_Cells_B1_L4_110211_PBMC_10132011_B01.fcs
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689508			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003998		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578706	Flow cytometry result	Panel_P9_B1_P9_110211_PBMC_10132011_B01.578706.fcs	Panel_P9_B1_P9_110211_PBMC_10132011_B01.fcs
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689508			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004068		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	578776	Flow cytometry result	Panel_L2_B4_L2_110211_PBMC_10132011_B04.578776.fcs	Panel_L2_B4_L2_110211_PBMC_10132011_B04.fcs
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689508			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004345		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579053	Flow cytometry result	Panel_P1_B10_P1_110211_PBMC_10132011_B10.579053.fcs	Panel_P1_B10_P1_110211_PBMC_10132011_B10.fcs
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689508			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004465		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579173	Flow cytometry result	Panel_P2_B7_P2_110211_PBMC_10132011_B07.579173.fcs	Panel_P2_B7_P2_110211_PBMC_10132011_B07.fcs
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689508			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005236		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579944	Flow cytometry result	Panel_P13_B10_P13_110211_PBMC_10132011_B10.579944.fcs	Panel_P13_B10_P13_110211_PBMC_10132011_B10.fcs
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689508			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005412		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580120	Flow cytometry result	Panel_P10_B4_P10_110211_PBMC_10132011_B04.580120.fcs	Panel_P10_B4_P10_110211_PBMC_10132011_B04.fcs
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689508			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005422		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	580130	Flow cytometry result	Panel_L1_B1_L1_110211_PBMC_10132011_B01.580130.fcs	Panel_L1_B1_L1_110211_PBMC_10132011_B01.fcs
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689508			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005619		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	580327	Flow cytometry result	Panel_L3_B7_L3_110211_PBMC_10132011_B07.580327.fcs	Panel_L3_B7_L3_110211_PBMC_10132011_B07.fcs
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689509			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003663		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578302	Flow cytometry result	Panel_P9_C1_P9_110211_PBMC_10182011_C01.578302.fcs	Panel_P9_C1_P9_110211_PBMC_10182011_C01.fcs
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689509			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003868		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	578570	Flow cytometry result	Panel_L2_C4_L2_110211_PBMC_10182011_C04.578570.fcs	Panel_L2_C4_L2_110211_PBMC_10182011_C04.fcs
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689509			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003967		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	578675	Flow cytometry result	Panel_L1_C1_L1_110211_PBMC_10182011_C01.578675.fcs	Panel_L1_C1_L1_110211_PBMC_10182011_C01.fcs
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689509			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004081		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	578789	Flow cytometry result	Panel_L5_MonoNKDC_C4_L5_110211_PBMC_10182011_C04.578789.fcs	Panel_L5_MonoNKDC_C4_L5_110211_PBMC_10182011_C04.fcs
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689509			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004090		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578798	Flow cytometry result	Panel_P10_C4_P10_110211_PBMC_10182011_C04.578798.fcs	Panel_P10_C4_P10_110211_PBMC_10182011_C04.fcs
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689509			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004221		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	578929	Flow cytometry result	Panel_L3_C7_L3_110211_PBMC_10182011_C07.578929.fcs	Panel_L3_C7_L3_110211_PBMC_10182011_C07.fcs
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689509			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004383		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579091	Flow cytometry result	Panel_L4_B_Cells_C1_L4_110211_PBMC_10182011_C01.579091.fcs	Panel_L4_B_Cells_C1_L4_110211_PBMC_10182011_C01.fcs
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689509			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004693		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579401	Flow cytometry result	Panel_P2_C7_P2_110211_PBMC_10182011_C07.579401.fcs	Panel_P2_C7_P2_110211_PBMC_10182011_C07.fcs
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689509			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004781		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579489	Flow cytometry result	Panel_P1_C10_P1_110211_PBMC_10182011_C10.579489.fcs	Panel_P1_C10_P1_110211_PBMC_10182011_C10.fcs
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689509			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004818		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579526	Flow cytometry result	Panel_P13_C10_P13_110211_PBMC_10182011_C10.579526.fcs	Panel_P13_C10_P13_110211_PBMC_10182011_C10.fcs
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689510			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003682		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	578333	Flow cytometry result	Panel_L5_MonoNKDC_D4_L5_110211_PBMC_11082011_D04.578333.fcs	Panel_L5_MonoNKDC_D4_L5_110211_PBMC_11082011_D04.fcs
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689510			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003841		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	578540	Flow cytometry result	Panel_L3_D7_L3_110211_PBMC_11082011_D07.578540.fcs	Panel_L3_D7_L3_110211_PBMC_11082011_D07.fcs
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689510			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004238		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578946	Flow cytometry result	Panel_P9_D1_P9_110211_PBMC_11082011_D01.578946.fcs	Panel_P9_D1_P9_110211_PBMC_11082011_D01.fcs
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689510			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004601		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579309	Flow cytometry result	Panel_L1_D1_L1_110211_PBMC_11082011_D01.579309.fcs	Panel_L1_D1_L1_110211_PBMC_11082011_D01.fcs
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689510			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004696		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579404	Flow cytometry result	Panel_L4_B_Cells_D1_L4_110211_PBMC_11082011_D01.579404.fcs	Panel_L4_B_Cells_D1_L4_110211_PBMC_11082011_D01.fcs
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689510			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004845		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579553	Flow cytometry result	Panel_L2_D4_L2_110211_PBMC_11082011_D04.579553.fcs	Panel_L2_D4_L2_110211_PBMC_11082011_D04.fcs
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689510			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004938		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579646	Flow cytometry result	Panel_P1_D10_P1_110211_PBMC_11082011_D10.579646.fcs	Panel_P1_D10_P1_110211_PBMC_11082011_D10.fcs
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689510			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005005		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579713	Flow cytometry result	Panel_P13_D10_P13_110211_PBMC_11082011_D10.579713.fcs	Panel_P13_D10_P13_110211_PBMC_11082011_D10.fcs
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689510			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005527		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	580235	Flow cytometry result	Panel_P2_D7_P2_110211_PBMC_11082011_D07.580235.fcs	Panel_P2_D7_P2_110211_PBMC_11082011_D07.fcs
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689510			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005575		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580283	Flow cytometry result	Panel_P10_D4_P10_110211_PBMC_11082011_D04.580283.fcs	Panel_P10_D4_P10_110211_PBMC_11082011_D04.fcs
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689511			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003889		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	578593	Flow cytometry result	Panel_L4_B_Cells_E1_L4_110214_PBMC_10122011_E01.578593.fcs	Panel_L4_B_Cells_E1_L4_110214_PBMC_10122011_E01.fcs
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689511			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003999		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	578707	Flow cytometry result	Panel_L3_E7_L3_110214_PBMC_10122011_E07.578707.fcs	Panel_L3_E7_L3_110214_PBMC_10122011_E07.fcs
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689511			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004158		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	578866	Flow cytometry result	Panel_L5_MonoNKDC_E4_L5_110214_PBMC_10122011_E04.578866.fcs	Panel_L5_MonoNKDC_E4_L5_110214_PBMC_10122011_E04.fcs
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689511			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004436		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579144	Flow cytometry result	Panel_P9_E1_P9_110214_PBMC_10122011_E01.579144.fcs	Panel_P9_E1_P9_110214_PBMC_10122011_E01.fcs
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689511			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004783		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579491	Flow cytometry result	Panel_P10_E4_P10_110214_PBMC_10122011_E04.579491.fcs	Panel_P10_E4_P10_110214_PBMC_10122011_E04.fcs
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689511			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004835		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579543	Flow cytometry result	Panel_P13_E10_P13_110214_PBMC_10122011_E10.579543.fcs	Panel_P13_E10_P13_110214_PBMC_10122011_E10.fcs
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689511			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004989		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579697	Flow cytometry result	Panel_P1_E10_P1_110214_PBMC_10122011_E10.579697.fcs	Panel_P1_E10_P1_110214_PBMC_10122011_E10.fcs
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689511			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005020		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579728	Flow cytometry result	Panel_L1_E1_L1_110214_PBMC_10122011_E01.579728.fcs	Panel_L1_E1_L1_110214_PBMC_10122011_E01.fcs
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689511			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005182		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579890	Flow cytometry result	Panel_P2_E7_P2_110214_PBMC_10122011_E07.579890.fcs	Panel_P2_E7_P2_110214_PBMC_10122011_E07.fcs
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689511			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005307		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	580015	Flow cytometry result	Panel_L2_E4_L2_110214_PBMC_10122011_E04.580015.fcs	Panel_L2_E4_L2_110214_PBMC_10122011_E04.fcs
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689512			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003823		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	578521	Flow cytometry result	Panel_P1_F10_P1_110214_PBMC_10142011_F10.578521.fcs	Panel_P1_F10_P1_110214_PBMC_10142011_F10.fcs
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689512			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004006		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578714	Flow cytometry result	Panel_P10_F4_P10_110214_PBMC_10142011_F04.578714.fcs	Panel_P10_F4_P10_110214_PBMC_10142011_F04.fcs
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689512			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004862		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579570	Flow cytometry result	Panel_L5_MonoNKDC_F4_L5_110214_PBMC_10142011_F04.579570.fcs	Panel_L5_MonoNKDC_F4_L5_110214_PBMC_10142011_F04.fcs
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689512			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004901		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579609	Flow cytometry result	Panel_L4_B_Cells_F1_L4_110214_PBMC_10142011_F01.579609.fcs	Panel_L4_B_Cells_F1_L4_110214_PBMC_10142011_F01.fcs
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689512			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004930		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579638	Flow cytometry result	Panel_L3_F7_L3_110214_PBMC_10142011_F07.579638.fcs	Panel_L3_F7_L3_110214_PBMC_10142011_F07.fcs
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689512			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005046		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579754	Flow cytometry result	Panel_L2_F4_L2_110214_PBMC_10142011_F04.579754.fcs	Panel_L2_F4_L2_110214_PBMC_10142011_F04.fcs
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689512			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005110		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579818	Flow cytometry result	Panel_P9_F1_P9_110214_PBMC_10142011_F01.579818.fcs	Panel_P9_F1_P9_110214_PBMC_10142011_F01.fcs
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689512			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005130		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579838	Flow cytometry result	Panel_P2_F7_P2_110214_PBMC_10142011_F07.579838.fcs	Panel_P2_F7_P2_110214_PBMC_10142011_F07.fcs
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689512			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005169		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579877	Flow cytometry result	Panel_L1_F1_L1_110214_PBMC_10142011_F01.579877.fcs	Panel_L1_F1_L1_110214_PBMC_10142011_F01.fcs
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689512			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005675		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	580383	Flow cytometry result	Panel_P13_F10_P13_110214_PBMC_10142011_F10.580383.fcs	Panel_P13_F10_P13_110214_PBMC_10142011_F10.fcs
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689513			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003913		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578617	Flow cytometry result	Panel_P9_G1_P9_110214_PBMC_10192011_G01.578617.fcs	Panel_P9_G1_P9_110214_PBMC_10192011_G01.fcs
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689513			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003978		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	578686	Flow cytometry result	Panel_P13_G10_P13_110214_PBMC_10192011_G10.578686.fcs	Panel_P13_G10_P13_110214_PBMC_10192011_G10.fcs
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689513			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004061		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	578769	Flow cytometry result	Panel_P2_G7_P2_110214_PBMC_10192011_G07.578769.fcs	Panel_P2_G7_P2_110214_PBMC_10192011_G07.fcs
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689513			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004101		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	578809	Flow cytometry result	Panel_L2_G4_L2_110214_PBMC_10192011_G04.578809.fcs	Panel_L2_G4_L2_110214_PBMC_10192011_G04.fcs
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689513			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004709		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579417	Flow cytometry result	Panel_L1_G1_L1_110214_PBMC_10192011_G01.579417.fcs	Panel_L1_G1_L1_110214_PBMC_10192011_G01.fcs
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689513			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004738		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579446	Flow cytometry result	Panel_L5_MonoNKDC_G4_L5_110214_PBMC_10192011_G04.579446.fcs	Panel_L5_MonoNKDC_G4_L5_110214_PBMC_10192011_G04.fcs
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689513			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004956		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579664	Flow cytometry result	Panel_L3_G7_L3_110214_PBMC_10192011_G07.579664.fcs	Panel_L3_G7_L3_110214_PBMC_10192011_G07.fcs
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689513			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005105		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579813	Flow cytometry result	Panel_P10_G4_P10_110214_PBMC_10192011_G04.579813.fcs	Panel_P10_G4_P10_110214_PBMC_10192011_G04.fcs
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689513			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005537		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	580245	Flow cytometry result	Panel_L4_B_Cells_G1_L4_110214_PBMC_10192011_G01.580245.fcs	Panel_L4_B_Cells_G1_L4_110214_PBMC_10192011_G01.fcs
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689513			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005659		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	580367	Flow cytometry result	Panel_P1_G10_P1_110214_PBMC_10192011_G10.580367.fcs	Panel_P1_G10_P1_110214_PBMC_10192011_G10.fcs
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689514			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003646		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	578272	Flow cytometry result	Panel_L4_B_Cells_H1_L4_110214_PBMC_11092011_H01.578272.fcs	Panel_L4_B_Cells_H1_L4_110214_PBMC_11092011_H01.fcs
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689514			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003720		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578392	Flow cytometry result	Panel_P9_H1_P9_110214_PBMC_11092011_H01.578392.fcs	Panel_P9_H1_P9_110214_PBMC_11092011_H01.fcs
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689514			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004016		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	578724	Flow cytometry result	Panel_P13_H10_P13_110214_PBMC_11092011_H10.578724.fcs	Panel_P13_H10_P13_110214_PBMC_11092011_H10.fcs
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689514			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004163		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578871	Flow cytometry result	Panel_P10_H4_P10_110214_PBMC_11092011_H04.578871.fcs	Panel_P10_H4_P10_110214_PBMC_11092011_H04.fcs
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689514			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004313		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579021	Flow cytometry result	Panel_L5_MonoNKDC_H4_L5_110214_PBMC_11092011_H04.579021.fcs	Panel_L5_MonoNKDC_H4_L5_110214_PBMC_11092011_H04.fcs
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689514			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004577		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579285	Flow cytometry result	Panel_P1_H10_P1_110214_PBMC_11092011_H10.579285.fcs	Panel_P1_H10_P1_110214_PBMC_11092011_H10.fcs
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689514			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005016		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579724	Flow cytometry result	Panel_L3_H7_L3_110214_PBMC_11092011_H07.579724.fcs	Panel_L3_H7_L3_110214_PBMC_11092011_H07.fcs
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689514			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005055		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579763	Flow cytometry result	Panel_L1_H1_L1_110214_PBMC_11092011_H01.579763.fcs	Panel_L1_H1_L1_110214_PBMC_11092011_H01.fcs
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689514			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005277		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579985	Flow cytometry result	Panel_L2_H4_L2_110214_PBMC_11092011_H04.579985.fcs	Panel_L2_H4_L2_110214_PBMC_11092011_H04.fcs
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689514			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005639		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	580347	Flow cytometry result	Panel_P2_H7_P2_110214_PBMC_11092011_H07.580347.fcs	Panel_P2_H7_P2_110214_PBMC_11092011_H07.fcs
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689515			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003759		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	578442	Flow cytometry result	Panel_L3_A8_L3_110215_PBMC_10122011_A08.578442.fcs	Panel_L3_A8_L3_110215_PBMC_10122011_A08.fcs
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689515			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003769		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	578453	Flow cytometry result	Panel_L5_MonoNKDC_A5_L5_110215_PBMC_10122011_A05.578453.fcs	Panel_L5_MonoNKDC_A5_L5_110215_PBMC_10122011_A05.fcs
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689515			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004302		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579010	Flow cytometry result	Panel_P2_A8_P2_110215_PBMC_10122011_A08.579010.fcs	Panel_P2_A8_P2_110215_PBMC_10122011_A08.fcs
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689515			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004405		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579113	Flow cytometry result	Panel_P13_A11_P13_110215_PBMC_10122011_A11.579113.fcs	Panel_P13_A11_P13_110215_PBMC_10122011_A11.fcs
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689515			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004445		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579153	Flow cytometry result	Panel_P9_A2_P9_110215_PBMC_10122011_A02.579153.fcs	Panel_P9_A2_P9_110215_PBMC_10122011_A02.fcs
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689515			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004460		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579168	Flow cytometry result	Panel_L1_A2_L1_110215_PBMC_10122011_A02.579168.fcs	Panel_L1_A2_L1_110215_PBMC_10122011_A02.fcs
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689515			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004570		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579278	Flow cytometry result	Panel_L4_B_Cells_A2_L4_110215_PBMC_10122011_A02.579278.fcs	Panel_L4_B_Cells_A2_L4_110215_PBMC_10122011_A02.fcs
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689515			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004870		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579578	Flow cytometry result	Panel_P1_A11_P1_110215_PBMC_10122011_A11.579578.fcs	Panel_P1_A11_P1_110215_PBMC_10122011_A11.fcs
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689515			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005611		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	580319	Flow cytometry result	Panel_L2_A5_L2_110215_PBMC_10122011_A05.580319.fcs	Panel_L2_A5_L2_110215_PBMC_10122011_A05.fcs
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689515			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005674		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580382	Flow cytometry result	Panel_P10_A5_P10_110215_PBMC_10122011_A05.580382.fcs	Panel_P10_A5_P10_110215_PBMC_10122011_A05.fcs
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689516			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003985		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	578693	Flow cytometry result	Panel_P13_B11_P13_110215_PBMC_10142011_B11.578693.fcs	Panel_P13_B11_P13_110215_PBMC_10142011_B11.fcs
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689516			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004266		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	578974	Flow cytometry result	Panel_L5_MonoNKDC_B5_L5_110215_PBMC_10142011_B05.578974.fcs	Panel_L5_MonoNKDC_B5_L5_110215_PBMC_10142011_B05.fcs
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689516			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004408		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579116	Flow cytometry result	Panel_L2_B5_L2_110215_PBMC_10142011_B05.579116.fcs	Panel_L2_B5_L2_110215_PBMC_10142011_B05.fcs
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689516			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004515		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579223	Flow cytometry result	Panel_P1_B11_P1_110215_PBMC_10142011_B11.579223.fcs	Panel_P1_B11_P1_110215_PBMC_10142011_B11.fcs
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689516			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004758		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579466	Flow cytometry result	Panel_P9_B2_P9_110215_PBMC_10142011_B02.579466.fcs	Panel_P9_B2_P9_110215_PBMC_10142011_B02.fcs
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689516			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005108		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579816	Flow cytometry result	Panel_P10_B5_P10_110215_PBMC_10142011_B05.579816.fcs	Panel_P10_B5_P10_110215_PBMC_10142011_B05.fcs
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689516			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005353		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	580061	Flow cytometry result	Panel_P2_B8_P2_110215_PBMC_10142011_B08.580061.fcs	Panel_P2_B8_P2_110215_PBMC_10142011_B08.fcs
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689516			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005450		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	580158	Flow cytometry result	Panel_L1_B2_L1_110215_PBMC_10142011_B02.580158.fcs	Panel_L1_B2_L1_110215_PBMC_10142011_B02.fcs
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689516			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005491		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	580199	Flow cytometry result	Panel_L3_B8_L3_110215_PBMC_10142011_B08.580199.fcs	Panel_L3_B8_L3_110215_PBMC_10142011_B08.fcs
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689516			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005691		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	580399	Flow cytometry result	Panel_L4_B_Cells_B2_L4_110215_PBMC_10142011_B02.580399.fcs	Panel_L4_B_Cells_B2_L4_110215_PBMC_10142011_B02.fcs
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689517			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003927		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	578632	Flow cytometry result	Panel_P1_C11_P1_110215_PBMC_10192011_C11.578632.fcs	Panel_P1_C11_P1_110215_PBMC_10192011_C11.fcs
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689517			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004086		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	578794	Flow cytometry result	Panel_L5_MonoNKDC_C5_L5_110215_PBMC_10192011_C05.578794.fcs	Panel_L5_MonoNKDC_C5_L5_110215_PBMC_10192011_C05.fcs
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689517			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004389		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579097	Flow cytometry result	Panel_L4_B_Cells_C2_L4_110215_PBMC_10192011_C02.579097.fcs	Panel_L4_B_Cells_C2_L4_110215_PBMC_10192011_C02.fcs
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689517			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004843		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579551	Flow cytometry result	Panel_P10_C5_P10_110215_PBMC_10192011_C05.579551.fcs	Panel_P10_C5_P10_110215_PBMC_10192011_C05.fcs
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689517			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004879		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579587	Flow cytometry result	Panel_L2_C5_L2_110215_PBMC_10192011_C05.579587.fcs	Panel_L2_C5_L2_110215_PBMC_10192011_C05.fcs
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689517			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004968		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579676	Flow cytometry result	Panel_P13_C11_P13_110215_PBMC_10192011_C11.579676.fcs	Panel_P13_C11_P13_110215_PBMC_10192011_C11.fcs
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689517			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005381		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	580089	Flow cytometry result	Panel_L3_C8_L3_110215_PBMC_10192011_C08.580089.fcs	Panel_L3_C8_L3_110215_PBMC_10192011_C08.fcs
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689517			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005387		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	580095	Flow cytometry result	Panel_L1_C2_L1_110215_PBMC_10192011_C02.580095.fcs	Panel_L1_C2_L1_110215_PBMC_10192011_C02.fcs
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689517			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005472		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580180	Flow cytometry result	Panel_P9_C2_P9_110215_PBMC_10192011_C02.580180.fcs	Panel_P9_C2_P9_110215_PBMC_10192011_C02.fcs
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689517			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005488		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	580196	Flow cytometry result	Panel_P2_C8_P2_110215_PBMC_10192011_C08.580196.fcs	Panel_P2_C8_P2_110215_PBMC_10192011_C08.fcs
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689518			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003714		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	578384	Flow cytometry result	Panel_L4_B_Cells_D2_L4_110215_PBMC_11092011_D02.578384.fcs	Panel_L4_B_Cells_D2_L4_110215_PBMC_11092011_D02.fcs
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689518			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004009		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578717	Flow cytometry result	Panel_P10_D5_P10_110215_PBMC_11092011_D05.578717.fcs	Panel_P10_D5_P10_110215_PBMC_11092011_D05.fcs
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689518			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004036		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	578744	Flow cytometry result	Panel_P2_D8_P2_110215_PBMC_11092011_D08.578744.fcs	Panel_P2_D8_P2_110215_PBMC_11092011_D08.fcs
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689518			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004228		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	578936	Flow cytometry result	Panel_P13_D11_P13_110215_PBMC_11092011_D11.578936.fcs	Panel_P13_D11_P13_110215_PBMC_11092011_D11.fcs
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689518			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004504		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579212	Flow cytometry result	Panel_L2_D5_L2_110215_PBMC_11092011_D05.579212.fcs	Panel_L2_D5_L2_110215_PBMC_11092011_D05.fcs
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689518			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004685		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579393	Flow cytometry result	Panel_L3_D8_L3_110215_PBMC_11092011_D08.579393.fcs	Panel_L3_D8_L3_110215_PBMC_11092011_D08.fcs
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689518			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004790		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579498	Flow cytometry result	Panel_P9_D2_P9_110215_PBMC_11092011_D02.579498.fcs	Panel_P9_D2_P9_110215_PBMC_11092011_D02.fcs
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689518			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005052		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579760	Flow cytometry result	Panel_L5_MonoNKDC_D5_L5_110215_PBMC_11092011_D05.579760.fcs	Panel_L5_MonoNKDC_D5_L5_110215_PBMC_11092011_D05.fcs
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689518			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005386		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	580094	Flow cytometry result	Panel_L1_D2_L1_110215_PBMC_11092011_D02.580094.fcs	Panel_L1_D2_L1_110215_PBMC_11092011_D02.fcs
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689518			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005556		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	580264	Flow cytometry result	Panel_P1_D11_P1_110215_PBMC_11092011_D11.580264.fcs	Panel_P1_D11_P1_110215_PBMC_11092011_D11.fcs
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689519			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003669		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	578312	Flow cytometry result	Panel_L3_E8_L3_110216_PBMC_10122011_E08.578312.fcs	Panel_L3_E8_L3_110216_PBMC_10122011_E08.fcs
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689519			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003671		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	578316	Flow cytometry result	Panel_L5_MonoNKDC_E5_L5_110216_PBMC_10122011_E05.578316.fcs	Panel_L5_MonoNKDC_E5_L5_110216_PBMC_10122011_E05.fcs
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689519			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003805		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	578500	Flow cytometry result	Panel_L4_B_Cells_E2_L4_110216_PBMC_10122011_E02.578500.fcs	Panel_L4_B_Cells_E2_L4_110216_PBMC_10122011_E02.fcs
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689519			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003931		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578636	Flow cytometry result	Panel_P9_E2_P9_110216_PBMC_10122011_E02.578636.fcs	Panel_P9_E2_P9_110216_PBMC_10122011_E02.fcs
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689519			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004297		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579005	Flow cytometry result	Panel_P10_E5_P10_110216_PBMC_10122011_E05.579005.fcs	Panel_P10_E5_P10_110216_PBMC_10122011_E05.fcs
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689519			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004318		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579026	Flow cytometry result	Panel_L1_E2_L1_110216_PBMC_10122011_E02.579026.fcs	Panel_L1_E2_L1_110216_PBMC_10122011_E02.fcs
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689519			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004841		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579549	Flow cytometry result	Panel_P13_E11_P13_110216_PBMC_10122011_E11.579549.fcs	Panel_P13_E11_P13_110216_PBMC_10122011_E11.fcs
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689519			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005275		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579983	Flow cytometry result	Panel_P1_E11_P1_110216_PBMC_10122011_E11.579983.fcs	Panel_P1_E11_P1_110216_PBMC_10122011_E11.fcs
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689519			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005340		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	580048	Flow cytometry result	Panel_P2_E8_P2_110216_PBMC_10122011_E08.580048.fcs	Panel_P2_E8_P2_110216_PBMC_10122011_E08.fcs
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689519			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005345		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	580053	Flow cytometry result	Panel_L2_E5_L2_110216_PBMC_10122011_E05.580053.fcs	Panel_L2_E5_L2_110216_PBMC_10122011_E05.fcs
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689520			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003708		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	578374	Flow cytometry result	Panel_L2_F5_L2_110216_PBMC_10142011_F05.578374.fcs	Panel_L2_F5_L2_110216_PBMC_10142011_F05.fcs
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689520			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003758		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	578441	Flow cytometry result	Panel_L4_B_Cells_F2_L4_110216_PBMC_10142011_F02.578441.fcs	Panel_L4_B_Cells_F2_L4_110216_PBMC_10142011_F02.fcs
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689520			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003848		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	578549	Flow cytometry result	Panel_L1_F2_L1_110216_PBMC_10142011_F02.578549.fcs	Panel_L1_F2_L1_110216_PBMC_10142011_F02.fcs
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689520			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003899		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	578603	Flow cytometry result	Panel_P1_F11_P1_110216_PBMC_10142011_F11.578603.fcs	Panel_P1_F11_P1_110216_PBMC_10142011_F11.fcs
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689520			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004740		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579448	Flow cytometry result	Panel_P10_F5_P10_110216_PBMC_10142011_F05.579448.fcs	Panel_P10_F5_P10_110216_PBMC_10142011_F05.fcs
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689520			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005093		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579801	Flow cytometry result	Panel_L3_F8_L3_110216_PBMC_10142011_F08.579801.fcs	Panel_L3_F8_L3_110216_PBMC_10142011_F08.fcs
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689520			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005153		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579861	Flow cytometry result	Panel_P2_F8_P2_110216_PBMC_10142011_F08.579861.fcs	Panel_P2_F8_P2_110216_PBMC_10142011_F08.fcs
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689520			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005319		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580027	Flow cytometry result	Panel_P9_F2_P9_110216_PBMC_10142011_F02.580027.fcs	Panel_P9_F2_P9_110216_PBMC_10142011_F02.fcs
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689520			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005487		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	580195	Flow cytometry result	Panel_L5_MonoNKDC_F5_L5_110216_PBMC_10142011_F05.580195.fcs	Panel_L5_MonoNKDC_F5_L5_110216_PBMC_10142011_F05.fcs
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689520			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005692		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	580400	Flow cytometry result	Panel_P13_F11_P13_110216_PBMC_10142011_F11.580400.fcs	Panel_P13_F11_P13_110216_PBMC_10142011_F11.fcs
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689521			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004304		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579012	Flow cytometry result	Panel_L1_G2_L1_110216_PBMC_10192011_G02.579012.fcs	Panel_L1_G2_L1_110216_PBMC_10192011_G02.fcs
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689521			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004641		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579349	Flow cytometry result	Panel_P9_G2_P9_110216_PBMC_10192011_G02.579349.fcs	Panel_P9_G2_P9_110216_PBMC_10192011_G02.fcs
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689521			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004660		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579368	Flow cytometry result	Panel_L5_MonoNKDC_G5_L5_110216_PBMC_10192011_G05.579368.fcs	Panel_L5_MonoNKDC_G5_L5_110216_PBMC_10192011_G05.fcs
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689521			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004707		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579415	Flow cytometry result	Panel_P1_G11_P1_110216_PBMC_10192011_G11.579415.fcs	Panel_P1_G11_P1_110216_PBMC_10192011_G11.fcs
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689521			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004861		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579569	Flow cytometry result	Panel_L4_B_Cells_G2_L4_110216_PBMC_10192011_G02.579569.fcs	Panel_L4_B_Cells_G2_L4_110216_PBMC_10192011_G02.fcs
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689521			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005096		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579804	Flow cytometry result	Panel_P10_G5_P10_110216_PBMC_10192011_G05.579804.fcs	Panel_P10_G5_P10_110216_PBMC_10192011_G05.fcs
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689521			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005191		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579899	Flow cytometry result	Panel_L3_G8_L3_110216_PBMC_10192011_G08.579899.fcs	Panel_L3_G8_L3_110216_PBMC_10192011_G08.fcs
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689521			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005214		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579922	Flow cytometry result	Panel_P2_G8_P2_110216_PBMC_10192011_G08.579922.fcs	Panel_P2_G8_P2_110216_PBMC_10192011_G08.fcs
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689521			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005355		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	580063	Flow cytometry result	Panel_P13_G11_P13_110216_PBMC_10192011_G11.580063.fcs	Panel_P13_G11_P13_110216_PBMC_10192011_G11.fcs
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689521			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005368		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	580076	Flow cytometry result	Panel_L2_G5_L2_110216_PBMC_10192011_G05.580076.fcs	Panel_L2_G5_L2_110216_PBMC_10192011_G05.fcs
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689522			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003824		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578522	Flow cytometry result	Panel_P10_H5_P10_110216_PBMC_11092011_H05.578522.fcs	Panel_P10_H5_P10_110216_PBMC_11092011_H05.fcs
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689522			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004411		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579119	Flow cytometry result	Panel_L4_B_Cells_H2_L4_110216_PBMC_11092011_H02.579119.fcs	Panel_L4_B_Cells_H2_L4_110216_PBMC_11092011_H02.fcs
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689522			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004530		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579238	Flow cytometry result	Panel_L1_H2_L1_110216_PBMC_11092011_H02.579238.fcs	Panel_L1_H2_L1_110216_PBMC_11092011_H02.fcs
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689522			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004928		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579636	Flow cytometry result	Panel_L2_H5_L2_110216_PBMC_11092011_H05.579636.fcs	Panel_L2_H5_L2_110216_PBMC_11092011_H05.fcs
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689522			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004978		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579686	Flow cytometry result	Panel_P9_H2_P9_110216_PBMC_11092011_H02.579686.fcs	Panel_P9_H2_P9_110216_PBMC_11092011_H02.fcs
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689522			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005106		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579814	Flow cytometry result	Panel_P1_H11_P1_110216_PBMC_11092011_H11.579814.fcs	Panel_P1_H11_P1_110216_PBMC_11092011_H11.fcs
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689522			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005124		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579832	Flow cytometry result	Panel_P2_H8_P2_110216_PBMC_11092011_H08.579832.fcs	Panel_P2_H8_P2_110216_PBMC_11092011_H08.fcs
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689522			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005413		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	580121	Flow cytometry result	Panel_L5_MonoNKDC_H5_L5_110216_PBMC_11092011_H05.580121.fcs	Panel_L5_MonoNKDC_H5_L5_110216_PBMC_11092011_H05.fcs
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689522			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005439		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	580147	Flow cytometry result	Panel_L3_H8_L3_110216_PBMC_11092011_H08.580147.fcs	Panel_L3_H8_L3_110216_PBMC_11092011_H08.fcs
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689522			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005459		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	580167	Flow cytometry result	Panel_P13_H11_P13_110216_PBMC_11092011_H11.580167.fcs	Panel_P13_H11_P13_110216_PBMC_11092011_H11.fcs
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689523			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003744		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	578424	Flow cytometry result	Panel_L2_A6_L2_110243_PBMC_10172011_A06.578424.fcs	Panel_L2_A6_L2_110243_PBMC_10172011_A06.fcs
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689523			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004157		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	578865	Flow cytometry result	Panel_P2_A9_P2_110243_PBMC_10172011_A09.578865.fcs	Panel_P2_A9_P2_110243_PBMC_10172011_A09.fcs
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689523			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004220		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	578928	Flow cytometry result	Panel_L4_B_Cells_A3_L4_110243_PBMC_10172011_A03.578928.fcs	Panel_L4_B_Cells_A3_L4_110243_PBMC_10172011_A03.fcs
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689523			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004291		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	578999	Flow cytometry result	Panel_L1_A3_L1_110243_PBMC_10172011_A03.578999.fcs	Panel_L1_A3_L1_110243_PBMC_10172011_A03.fcs
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689523			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004429		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579137	Flow cytometry result	Panel_L3_A9_L3_110243_PBMC_10172011_A09.579137.fcs	Panel_L3_A9_L3_110243_PBMC_10172011_A09.fcs
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689523			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004672		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579380	Flow cytometry result	Panel_P10_A6_P10_110243_PBMC_10172011_A06.579380.fcs	Panel_P10_A6_P10_110243_PBMC_10172011_A06.fcs
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689523			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004817		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579525	Flow cytometry result	Panel_P9_A3_P9_110243_PBMC_10172011_A03.579525.fcs	Panel_P9_A3_P9_110243_PBMC_10172011_A03.fcs
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689523			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005233		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579941	Flow cytometry result	Panel_P13_A12_P13_110243_PBMC_10172011_A12.579941.fcs	Panel_P13_A12_P13_110243_PBMC_10172011_A12.fcs
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689523			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005286		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579994	Flow cytometry result	Panel_L5_MonoNKDC_A6_L5_110243_PBMC_10172011_A06.579994.fcs	Panel_L5_MonoNKDC_A6_L5_110243_PBMC_10172011_A06.fcs
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689523			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005603		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	580311	Flow cytometry result	Panel_P1_A12_P1_110243_PBMC_10172011_A12.580311.fcs	Panel_P1_A12_P1_110243_PBMC_10172011_A12.fcs
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689524			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003851		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	578552	Flow cytometry result	Panel_L4_B_Cells_B3_L4_110243_PBMC_10192011_B03.578552.fcs	Panel_L4_B_Cells_B3_L4_110243_PBMC_10192011_B03.fcs
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689524			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004235		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578943	Flow cytometry result	Panel_P9_B3_P9_110243_PBMC_10192011_B03.578943.fcs	Panel_P9_B3_P9_110243_PBMC_10192011_B03.fcs
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689524			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004503		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579211	Flow cytometry result	Panel_L2_B6_L2_110243_PBMC_10192011_B06.579211.fcs	Panel_L2_B6_L2_110243_PBMC_10192011_B06.fcs
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689524			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004604		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579312	Flow cytometry result	Panel_L3_B9_L3_110243_PBMC_10192011_B09.579312.fcs	Panel_L3_B9_L3_110243_PBMC_10192011_B09.fcs
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689524			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004609		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579317	Flow cytometry result	Panel_L5_MonoNKDC_B6_L5_110243_PBMC_10192011_B06.579317.fcs	Panel_L5_MonoNKDC_B6_L5_110243_PBMC_10192011_B06.fcs
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689524			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004646		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579354	Flow cytometry result	Panel_P2_B9_P2_110243_PBMC_10192011_B09.579354.fcs	Panel_P2_B9_P2_110243_PBMC_10192011_B09.fcs
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689524			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004977		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579685	Flow cytometry result	Panel_P10_B6_P10_110243_PBMC_10192011_B06.579685.fcs	Panel_P10_B6_P10_110243_PBMC_10192011_B06.fcs
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689524			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005186		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579894	Flow cytometry result	Panel_P1_B12_P1_110243_PBMC_10192011_B12.579894.fcs	Panel_P1_B12_P1_110243_PBMC_10192011_B12.fcs
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689524			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005285		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579993	Flow cytometry result	Panel_P13_B12_P13_110243_PBMC_10192011_B12.579993.fcs	Panel_P13_B12_P13_110243_PBMC_10192011_B12.fcs
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689524			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005634		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	580342	Flow cytometry result	Panel_L1_B3_L1_110243_PBMC_10192011_B03.580342.fcs	Panel_L1_B3_L1_110243_PBMC_10192011_B03.fcs
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689525			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003816		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	578512	Flow cytometry result	Panel_L1_C3_L1_110243_PBMC_10242011_C03.578512.fcs	Panel_L1_C3_L1_110243_PBMC_10242011_C03.fcs
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689525			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004139		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	578847	Flow cytometry result	Panel_P13_C12_P13_110243_PBMC_10242011_C12.578847.fcs	Panel_P13_C12_P13_110243_PBMC_10242011_C12.fcs
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689525			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004176		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	578884	Flow cytometry result	Panel_L4_B_Cells_C3_L4_110243_PBMC_10242011_C03.578884.fcs	Panel_L4_B_Cells_C3_L4_110243_PBMC_10242011_C03.fcs
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689525			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004433		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579141	Flow cytometry result	Panel_P1_C12_P1_110243_PBMC_10242011_C12.579141.fcs	Panel_P1_C12_P1_110243_PBMC_10242011_C12.fcs
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689525			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004541		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579249	Flow cytometry result	Panel_P9_C3_P9_110243_PBMC_10242011_C03.579249.fcs	Panel_P9_C3_P9_110243_PBMC_10242011_C03.fcs
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689525			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004782		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579490	Flow cytometry result	Panel_L3_C9_L3_110243_PBMC_10242011_C09.579490.fcs	Panel_L3_C9_L3_110243_PBMC_10242011_C09.fcs
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689525			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004937		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579645	Flow cytometry result	Panel_L2_C6_L2_110243_PBMC_10242011_C06.579645.fcs	Panel_L2_C6_L2_110243_PBMC_10242011_C06.fcs
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689525			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005143		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579851	Flow cytometry result	Panel_P10_C6_P10_110243_PBMC_10242011_C06.579851.fcs	Panel_P10_C6_P10_110243_PBMC_10242011_C06.fcs
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689525			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005576		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	580284	Flow cytometry result	Panel_L5_MonoNKDC_C6_L5_110243_PBMC_10242011_C06.580284.fcs	Panel_L5_MonoNKDC_C6_L5_110243_PBMC_10242011_C06.fcs
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689525			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005666		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	580374	Flow cytometry result	Panel_P2_C9_P2_110243_PBMC_10242011_C09.580374.fcs	Panel_P2_C9_P2_110243_PBMC_10242011_C09.fcs
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689526			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003734		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	578411	Flow cytometry result	Panel_P1_D12_P1_110243_PBMC_11142011_D12.578411.fcs	Panel_P1_D12_P1_110243_PBMC_11142011_D12.fcs
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689526			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004095		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578803	Flow cytometry result	Panel_P10_D6_P10_110243_PBMC_11142011_D06.578803.fcs	Panel_P10_D6_P10_110243_PBMC_11142011_D06.fcs
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689526			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004260		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	578968	Flow cytometry result	Panel_L4_B_Cells_D3_L4_110243_PBMC_11142011_D03.578968.fcs	Panel_L4_B_Cells_D3_L4_110243_PBMC_11142011_D03.fcs
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689526			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004395		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579103	Flow cytometry result	Panel_L5_MonoNKDC_D6_L5_110243_PBMC_11142011_D06.579103.fcs	Panel_L5_MonoNKDC_D6_L5_110243_PBMC_11142011_D06.fcs
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689526			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004476		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579184	Flow cytometry result	Panel_P2_D9_P2_110243_PBMC_11142011_D09.579184.fcs	Panel_P2_D9_P2_110243_PBMC_11142011_D09.fcs
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689526			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004714		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579422	Flow cytometry result	Panel_L1_D3_L1_110243_PBMC_11142011_D03.579422.fcs	Panel_L1_D3_L1_110243_PBMC_11142011_D03.fcs
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689526			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004985		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579693	Flow cytometry result	Panel_L2_D6_L2_110243_PBMC_11142011_D06.579693.fcs	Panel_L2_D6_L2_110243_PBMC_11142011_D06.fcs
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689526			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005118		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579826	Flow cytometry result	Panel_P9_D3_P9_110243_PBMC_11142011_D03.579826.fcs	Panel_P9_D3_P9_110243_PBMC_11142011_D03.fcs
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689526			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005197		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579905	Flow cytometry result	Panel_P13_D12_P13_110243_PBMC_11142011_D12.579905.fcs	Panel_P13_D12_P13_110243_PBMC_11142011_D12.fcs
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689526			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005680		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	580388	Flow cytometry result	Panel_L3_D9_L3_110243_PBMC_11142011_D09.580388.fcs	Panel_L3_D9_L3_110243_PBMC_11142011_D09.fcs
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689527			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003783		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	578470	Flow cytometry result	Panel_L3_A7_L3_110244_PBMC_10172011_A07.578470.fcs	Panel_L3_A7_L3_110244_PBMC_10172011_A07.fcs
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689527			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003850		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	578551	Flow cytometry result	Panel_L5_MonoNKDC_A4_L5_110244_PBMC_10172011_A04.578551.fcs	Panel_L5_MonoNKDC_A4_L5_110244_PBMC_10172011_A04.fcs
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689527			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004092		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	578800	Flow cytometry result	Panel_L4_B_Cells_A1_L4_110244_PBMC_10172011_A01.578800.fcs	Panel_L4_B_Cells_A1_L4_110244_PBMC_10172011_A01.fcs
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689527			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004789		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579497	Flow cytometry result	Panel_P1_A10_P1_110244_PBMC_10172011_A10.579497.fcs	Panel_P1_A10_P1_110244_PBMC_10172011_A10.fcs
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689527			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004876		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579584	Flow cytometry result	Panel_P13_A10_P13_110244_PBMC_10172011_A10.579584.fcs	Panel_P13_A10_P13_110244_PBMC_10172011_A10.fcs
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689527			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004896		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579604	Flow cytometry result	Panel_L1_A1_L1_110244_PBMC_10172011_A01.579604.fcs	Panel_L1_A1_L1_110244_PBMC_10172011_A01.fcs
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689527			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004960		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579668	Flow cytometry result	Panel_P9_A1_P9_110244_PBMC_10172011_A01.579668.fcs	Panel_P9_A1_P9_110244_PBMC_10172011_A01.fcs
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689527			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005198		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579906	Flow cytometry result	Panel_P10_A4_P10_110244_PBMC_10172011_A04.579906.fcs	Panel_P10_A4_P10_110244_PBMC_10172011_A04.fcs
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689527			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005199		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579907	Flow cytometry result	Panel_L2_A4_L2_110244_PBMC_10172011_A04.579907.fcs	Panel_L2_A4_L2_110244_PBMC_10172011_A04.fcs
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689527			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005212		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579920	Flow cytometry result	Panel_P2_A7_P2_110244_PBMC_10172011_A07.579920.fcs	Panel_P2_A7_P2_110244_PBMC_10172011_A07.fcs
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689528			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003836		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	578534	Flow cytometry result	Panel_P13_B10_P13_110244_PBMC_10192011_B10.578534.fcs	Panel_P13_B10_P13_110244_PBMC_10192011_B10.fcs
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689528			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003881		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578585	Flow cytometry result	Panel_P10_B4_P10_110244_PBMC_10192011_B04.578585.fcs	Panel_P10_B4_P10_110244_PBMC_10192011_B04.fcs
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689528			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003897		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	578601	Flow cytometry result	Panel_L2_B4_L2_110244_PBMC_10192011_B04.578601.fcs	Panel_L2_B4_L2_110244_PBMC_10192011_B04.fcs
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689528			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004044		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	578752	Flow cytometry result	Panel_P1_B10_P1_110244_PBMC_10192011_B10.578752.fcs	Panel_P1_B10_P1_110244_PBMC_10192011_B10.fcs
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689528			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004080		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578788	Flow cytometry result	Panel_P9_B1_P9_110244_PBMC_10192011_B01.578788.fcs	Panel_P9_B1_P9_110244_PBMC_10192011_B01.fcs
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689528			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004522		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579230	Flow cytometry result	Panel_L4_B_Cells_B1_L4_110244_PBMC_10192011_B01.579230.fcs	Panel_L4_B_Cells_B1_L4_110244_PBMC_10192011_B01.fcs
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689528			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004602		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579310	Flow cytometry result	Panel_L5_MonoNKDC_B4_L5_110244_PBMC_10192011_B04.579310.fcs	Panel_L5_MonoNKDC_B4_L5_110244_PBMC_10192011_B04.fcs
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689528			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004915		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579623	Flow cytometry result	Panel_L1_B1_L1_110244_PBMC_10192011_B01.579623.fcs	Panel_L1_B1_L1_110244_PBMC_10192011_B01.fcs
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689528			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005082		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579790	Flow cytometry result	Panel_P2_B7_P2_110244_PBMC_10192011_B07.579790.fcs	Panel_P2_B7_P2_110244_PBMC_10192011_B07.fcs
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689528			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005121		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579829	Flow cytometry result	Panel_L3_B7_L3_110244_PBMC_10192011_B07.579829.fcs	Panel_L3_B7_L3_110244_PBMC_10192011_B07.fcs
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689529			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003773		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	578459	Flow cytometry result	Panel_L5_MonoNKDC_C4_L5_110244_PBMC_10242011_C04.578459.fcs	Panel_L5_MonoNKDC_C4_L5_110244_PBMC_10242011_C04.fcs
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689529			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003954		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	578661	Flow cytometry result	Panel_L3_C7_L3_110244_PBMC_10242011_C07.578661.fcs	Panel_L3_C7_L3_110244_PBMC_10242011_C07.fcs
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689529			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003959		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	578666	Flow cytometry result	Panel_L1_C1_L1_110244_PBMC_10242011_C01.578666.fcs	Panel_L1_C1_L1_110244_PBMC_10242011_C01.fcs
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689529			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004567		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579275	Flow cytometry result	Panel_P9_C1_P9_110244_PBMC_10242011_C01.579275.fcs	Panel_P9_C1_P9_110244_PBMC_10242011_C01.fcs
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689529			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004988		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579696	Flow cytometry result	Panel_P10_C4_P10_110244_PBMC_10242011_C04.579696.fcs	Panel_P10_C4_P10_110244_PBMC_10242011_C04.fcs
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689529			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004990		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579698	Flow cytometry result	Panel_P2_C7_P2_110244_PBMC_10242011_C07.579698.fcs	Panel_P2_C7_P2_110244_PBMC_10242011_C07.fcs
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689529			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005059		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579767	Flow cytometry result	Panel_L4_B_Cells_C1_L4_110244_PBMC_10242011_C01.579767.fcs	Panel_L4_B_Cells_C1_L4_110244_PBMC_10242011_C01.fcs
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689529			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005144		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579852	Flow cytometry result	Panel_P1_C10_P1_110244_PBMC_10242011_C10.579852.fcs	Panel_P1_C10_P1_110244_PBMC_10242011_C10.fcs
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689529			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005449		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	580157	Flow cytometry result	Panel_L2_C4_L2_110244_PBMC_10242011_C04.580157.fcs	Panel_L2_C4_L2_110244_PBMC_10242011_C04.fcs
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689529			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005635		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	580343	Flow cytometry result	Panel_P13_C10_P13_110244_PBMC_10242011_C10.580343.fcs	Panel_P13_C10_P13_110244_PBMC_10242011_C10.fcs
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689530			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003856		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578557	Flow cytometry result	Panel_P9_D1_P9_110244_PBMC_11142011_D01.578557.fcs	Panel_P9_D1_P9_110244_PBMC_11142011_D01.fcs
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689530			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003912		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578616	Flow cytometry result	Panel_P10_D4_P10_110244_PBMC_11142011_D04.578616.fcs	Panel_P10_D4_P10_110244_PBMC_11142011_D04.fcs
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689530			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003920		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	578625	Flow cytometry result	Panel_L5_MonoNKDC_D4_L5_110244_PBMC_11142011_D04.578625.fcs	Panel_L5_MonoNKDC_D4_L5_110244_PBMC_11142011_D04.fcs
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689530			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003945		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	578651	Flow cytometry result	Panel_L4_B_Cells_D1_L4_110244_PBMC_11142011_D01.578651.fcs	Panel_L4_B_Cells_D1_L4_110244_PBMC_11142011_D01.fcs
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689530			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005159		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579867	Flow cytometry result	Panel_P1_D10_P1_110244_PBMC_11142011_D10.579867.fcs	Panel_P1_D10_P1_110244_PBMC_11142011_D10.fcs
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689530			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005265		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579973	Flow cytometry result	Panel_P2_D7_P2_110244_PBMC_11142011_D07.579973.fcs	Panel_P2_D7_P2_110244_PBMC_11142011_D07.fcs
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689530			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005325		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	580033	Flow cytometry result	Panel_L2_D4_L2_110244_PBMC_11142011_D04.580033.fcs	Panel_L2_D4_L2_110244_PBMC_11142011_D04.fcs
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689530			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005502		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	580210	Flow cytometry result	Panel_P13_D10_P13_110244_PBMC_11142011_D10.580210.fcs	Panel_P13_D10_P13_110244_PBMC_11142011_D10.fcs
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689530			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005533		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	580241	Flow cytometry result	Panel_L3_D7_L3_110244_PBMC_11142011_D07.580241.fcs	Panel_L3_D7_L3_110244_PBMC_11142011_D07.fcs
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689530			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005543		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	580251	Flow cytometry result	Panel_L1_D1_L1_110244_PBMC_11142011_D01.580251.fcs	Panel_L1_D1_L1_110244_PBMC_11142011_D01.fcs
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752377			PBMC		38	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003794		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	578486	Flow cytometry result	Panel_P13_D10_P13_110244_PBMC_11242011_D10.578486.fcs	Panel_P13_D10_P13_110244_PBMC_11242011_D10.fcs
SUB120449	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752378			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003687		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	578340	Flow cytometry result	Panel_L4_B_Cells_E3_L4_110247_PBMC_10172011_E03.578340.fcs	Panel_L4_B_Cells_E3_L4_110247_PBMC_10172011_E03.fcs
SUB120449	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752378			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003774		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578460	Flow cytometry result	Panel_P10_E6_P10_110247_PBMC_10172011_E06.578460.fcs	Panel_P10_E6_P10_110247_PBMC_10172011_E06.fcs
SUB120449	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752378			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003830		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	578528	Flow cytometry result	Panel_P2_E9_P2_110247_PBMC_10172011_E09.578528.fcs	Panel_P2_E9_P2_110247_PBMC_10172011_E09.fcs
SUB120449	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752378			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003905		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	578609	Flow cytometry result	Panel_L3_E9_L3_110247_PBMC_10172011_E09.578609.fcs	Panel_L3_E9_L3_110247_PBMC_10172011_E09.fcs
SUB120449	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752378			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004585		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579293	Flow cytometry result	Panel_P13_E12_P13_110247_PBMC_10172011_E12.579293.fcs	Panel_P13_E12_P13_110247_PBMC_10172011_E12.fcs
SUB120449	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752378			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004681		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579389	Flow cytometry result	Panel_P1_E12_P1_110247_PBMC_10172011_E12.579389.fcs	Panel_P1_E12_P1_110247_PBMC_10172011_E12.fcs
SUB120449	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752378			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004996		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579704	Flow cytometry result	Panel_L5_MonoNKDC_E6_L5_110247_PBMC_10172011_E06.579704.fcs	Panel_L5_MonoNKDC_E6_L5_110247_PBMC_10172011_E06.fcs
SUB120449	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752378			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005021		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579729	Flow cytometry result	Panel_L2_E6_L2_110247_PBMC_10172011_E06.579729.fcs	Panel_L2_E6_L2_110247_PBMC_10172011_E06.fcs
SUB120449	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752378			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005139		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579847	Flow cytometry result	Panel_P9_E3_P9_110247_PBMC_10172011_E03.579847.fcs	Panel_P9_E3_P9_110247_PBMC_10172011_E03.fcs
SUB120449	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752378			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005627		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	580335	Flow cytometry result	Panel_L1_E3_L1_110247_PBMC_10172011_E03.580335.fcs	Panel_L1_E3_L1_110247_PBMC_10172011_E03.fcs
SUB120449	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752379			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003653		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	578284	Flow cytometry result	Panel_L5_MonoNKDC_F6_L5_110247_PBMC_10192011_F06.578284.fcs	Panel_L5_MonoNKDC_F6_L5_110247_PBMC_10192011_F06.fcs
SUB120449	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752379			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003751		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578433	Flow cytometry result	Panel_P9_F3_P9_110247_PBMC_10192011_F03.578433.fcs	Panel_P9_F3_P9_110247_PBMC_10192011_F03.fcs
SUB120449	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752379			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003811		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	578506	Flow cytometry result	Panel_P2_F9_P2_110247_PBMC_10192011_F09.578506.fcs	Panel_P2_F9_P2_110247_PBMC_10192011_F09.fcs
SUB120449	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752379			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004219		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	578927	Flow cytometry result	Panel_L4_B_Cells_F3_L4_110247_PBMC_10192011_F03.578927.fcs	Panel_L4_B_Cells_F3_L4_110247_PBMC_10192011_F03.fcs
SUB120449	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752379			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004298		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579006	Flow cytometry result	Panel_P1_F12_P1_110247_PBMC_10192011_F12.579006.fcs	Panel_P1_F12_P1_110247_PBMC_10192011_F12.fcs
SUB120449	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752379			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004338		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579046	Flow cytometry result	Panel_P10_F6_P10_110247_PBMC_10192011_F06.579046.fcs	Panel_P10_F6_P10_110247_PBMC_10192011_F06.fcs
SUB120449	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752379			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004764		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579472	Flow cytometry result	Panel_P13_F12_P13_110247_PBMC_10192011_F12.579472.fcs	Panel_P13_F12_P13_110247_PBMC_10192011_F12.fcs
SUB120449	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752379			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004955		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579663	Flow cytometry result	Panel_L1_F3_L1_110247_PBMC_10192011_F03.579663.fcs	Panel_L1_F3_L1_110247_PBMC_10192011_F03.fcs
SUB120449	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752379			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004958		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579666	Flow cytometry result	Panel_L2_F6_L2_110247_PBMC_10192011_F06.579666.fcs	Panel_L2_F6_L2_110247_PBMC_10192011_F06.fcs
SUB120449	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752379			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005326		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	580034	Flow cytometry result	Panel_L3_F9_L3_110247_PBMC_10192011_F09.580034.fcs	Panel_L3_F9_L3_110247_PBMC_10192011_F09.fcs
SUB120449	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752380			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004048		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	578756	Flow cytometry result	Panel_P13_G12_P13_110247_PBMC_10242011_G12.578756.fcs	Panel_P13_G12_P13_110247_PBMC_10242011_G12.fcs
SUB120449	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752380			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004204		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	578912	Flow cytometry result	Panel_P2_G9_P2_110247_PBMC_10242011_G09.578912.fcs	Panel_P2_G9_P2_110247_PBMC_10242011_G09.fcs
SUB120449	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752380			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004258		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578966	Flow cytometry result	Panel_P9_G3_P9_110247_PBMC_10242011_G03.578966.fcs	Panel_P9_G3_P9_110247_PBMC_10242011_G03.fcs
SUB120449	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752380			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004364		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579072	Flow cytometry result	Panel_P10_G6_P10_110247_PBMC_10242011_G06.579072.fcs	Panel_P10_G6_P10_110247_PBMC_10242011_G06.fcs
SUB120449	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752380			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004490		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579198	Flow cytometry result	Panel_L1_G3_L1_110247_PBMC_10242011_G03.579198.fcs	Panel_L1_G3_L1_110247_PBMC_10242011_G03.fcs
SUB120449	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752380			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004607		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579315	Flow cytometry result	Panel_L4_B_Cells_G3_L4_110247_PBMC_10242011_G03.579315.fcs	Panel_L4_B_Cells_G3_L4_110247_PBMC_10242011_G03.fcs
SUB120449	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752380			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004684		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579392	Flow cytometry result	Panel_L3_G9_L3_110247_PBMC_10242011_G09.579392.fcs	Panel_L3_G9_L3_110247_PBMC_10242011_G09.fcs
SUB120449	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752380			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004775		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579483	Flow cytometry result	Panel_P1_G12_P1_110247_PBMC_10242011_G12.579483.fcs	Panel_P1_G12_P1_110247_PBMC_10242011_G12.fcs
SUB120449	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752380			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004941		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579649	Flow cytometry result	Panel_L2_G6_L2_110247_PBMC_10242011_G06.579649.fcs	Panel_L2_G6_L2_110247_PBMC_10242011_G06.fcs
SUB120449	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752380			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005588		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	580296	Flow cytometry result	Panel_L5_MonoNKDC_G6_L5_110247_PBMC_10242011_G06.580296.fcs	Panel_L5_MonoNKDC_G6_L5_110247_PBMC_10242011_G06.fcs
SUB120449	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752381			PBMC		8	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004715		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579423	Flow cytometry result	Panel_P2_G9_P2_110247_PBMC_10252011_G09.579423.fcs	Panel_P2_G9_P2_110247_PBMC_10252011_G09.fcs
SUB120449	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752382			PBMC		24	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004527		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579235	Flow cytometry result	Panel_L1_G3_L1_110247_PBMC_11102011_G03.579235.fcs	Panel_L1_G3_L1_110247_PBMC_11102011_G03.fcs
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689531			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003870		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	578572	Flow cytometry result	Panel_L1_E1_L1_110248_PBMC_10172011_E01.578572.fcs	Panel_L1_E1_L1_110248_PBMC_10172011_E01.fcs
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689531			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003887		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578591	Flow cytometry result	Panel_P10_E4_P10_110248_PBMC_10172011_E04.578591.fcs	Panel_P10_E4_P10_110248_PBMC_10172011_E04.fcs
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689531			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004214		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	578922	Flow cytometry result	Panel_P13_E10_P13_110248_PBMC_10172011_E10.578922.fcs	Panel_P13_E10_P13_110248_PBMC_10172011_E10.fcs
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689531			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004448		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579156	Flow cytometry result	Panel_L3_E7_L3_110248_PBMC_10172011_E07.579156.fcs	Panel_L3_E7_L3_110248_PBMC_10172011_E07.fcs
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689531			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004519		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579227	Flow cytometry result	Panel_P9_E1_P9_110248_PBMC_10172011_E01.579227.fcs	Panel_P9_E1_P9_110248_PBMC_10172011_E01.fcs
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689531			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004755		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579463	Flow cytometry result	Panel_P1_E10_P1_110248_PBMC_10172011_E10.579463.fcs	Panel_P1_E10_P1_110248_PBMC_10172011_E10.fcs
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689531			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005178		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579886	Flow cytometry result	Panel_L5_MonoNKDC_E4_L5_110248_PBMC_10172011_E04.579886.fcs	Panel_L5_MonoNKDC_E4_L5_110248_PBMC_10172011_E04.fcs
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689531			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005230		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579938	Flow cytometry result	Panel_L2_E4_L2_110248_PBMC_10172011_E04.579938.fcs	Panel_L2_E4_L2_110248_PBMC_10172011_E04.fcs
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689531			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005407		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	580115	Flow cytometry result	Panel_L4_B_Cells_E1_L4_110248_PBMC_10172011_E01.580115.fcs	Panel_L4_B_Cells_E1_L4_110248_PBMC_10172011_E01.fcs
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689531			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005427		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	580135	Flow cytometry result	Panel_P2_E7_P2_110248_PBMC_10172011_E07.580135.fcs	Panel_P2_E7_P2_110248_PBMC_10172011_E07.fcs
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689532			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003658		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	578293	Flow cytometry result	Panel_P1_F10_P1_110248_PBMC_10192011_F10.578293.fcs	Panel_P1_F10_P1_110248_PBMC_10192011_F10.fcs
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689532			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003675		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	578323	Flow cytometry result	Panel_L2_F4_L2_110248_PBMC_10192011_F04.578323.fcs	Panel_L2_F4_L2_110248_PBMC_10192011_F04.fcs
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689532			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004202		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	578910	Flow cytometry result	Panel_P2_F7_P2_110248_PBMC_10192011_F07.578910.fcs	Panel_P2_F7_P2_110248_PBMC_10192011_F07.fcs
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689532			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004299		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579007	Flow cytometry result	Panel_P9_F1_P9_110248_PBMC_10192011_F01.579007.fcs	Panel_P9_F1_P9_110248_PBMC_10192011_F01.fcs
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689532			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004374		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579082	Flow cytometry result	Panel_L1_F1_L1_110248_PBMC_10192011_F01.579082.fcs	Panel_L1_F1_L1_110248_PBMC_10192011_F01.fcs
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689532			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004635		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579343	Flow cytometry result	Panel_L5_MonoNKDC_F4_L5_110248_PBMC_10192011_F04.579343.fcs	Panel_L5_MonoNKDC_F4_L5_110248_PBMC_10192011_F04.fcs
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689532			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004737		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579445	Flow cytometry result	Panel_L4_B_Cells_F1_L4_110248_PBMC_10192011_F01.579445.fcs	Panel_L4_B_Cells_F1_L4_110248_PBMC_10192011_F01.fcs
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689532			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004772		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579480	Flow cytometry result	Panel_L3_F7_L3_110248_PBMC_10192011_F07.579480.fcs	Panel_L3_F7_L3_110248_PBMC_10192011_F07.fcs
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689532			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004780		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579488	Flow cytometry result	Panel_P10_F4_P10_110248_PBMC_10192011_F04.579488.fcs	Panel_P10_F4_P10_110248_PBMC_10192011_F04.fcs
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689532			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004823		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579531	Flow cytometry result	Panel_P13_F10_P13_110248_PBMC_10192011_F10.579531.fcs	Panel_P13_F10_P13_110248_PBMC_10192011_F10.fcs
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689533			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003665		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	578306	Flow cytometry result	Panel_P1_G10_P1_110248_PBMC_10242011_G10.578306.fcs	Panel_P1_G10_P1_110248_PBMC_10242011_G10.fcs
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689533			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003895		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	578599	Flow cytometry result	Panel_L5_MonoNKDC_G4_L5_110248_PBMC_10242011_G04.578599.fcs	Panel_L5_MonoNKDC_G4_L5_110248_PBMC_10242011_G04.fcs
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689533			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004191		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	578899	Flow cytometry result	Panel_P13_G10_P13_110248_PBMC_10242011_G10.578899.fcs	Panel_P13_G10_P13_110248_PBMC_10242011_G10.fcs
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689533			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004259		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578967	Flow cytometry result	Panel_P9_G1_P9_110248_PBMC_10242011_G01.578967.fcs	Panel_P9_G1_P9_110248_PBMC_10242011_G01.fcs
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689533			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004439		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579147	Flow cytometry result	Panel_P2_G7_P2_110248_PBMC_10242011_G07.579147.fcs	Panel_P2_G7_P2_110248_PBMC_10242011_G07.fcs
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689533			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004473		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579181	Flow cytometry result	Panel_L2_G4_L2_110248_PBMC_10242011_G04.579181.fcs	Panel_L2_G4_L2_110248_PBMC_10242011_G04.fcs
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689533			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005299		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580007	Flow cytometry result	Panel_P10_G4_P10_110248_PBMC_10242011_G04.580007.fcs	Panel_P10_G4_P10_110248_PBMC_10242011_G04.fcs
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689533			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005303		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	580011	Flow cytometry result	Panel_L4_B_Cells_G1_L4_110248_PBMC_10242011_G01.580011.fcs	Panel_L4_B_Cells_G1_L4_110248_PBMC_10242011_G01.fcs
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689533			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005530		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	580238	Flow cytometry result	Panel_L1_G1_L1_110248_PBMC_10242011_G01.580238.fcs	Panel_L1_G1_L1_110248_PBMC_10242011_G01.fcs
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689533			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005625		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	580333	Flow cytometry result	Panel_L3_G7_L3_110248_PBMC_10242011_G07.580333.fcs	Panel_L3_G7_L3_110248_PBMC_10242011_G07.fcs
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689534			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003667		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	578309	Flow cytometry result	Panel_L1_H1_L1_110248_PBMC_11142011_H01.578309.fcs	Panel_L1_H1_L1_110248_PBMC_11142011_H01.fcs
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689534			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004145		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	578853	Flow cytometry result	Panel_L4_B_Cells_H1_L4_110248_PBMC_11142011_H01.578853.fcs	Panel_L4_B_Cells_H1_L4_110248_PBMC_11142011_H01.fcs
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689534			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004414		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579122	Flow cytometry result	Panel_P9_H1_P9_110248_PBMC_11142011_H01.579122.fcs	Panel_P9_H1_P9_110248_PBMC_11142011_H01.fcs
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689534			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004441		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579149	Flow cytometry result	Panel_P10_H4_P10_110248_PBMC_11142011_H04.579149.fcs	Panel_P10_H4_P10_110248_PBMC_11142011_H04.fcs
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689534			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004785		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579493	Flow cytometry result	Panel_P2_H7_P2_110248_PBMC_11142011_H07.579493.fcs	Panel_P2_H7_P2_110248_PBMC_11142011_H07.fcs
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689534			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004885		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579593	Flow cytometry result	Panel_L3_H7_L3_110248_PBMC_11142011_H07.579593.fcs	Panel_L3_H7_L3_110248_PBMC_11142011_H07.fcs
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689534			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004909		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579617	Flow cytometry result	Panel_P1_H10_P1_110248_PBMC_11142011_H10.579617.fcs	Panel_P1_H10_P1_110248_PBMC_11142011_H10.fcs
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689534			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005167		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579875	Flow cytometry result	Panel_L2_H4_L2_110248_PBMC_11142011_H04.579875.fcs	Panel_L2_H4_L2_110248_PBMC_11142011_H04.fcs
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689534			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005328		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	580036	Flow cytometry result	Panel_P13_H10_P13_110248_PBMC_11142011_H10.580036.fcs	Panel_P13_H10_P13_110248_PBMC_11142011_H10.fcs
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689534			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005664		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	580372	Flow cytometry result	Panel_L5_MonoNKDC_H4_L5_110248_PBMC_11142011_H04.580372.fcs	Panel_L5_MonoNKDC_H4_L5_110248_PBMC_11142011_H04.fcs
SUB120451	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752383			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003699		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	578361	Flow cytometry result	Panel_L2_E6_L2_110249_PBMC_10172011_E06.578361.fcs	Panel_L2_E6_L2_110249_PBMC_10172011_E06.fcs
SUB120451	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752383			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004418		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579126	Flow cytometry result	Panel_P13_E12_P13_110249_PBMC_10172011_E12.579126.fcs	Panel_P13_E12_P13_110249_PBMC_10172011_E12.fcs
SUB120451	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752383			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004902		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579610	Flow cytometry result	Panel_L5_MonoNKDC_E6_L5_110249_PBMC_10172011_E06.579610.fcs	Panel_L5_MonoNKDC_E6_L5_110249_PBMC_10172011_E06.fcs
SUB120451	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752383			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004957		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579665	Flow cytometry result	Panel_P1_E12_P1_110249_PBMC_10172011_E12.579665.fcs	Panel_P1_E12_P1_110249_PBMC_10172011_E12.fcs
SUB120451	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752383			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005084		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579792	Flow cytometry result	Panel_L1_E3_L1_110249_PBMC_10172011_E03.579792.fcs	Panel_L1_E3_L1_110249_PBMC_10172011_E03.fcs
SUB120451	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752383			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005165		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579873	Flow cytometry result	Panel_L3_E9_L3_110249_PBMC_10172011_E09.579873.fcs	Panel_L3_E9_L3_110249_PBMC_10172011_E09.fcs
SUB120451	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752383			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005272		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579980	Flow cytometry result	Panel_L4_B_Cells_E3_L4_110249_PBMC_10172011_E03.579980.fcs	Panel_L4_B_Cells_E3_L4_110249_PBMC_10172011_E03.fcs
SUB120451	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752383			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005371		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580079	Flow cytometry result	Panel_P10_E6_P10_110249_PBMC_10172011_E06.580079.fcs	Panel_P10_E6_P10_110249_PBMC_10172011_E06.fcs
SUB120451	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752383			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005462		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	580170	Flow cytometry result	Panel_P2_E9_P2_110249_PBMC_10172011_E09.580170.fcs	Panel_P2_E9_P2_110249_PBMC_10172011_E09.fcs
SUB120451	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752383			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005577		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580285	Flow cytometry result	Panel_P9_E3_P9_110249_PBMC_10172011_E03.580285.fcs	Panel_P9_E3_P9_110249_PBMC_10172011_E03.fcs
SUB120451	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752384			PBMC		1	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005493		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	580201	Flow cytometry result	Panel_L5_MonoNKDC_G6_L5_110249_PBMC_10182011_G06.580201.fcs	Panel_L5_MonoNKDC_G6_L5_110249_PBMC_10182011_G06.fcs
SUB120451	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752385			PBMC		3	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003641		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578262	Flow cytometry result	Panel_P9_F3_P9_110249_PBMC_10192011_F03.578262.fcs	Panel_P9_F3_P9_110249_PBMC_10192011_F03.fcs
SUB120451	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752385			PBMC		3	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003796		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	578488	Flow cytometry result	Panel_L4_B_Cells_F3_L4_110249_PBMC_10192011_F03.578488.fcs	Panel_L4_B_Cells_F3_L4_110249_PBMC_10192011_F03.fcs
SUB120451	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752385			PBMC		3	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003863		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	578565	Flow cytometry result	Panel_P1_F12_P1_110249_PBMC_10192011_F12.578565.fcs	Panel_P1_F12_P1_110249_PBMC_10192011_F12.fcs
SUB120451	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752385			PBMC		3	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003869		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	578571	Flow cytometry result	Panel_L2_F6_L2_110249_PBMC_10192011_F06.578571.fcs	Panel_L2_F6_L2_110249_PBMC_10192011_F06.fcs
SUB120451	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752385			PBMC		3	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004293		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579001	Flow cytometry result	Panel_P10_F6_P10_110249_PBMC_10192011_F06.579001.fcs	Panel_P10_F6_P10_110249_PBMC_10192011_F06.fcs
SUB120451	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752385			PBMC		3	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004558		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579266	Flow cytometry result	Panel_P13_F12_P13_110249_PBMC_10192011_F12.579266.fcs	Panel_P13_F12_P13_110249_PBMC_10192011_F12.fcs
SUB120451	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752385			PBMC		3	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004584		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579292	Flow cytometry result	Panel_L5_MonoNKDC_F6_L5_110249_PBMC_10192011_F06.579292.fcs	Panel_L5_MonoNKDC_F6_L5_110249_PBMC_10192011_F06.fcs
SUB120451	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752385			PBMC		3	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005035		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579743	Flow cytometry result	Panel_L1_F3_L1_110249_PBMC_10192011_F03.579743.fcs	Panel_L1_F3_L1_110249_PBMC_10192011_F03.fcs
SUB120451	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752385			PBMC		3	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005104		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579812	Flow cytometry result	Panel_L3_F9_L3_110249_PBMC_10192011_F09.579812.fcs	Panel_L3_F9_L3_110249_PBMC_10192011_F09.fcs
SUB120451	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752385			PBMC		3	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005583		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	580291	Flow cytometry result	Panel_P2_F9_P2_110249_PBMC_10192011_F09.580291.fcs	Panel_P2_F9_P2_110249_PBMC_10192011_F09.fcs
SUB120451	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752386			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003975		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	578683	Flow cytometry result	Panel_L1_G3_L1_110249_PBMC_10242011_G03.578683.fcs	Panel_L1_G3_L1_110249_PBMC_10242011_G03.fcs
SUB120451	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752386			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004093		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	578801	Flow cytometry result	Panel_L4_B_Cells_G3_L4_110249_PBMC_10242011_G03.578801.fcs	Panel_L4_B_Cells_G3_L4_110249_PBMC_10242011_G03.fcs
SUB120451	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752386			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004525		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579233	Flow cytometry result	Panel_L5_MonoNKDC_G6_L5_110249_PBMC_10242011_G06.579233.fcs	Panel_L5_MonoNKDC_G6_L5_110249_PBMC_10242011_G06.fcs
SUB120451	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752386			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004643		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579351	Flow cytometry result	Panel_L2_G6_L2_110249_PBMC_10242011_G06.579351.fcs	Panel_L2_G6_L2_110249_PBMC_10242011_G06.fcs
SUB120451	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752386			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004687		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579395	Flow cytometry result	Panel_P10_G6_P10_110249_PBMC_10242011_G06.579395.fcs	Panel_P10_G6_P10_110249_PBMC_10242011_G06.fcs
SUB120451	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752386			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005050		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579758	Flow cytometry result	Panel_P1_G12_P1_110249_PBMC_10242011_G12.579758.fcs	Panel_P1_G12_P1_110249_PBMC_10242011_G12.fcs
SUB120451	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752386			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005137		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579845	Flow cytometry result	Panel_P13_G12_P13_110249_PBMC_10242011_G12.579845.fcs	Panel_P13_G12_P13_110249_PBMC_10242011_G12.fcs
SUB120451	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752386			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005185		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579893	Flow cytometry result	Panel_P2_G9_P2_110249_PBMC_10242011_G09.579893.fcs	Panel_P2_G9_P2_110249_PBMC_10242011_G09.fcs
SUB120451	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752386			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005187		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579895	Flow cytometry result	Panel_L3_G9_L3_110249_PBMC_10242011_G09.579895.fcs	Panel_L3_G9_L3_110249_PBMC_10242011_G09.fcs
SUB120451	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752386			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005540		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580248	Flow cytometry result	Panel_P9_G3_P9_110249_PBMC_10242011_G03.580248.fcs	Panel_P9_G3_P9_110249_PBMC_10242011_G03.fcs
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689535			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003838		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	578537	Flow cytometry result	Panel_P1_A11_P1_110250_PBMC_10172011_A11.578537.fcs	Panel_P1_A11_P1_110250_PBMC_10172011_A11.fcs
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689535			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003845		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578545	Flow cytometry result	Panel_P9_A2_P9_110250_PBMC_10172011_A02.578545.fcs	Panel_P9_A2_P9_110250_PBMC_10172011_A02.fcs
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689535			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004599		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579307	Flow cytometry result	Panel_L1_A2_L1_110250_PBMC_10172011_A02.579307.fcs	Panel_L1_A2_L1_110250_PBMC_10172011_A02.fcs
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689535			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004615		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579323	Flow cytometry result	Panel_L5_MonoNKDC_A5_L5_110250_PBMC_10172011_A05.579323.fcs	Panel_L5_MonoNKDC_A5_L5_110250_PBMC_10172011_A05.fcs
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689535			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004771		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579479	Flow cytometry result	Panel_P2_A8_P2_110250_PBMC_10172011_A08.579479.fcs	Panel_P2_A8_P2_110250_PBMC_10172011_A08.fcs
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689535			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005148		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579856	Flow cytometry result	Panel_P13_A11_P13_110250_PBMC_10172011_A11.579856.fcs	Panel_P13_A11_P13_110250_PBMC_10172011_A11.fcs
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689535			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005235		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579943	Flow cytometry result	Panel_L4_B_Cells_A2_L4_110250_PBMC_10172011_A02.579943.fcs	Panel_L4_B_Cells_A2_L4_110250_PBMC_10172011_A02.fcs
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689535			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005320		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	580028	Flow cytometry result	Panel_L2_A5_L2_110250_PBMC_10172011_A05.580028.fcs	Panel_L2_A5_L2_110250_PBMC_10172011_A05.fcs
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689535			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005447		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	580155	Flow cytometry result	Panel_L3_A8_L3_110250_PBMC_10172011_A08.580155.fcs	Panel_L3_A8_L3_110250_PBMC_10172011_A08.fcs
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689535			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005694		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580402	Flow cytometry result	Panel_P10_A5_P10_110250_PBMC_10172011_A05.580402.fcs	Panel_P10_A5_P10_110250_PBMC_10172011_A05.fcs
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689536			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003670		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	578314	Flow cytometry result	Panel_L2_B5_L2_110250_PBMC_10192011_B05.578314.fcs	Panel_L2_B5_L2_110250_PBMC_10192011_B05.fcs
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689536			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003703		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	578368	Flow cytometry result	Panel_P2_B8_P2_110250_PBMC_10192011_B08.578368.fcs	Panel_P2_B8_P2_110250_PBMC_10192011_B08.fcs
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689536			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003896		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	578600	Flow cytometry result	Panel_P13_B11_P13_110250_PBMC_10192011_B11.578600.fcs	Panel_P13_B11_P13_110250_PBMC_10192011_B11.fcs
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689536			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004442		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579150	Flow cytometry result	Panel_L1_B2_L1_110250_PBMC_10192011_B02.579150.fcs	Panel_L1_B2_L1_110250_PBMC_10192011_B02.fcs
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689536			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004647		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579355	Flow cytometry result	Panel_P1_B11_P1_110250_PBMC_10192011_B11.579355.fcs	Panel_P1_B11_P1_110250_PBMC_10192011_B11.fcs
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689536			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004873		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579581	Flow cytometry result	Panel_P9_B2_P9_110250_PBMC_10192011_B02.579581.fcs	Panel_P9_B2_P9_110250_PBMC_10192011_B02.fcs
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689536			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005034		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579742	Flow cytometry result	Panel_L5_MonoNKDC_B5_L5_110250_PBMC_10192011_B05.579742.fcs	Panel_L5_MonoNKDC_B5_L5_110250_PBMC_10192011_B05.fcs
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689536			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005063		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579771	Flow cytometry result	Panel_L4_B_Cells_B2_L4_110250_PBMC_10192011_B02.579771.fcs	Panel_L4_B_Cells_B2_L4_110250_PBMC_10192011_B02.fcs
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689536			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005173		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579881	Flow cytometry result	Panel_L3_B8_L3_110250_PBMC_10192011_B08.579881.fcs	Panel_L3_B8_L3_110250_PBMC_10192011_B08.fcs
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689536			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005454		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580162	Flow cytometry result	Panel_P10_B5_P10_110250_PBMC_10192011_B05.580162.fcs	Panel_P10_B5_P10_110250_PBMC_10192011_B05.fcs
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689537			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003649		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	578277	Flow cytometry result	Panel_P2_C8_P2_110250_PBMC_10242011_C08.578277.fcs	Panel_P2_C8_P2_110250_PBMC_10242011_C08.fcs
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689537			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003812		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	578508	Flow cytometry result	Panel_P1_C11_P1_110250_PBMC_10242011_C11.578508.fcs	Panel_P1_C11_P1_110250_PBMC_10242011_C11.fcs
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689537			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003826		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578524	Flow cytometry result	Panel_P9_C2_P9_110250_PBMC_10242011_C02.578524.fcs	Panel_P9_C2_P9_110250_PBMC_10242011_C02.fcs
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689537			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003891		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578595	Flow cytometry result	Panel_P10_C5_P10_110250_PBMC_10242011_C05.578595.fcs	Panel_P10_C5_P10_110250_PBMC_10242011_C05.fcs
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689537			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003976		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	578684	Flow cytometry result	Panel_L2_C5_L2_110250_PBMC_10242011_C05.578684.fcs	Panel_L2_C5_L2_110250_PBMC_10242011_C05.fcs
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689537			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004884		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579592	Flow cytometry result	Panel_P13_C11_P13_110250_PBMC_10242011_C11.579592.fcs	Panel_P13_C11_P13_110250_PBMC_10242011_C11.fcs
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689537			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004945		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579653	Flow cytometry result	Panel_L1_C2_L1_110250_PBMC_10242011_C02.579653.fcs	Panel_L1_C2_L1_110250_PBMC_10242011_C02.fcs
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689537			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005302		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	580010	Flow cytometry result	Panel_L4_B_Cells_C2_L4_110250_PBMC_10242011_C02.580010.fcs	Panel_L4_B_Cells_C2_L4_110250_PBMC_10242011_C02.fcs
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689537			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005431		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	580139	Flow cytometry result	Panel_L3_C8_L3_110250_PBMC_10242011_C08.580139.fcs	Panel_L3_C8_L3_110250_PBMC_10242011_C08.fcs
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689537			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005644		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	580352	Flow cytometry result	Panel_L5_MonoNKDC_C5_L5_110250_PBMC_10242011_C05.580352.fcs	Panel_L5_MonoNKDC_C5_L5_110250_PBMC_10242011_C05.fcs
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689538			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004193		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	578901	Flow cytometry result	Panel_P2_D8_P2_110250_PBMC_11142011_D08.578901.fcs	Panel_P2_D8_P2_110250_PBMC_11142011_D08.fcs
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689538			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004495		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579203	Flow cytometry result	Panel_L1_D2_L1_110250_PBMC_11142011_D02.579203.fcs	Panel_L1_D2_L1_110250_PBMC_11142011_D02.fcs
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689538			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004610		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579318	Flow cytometry result	Panel_P13_D11_P13_110250_PBMC_11142011_D11.579318.fcs	Panel_P13_D11_P13_110250_PBMC_11142011_D11.fcs
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689538			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004682		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579390	Flow cytometry result	Panel_P1_D11_P1_110250_PBMC_11142011_D11.579390.fcs	Panel_P1_D11_P1_110250_PBMC_11142011_D11.fcs
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689538			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004806		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579514	Flow cytometry result	Panel_P10_D5_P10_110250_PBMC_11142011_D05.579514.fcs	Panel_P10_D5_P10_110250_PBMC_11142011_D05.fcs
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689538			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004907		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579615	Flow cytometry result	Panel_L4_B_Cells_D2_L4_110250_PBMC_11142011_D02.579615.fcs	Panel_L4_B_Cells_D2_L4_110250_PBMC_11142011_D02.fcs
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689538			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005010		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579718	Flow cytometry result	Panel_L2_D5_L2_110250_PBMC_11142011_D05.579718.fcs	Panel_L2_D5_L2_110250_PBMC_11142011_D05.fcs
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689538			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005097		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579805	Flow cytometry result	Panel_L3_D8_L3_110250_PBMC_11142011_D08.579805.fcs	Panel_L3_D8_L3_110250_PBMC_11142011_D08.fcs
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689538			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005310		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580018	Flow cytometry result	Panel_P9_D2_P9_110250_PBMC_11142011_D02.580018.fcs	Panel_P9_D2_P9_110250_PBMC_11142011_D02.fcs
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689538			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005494		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	580202	Flow cytometry result	Panel_L5_MonoNKDC_D5_L5_110250_PBMC_11142011_D05.580202.fcs	Panel_L5_MonoNKDC_D5_L5_110250_PBMC_11142011_D05.fcs
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752387			PBMC		38	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003876		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	578579	Flow cytometry result	Panel_P13_D11_P13_110250_PBMC_11242011_D11.578579.fcs	Panel_P13_D11_P13_110250_PBMC_11242011_D11.fcs
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752387			PBMC		38	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005400		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	580108	Flow cytometry result	Panel_L4_B_Cells_D2_L4_110250_PBMC_11242011_D02.580108.fcs	Panel_L4_B_Cells_D2_L4_110250_PBMC_11242011_D02.fcs
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689539			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003642		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	578264	Flow cytometry result	Panel_P1_E11_P1_110255_PBMC_10172011_E11.578264.fcs	Panel_P1_E11_P1_110255_PBMC_10172011_E11.fcs
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689539			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004038		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	578746	Flow cytometry result	Panel_L2_E5_L2_110255_PBMC_10172011_E05.578746.fcs	Panel_L2_E5_L2_110255_PBMC_10172011_E05.fcs
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689539			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004170		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	578878	Flow cytometry result	Panel_P2_E8_P2_110255_PBMC_10172011_E08.578878.fcs	Panel_P2_E8_P2_110255_PBMC_10172011_E08.fcs
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689539			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004289		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	578997	Flow cytometry result	Panel_L3_E8_L3_110255_PBMC_10172011_E08.578997.fcs	Panel_L3_E8_L3_110255_PBMC_10172011_E08.fcs
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689539			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004339		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579047	Flow cytometry result	Panel_L5_MonoNKDC_E5_L5_110255_PBMC_10172011_E05.579047.fcs	Panel_L5_MonoNKDC_E5_L5_110255_PBMC_10172011_E05.fcs
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689539			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004461		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579169	Flow cytometry result	Panel_P13_E11_P13_110255_PBMC_10172011_E11.579169.fcs	Panel_P13_E11_P13_110255_PBMC_10172011_E11.fcs
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689539			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004571		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579279	Flow cytometry result	Panel_P9_E2_P9_110255_PBMC_10172011_E02.579279.fcs	Panel_P9_E2_P9_110255_PBMC_10172011_E02.fcs
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689539			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004979		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579687	Flow cytometry result	Panel_L4_B_Cells_E2_L4_110255_PBMC_10172011_E02.579687.fcs	Panel_L4_B_Cells_E2_L4_110255_PBMC_10172011_E02.fcs
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689539			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005430		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	580138	Flow cytometry result	Panel_L1_E2_L1_110255_PBMC_10172011_E02.580138.fcs	Panel_L1_E2_L1_110255_PBMC_10172011_E02.fcs
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689539			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005646		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580354	Flow cytometry result	Panel_P10_E5_P10_110255_PBMC_10172011_E05.580354.fcs	Panel_P10_E5_P10_110255_PBMC_10172011_E05.fcs
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689540			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003721		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	578393	Flow cytometry result	Panel_L3_F8_L3_110255_PBMC_10192011_F08.578393.fcs	Panel_L3_F8_L3_110255_PBMC_10192011_F08.fcs
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689540			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003982		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	578690	Flow cytometry result	Panel_P2_F8_P2_110255_PBMC_10192011_F08.578690.fcs	Panel_P2_F8_P2_110255_PBMC_10192011_F08.fcs
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689540			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004026		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	578734	Flow cytometry result	Panel_P1_F11_P1_110255_PBMC_10192011_F11.578734.fcs	Panel_P1_F11_P1_110255_PBMC_10192011_F11.fcs
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689540			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004213		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	578921	Flow cytometry result	Panel_L1_F2_L1_110255_PBMC_10192011_F02.578921.fcs	Panel_L1_F2_L1_110255_PBMC_10192011_F02.fcs
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689540			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004346		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579054	Flow cytometry result	Panel_L2_F5_L2_110255_PBMC_10192011_F05.579054.fcs	Panel_L2_F5_L2_110255_PBMC_10192011_F05.fcs
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689540			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004579		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579287	Flow cytometry result	Panel_P13_F11_P13_110255_PBMC_10192011_F11.579287.fcs	Panel_P13_F11_P13_110255_PBMC_10192011_F11.fcs
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689540			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004793		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579501	Flow cytometry result	Panel_P10_F5_P10_110255_PBMC_10192011_F05.579501.fcs	Panel_P10_F5_P10_110255_PBMC_10192011_F05.fcs
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689540			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005456		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	580164	Flow cytometry result	Panel_L5_MonoNKDC_F5_L5_110255_PBMC_10192011_F05.580164.fcs	Panel_L5_MonoNKDC_F5_L5_110255_PBMC_10192011_F05.fcs
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689540			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005545		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	580253	Flow cytometry result	Panel_L4_B_Cells_F2_L4_110255_PBMC_10192011_F02.580253.fcs	Panel_L4_B_Cells_F2_L4_110255_PBMC_10192011_F02.fcs
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689540			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005552		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580260	Flow cytometry result	Panel_P9_F2_P9_110255_PBMC_10192011_F02.580260.fcs	Panel_P9_F2_P9_110255_PBMC_10192011_F02.fcs
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689541			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003668		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578310	Flow cytometry result	Panel_P10_G5_P10_110255_PBMC_10242011_G05.578310.fcs	Panel_P10_G5_P10_110255_PBMC_10242011_G05.fcs
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689541			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004340		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579048	Flow cytometry result	Panel_P1_G11_P1_110255_PBMC_10242011_G11.579048.fcs	Panel_P1_G11_P1_110255_PBMC_10242011_G11.fcs
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689541			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004400		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579108	Flow cytometry result	Panel_L3_G8_L3_110255_PBMC_10242011_G08.579108.fcs	Panel_L3_G8_L3_110255_PBMC_10242011_G08.fcs
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689541			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004417		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579125	Flow cytometry result	Panel_P2_G8_P2_110255_PBMC_10242011_G08.579125.fcs	Panel_P2_G8_P2_110255_PBMC_10242011_G08.fcs
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689541			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004446		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579154	Flow cytometry result	Panel_P9_G2_P9_110255_PBMC_10242011_G02.579154.fcs	Panel_P9_G2_P9_110255_PBMC_10242011_G02.fcs
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689541			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004578		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579286	Flow cytometry result	Panel_P13_G11_P13_110255_PBMC_10242011_G11.579286.fcs	Panel_P13_G11_P13_110255_PBMC_10242011_G11.fcs
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689541			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004632		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579340	Flow cytometry result	Panel_L4_B_Cells_G2_L4_110255_PBMC_10242011_G02.579340.fcs	Panel_L4_B_Cells_G2_L4_110255_PBMC_10242011_G02.fcs
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689541			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004828		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579536	Flow cytometry result	Panel_L1_G2_L1_110255_PBMC_10242011_G02.579536.fcs	Panel_L1_G2_L1_110255_PBMC_10242011_G02.fcs
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689541			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005180		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579888	Flow cytometry result	Panel_L2_G5_L2_110255_PBMC_10242011_G05.579888.fcs	Panel_L2_G5_L2_110255_PBMC_10242011_G05.fcs
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689541			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005391		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	580099	Flow cytometry result	Panel_L5_MonoNKDC_G5_L5_110255_PBMC_10242011_G05.580099.fcs	Panel_L5_MonoNKDC_G5_L5_110255_PBMC_10242011_G05.fcs
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689542			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003725		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	578399	Flow cytometry result	Panel_L3_H8_L3_110255_PBMC_11142011_H08.578399.fcs	Panel_L3_H8_L3_110255_PBMC_11142011_H08.fcs
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689542			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004270		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	578978	Flow cytometry result	Panel_P13_H11_P13_110255_PBMC_11142011_H11.578978.fcs	Panel_P13_H11_P13_110255_PBMC_11142011_H11.fcs
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689542			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004463		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579171	Flow cytometry result	Panel_L1_H2_L1_110255_PBMC_11142011_H02.579171.fcs	Panel_L1_H2_L1_110255_PBMC_11142011_H02.fcs
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689542			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004592		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579300	Flow cytometry result	Panel_P1_H11_P1_110255_PBMC_11142011_H11.579300.fcs	Panel_P1_H11_P1_110255_PBMC_11142011_H11.fcs
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689542			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004721		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579429	Flow cytometry result	Panel_L4_B_Cells_H2_L4_110255_PBMC_11142011_H02.579429.fcs	Panel_L4_B_Cells_H2_L4_110255_PBMC_11142011_H02.fcs
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689542			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005044		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579752	Flow cytometry result	Panel_P2_H8_P2_110255_PBMC_11142011_H08.579752.fcs	Panel_P2_H8_P2_110255_PBMC_11142011_H08.fcs
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689542			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005083		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579791	Flow cytometry result	Panel_L2_H5_L2_110255_PBMC_11142011_H05.579791.fcs	Panel_L2_H5_L2_110255_PBMC_11142011_H05.fcs
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689542			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005248		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579956	Flow cytometry result	Panel_P9_H2_P9_110255_PBMC_11142011_H02.579956.fcs	Panel_P9_H2_P9_110255_PBMC_11142011_H02.fcs
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689542			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005369		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580077	Flow cytometry result	Panel_P10_H5_P10_110255_PBMC_11142011_H05.580077.fcs	Panel_P10_H5_P10_110255_PBMC_11142011_H05.fcs
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689542			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005656		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	580364	Flow cytometry result	Panel_L5_MonoNKDC_H5_L5_110255_PBMC_11142011_H05.580364.fcs	Panel_L5_MonoNKDC_H5_L5_110255_PBMC_11142011_H05.fcs
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689543			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003700		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	578362	Flow cytometry result	Panel_P13_A12_P13_110256_PBMC_10172011_A12.578362.fcs	Panel_P13_A12_P13_110256_PBMC_10172011_A12.fcs
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689543			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003735		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	578413	Flow cytometry result	Panel_L5_MonoNKDC_A6_L5_110256_PBMC_10172011_A06.578413.fcs	Panel_L5_MonoNKDC_A6_L5_110256_PBMC_10172011_A06.fcs
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689543			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003852		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	578553	Flow cytometry result	Panel_L2_A6_L2_110256_PBMC_10172011_A06.578553.fcs	Panel_L2_A6_L2_110256_PBMC_10172011_A06.fcs
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689543			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004030		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578738	Flow cytometry result	Panel_P10_A6_P10_110256_PBMC_10172011_A06.578738.fcs	Panel_P10_A6_P10_110256_PBMC_10172011_A06.fcs
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689543			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004041		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	578749	Flow cytometry result	Panel_L4_B_Cells_A3_L4_110256_PBMC_10172011_A03.578749.fcs	Panel_L4_B_Cells_A3_L4_110256_PBMC_10172011_A03.fcs
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689543			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004382		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579090	Flow cytometry result	Panel_P1_A12_P1_110256_PBMC_10172011_A12.579090.fcs	Panel_P1_A12_P1_110256_PBMC_10172011_A12.fcs
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689543			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004734		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579442	Flow cytometry result	Panel_P9_A3_P9_110256_PBMC_10172011_A03.579442.fcs	Panel_P9_A3_P9_110256_PBMC_10172011_A03.fcs
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689543			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004962		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579670	Flow cytometry result	Panel_L1_A3_L1_110256_PBMC_10172011_A03.579670.fcs	Panel_L1_A3_L1_110256_PBMC_10172011_A03.fcs
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689543			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005071		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579779	Flow cytometry result	Panel_P2_A9_P2_110256_PBMC_10172011_A09.579779.fcs	Panel_P2_A9_P2_110256_PBMC_10172011_A09.fcs
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689543			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005479		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	580187	Flow cytometry result	Panel_L3_A9_L3_110256_PBMC_10172011_A09.580187.fcs	Panel_L3_A9_L3_110256_PBMC_10172011_A09.fcs
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689544			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003924		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	578629	Flow cytometry result	Panel_L2_B6_L2_110256_PBMC_10192011_B06.578629.fcs	Panel_L2_B6_L2_110256_PBMC_10192011_B06.fcs
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689544			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003941		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	578647	Flow cytometry result	Panel_P13_B12_P13_110256_PBMC_10192011_B12.578647.fcs	Panel_P13_B12_P13_110256_PBMC_10192011_B12.fcs
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689544			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003946		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578652	Flow cytometry result	Panel_P9_B3_P9_110256_PBMC_10192011_B03.578652.fcs	Panel_P9_B3_P9_110256_PBMC_10192011_B03.fcs
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689544			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004181		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	578889	Flow cytometry result	Panel_L4_B_Cells_B3_L4_110256_PBMC_10192011_B03.578889.fcs	Panel_L4_B_Cells_B3_L4_110256_PBMC_10192011_B03.fcs
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689544			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004716		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579424	Flow cytometry result	Panel_L5_MonoNKDC_B6_L5_110256_PBMC_10192011_B06.579424.fcs	Panel_L5_MonoNKDC_B6_L5_110256_PBMC_10192011_B06.fcs
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689544			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005231		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579939	Flow cytometry result	Panel_L1_B3_L1_110256_PBMC_10192011_B03.579939.fcs	Panel_L1_B3_L1_110256_PBMC_10192011_B03.fcs
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689544			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005304		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	580012	Flow cytometry result	Panel_L3_B9_L3_110256_PBMC_10192011_B09.580012.fcs	Panel_L3_B9_L3_110256_PBMC_10192011_B09.fcs
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689544			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005309		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580017	Flow cytometry result	Panel_P10_B6_P10_110256_PBMC_10192011_B06.580017.fcs	Panel_P10_B6_P10_110256_PBMC_10192011_B06.fcs
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689544			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005364		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	580072	Flow cytometry result	Panel_P1_B12_P1_110256_PBMC_10192011_B12.580072.fcs	Panel_P1_B12_P1_110256_PBMC_10192011_B12.fcs
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689544			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005555		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	580263	Flow cytometry result	Panel_P2_B9_P2_110256_PBMC_10192011_B09.580263.fcs	Panel_P2_B9_P2_110256_PBMC_10192011_B09.fcs
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689545			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003640		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	578260	Flow cytometry result	Panel_P2_C9_P2_110256_PBMC_10242011_C09.578260.fcs	Panel_P2_C9_P2_110256_PBMC_10242011_C09.fcs
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689545			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003643		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	578266	Flow cytometry result	Panel_L1_C3_L1_110256_PBMC_10242011_C03.578266.fcs	Panel_L1_C3_L1_110256_PBMC_10242011_C03.fcs
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689545			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004505		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579213	Flow cytometry result	Panel_P10_C6_P10_110256_PBMC_10242011_C06.579213.fcs	Panel_P10_C6_P10_110256_PBMC_10242011_C06.fcs
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689545			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004535		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579243	Flow cytometry result	Panel_L5_MonoNKDC_C6_L5_110256_PBMC_10242011_C06.579243.fcs	Panel_L5_MonoNKDC_C6_L5_110256_PBMC_10242011_C06.fcs
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689545			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004591		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579299	Flow cytometry result	Panel_P1_C12_P1_110256_PBMC_10242011_C12.579299.fcs	Panel_P1_C12_P1_110256_PBMC_10242011_C12.fcs
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689545			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004745		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579453	Flow cytometry result	Panel_L4_B_Cells_C3_L4_110256_PBMC_10242011_C03.579453.fcs	Panel_L4_B_Cells_C3_L4_110256_PBMC_10242011_C03.fcs
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689545			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004804		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579512	Flow cytometry result	Panel_L3_C9_L3_110256_PBMC_10242011_C09.579512.fcs	Panel_L3_C9_L3_110256_PBMC_10242011_C09.fcs
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689545			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005623		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	580331	Flow cytometry result	Panel_L2_C6_L2_110256_PBMC_10242011_C06.580331.fcs	Panel_L2_C6_L2_110256_PBMC_10242011_C06.fcs
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689545			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005667		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	580375	Flow cytometry result	Panel_P13_C12_P13_110256_PBMC_10242011_C12.580375.fcs	Panel_P13_C12_P13_110256_PBMC_10242011_C12.fcs
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689545			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005672		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580380	Flow cytometry result	Panel_P9_C3_P9_110256_PBMC_10242011_C03.580380.fcs	Panel_P9_C3_P9_110256_PBMC_10242011_C03.fcs
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689546			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004123		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	578831	Flow cytometry result	Panel_P13_D12_P13_110256_PBMC_11142011_D12.578831.fcs	Panel_P13_D12_P13_110256_PBMC_11142011_D12.fcs
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689546			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004168		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	578876	Flow cytometry result	Panel_P1_D12_P1_110256_PBMC_11142011_D12.578876.fcs	Panel_P1_D12_P1_110256_PBMC_11142011_D12.fcs
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689546			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004500		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579208	Flow cytometry result	Panel_L5_MonoNKDC_D6_L5_110256_PBMC_11142011_D06.579208.fcs	Panel_L5_MonoNKDC_D6_L5_110256_PBMC_11142011_D06.fcs
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689546			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004625		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579333	Flow cytometry result	Panel_P2_D9_P2_110256_PBMC_11142011_D09.579333.fcs	Panel_P2_D9_P2_110256_PBMC_11142011_D09.fcs
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689546			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005070		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579778	Flow cytometry result	Panel_P10_D6_P10_110256_PBMC_11142011_D06.579778.fcs	Panel_P10_D6_P10_110256_PBMC_11142011_D06.fcs
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689546			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005117		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579825	Flow cytometry result	Panel_L1_D3_L1_110256_PBMC_11142011_D03.579825.fcs	Panel_L1_D3_L1_110256_PBMC_11142011_D03.fcs
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689546			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005489		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	580197	Flow cytometry result	Panel_L4_B_Cells_D3_L4_110256_PBMC_11142011_D03.580197.fcs	Panel_L4_B_Cells_D3_L4_110256_PBMC_11142011_D03.fcs
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689546			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005610		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	580318	Flow cytometry result	Panel_L2_D6_L2_110256_PBMC_11142011_D06.580318.fcs	Panel_L2_D6_L2_110256_PBMC_11142011_D06.fcs
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689546			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005630		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	580338	Flow cytometry result	Panel_L3_D9_L3_110256_PBMC_11142011_D09.580338.fcs	Panel_L3_D9_L3_110256_PBMC_11142011_D09.fcs
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689546			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005699		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580407	Flow cytometry result	Panel_P9_D3_P9_110256_PBMC_11142011_D03.580407.fcs	Panel_P9_D3_P9_110256_PBMC_11142011_D03.fcs
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752388			PBMC		38	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004547		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579255	Flow cytometry result	Panel_L4_B_Cells_D3_L4_110256_PBMC_11242011_D03.579255.fcs	Panel_L4_B_Cells_D3_L4_110256_PBMC_11242011_D03.fcs
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752388			PBMC		38	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004929		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579637	Flow cytometry result	Panel_P13_D12_P13_110256_PBMC_11242011_D12.579637.fcs	Panel_P13_D12_P13_110256_PBMC_11242011_D12.fcs
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689547			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003701		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	578364	Flow cytometry result	Panel_P13_A10_P13_110257_PBMC_10172011_A10.578364.fcs	Panel_P13_A10_P13_110257_PBMC_10172011_A10.fcs
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689547			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003866		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	578568	Flow cytometry result	Panel_L3_A7_L3_110257_PBMC_10172011_A07.578568.fcs	Panel_L3_A7_L3_110257_PBMC_10172011_A07.fcs
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689547			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003906		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	578610	Flow cytometry result	Panel_L5_MonoNKDC_A4_L5_110257_PBMC_10172011_A04.578610.fcs	Panel_L5_MonoNKDC_A4_L5_110257_PBMC_10172011_A04.fcs
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689547			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004600		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579308	Flow cytometry result	Panel_P1_A10_P1_110257_PBMC_10172011_A10.579308.fcs	Panel_P1_A10_P1_110257_PBMC_10172011_A10.fcs
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689547			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004697		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579405	Flow cytometry result	Panel_P9_A1_P9_110257_PBMC_10172011_A01.579405.fcs	Panel_P9_A1_P9_110257_PBMC_10172011_A01.fcs
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689547			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004842		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579550	Flow cytometry result	Panel_L4_B_Cells_A1_L4_110257_PBMC_10172011_A01.579550.fcs	Panel_L4_B_Cells_A1_L4_110257_PBMC_10172011_A01.fcs
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689547			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005294		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	580002	Flow cytometry result	Panel_P2_A7_P2_110257_PBMC_10172011_A07.580002.fcs	Panel_P2_A7_P2_110257_PBMC_10172011_A07.fcs
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689547			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005394		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580102	Flow cytometry result	Panel_P10_A4_P10_110257_PBMC_10172011_A04.580102.fcs	Panel_P10_A4_P10_110257_PBMC_10172011_A04.fcs
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689547			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005436		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	580144	Flow cytometry result	Panel_L2_A4_L2_110257_PBMC_10172011_A04.580144.fcs	Panel_L2_A4_L2_110257_PBMC_10172011_A04.fcs
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689547			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005591		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	580299	Flow cytometry result	Panel_L1_A1_L1_110257_PBMC_10172011_A01.580299.fcs	Panel_L1_A1_L1_110257_PBMC_10172011_A01.fcs
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689548			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003843		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	578543	Flow cytometry result	Panel_P1_B10_P1_110257_PBMC_10192011_B10.578543.fcs	Panel_P1_B10_P1_110257_PBMC_10192011_B10.fcs
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689548			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004097		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578805	Flow cytometry result	Panel_P10_B4_P10_110257_PBMC_10192011_B04.578805.fcs	Panel_P10_B4_P10_110257_PBMC_10192011_B04.fcs
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689548			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004268		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	578976	Flow cytometry result	Panel_L2_B4_L2_110257_PBMC_10192011_B04.578976.fcs	Panel_L2_B4_L2_110257_PBMC_10192011_B04.fcs
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689548			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004301		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579009	Flow cytometry result	Panel_L3_B7_L3_110257_PBMC_10192011_B07.579009.fcs	Panel_L3_B7_L3_110257_PBMC_10192011_B07.fcs
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689548			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005147		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579855	Flow cytometry result	Panel_L5_MonoNKDC_B4_L5_110257_PBMC_10192011_B04.579855.fcs	Panel_L5_MonoNKDC_B4_L5_110257_PBMC_10192011_B04.fcs
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689548			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005335		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	580043	Flow cytometry result	Panel_L1_B1_L1_110257_PBMC_10192011_B01.580043.fcs	Panel_L1_B1_L1_110257_PBMC_10192011_B01.fcs
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689548			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005433		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	580141	Flow cytometry result	Panel_P13_B10_P13_110257_PBMC_10192011_B10.580141.fcs	Panel_P13_B10_P13_110257_PBMC_10192011_B10.fcs
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689548			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005437		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580145	Flow cytometry result	Panel_P9_B1_P9_110257_PBMC_10192011_B01.580145.fcs	Panel_P9_B1_P9_110257_PBMC_10192011_B01.fcs
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689548			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005477		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	580185	Flow cytometry result	Panel_L4_B_Cells_B1_L4_110257_PBMC_10192011_B01.580185.fcs	Panel_L4_B_Cells_B1_L4_110257_PBMC_10192011_B01.fcs
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689548			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005609		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	580317	Flow cytometry result	Panel_P2_B7_P2_110257_PBMC_10192011_B07.580317.fcs	Panel_P2_B7_P2_110257_PBMC_10192011_B07.fcs
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689549			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003763		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578446	Flow cytometry result	Panel_P10_C4_P10_110257_PBMC_10242011_C04.578446.fcs	Panel_P10_C4_P10_110257_PBMC_10242011_C04.fcs
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689549			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003872		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	578574	Flow cytometry result	Panel_L5_MonoNKDC_C4_L5_110257_PBMC_10242011_C04.578574.fcs	Panel_L5_MonoNKDC_C4_L5_110257_PBMC_10242011_C04.fcs
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689549			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004322		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579030	Flow cytometry result	Panel_L2_C4_L2_110257_PBMC_10242011_C04.579030.fcs	Panel_L2_C4_L2_110257_PBMC_10242011_C04.fcs
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689549			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004353		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579061	Flow cytometry result	Panel_P13_C10_P13_110257_PBMC_10242011_C10.579061.fcs	Panel_P13_C10_P13_110257_PBMC_10242011_C10.fcs
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689549			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004553		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579261	Flow cytometry result	Panel_P2_C7_P2_110257_PBMC_10242011_C07.579261.fcs	Panel_P2_C7_P2_110257_PBMC_10242011_C07.fcs
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689549			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004821		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579529	Flow cytometry result	Panel_L4_B_Cells_C1_L4_110257_PBMC_10242011_C01.579529.fcs	Panel_L4_B_Cells_C1_L4_110257_PBMC_10242011_C01.fcs
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689549			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005245		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579953	Flow cytometry result	Panel_L1_C1_L1_110257_PBMC_10242011_C01.579953.fcs	Panel_L1_C1_L1_110257_PBMC_10242011_C01.fcs
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689549			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005426		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	580134	Flow cytometry result	Panel_P1_C10_P1_110257_PBMC_10242011_C10.580134.fcs	Panel_P1_C10_P1_110257_PBMC_10242011_C10.fcs
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689549			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005518		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580226	Flow cytometry result	Panel_P9_C1_P9_110257_PBMC_10242011_C01.580226.fcs	Panel_P9_C1_P9_110257_PBMC_10242011_C01.fcs
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689549			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005593		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	580301	Flow cytometry result	Panel_L3_C7_L3_110257_PBMC_10242011_C07.580301.fcs	Panel_L3_C7_L3_110257_PBMC_10242011_C07.fcs
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689550			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003883		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	578587	Flow cytometry result	Panel_L5_MonoNKDC_D4_L5_110257_PBMC_11142011_D04.578587.fcs	Panel_L5_MonoNKDC_D4_L5_110257_PBMC_11142011_D04.fcs
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689550			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004033		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	578741	Flow cytometry result	Panel_P2_D7_P2_110257_PBMC_11142011_D07.578741.fcs	Panel_P2_D7_P2_110257_PBMC_11142011_D07.fcs
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689550			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004242		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	578950	Flow cytometry result	Panel_L3_D7_L3_110257_PBMC_11142011_D07.578950.fcs	Panel_L3_D7_L3_110257_PBMC_11142011_D07.fcs
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689550			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004292		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579000	Flow cytometry result	Panel_L4_B_Cells_D1_L4_110257_PBMC_11142011_D01.579000.fcs	Panel_L4_B_Cells_D1_L4_110257_PBMC_11142011_D01.fcs
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689550			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004491		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579199	Flow cytometry result	Panel_P13_D10_P13_110257_PBMC_11142011_D10.579199.fcs	Panel_P13_D10_P13_110257_PBMC_11142011_D10.fcs
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689550			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004670		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579378	Flow cytometry result	Panel_P9_D1_P9_110257_PBMC_11142011_D01.579378.fcs	Panel_P9_D1_P9_110257_PBMC_11142011_D01.fcs
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689550			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004918		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579626	Flow cytometry result	Panel_P1_D10_P1_110257_PBMC_11142011_D10.579626.fcs	Panel_P1_D10_P1_110257_PBMC_11142011_D10.fcs
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689550			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005390		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	580098	Flow cytometry result	Panel_L1_D1_L1_110257_PBMC_11142011_D01.580098.fcs	Panel_L1_D1_L1_110257_PBMC_11142011_D01.fcs
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689550			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005589		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	580297	Flow cytometry result	Panel_L2_D4_L2_110257_PBMC_11142011_D04.580297.fcs	Panel_L2_D4_L2_110257_PBMC_11142011_D04.fcs
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689550			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005668		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580376	Flow cytometry result	Panel_P10_D4_P10_110257_PBMC_11142011_D04.580376.fcs	Panel_P10_D4_P10_110257_PBMC_11142011_D04.fcs
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689551			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003771		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	578455	Flow cytometry result	Panel_P1_E10_P1_110258_PBMC_10172011_E10.578455.fcs	Panel_P1_E10_P1_110258_PBMC_10172011_E10.fcs
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689551			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003840		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	578539	Flow cytometry result	Panel_P2_E7_P2_110258_PBMC_10172011_E07.578539.fcs	Panel_P2_E7_P2_110258_PBMC_10172011_E07.fcs
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689551			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003854		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	578555	Flow cytometry result	Panel_L4_B_Cells_E1_L4_110258_PBMC_10172011_E01.578555.fcs	Panel_L4_B_Cells_E1_L4_110258_PBMC_10172011_E01.fcs
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689551			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003898		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	578602	Flow cytometry result	Panel_P13_E10_P13_110258_PBMC_10172011_E10.578602.fcs	Panel_P13_E10_P13_110258_PBMC_10172011_E10.fcs
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689551			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004056		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578764	Flow cytometry result	Panel_P10_E4_P10_110258_PBMC_10172011_E04.578764.fcs	Panel_P10_E4_P10_110258_PBMC_10172011_E04.fcs
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689551			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004269		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	578977	Flow cytometry result	Panel_L5_MonoNKDC_E4_L5_110258_PBMC_10172011_E04.578977.fcs	Panel_L5_MonoNKDC_E4_L5_110258_PBMC_10172011_E04.fcs
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689551			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004597		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579305	Flow cytometry result	Panel_P9_E1_P9_110258_PBMC_10172011_E01.579305.fcs	Panel_P9_E1_P9_110258_PBMC_10172011_E01.fcs
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689551			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004940		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579648	Flow cytometry result	Panel_L2_E4_L2_110258_PBMC_10172011_E04.579648.fcs	Panel_L2_E4_L2_110258_PBMC_10172011_E04.fcs
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689551			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005054		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579762	Flow cytometry result	Panel_L3_E7_L3_110258_PBMC_10172011_E07.579762.fcs	Panel_L3_E7_L3_110258_PBMC_10172011_E07.fcs
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689551			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005259		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579967	Flow cytometry result	Panel_L1_E1_L1_110258_PBMC_10172011_E01.579967.fcs	Panel_L1_E1_L1_110258_PBMC_10172011_E01.fcs
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689552			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003660		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	578296	Flow cytometry result	Panel_L2_F4_L2_110258_PBMC_10192011_F04.578296.fcs	Panel_L2_F4_L2_110258_PBMC_10192011_F04.fcs
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689552			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003814		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	578510	Flow cytometry result	Panel_L1_F1_L1_110258_PBMC_10192011_F01.578510.fcs	Panel_L1_F1_L1_110258_PBMC_10192011_F01.fcs
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689552			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003919		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578624	Flow cytometry result	Panel_P9_F1_P9_110258_PBMC_10192011_F01.578624.fcs	Panel_P9_F1_P9_110258_PBMC_10192011_F01.fcs
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689552			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004249		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	578957	Flow cytometry result	Panel_L3_F7_L3_110258_PBMC_10192011_F07.578957.fcs	Panel_L3_F7_L3_110258_PBMC_10192011_F07.fcs
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689552			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004305		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579013	Flow cytometry result	Panel_L5_MonoNKDC_F4_L5_110258_PBMC_10192011_F04.579013.fcs	Panel_L5_MonoNKDC_F4_L5_110258_PBMC_10192011_F04.fcs
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689552			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004432		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579140	Flow cytometry result	Panel_P2_F7_P2_110258_PBMC_10192011_F07.579140.fcs	Panel_P2_F7_P2_110258_PBMC_10192011_F07.fcs
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689552			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004695		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579403	Flow cytometry result	Panel_P1_F10_P1_110258_PBMC_10192011_F10.579403.fcs	Panel_P1_F10_P1_110258_PBMC_10192011_F10.fcs
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689552			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004798		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579506	Flow cytometry result	Panel_L4_B_Cells_F1_L4_110258_PBMC_10192011_F01.579506.fcs	Panel_L4_B_Cells_F1_L4_110258_PBMC_10192011_F01.fcs
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689552			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005378		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580086	Flow cytometry result	Panel_P10_F4_P10_110258_PBMC_10192011_F04.580086.fcs	Panel_P10_F4_P10_110258_PBMC_10192011_F04.fcs
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689552			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005380		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	580088	Flow cytometry result	Panel_P13_F10_P13_110258_PBMC_10192011_F10.580088.fcs	Panel_P13_F10_P13_110258_PBMC_10192011_F10.fcs
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689553			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003651		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	578280	Flow cytometry result	Panel_L5_MonoNKDC_G4_L5_110258_PBMC_10242011_G04.578280.fcs	Panel_L5_MonoNKDC_G4_L5_110258_PBMC_10242011_G04.fcs
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689553			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004141		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	578849	Flow cytometry result	Panel_P13_G10_P13_110258_PBMC_10242011_G10.578849.fcs	Panel_P13_G10_P13_110258_PBMC_10242011_G10.fcs
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689553			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004756		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579464	Flow cytometry result	Panel_L1_G1_L1_110258_PBMC_10242011_G01.579464.fcs	Panel_L1_G1_L1_110258_PBMC_10242011_G01.fcs
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689553			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004810		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579518	Flow cytometry result	Panel_L2_G4_L2_110258_PBMC_10242011_G04.579518.fcs	Panel_L2_G4_L2_110258_PBMC_10242011_G04.fcs
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689553			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004829		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579537	Flow cytometry result	Panel_L4_B_Cells_G1_L4_110258_PBMC_10242011_G01.579537.fcs	Panel_L4_B_Cells_G1_L4_110258_PBMC_10242011_G01.fcs
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689553			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005064		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579772	Flow cytometry result	Panel_P1_G10_P1_110258_PBMC_10242011_G10.579772.fcs	Panel_P1_G10_P1_110258_PBMC_10242011_G10.fcs
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689553			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005254		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579962	Flow cytometry result	Panel_P10_G4_P10_110258_PBMC_10242011_G04.579962.fcs	Panel_P10_G4_P10_110258_PBMC_10242011_G04.fcs
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689553			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005267		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579975	Flow cytometry result	Panel_P9_G1_P9_110258_PBMC_10242011_G01.579975.fcs	Panel_P9_G1_P9_110258_PBMC_10242011_G01.fcs
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689553			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005501		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	580209	Flow cytometry result	Panel_P2_G7_P2_110258_PBMC_10242011_G07.580209.fcs	Panel_P2_G7_P2_110258_PBMC_10242011_G07.fcs
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689553			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005641		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	580349	Flow cytometry result	Panel_L3_G7_L3_110258_PBMC_10242011_G07.580349.fcs	Panel_L3_G7_L3_110258_PBMC_10242011_G07.fcs
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689554			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003666		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578307	Flow cytometry result	Panel_P9_H1_P9_110258_PBMC_11142011_H01.578307.fcs	Panel_P9_H1_P9_110258_PBMC_11142011_H01.fcs
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689554			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004402		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579110	Flow cytometry result	Panel_L4_B_Cells_H1_L4_110258_PBMC_11142011_H01.579110.fcs	Panel_L4_B_Cells_H1_L4_110258_PBMC_11142011_H01.fcs
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689554			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004480		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579188	Flow cytometry result	Panel_P1_H10_P1_110258_PBMC_11142011_H10.579188.fcs	Panel_P1_H10_P1_110258_PBMC_11142011_H10.fcs
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689554			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004920		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579628	Flow cytometry result	Panel_L5_MonoNKDC_H4_L5_110258_PBMC_11142011_H04.579628.fcs	Panel_L5_MonoNKDC_H4_L5_110258_PBMC_11142011_H04.fcs
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689554			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005200		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579908	Flow cytometry result	Panel_L1_H1_L1_110258_PBMC_11142011_H01.579908.fcs	Panel_L1_H1_L1_110258_PBMC_11142011_H01.fcs
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689554			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005227		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579935	Flow cytometry result	Panel_P13_H10_P13_110258_PBMC_11142011_H10.579935.fcs	Panel_P13_H10_P13_110258_PBMC_11142011_H10.fcs
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689554			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005296		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	580004	Flow cytometry result	Panel_P2_H7_P2_110258_PBMC_11142011_H07.580004.fcs	Panel_P2_H7_P2_110258_PBMC_11142011_H07.fcs
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689554			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005452		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	580160	Flow cytometry result	Panel_L3_H7_L3_110258_PBMC_11142011_H07.580160.fcs	Panel_L3_H7_L3_110258_PBMC_11142011_H07.fcs
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689554			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005500		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	580208	Flow cytometry result	Panel_L2_H4_L2_110258_PBMC_11142011_H04.580208.fcs	Panel_L2_H4_L2_110258_PBMC_11142011_H04.fcs
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689554			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005542		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580250	Flow cytometry result	Panel_P10_H4_P10_110258_PBMC_11142011_H04.580250.fcs	Panel_P10_H4_P10_110258_PBMC_11142011_H04.fcs
SUB120461	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752389			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003731		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	578407	Flow cytometry result	Panel_L1_E3_L1_110259_PBMC_10172011_E03.578407.fcs	Panel_L1_E3_L1_110259_PBMC_10172011_E03.fcs
SUB120461	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752389			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003804		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	578499	Flow cytometry result	Panel_P13_E12_P13_110259_PBMC_10172011_E12.578499.fcs	Panel_P13_E12_P13_110259_PBMC_10172011_E12.fcs
SUB120461	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752389			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003819		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	578516	Flow cytometry result	Panel_L3_E9_L3_110259_PBMC_10172011_E09.578516.fcs	Panel_L3_E9_L3_110259_PBMC_10172011_E09.fcs
SUB120461	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752389			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004342		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579050	Flow cytometry result	Panel_P10_E6_P10_110259_PBMC_10172011_E06.579050.fcs	Panel_P10_E6_P10_110259_PBMC_10172011_E06.fcs
SUB120461	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752389			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004669		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579377	Flow cytometry result	Panel_L5_MonoNKDC_E6_L5_110259_PBMC_10172011_E06.579377.fcs	Panel_L5_MonoNKDC_E6_L5_110259_PBMC_10172011_E06.fcs
SUB120461	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752389			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004797		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579505	Flow cytometry result	Panel_L2_E6_L2_110259_PBMC_10172011_E06.579505.fcs	Panel_L2_E6_L2_110259_PBMC_10172011_E06.fcs
SUB120461	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752389			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004872		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579580	Flow cytometry result	Panel_P2_E9_P2_110259_PBMC_10172011_E09.579580.fcs	Panel_P2_E9_P2_110259_PBMC_10172011_E09.fcs
SUB120461	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752389			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004983		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579691	Flow cytometry result	Panel_P1_E12_P1_110259_PBMC_10172011_E12.579691.fcs	Panel_P1_E12_P1_110259_PBMC_10172011_E12.fcs
SUB120461	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752389			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005241		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579949	Flow cytometry result	Panel_P9_E3_P9_110259_PBMC_10172011_E03.579949.fcs	Panel_P9_E3_P9_110259_PBMC_10172011_E03.fcs
SUB120461	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752389			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005563		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	580271	Flow cytometry result	Panel_L4_B_Cells_E3_L4_110259_PBMC_10172011_E03.580271.fcs	Panel_L4_B_Cells_E3_L4_110259_PBMC_10172011_E03.fcs
SUB120461	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752390			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003776		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578463	Flow cytometry result	Panel_P9_F3_P9_110259_PBMC_10192011_F03.578463.fcs	Panel_P9_F3_P9_110259_PBMC_10192011_F03.fcs
SUB120461	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752390			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004053		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	578761	Flow cytometry result	Panel_L1_F3_L1_110259_PBMC_10192011_F03.578761.fcs	Panel_L1_F3_L1_110259_PBMC_10192011_F03.fcs
SUB120461	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752390			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004637		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579345	Flow cytometry result	Panel_P2_F9_P2_110259_PBMC_10192011_F09.579345.fcs	Panel_P2_F9_P2_110259_PBMC_10192011_F09.fcs
SUB120461	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752390			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004757		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579465	Flow cytometry result	Panel_P10_F6_P10_110259_PBMC_10192011_F06.579465.fcs	Panel_P10_F6_P10_110259_PBMC_10192011_F06.fcs
SUB120461	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752390			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004814		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579522	Flow cytometry result	Panel_L3_F9_L3_110259_PBMC_10192011_F09.579522.fcs	Panel_L3_F9_L3_110259_PBMC_10192011_F09.fcs
SUB120461	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752390			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004905		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579613	Flow cytometry result	Panel_P13_F12_P13_110259_PBMC_10192011_F12.579613.fcs	Panel_P13_F12_P13_110259_PBMC_10192011_F12.fcs
SUB120461	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752390			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005269		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579977	Flow cytometry result	Panel_L2_F6_L2_110259_PBMC_10192011_F06.579977.fcs	Panel_L2_F6_L2_110259_PBMC_10192011_F06.fcs
SUB120461	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752390			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005316		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	580024	Flow cytometry result	Panel_L5_MonoNKDC_F6_L5_110259_PBMC_10192011_F06.580024.fcs	Panel_L5_MonoNKDC_F6_L5_110259_PBMC_10192011_F06.fcs
SUB120461	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752390			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005513		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	580221	Flow cytometry result	Panel_P1_F12_P1_110259_PBMC_10192011_F12.580221.fcs	Panel_P1_F12_P1_110259_PBMC_10192011_F12.fcs
SUB120461	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752390			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005536		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	580244	Flow cytometry result	Panel_L4_B_Cells_F3_L4_110259_PBMC_10192011_F03.580244.fcs	Panel_L4_B_Cells_F3_L4_110259_PBMC_10192011_F03.fcs
SUB120461	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752391			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003690		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578345	Flow cytometry result	Panel_P10_G6_P10_110259_PBMC_10242011_G06.578345.fcs	Panel_P10_G6_P10_110259_PBMC_10242011_G06.fcs
SUB120461	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752391			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003859		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	578561	Flow cytometry result	Panel_L5_MonoNKDC_G6_L5_110259_PBMC_10242011_G06.578561.fcs	Panel_L5_MonoNKDC_G6_L5_110259_PBMC_10242011_G06.fcs
SUB120461	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752391			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003900		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	578604	Flow cytometry result	Panel_L1_G3_L1_110259_PBMC_10242011_G03.578604.fcs	Panel_L1_G3_L1_110259_PBMC_10242011_G03.fcs
SUB120461	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752391			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004243		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578951	Flow cytometry result	Panel_P9_G3_P9_110259_PBMC_10242011_G03.578951.fcs	Panel_P9_G3_P9_110259_PBMC_10242011_G03.fcs
SUB120461	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752391			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004273		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	578981	Flow cytometry result	Panel_L2_G6_L2_110259_PBMC_10242011_G06.578981.fcs	Panel_L2_G6_L2_110259_PBMC_10242011_G06.fcs
SUB120461	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752391			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004587		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579295	Flow cytometry result	Panel_P1_G12_P1_110259_PBMC_10242011_G12.579295.fcs	Panel_P1_G12_P1_110259_PBMC_10242011_G12.fcs
SUB120461	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752391			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004722		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579430	Flow cytometry result	Panel_P13_G12_P13_110259_PBMC_10242011_G12.579430.fcs	Panel_P13_G12_P13_110259_PBMC_10242011_G12.fcs
SUB120461	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752391			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004890		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579598	Flow cytometry result	Panel_P2_G9_P2_110259_PBMC_10242011_G09.579598.fcs	Panel_P2_G9_P2_110259_PBMC_10242011_G09.fcs
SUB120461	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752391			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005249		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579957	Flow cytometry result	Panel_L3_G9_L3_110259_PBMC_10242011_G09.579957.fcs	Panel_L3_G9_L3_110259_PBMC_10242011_G09.fcs
SUB120461	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752391			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005522		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	580230	Flow cytometry result	Panel_L4_B_Cells_G3_L4_110259_PBMC_10242011_G03.580230.fcs	Panel_L4_B_Cells_G3_L4_110259_PBMC_10242011_G03.fcs
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689555			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003724		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	578398	Flow cytometry result	Panel_L1_A2_L1_110260_PBMC_10172011_A02.578398.fcs	Panel_L1_A2_L1_110260_PBMC_10172011_A02.fcs
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689555			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004182		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	578890	Flow cytometry result	Panel_L3_A8_L3_110260_PBMC_10172011_A08.578890.fcs	Panel_L3_A8_L3_110260_PBMC_10172011_A08.fcs
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689555			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004373		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579081	Flow cytometry result	Panel_L4_B_Cells_A2_L4_110260_PBMC_10172011_A02.579081.fcs	Panel_L4_B_Cells_A2_L4_110260_PBMC_10172011_A02.fcs
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689555			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004486		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579194	Flow cytometry result	Panel_L5_MonoNKDC_A5_L5_110260_PBMC_10172011_A05.579194.fcs	Panel_L5_MonoNKDC_A5_L5_110260_PBMC_10172011_A05.fcs
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689555			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004520		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579228	Flow cytometry result	Panel_P10_A5_P10_110260_PBMC_10172011_A05.579228.fcs	Panel_P10_A5_P10_110260_PBMC_10172011_A05.fcs
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689555			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004529		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579237	Flow cytometry result	Panel_P2_A8_P2_110260_PBMC_10172011_A08.579237.fcs	Panel_P2_A8_P2_110260_PBMC_10172011_A08.fcs
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689555			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004552		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579260	Flow cytometry result	Panel_P1_A11_P1_110260_PBMC_10172011_A11.579260.fcs	Panel_P1_A11_P1_110260_PBMC_10172011_A11.fcs
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689555			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004903		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579611	Flow cytometry result	Panel_L2_A5_L2_110260_PBMC_10172011_A05.579611.fcs	Panel_L2_A5_L2_110260_PBMC_10172011_A05.fcs
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689555			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005086		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579794	Flow cytometry result	Panel_P13_A11_P13_110260_PBMC_10172011_A11.579794.fcs	Panel_P13_A11_P13_110260_PBMC_10172011_A11.fcs
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689555			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005321		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580029	Flow cytometry result	Panel_P9_A2_P9_110260_PBMC_10172011_A02.580029.fcs	Panel_P9_A2_P9_110260_PBMC_10172011_A02.fcs
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689556			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003846		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	578546	Flow cytometry result	Panel_L4_B_Cells_B2_L4_110260_PBMC_10192011_B02.578546.fcs	Panel_L4_B_Cells_B2_L4_110260_PBMC_10192011_B02.fcs
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689556			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004164		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578872	Flow cytometry result	Panel_P10_B5_P10_110260_PBMC_10192011_B05.578872.fcs	Panel_P10_B5_P10_110260_PBMC_10192011_B05.fcs
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689556			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004748		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579456	Flow cytometry result	Panel_L2_B5_L2_110260_PBMC_10192011_B05.579456.fcs	Panel_L2_B5_L2_110260_PBMC_10192011_B05.fcs
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689556			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005284		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579992	Flow cytometry result	Panel_P2_B8_P2_110260_PBMC_10192011_B08.579992.fcs	Panel_P2_B8_P2_110260_PBMC_10192011_B08.fcs
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689556			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005331		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	580039	Flow cytometry result	Panel_P1_B11_P1_110260_PBMC_10192011_B11.580039.fcs	Panel_P1_B11_P1_110260_PBMC_10192011_B11.fcs
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689556			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005367		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	580075	Flow cytometry result	Panel_P13_B11_P13_110260_PBMC_10192011_B11.580075.fcs	Panel_P13_B11_P13_110260_PBMC_10192011_B11.fcs
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689556			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005401		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580109	Flow cytometry result	Panel_P9_B2_P9_110260_PBMC_10192011_B02.580109.fcs	Panel_P9_B2_P9_110260_PBMC_10192011_B02.fcs
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689556			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005478		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	580186	Flow cytometry result	Panel_L3_B8_L3_110260_PBMC_10192011_B08.580186.fcs	Panel_L3_B8_L3_110260_PBMC_10192011_B08.fcs
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689556			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005505		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	580213	Flow cytometry result	Panel_L1_B2_L1_110260_PBMC_10192011_B02.580213.fcs	Panel_L1_B2_L1_110260_PBMC_10192011_B02.fcs
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689556			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005585		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	580293	Flow cytometry result	Panel_L5_MonoNKDC_B5_L5_110260_PBMC_10192011_B05.580293.fcs	Panel_L5_MonoNKDC_B5_L5_110260_PBMC_10192011_B05.fcs
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689557			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003894		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578598	Flow cytometry result	Panel_P10_C5_P10_110260_PBMC_10242011_C05.578598.fcs	Panel_P10_C5_P10_110260_PBMC_10242011_C05.fcs
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689557			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003911		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	578615	Flow cytometry result	Panel_L4_B_Cells_C2_L4_110260_PBMC_10242011_C02.578615.fcs	Panel_L4_B_Cells_C2_L4_110260_PBMC_10242011_C02.fcs
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689557			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004210		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	578918	Flow cytometry result	Panel_P13_C11_P13_110260_PBMC_10242011_C11.578918.fcs	Panel_P13_C11_P13_110260_PBMC_10242011_C11.fcs
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689557			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004246		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	578954	Flow cytometry result	Panel_P2_C8_P2_110260_PBMC_10242011_C08.578954.fcs	Panel_P2_C8_P2_110260_PBMC_10242011_C08.fcs
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689557			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004359		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579067	Flow cytometry result	Panel_P1_C11_P1_110260_PBMC_10242011_C11.579067.fcs	Panel_P1_C11_P1_110260_PBMC_10242011_C11.fcs
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689557			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004362		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579070	Flow cytometry result	Panel_L1_C2_L1_110260_PBMC_10242011_C02.579070.fcs	Panel_L1_C2_L1_110260_PBMC_10242011_C02.fcs
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689557			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004626		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579334	Flow cytometry result	Panel_L3_C8_L3_110260_PBMC_10242011_C08.579334.fcs	Panel_L3_C8_L3_110260_PBMC_10242011_C08.fcs
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689557			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004752		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579460	Flow cytometry result	Panel_P9_C2_P9_110260_PBMC_10242011_C02.579460.fcs	Panel_P9_C2_P9_110260_PBMC_10242011_C02.fcs
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689557			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004934		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579642	Flow cytometry result	Panel_L2_C5_L2_110260_PBMC_10242011_C05.579642.fcs	Panel_L2_C5_L2_110260_PBMC_10242011_C05.fcs
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689557			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005375		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	580083	Flow cytometry result	Panel_L5_MonoNKDC_C5_L5_110260_PBMC_10242011_C05.580083.fcs	Panel_L5_MonoNKDC_C5_L5_110260_PBMC_10242011_C05.fcs
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689558			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004117		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	578825	Flow cytometry result	Panel_L1_D2_L1_110260_PBMC_11142011_D02.578825.fcs	Panel_L1_D2_L1_110260_PBMC_11142011_D02.fcs
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689558			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004189		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	578897	Flow cytometry result	Panel_L5_MonoNKDC_D5_L5_110260_PBMC_11142011_D05.578897.fcs	Panel_L5_MonoNKDC_D5_L5_110260_PBMC_11142011_D05.fcs
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689558			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004254		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	578962	Flow cytometry result	Panel_L2_D5_L2_110260_PBMC_11142011_D05.578962.fcs	Panel_L2_D5_L2_110260_PBMC_11142011_D05.fcs
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689558			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004265		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	578973	Flow cytometry result	Panel_L4_B_Cells_D2_L4_110260_PBMC_11142011_D02.578973.fcs	Panel_L4_B_Cells_D2_L4_110260_PBMC_11142011_D02.fcs
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689558			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004401		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579109	Flow cytometry result	Panel_P13_D11_P13_110260_PBMC_11142011_D11.579109.fcs	Panel_P13_D11_P13_110260_PBMC_11142011_D11.fcs
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689558			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004459		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579167	Flow cytometry result	Panel_P10_D5_P10_110260_PBMC_11142011_D05.579167.fcs	Panel_P10_D5_P10_110260_PBMC_11142011_D05.fcs
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689558			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004708		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579416	Flow cytometry result	Panel_L3_D8_L3_110260_PBMC_11142011_D08.579416.fcs	Panel_L3_D8_L3_110260_PBMC_11142011_D08.fcs
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689558			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004904		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579612	Flow cytometry result	Panel_P1_D11_P1_110260_PBMC_11142011_D11.579612.fcs	Panel_P1_D11_P1_110260_PBMC_11142011_D11.fcs
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689558			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004987		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579695	Flow cytometry result	Panel_P9_D2_P9_110260_PBMC_11142011_D02.579695.fcs	Panel_P9_D2_P9_110260_PBMC_11142011_D02.fcs
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689558			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005131		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579839	Flow cytometry result	Panel_P2_D8_P2_110260_PBMC_11142011_D08.579839.fcs	Panel_P2_D8_P2_110260_PBMC_11142011_D08.fcs
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689559			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003791		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	578482	Flow cytometry result	Panel_P2_E8_P2_110264_PBMC_10172011_E08.578482.fcs	Panel_P2_E8_P2_110264_PBMC_10172011_E08.fcs
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689559			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003879		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	578582	Flow cytometry result	Panel_L5_MonoNKDC_E5_L5_110264_PBMC_10172011_E05.578582.fcs	Panel_L5_MonoNKDC_E5_L5_110264_PBMC_10172011_E05.fcs
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689559			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004347		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579055	Flow cytometry result	Panel_L4_B_Cells_E2_L4_110264_PBMC_10172011_E02.579055.fcs	Panel_L4_B_Cells_E2_L4_110264_PBMC_10172011_E02.fcs
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689559			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004543		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579251	Flow cytometry result	Panel_L1_E2_L1_110264_PBMC_10172011_E02.579251.fcs	Panel_L1_E2_L1_110264_PBMC_10172011_E02.fcs
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689559			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004596		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579304	Flow cytometry result	Panel_P9_E2_P9_110264_PBMC_10172011_E02.579304.fcs	Panel_P9_E2_P9_110264_PBMC_10172011_E02.fcs
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689559			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004866		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579574	Flow cytometry result	Panel_P10_E5_P10_110264_PBMC_10172011_E05.579574.fcs	Panel_P10_E5_P10_110264_PBMC_10172011_E05.fcs
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689559			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004954		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579662	Flow cytometry result	Panel_L2_E5_L2_110264_PBMC_10172011_E05.579662.fcs	Panel_L2_E5_L2_110264_PBMC_10172011_E05.fcs
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689559			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005116		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579824	Flow cytometry result	Panel_P13_E11_P13_110264_PBMC_10172011_E11.579824.fcs	Panel_P13_E11_P13_110264_PBMC_10172011_E11.fcs
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689559			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005339		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	580047	Flow cytometry result	Panel_P1_E11_P1_110264_PBMC_10172011_E11.580047.fcs	Panel_P1_E11_P1_110264_PBMC_10172011_E11.fcs
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689559			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005463		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	580171	Flow cytometry result	Panel_L3_E8_L3_110264_PBMC_10172011_E08.580171.fcs	Panel_L3_E8_L3_110264_PBMC_10172011_E08.fcs
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689560			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003808		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	578503	Flow cytometry result	Panel_L5_MonoNKDC_F5_L5_110264_PBMC_10192011_F05.578503.fcs	Panel_L5_MonoNKDC_F5_L5_110264_PBMC_10192011_F05.fcs
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689560			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003955		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578662	Flow cytometry result	Panel_P10_F5_P10_110264_PBMC_10192011_F05.578662.fcs	Panel_P10_F5_P10_110264_PBMC_10192011_F05.fcs
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689560			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004027		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	578735	Flow cytometry result	Panel_P13_F11_P13_110264_PBMC_10192011_F11.578735.fcs	Panel_P13_F11_P13_110264_PBMC_10192011_F11.fcs
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689560			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004096		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	578804	Flow cytometry result	Panel_L3_F8_L3_110264_PBMC_10192011_F08.578804.fcs	Panel_L3_F8_L3_110264_PBMC_10192011_F08.fcs
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689560			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004419		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579127	Flow cytometry result	Panel_P9_F2_P9_110264_PBMC_10192011_F02.579127.fcs	Panel_P9_F2_P9_110264_PBMC_10192011_F02.fcs
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689560			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004700		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579408	Flow cytometry result	Panel_L1_F2_L1_110264_PBMC_10192011_F02.579408.fcs	Panel_L1_F2_L1_110264_PBMC_10192011_F02.fcs
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689560			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005041		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579749	Flow cytometry result	Panel_P1_F11_P1_110264_PBMC_10192011_F11.579749.fcs	Panel_P1_F11_P1_110264_PBMC_10192011_F11.fcs
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689560			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005045		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579753	Flow cytometry result	Panel_P2_F8_P2_110264_PBMC_10192011_F08.579753.fcs	Panel_P2_F8_P2_110264_PBMC_10192011_F08.fcs
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689560			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005210		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579918	Flow cytometry result	Panel_L4_B_Cells_F2_L4_110264_PBMC_10192011_F02.579918.fcs	Panel_L4_B_Cells_F2_L4_110264_PBMC_10192011_F02.fcs
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689560			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005584		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	580292	Flow cytometry result	Panel_L2_F5_L2_110264_PBMC_10192011_F05.580292.fcs	Panel_L2_F5_L2_110264_PBMC_10192011_F05.fcs
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689561			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003821		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	578519	Flow cytometry result	Panel_L5_MonoNKDC_G5_L5_110264_PBMC_10242011_G05.578519.fcs	Panel_L5_MonoNKDC_G5_L5_110264_PBMC_10242011_G05.fcs
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689561			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003990		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	578698	Flow cytometry result	Panel_L4_B_Cells_G2_L4_110264_PBMC_10242011_G02.578698.fcs	Panel_L4_B_Cells_G2_L4_110264_PBMC_10242011_G02.fcs
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689561			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004369		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579077	Flow cytometry result	Panel_P2_G8_P2_110264_PBMC_10242011_G08.579077.fcs	Panel_P2_G8_P2_110264_PBMC_10242011_G08.fcs
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689561			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004453		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579161	Flow cytometry result	Panel_P9_G2_P9_110264_PBMC_10242011_G02.579161.fcs	Panel_P9_G2_P9_110264_PBMC_10242011_G02.fcs
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689561			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004642		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579350	Flow cytometry result	Panel_P1_G11_P1_110264_PBMC_10242011_G11.579350.fcs	Panel_P1_G11_P1_110264_PBMC_10242011_G11.fcs
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689561			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004644		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579352	Flow cytometry result	Panel_L1_G2_L1_110264_PBMC_10242011_G02.579352.fcs	Panel_L1_G2_L1_110264_PBMC_10242011_G02.fcs
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689561			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004673		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579381	Flow cytometry result	Panel_L3_G8_L3_110264_PBMC_10242011_G08.579381.fcs	Panel_L3_G8_L3_110264_PBMC_10242011_G08.fcs
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689561			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005334		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	580042	Flow cytometry result	Panel_P13_G11_P13_110264_PBMC_10242011_G11.580042.fcs	Panel_P13_G11_P13_110264_PBMC_10242011_G11.fcs
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689561			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005471		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580179	Flow cytometry result	Panel_P10_G5_P10_110264_PBMC_10242011_G05.580179.fcs	Panel_P10_G5_P10_110264_PBMC_10242011_G05.fcs
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689561			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005632		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	580340	Flow cytometry result	Panel_L2_G5_L2_110264_PBMC_10242011_G05.580340.fcs	Panel_L2_G5_L2_110264_PBMC_10242011_G05.fcs
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689562			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003650		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	578278	Flow cytometry result	Panel_L3_H8_L3_110264_PBMC_11142011_H08.578278.fcs	Panel_L3_H8_L3_110264_PBMC_11142011_H08.fcs
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689562			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003684		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	578335	Flow cytometry result	Panel_L5_MonoNKDC_H5_L5_110264_PBMC_11142011_H05.578335.fcs	Panel_L5_MonoNKDC_H5_L5_110264_PBMC_11142011_H05.fcs
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689562			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003835		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	578533	Flow cytometry result	Panel_P2_H8_P2_110264_PBMC_11142011_H08.578533.fcs	Panel_P2_H8_P2_110264_PBMC_11142011_H08.fcs
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689562			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004517		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579225	Flow cytometry result	Panel_P9_H2_P9_110264_PBMC_11142011_H02.579225.fcs	Panel_P9_H2_P9_110264_PBMC_11142011_H02.fcs
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689562			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005115		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579823	Flow cytometry result	Panel_P1_H11_P1_110264_PBMC_11142011_H11.579823.fcs	Panel_P1_H11_P1_110264_PBMC_11142011_H11.fcs
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689562			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005225		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579933	Flow cytometry result	Panel_L4_B_Cells_H2_L4_110264_PBMC_11142011_H02.579933.fcs	Panel_L4_B_Cells_H2_L4_110264_PBMC_11142011_H02.fcs
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689562			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005327		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	580035	Flow cytometry result	Panel_L1_H2_L1_110264_PBMC_11142011_H02.580035.fcs	Panel_L1_H2_L1_110264_PBMC_11142011_H02.fcs
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689562			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005415		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580123	Flow cytometry result	Panel_P10_H5_P10_110264_PBMC_11142011_H05.580123.fcs	Panel_P10_H5_P10_110264_PBMC_11142011_H05.fcs
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689562			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005560		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	580268	Flow cytometry result	Panel_P13_H11_P13_110264_PBMC_11142011_H11.580268.fcs	Panel_P13_H11_P13_110264_PBMC_11142011_H11.fcs
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689562			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005676		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	580384	Flow cytometry result	Panel_L2_H5_L2_110264_PBMC_11142011_H05.580384.fcs	Panel_L2_H5_L2_110264_PBMC_11142011_H05.fcs
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689563			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003659		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	578294	Flow cytometry result	Panel_L1_A3_L1_110265_PBMC_10172011_A03.578294.fcs	Panel_L1_A3_L1_110265_PBMC_10172011_A03.fcs
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689563			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003787		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	578477	Flow cytometry result	Panel_L4_B_Cells_A3_L4_110265_PBMC_10172011_A03.578477.fcs	Panel_L4_B_Cells_A3_L4_110265_PBMC_10172011_A03.fcs
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689563			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003908		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	578612	Flow cytometry result	Panel_P1_A12_P1_110265_PBMC_10172011_A12.578612.fcs	Panel_P1_A12_P1_110265_PBMC_10172011_A12.fcs
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689563			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004247		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	578955	Flow cytometry result	Panel_L5_MonoNKDC_A6_L5_110265_PBMC_10172011_A06.578955.fcs	Panel_L5_MonoNKDC_A6_L5_110265_PBMC_10172011_A06.fcs
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689563			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004404		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579112	Flow cytometry result	Panel_L3_A9_L3_110265_PBMC_10172011_A09.579112.fcs	Panel_L3_A9_L3_110265_PBMC_10172011_A09.fcs
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689563			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004800		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579508	Flow cytometry result	Panel_L2_A6_L2_110265_PBMC_10172011_A06.579508.fcs	Panel_L2_A6_L2_110265_PBMC_10172011_A06.fcs
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689563			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004878		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579586	Flow cytometry result	Panel_P10_A6_P10_110265_PBMC_10172011_A06.579586.fcs	Panel_P10_A6_P10_110265_PBMC_10172011_A06.fcs
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689563			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005161		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579869	Flow cytometry result	Panel_P9_A3_P9_110265_PBMC_10172011_A03.579869.fcs	Panel_P9_A3_P9_110265_PBMC_10172011_A03.fcs
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689563			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005399		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	580107	Flow cytometry result	Panel_P13_A12_P13_110265_PBMC_10172011_A12.580107.fcs	Panel_P13_A12_P13_110265_PBMC_10172011_A12.fcs
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689563			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005693		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	580401	Flow cytometry result	Panel_P2_A9_P2_110265_PBMC_10172011_A09.580401.fcs	Panel_P2_A9_P2_110265_PBMC_10172011_A09.fcs
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689564			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004019		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	578727	Flow cytometry result	Panel_P13_B12_P13_110265_PBMC_10192011_B12.578727.fcs	Panel_P13_B12_P13_110265_PBMC_10192011_B12.fcs
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689564			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004105		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	578813	Flow cytometry result	Panel_P2_B9_P2_110265_PBMC_10192011_B09.578813.fcs	Panel_P2_B9_P2_110265_PBMC_10192011_B09.fcs
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689564			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004207		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	578915	Flow cytometry result	Panel_L5_MonoNKDC_B6_L5_110265_PBMC_10192011_B06.578915.fcs	Panel_L5_MonoNKDC_B6_L5_110265_PBMC_10192011_B06.fcs
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689564			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004281		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	578989	Flow cytometry result	Panel_L2_B6_L2_110265_PBMC_10192011_B06.578989.fcs	Panel_L2_B6_L2_110265_PBMC_10192011_B06.fcs
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689564			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004811		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579519	Flow cytometry result	Panel_L3_B9_L3_110265_PBMC_10192011_B09.579519.fcs	Panel_L3_B9_L3_110265_PBMC_10192011_B09.fcs
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689564			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005089		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579797	Flow cytometry result	Panel_P9_B3_P9_110265_PBMC_10192011_B03.579797.fcs	Panel_P9_B3_P9_110265_PBMC_10192011_B03.fcs
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689564			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005128		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579836	Flow cytometry result	Panel_P1_B12_P1_110265_PBMC_10192011_B12.579836.fcs	Panel_P1_B12_P1_110265_PBMC_10192011_B12.fcs
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689564			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005485		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580193	Flow cytometry result	Panel_P10_B6_P10_110265_PBMC_10192011_B06.580193.fcs	Panel_P10_B6_P10_110265_PBMC_10192011_B06.fcs
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689564			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005546		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	580254	Flow cytometry result	Panel_L1_B3_L1_110265_PBMC_10192011_B03.580254.fcs	Panel_L1_B3_L1_110265_PBMC_10192011_B03.fcs
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689564			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005649		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	580357	Flow cytometry result	Panel_L4_B_Cells_B3_L4_110265_PBMC_10192011_B03.580357.fcs	Panel_L4_B_Cells_B3_L4_110265_PBMC_10192011_B03.fcs
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689565			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003809		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578504	Flow cytometry result	Panel_P10_C6_P10_110265_PBMC_10242011_C06.578504.fcs	Panel_P10_C6_P10_110265_PBMC_10242011_C06.fcs
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689565			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003968		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	578676	Flow cytometry result	Panel_P2_C9_P2_110265_PBMC_10242011_C09.578676.fcs	Panel_P2_C9_P2_110265_PBMC_10242011_C09.fcs
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689565			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004174		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	578882	Flow cytometry result	Panel_P1_C12_P1_110265_PBMC_10242011_C12.578882.fcs	Panel_P1_C12_P1_110265_PBMC_10242011_C12.fcs
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689565			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004627		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579335	Flow cytometry result	Panel_L1_C3_L1_110265_PBMC_10242011_C03.579335.fcs	Panel_L1_C3_L1_110265_PBMC_10242011_C03.fcs
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689565			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004650		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579358	Flow cytometry result	Panel_P13_C12_P13_110265_PBMC_10242011_C12.579358.fcs	Panel_P13_C12_P13_110265_PBMC_10242011_C12.fcs
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689565			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004779		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579487	Flow cytometry result	Panel_L4_B_Cells_C3_L4_110265_PBMC_10242011_C03.579487.fcs	Panel_L4_B_Cells_C3_L4_110265_PBMC_10242011_C03.fcs
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689565			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004897		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579605	Flow cytometry result	Panel_P9_C3_P9_110265_PBMC_10242011_C03.579605.fcs	Panel_P9_C3_P9_110265_PBMC_10242011_C03.fcs
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689565			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005280		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579988	Flow cytometry result	Panel_L2_C6_L2_110265_PBMC_10242011_C06.579988.fcs	Panel_L2_C6_L2_110265_PBMC_10242011_C06.fcs
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689565			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005290		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579998	Flow cytometry result	Panel_L5_MonoNKDC_C6_L5_110265_PBMC_10242011_C06.579998.fcs	Panel_L5_MonoNKDC_C6_L5_110265_PBMC_10242011_C06.fcs
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689565			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005620		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	580328	Flow cytometry result	Panel_L3_C9_L3_110265_PBMC_10242011_C09.580328.fcs	Panel_L3_C9_L3_110265_PBMC_10242011_C09.fcs
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689566			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003654		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	578286	Flow cytometry result	Panel_L3_D9_L3_110265_PBMC_11142011_D09.578286.fcs	Panel_L3_D9_L3_110265_PBMC_11142011_D09.fcs
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689566			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003815		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	578511	Flow cytometry result	Panel_L2_D6_L2_110265_PBMC_11142011_D06.578511.fcs	Panel_L2_D6_L2_110265_PBMC_11142011_D06.fcs
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689566			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004102		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	578810	Flow cytometry result	Panel_L4_B_Cells_D3_L4_110265_PBMC_11142011_D03.578810.fcs	Panel_L4_B_Cells_D3_L4_110265_PBMC_11142011_D03.fcs
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689566			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004239		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578947	Flow cytometry result	Panel_P9_D3_P9_110265_PBMC_11142011_D03.578947.fcs	Panel_P9_D3_P9_110265_PBMC_11142011_D03.fcs
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689566			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004290		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	578998	Flow cytometry result	Panel_P1_D12_P1_110265_PBMC_11142011_D12.578998.fcs	Panel_P1_D12_P1_110265_PBMC_11142011_D12.fcs
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689566			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004415		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579123	Flow cytometry result	Panel_P10_D6_P10_110265_PBMC_11142011_D06.579123.fcs	Panel_P10_D6_P10_110265_PBMC_11142011_D06.fcs
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689566			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004910		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579618	Flow cytometry result	Panel_P2_D9_P2_110265_PBMC_11142011_D09.579618.fcs	Panel_P2_D9_P2_110265_PBMC_11142011_D09.fcs
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689566			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005146		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579854	Flow cytometry result	Panel_L1_D3_L1_110265_PBMC_11142011_D03.579854.fcs	Panel_L1_D3_L1_110265_PBMC_11142011_D03.fcs
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689566			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005255		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579963	Flow cytometry result	Panel_P13_D12_P13_110265_PBMC_11142011_D12.579963.fcs	Panel_P13_D12_P13_110265_PBMC_11142011_D12.fcs
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689566			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005438		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	580146	Flow cytometry result	Panel_L5_MonoNKDC_D6_L5_110265_PBMC_11142011_D06.580146.fcs	Panel_L5_MonoNKDC_D6_L5_110265_PBMC_11142011_D06.fcs
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689567			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003947		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	578653	Flow cytometry result	Panel_L4_B_Cells_A1_L4_110267_PBMC_10172011_A01.578653.fcs	Panel_L4_B_Cells_A1_L4_110267_PBMC_10172011_A01.fcs
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689567			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004368		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579076	Flow cytometry result	Panel_L3_A7_L3_110267_PBMC_10172011_A07.579076.fcs	Panel_L3_A7_L3_110267_PBMC_10172011_A07.fcs
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689567			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004393		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579101	Flow cytometry result	Panel_P10_A4_P10_110267_PBMC_10172011_A04.579101.fcs	Panel_P10_A4_P10_110267_PBMC_10172011_A04.fcs
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689567			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004496		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579204	Flow cytometry result	Panel_P13_A10_P13_110267_PBMC_10172011_A10.579204.fcs	Panel_P13_A10_P13_110267_PBMC_10172011_A10.fcs
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689567			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004894		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579602	Flow cytometry result	Panel_L1_A1_L1_110267_PBMC_10172011_A01.579602.fcs	Panel_L1_A1_L1_110267_PBMC_10172011_A01.fcs
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689567			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004924		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579632	Flow cytometry result	Panel_L2_A4_L2_110267_PBMC_10172011_A04.579632.fcs	Panel_L2_A4_L2_110267_PBMC_10172011_A04.fcs
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689567			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005193		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579901	Flow cytometry result	Panel_P2_A7_P2_110267_PBMC_10172011_A07.579901.fcs	Panel_P2_A7_P2_110267_PBMC_10172011_A07.fcs
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689567			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005404		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	580112	Flow cytometry result	Panel_P1_A10_P1_110267_PBMC_10172011_A10.580112.fcs	Panel_P1_A10_P1_110267_PBMC_10172011_A10.fcs
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689567			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005473		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580181	Flow cytometry result	Panel_P9_A1_P9_110267_PBMC_10172011_A01.580181.fcs	Panel_P9_A1_P9_110267_PBMC_10172011_A01.fcs
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689567			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005497		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	580205	Flow cytometry result	Panel_L5_MonoNKDC_A4_L5_110267_PBMC_10172011_A04.580205.fcs	Panel_L5_MonoNKDC_A4_L5_110267_PBMC_10172011_A04.fcs
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689568			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003810		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	578505	Flow cytometry result	Panel_L3_B7_L3_110267_PBMC_10192011_B07.578505.fcs	Panel_L3_B7_L3_110267_PBMC_10192011_B07.fcs
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689568			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003828		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	578526	Flow cytometry result	Panel_P13_B10_P13_110267_PBMC_10192011_B10.578526.fcs	Panel_P13_B10_P13_110267_PBMC_10192011_B10.fcs
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689568			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003928		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	578633	Flow cytometry result	Panel_L1_B1_L1_110267_PBMC_10192011_B01.578633.fcs	Panel_L1_B1_L1_110267_PBMC_10192011_B01.fcs
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689568			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004017		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	578725	Flow cytometry result	Panel_P1_B10_P1_110267_PBMC_10192011_B10.578725.fcs	Panel_P1_B10_P1_110267_PBMC_10192011_B10.fcs
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689568			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004160		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	578868	Flow cytometry result	Panel_P2_B7_P2_110267_PBMC_10192011_B07.578868.fcs	Panel_P2_B7_P2_110267_PBMC_10192011_B07.fcs
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689568			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004244		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	578952	Flow cytometry result	Panel_L2_B4_L2_110267_PBMC_10192011_B04.578952.fcs	Panel_L2_B4_L2_110267_PBMC_10192011_B04.fcs
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689568			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004365		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579073	Flow cytometry result	Panel_L4_B_Cells_B1_L4_110267_PBMC_10192011_B01.579073.fcs	Panel_L4_B_Cells_B1_L4_110267_PBMC_10192011_B01.fcs
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689568			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004976		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579684	Flow cytometry result	Panel_P9_B1_P9_110267_PBMC_10192011_B01.579684.fcs	Panel_P9_B1_P9_110267_PBMC_10192011_B01.fcs
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689568			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005094		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579802	Flow cytometry result	Panel_L5_MonoNKDC_B4_L5_110267_PBMC_10192011_B04.579802.fcs	Panel_L5_MonoNKDC_B4_L5_110267_PBMC_10192011_B04.fcs
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689568			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005336		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580044	Flow cytometry result	Panel_P10_B4_P10_110267_PBMC_10192011_B04.580044.fcs	Panel_P10_B4_P10_110267_PBMC_10192011_B04.fcs
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689569			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003803		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578498	Flow cytometry result	Panel_P9_C1_P9_110267_PBMC_10242011_C01.578498.fcs	Panel_P9_C1_P9_110267_PBMC_10242011_C01.fcs
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689569			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003903		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	578607	Flow cytometry result	Panel_L2_C4_L2_110267_PBMC_10242011_C04.578607.fcs	Panel_L2_C4_L2_110267_PBMC_10242011_C04.fcs
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689569			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004045		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578753	Flow cytometry result	Panel_P10_C4_P10_110267_PBMC_10242011_C04.578753.fcs	Panel_P10_C4_P10_110267_PBMC_10242011_C04.fcs
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689569			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004257		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	578965	Flow cytometry result	Panel_P1_C10_P1_110267_PBMC_10242011_C10.578965.fcs	Panel_P1_C10_P1_110267_PBMC_10242011_C10.fcs
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689569			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004450		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579158	Flow cytometry result	Panel_L4_B_Cells_C1_L4_110267_PBMC_10242011_C01.579158.fcs	Panel_L4_B_Cells_C1_L4_110267_PBMC_10242011_C01.fcs
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689569			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004556		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579264	Flow cytometry result	Panel_P2_C7_P2_110267_PBMC_10242011_C07.579264.fcs	Panel_P2_C7_P2_110267_PBMC_10242011_C07.fcs
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689569			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004594		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579302	Flow cytometry result	Panel_L1_C1_L1_110267_PBMC_10242011_C01.579302.fcs	Panel_L1_C1_L1_110267_PBMC_10242011_C01.fcs
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689569			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005119		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579827	Flow cytometry result	Panel_P13_C10_P13_110267_PBMC_10242011_C10.579827.fcs	Panel_P13_C10_P13_110267_PBMC_10242011_C10.fcs
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689569			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005612		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	580320	Flow cytometry result	Panel_L5_MonoNKDC_C4_L5_110267_PBMC_10242011_C04.580320.fcs	Panel_L5_MonoNKDC_C4_L5_110267_PBMC_10242011_C04.fcs
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689569			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005622		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	580330	Flow cytometry result	Panel_L3_C7_L3_110267_PBMC_10242011_C07.580330.fcs	Panel_L3_C7_L3_110267_PBMC_10242011_C07.fcs
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689570			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003964		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	578672	Flow cytometry result	Panel_P1_D10_P1_110267_PBMC_11142011_D10.578672.fcs	Panel_P1_D10_P1_110267_PBMC_11142011_D10.fcs
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689570			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004067		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	578775	Flow cytometry result	Panel_P2_D7_P2_110267_PBMC_11142011_D07.578775.fcs	Panel_P2_D7_P2_110267_PBMC_11142011_D07.fcs
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689570			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004452		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579160	Flow cytometry result	Panel_L4_B_Cells_D1_L4_110267_PBMC_11142011_D01.579160.fcs	Panel_L4_B_Cells_D1_L4_110267_PBMC_11142011_D01.fcs
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689570			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004544		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579252	Flow cytometry result	Panel_P10_D4_P10_110267_PBMC_11142011_D04.579252.fcs	Panel_P10_D4_P10_110267_PBMC_11142011_D04.fcs
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689570			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004664		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579372	Flow cytometry result	Panel_L5_MonoNKDC_D4_L5_110267_PBMC_11142011_D04.579372.fcs	Panel_L5_MonoNKDC_D4_L5_110267_PBMC_11142011_D04.fcs
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689570			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004868		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579576	Flow cytometry result	Panel_L1_D1_L1_110267_PBMC_11142011_D01.579576.fcs	Panel_L1_D1_L1_110267_PBMC_11142011_D01.fcs
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689570			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004936		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579644	Flow cytometry result	Panel_P9_D1_P9_110267_PBMC_11142011_D01.579644.fcs	Panel_P9_D1_P9_110267_PBMC_11142011_D01.fcs
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689570			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004998		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579706	Flow cytometry result	Panel_L3_D7_L3_110267_PBMC_11142011_D07.579706.fcs	Panel_L3_D7_L3_110267_PBMC_11142011_D07.fcs
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689570			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005170		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579878	Flow cytometry result	Panel_P13_D10_P13_110267_PBMC_11142011_D10.579878.fcs	Panel_P13_D10_P13_110267_PBMC_11142011_D10.fcs
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689570			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005318		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	580026	Flow cytometry result	Panel_L2_D4_L2_110267_PBMC_11142011_D04.580026.fcs	Panel_L2_D4_L2_110267_PBMC_11142011_D04.fcs
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689571			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003711		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	578379	Flow cytometry result	Panel_P13_E10_P13_110268_PBMC_10172011_E10.578379.fcs	Panel_P13_E10_P13_110268_PBMC_10172011_E10.fcs
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689571			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003818		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	578514	Flow cytometry result	Panel_P2_E7_P2_110268_PBMC_10172011_E07.578514.fcs	Panel_P2_E7_P2_110268_PBMC_10172011_E07.fcs
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689571			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003915		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	578619	Flow cytometry result	Panel_L2_E4_L2_110268_PBMC_10172011_E04.578619.fcs	Panel_L2_E4_L2_110268_PBMC_10172011_E04.fcs
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689571			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004040		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	578748	Flow cytometry result	Panel_L1_E1_L1_110268_PBMC_10172011_E01.578748.fcs	Panel_L1_E1_L1_110268_PBMC_10172011_E01.fcs
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689571			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004172		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	578880	Flow cytometry result	Panel_L5_MonoNKDC_E4_L5_110268_PBMC_10172011_E04.578880.fcs	Panel_L5_MonoNKDC_E4_L5_110268_PBMC_10172011_E04.fcs
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689571			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004603		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579311	Flow cytometry result	Panel_L3_E7_L3_110268_PBMC_10172011_E07.579311.fcs	Panel_L3_E7_L3_110268_PBMC_10172011_E07.fcs
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689571			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004914		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579622	Flow cytometry result	Panel_L4_B_Cells_E1_L4_110268_PBMC_10172011_E01.579622.fcs	Panel_L4_B_Cells_E1_L4_110268_PBMC_10172011_E01.fcs
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689571			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005289		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579997	Flow cytometry result	Panel_P1_E10_P1_110268_PBMC_10172011_E10.579997.fcs	Panel_P1_E10_P1_110268_PBMC_10172011_E10.fcs
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689571			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005444		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580152	Flow cytometry result	Panel_P10_E4_P10_110268_PBMC_10172011_E04.580152.fcs	Panel_P10_E4_P10_110268_PBMC_10172011_E04.fcs
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689571			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005652		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580360	Flow cytometry result	Panel_P9_E1_P9_110268_PBMC_10172011_E01.580360.fcs	Panel_P9_E1_P9_110268_PBMC_10172011_E01.fcs
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689572			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003909		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	578613	Flow cytometry result	Panel_L2_F4_L2_110268_PBMC_10192011_F04.578613.fcs	Panel_L2_F4_L2_110268_PBMC_10192011_F04.fcs
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689572			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004058		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578766	Flow cytometry result	Panel_P10_F4_P10_110268_PBMC_10192011_F04.578766.fcs	Panel_P10_F4_P10_110268_PBMC_10192011_F04.fcs
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689572			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004131		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	578839	Flow cytometry result	Panel_L5_MonoNKDC_F4_L5_110268_PBMC_10192011_F04.578839.fcs	Panel_L5_MonoNKDC_F4_L5_110268_PBMC_10192011_F04.fcs
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689572			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004230		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	578938	Flow cytometry result	Panel_L1_F1_L1_110268_PBMC_10192011_F01.578938.fcs	Panel_L1_F1_L1_110268_PBMC_10192011_F01.fcs
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689572			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004750		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579458	Flow cytometry result	Panel_L4_B_Cells_F1_L4_110268_PBMC_10192011_F01.579458.fcs	Panel_L4_B_Cells_F1_L4_110268_PBMC_10192011_F01.fcs
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689572			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004816		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579524	Flow cytometry result	Panel_P9_F1_P9_110268_PBMC_10192011_F01.579524.fcs	Panel_P9_F1_P9_110268_PBMC_10192011_F01.fcs
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689572			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004888		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579596	Flow cytometry result	Panel_P13_F10_P13_110268_PBMC_10192011_F10.579596.fcs	Panel_P13_F10_P13_110268_PBMC_10192011_F10.fcs
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689572			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005077		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579785	Flow cytometry result	Panel_P1_F10_P1_110268_PBMC_10192011_F10.579785.fcs	Panel_P1_F10_P1_110268_PBMC_10192011_F10.fcs
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689572			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005356		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	580064	Flow cytometry result	Panel_P2_F7_P2_110268_PBMC_10192011_F07.580064.fcs	Panel_P2_F7_P2_110268_PBMC_10192011_F07.fcs
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689572			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005508		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	580216	Flow cytometry result	Panel_L3_F7_L3_110268_PBMC_10192011_F07.580216.fcs	Panel_L3_F7_L3_110268_PBMC_10192011_F07.fcs
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689573			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003702		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	578366	Flow cytometry result	Panel_L1_G1_L1_110268_PBMC_10242011_G01.578366.fcs	Panel_L1_G1_L1_110268_PBMC_10242011_G01.fcs
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689573			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003713		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578383	Flow cytometry result	Panel_P10_G4_P10_110268_PBMC_10242011_G04.578383.fcs	Panel_P10_G4_P10_110268_PBMC_10242011_G04.fcs
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689573			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003831		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	578529	Flow cytometry result	Panel_P2_G7_P2_110268_PBMC_10242011_G07.578529.fcs	Panel_P2_G7_P2_110268_PBMC_10242011_G07.fcs
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689573			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004129		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	578837	Flow cytometry result	Panel_L4_B_Cells_G1_L4_110268_PBMC_10242011_G01.578837.fcs	Panel_L4_B_Cells_G1_L4_110268_PBMC_10242011_G01.fcs
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689573			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004447		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579155	Flow cytometry result	Panel_P1_G10_P1_110268_PBMC_10242011_G10.579155.fcs	Panel_P1_G10_P1_110268_PBMC_10242011_G10.fcs
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689573			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004531		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579239	Flow cytometry result	Panel_L5_MonoNKDC_G4_L5_110268_PBMC_10242011_G04.579239.fcs	Panel_L5_MonoNKDC_G4_L5_110268_PBMC_10242011_G04.fcs
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689573			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004984		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579692	Flow cytometry result	Panel_L2_G4_L2_110268_PBMC_10242011_G04.579692.fcs	Panel_L2_G4_L2_110268_PBMC_10242011_G04.fcs
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689573			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005062		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579770	Flow cytometry result	Panel_P9_G1_P9_110268_PBMC_10242011_G01.579770.fcs	Panel_P9_G1_P9_110268_PBMC_10242011_G01.fcs
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689573			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005113		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579821	Flow cytometry result	Panel_P13_G10_P13_110268_PBMC_10242011_G10.579821.fcs	Panel_P13_G10_P13_110268_PBMC_10242011_G10.fcs
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689573			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005172		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579880	Flow cytometry result	Panel_L3_G7_L3_110268_PBMC_10242011_G07.579880.fcs	Panel_L3_G7_L3_110268_PBMC_10242011_G07.fcs
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752392			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003871		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578573	Flow cytometry result	Panel_P9_H1_P9_110268_PBMC_11142011_H01.578573.fcs	Panel_P9_H1_P9_110268_PBMC_11142011_H01.fcs
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752392			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004011		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578719	Flow cytometry result	Panel_P10_H4_P10_110268_PBMC_11142011_H04.578719.fcs	Panel_P10_H4_P10_110268_PBMC_11142011_H04.fcs
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752392			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004662		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579370	Flow cytometry result	Panel_L2_H4_L2_110268_PBMC_11142011_H04.579370.fcs	Panel_L2_H4_L2_110268_PBMC_11142011_H04.fcs
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752392			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004741		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579449	Flow cytometry result	Panel_P2_H7_P2_110268_PBMC_11142011_H07.579449.fcs	Panel_P2_H7_P2_110268_PBMC_11142011_H07.fcs
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752392			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004946		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579654	Flow cytometry result	Panel_L3_H7_L3_110268_PBMC_11142011_H07.579654.fcs	Panel_L3_H7_L3_110268_PBMC_11142011_H07.fcs
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752392			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004951		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579659	Flow cytometry result	Panel_L4_B_Cells_H1_L4_110268_PBMC_11142011_H01.579659.fcs	Panel_L4_B_Cells_H1_L4_110268_PBMC_11142011_H01.fcs
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752392			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005053		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579761	Flow cytometry result	Panel_P13_H10_P13_110268_PBMC_11142011_H10.579761.fcs	Panel_P13_H10_P13_110268_PBMC_11142011_H10.fcs
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752392			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005293		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	580001	Flow cytometry result	Panel_L5_MonoNKDC_H4_L5_110268_PBMC_11142011_H04.580001.fcs	Panel_L5_MonoNKDC_H4_L5_110268_PBMC_11142011_H04.fcs
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752392			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005549		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	580257	Flow cytometry result	Panel_P1_H10_P1_110268_PBMC_11142011_H10.580257.fcs	Panel_P1_H10_P1_110268_PBMC_11142011_H10.fcs
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752392			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005595		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	580303	Flow cytometry result	Panel_L1_H1_L1_110268_PBMC_11142011_H01.580303.fcs	Panel_L1_H1_L1_110268_PBMC_11142011_H01.fcs
SUB120471	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752393			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003986		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	578694	Flow cytometry result	Panel_P1_E12_P1_110269_PBMC_10172011_E12.578694.fcs	Panel_P1_E12_P1_110269_PBMC_10172011_E12.fcs
SUB120471	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752393			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004124		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578832	Flow cytometry result	Panel_P10_E6_P10_110269_PBMC_10172011_E06.578832.fcs	Panel_P10_E6_P10_110269_PBMC_10172011_E06.fcs
SUB120471	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752393			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004310		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579018	Flow cytometry result	Panel_P9_E3_P9_110269_PBMC_10172011_E03.579018.fcs	Panel_P9_E3_P9_110269_PBMC_10172011_E03.fcs
SUB120471	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752393			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004349		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579057	Flow cytometry result	Panel_P2_E9_P2_110269_PBMC_10172011_E09.579057.fcs	Panel_P2_E9_P2_110269_PBMC_10172011_E09.fcs
SUB120471	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752393			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004376		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579084	Flow cytometry result	Panel_L1_E3_L1_110269_PBMC_10172011_E03.579084.fcs	Panel_L1_E3_L1_110269_PBMC_10172011_E03.fcs
SUB120471	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752393			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004469		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579177	Flow cytometry result	Panel_P13_E12_P13_110269_PBMC_10172011_E12.579177.fcs	Panel_P13_E12_P13_110269_PBMC_10172011_E12.fcs
SUB120471	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752393			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004512		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579220	Flow cytometry result	Panel_L2_E6_L2_110269_PBMC_10172011_E06.579220.fcs	Panel_L2_E6_L2_110269_PBMC_10172011_E06.fcs
SUB120471	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752393			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004735		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579443	Flow cytometry result	Panel_L5_MonoNKDC_E6_L5_110269_PBMC_10172011_E06.579443.fcs	Panel_L5_MonoNKDC_E6_L5_110269_PBMC_10172011_E06.fcs
SUB120471	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752393			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005414		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	580122	Flow cytometry result	Panel_L3_E9_L3_110269_PBMC_10172011_E09.580122.fcs	Panel_L3_E9_L3_110269_PBMC_10172011_E09.fcs
SUB120471	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752393			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005600		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	580308	Flow cytometry result	Panel_L4_B_Cells_E3_L4_110269_PBMC_10172011_E03.580308.fcs	Panel_L4_B_Cells_E3_L4_110269_PBMC_10172011_E03.fcs
SUB120471	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752394			PBMC		1	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005354		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	580062	Flow cytometry result	Panel_L5_MonoNKDC_E6_L5_110269_PBMC_10182011_E06.580062.fcs	Panel_L5_MonoNKDC_E6_L5_110269_PBMC_10182011_E06.fcs
SUB120471	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752395			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003754		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578437	Flow cytometry result	Panel_P9_F3_P9_110269_PBMC_10192011_F03.578437.fcs	Panel_P9_F3_P9_110269_PBMC_10192011_F03.fcs
SUB120471	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752395			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003855		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	578556	Flow cytometry result	Panel_P1_F12_P1_110269_PBMC_10192011_F12.578556.fcs	Panel_P1_F12_P1_110269_PBMC_10192011_F12.fcs
SUB120471	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752395			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003875		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	578578	Flow cytometry result	Panel_P2_F9_P2_110269_PBMC_10192011_F09.578578.fcs	Panel_P2_F9_P2_110269_PBMC_10192011_F09.fcs
SUB120471	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752395			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003957		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	578664	Flow cytometry result	Panel_L5_MonoNKDC_F6_L5_110269_PBMC_10192011_F06.578664.fcs	Panel_L5_MonoNKDC_F6_L5_110269_PBMC_10192011_F06.fcs
SUB120471	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752395			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004024		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	578732	Flow cytometry result	Panel_L1_F3_L1_110269_PBMC_10192011_F03.578732.fcs	Panel_L1_F3_L1_110269_PBMC_10192011_F03.fcs
SUB120471	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752395			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004103		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	578811	Flow cytometry result	Panel_L2_F6_L2_110269_PBMC_10192011_F06.578811.fcs	Panel_L2_F6_L2_110269_PBMC_10192011_F06.fcs
SUB120471	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752395			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004384		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579092	Flow cytometry result	Panel_L4_B_Cells_F3_L4_110269_PBMC_10192011_F03.579092.fcs	Panel_L4_B_Cells_F3_L4_110269_PBMC_10192011_F03.fcs
SUB120471	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752395			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004686		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579394	Flow cytometry result	Panel_P13_F12_P13_110269_PBMC_10192011_F12.579394.fcs	Panel_P13_F12_P13_110269_PBMC_10192011_F12.fcs
SUB120471	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752395			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005087		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579795	Flow cytometry result	Panel_P10_F6_P10_110269_PBMC_10192011_F06.579795.fcs	Panel_P10_F6_P10_110269_PBMC_10192011_F06.fcs
SUB120471	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752395			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005420		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	580128	Flow cytometry result	Panel_L3_F9_L3_110269_PBMC_10192011_F09.580128.fcs	Panel_L3_F9_L3_110269_PBMC_10192011_F09.fcs
SUB120471	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752396			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003800		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	578493	Flow cytometry result	Panel_L5_MonoNKDC_G6_L5_110269_PBMC_10242011_G06.578493.fcs	Panel_L5_MonoNKDC_G6_L5_110269_PBMC_10242011_G06.fcs
SUB120471	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752396			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003885		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	578589	Flow cytometry result	Panel_L2_G6_L2_110269_PBMC_10242011_G06.578589.fcs	Panel_L2_G6_L2_110269_PBMC_10242011_G06.fcs
SUB120471	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752396			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004059		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	578767	Flow cytometry result	Panel_L3_G9_L3_110269_PBMC_10242011_G09.578767.fcs	Panel_L3_G9_L3_110269_PBMC_10242011_G09.fcs
SUB120471	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752396			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004218		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578926	Flow cytometry result	Panel_P9_G3_P9_110269_PBMC_10242011_G03.578926.fcs	Panel_P9_G3_P9_110269_PBMC_10242011_G03.fcs
SUB120471	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752396			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004256		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	578964	Flow cytometry result	Panel_L1_G3_L1_110269_PBMC_10242011_G03.578964.fcs	Panel_L1_G3_L1_110269_PBMC_10242011_G03.fcs
SUB120471	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752396			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004263		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	578971	Flow cytometry result	Panel_P1_G12_P1_110269_PBMC_10242011_G12.578971.fcs	Panel_P1_G12_P1_110269_PBMC_10242011_G12.fcs
SUB120471	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752396			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004815		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579523	Flow cytometry result	Panel_P10_G6_P10_110269_PBMC_10242011_G06.579523.fcs	Panel_P10_G6_P10_110269_PBMC_10242011_G06.fcs
SUB120471	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752396			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005504		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	580212	Flow cytometry result	Panel_L4_B_Cells_G3_L4_110269_PBMC_10242011_G03.580212.fcs	Panel_L4_B_Cells_G3_L4_110269_PBMC_10242011_G03.fcs
SUB120471	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752396			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005631		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	580339	Flow cytometry result	Panel_P2_G9_P2_110269_PBMC_10242011_G09.580339.fcs	Panel_P2_G9_P2_110269_PBMC_10242011_G09.fcs
SUB120471	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752396			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005670		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	580378	Flow cytometry result	Panel_P13_G12_P13_110269_PBMC_10242011_G12.580378.fcs	Panel_P13_G12_P13_110269_PBMC_10242011_G12.fcs
SUB120472	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at enrollment		23	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689575			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004118		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578826	Flow cytometry result	Panel_P9_E3_P9_110270_PBMC_10172011_E03.578826.fcs	Panel_P9_E3_P9_110270_PBMC_10172011_E03.fcs
SUB120472	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at enrollment		23	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689575			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004151		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	578859	Flow cytometry result	Panel_L4_B_Cells_E3_L4_110270_PBMC_10172011_E03.578859.fcs	Panel_L4_B_Cells_E3_L4_110270_PBMC_10172011_E03.fcs
SUB120472	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at enrollment		23	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689575			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004280		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	578988	Flow cytometry result	Panel_P13_E12_P13_110270_PBMC_10172011_E12.578988.fcs	Panel_P13_E12_P13_110270_PBMC_10172011_E12.fcs
SUB120472	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at enrollment		23	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689575			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004360		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579068	Flow cytometry result	Panel_L2_E6_L2_110270_PBMC_10172011_E06.579068.fcs	Panel_L2_E6_L2_110270_PBMC_10172011_E06.fcs
SUB120472	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at enrollment		23	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689575			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004367		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579075	Flow cytometry result	Panel_P10_E6_P10_110270_PBMC_10172011_E06.579075.fcs	Panel_P10_E6_P10_110270_PBMC_10172011_E06.fcs
SUB120472	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at enrollment		23	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689575			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004774		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579482	Flow cytometry result	Panel_L5_MonoNKDC_E6_L5_110270_PBMC_10172011_E06.579482.fcs	Panel_L5_MonoNKDC_E6_L5_110270_PBMC_10172011_E06.fcs
SUB120472	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at enrollment		23	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689575			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004899		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579607	Flow cytometry result	Panel_P2_E9_P2_110270_PBMC_10172011_E09.579607.fcs	Panel_P2_E9_P2_110270_PBMC_10172011_E09.fcs
SUB120472	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at enrollment		23	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689575			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004916		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579624	Flow cytometry result	Panel_L1_E3_L1_110270_PBMC_10172011_E03.579624.fcs	Panel_L1_E3_L1_110270_PBMC_10172011_E03.fcs
SUB120472	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at enrollment		23	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689575			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005365		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	580073	Flow cytometry result	Panel_P1_E12_P1_110270_PBMC_10172011_E12.580073.fcs	Panel_P1_E12_P1_110270_PBMC_10172011_E12.fcs
SUB120472	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at enrollment		23	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689575			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005572		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	580280	Flow cytometry result	Panel_L3_E9_L3_110270_PBMC_10172011_E09.580280.fcs	Panel_L3_E9_L3_110270_PBMC_10172011_E09.fcs
SUB120472	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at enrollment		23	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689576			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003813		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578509	Flow cytometry result	Panel_P10_F6_P10_110270_PBMC_10192011_F06.578509.fcs	Panel_P10_F6_P10_110270_PBMC_10192011_F06.fcs
SUB120472	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at enrollment		23	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689576			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003849		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578550	Flow cytometry result	Panel_P9_F3_P9_110270_PBMC_10192011_F03.578550.fcs	Panel_P9_F3_P9_110270_PBMC_10192011_F03.fcs
SUB120472	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at enrollment		23	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689576			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004000		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	578708	Flow cytometry result	Panel_L2_F6_L2_110270_PBMC_10192011_F06.578708.fcs	Panel_L2_F6_L2_110270_PBMC_10192011_F06.fcs
SUB120472	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at enrollment		23	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689576			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004077		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	578785	Flow cytometry result	Panel_P13_F12_P13_110270_PBMC_10192011_F12.578785.fcs	Panel_P13_F12_P13_110270_PBMC_10192011_F12.fcs
SUB120472	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at enrollment		23	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689576			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004153		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	578861	Flow cytometry result	Panel_P1_F12_P1_110270_PBMC_10192011_F12.578861.fcs	Panel_P1_F12_P1_110270_PBMC_10192011_F12.fcs
SUB120472	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at enrollment		23	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689576			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005103		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579811	Flow cytometry result	Panel_L5_MonoNKDC_F6_L5_110270_PBMC_10192011_F06.579811.fcs	Panel_L5_MonoNKDC_F6_L5_110270_PBMC_10192011_F06.fcs
SUB120472	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at enrollment		23	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689576			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005298		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	580006	Flow cytometry result	Panel_L3_F9_L3_110270_PBMC_10192011_F09.580006.fcs	Panel_L3_F9_L3_110270_PBMC_10192011_F09.fcs
SUB120472	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at enrollment		23	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689576			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005468		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	580176	Flow cytometry result	Panel_L1_F3_L1_110270_PBMC_10192011_F03.580176.fcs	Panel_L1_F3_L1_110270_PBMC_10192011_F03.fcs
SUB120472	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at enrollment		23	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689576			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005475		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	580183	Flow cytometry result	Panel_P2_F9_P2_110270_PBMC_10192011_F09.580183.fcs	Panel_P2_F9_P2_110270_PBMC_10192011_F09.fcs
SUB120472	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at enrollment		23	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689576			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005590		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	580298	Flow cytometry result	Panel_L4_B_Cells_F3_L4_110270_PBMC_10192011_F03.580298.fcs	Panel_L4_B_Cells_F3_L4_110270_PBMC_10192011_F03.fcs
SUB120472	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at enrollment		23	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689577			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003679		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	578329	Flow cytometry result	Panel_P13_G12_P13_110270_PBMC_10242011_G12.578329.fcs	Panel_P13_G12_P13_110270_PBMC_10242011_G12.fcs
SUB120472	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at enrollment		23	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689577			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003861		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578563	Flow cytometry result	Panel_P9_G3_P9_110270_PBMC_10242011_G03.578563.fcs	Panel_P9_G3_P9_110270_PBMC_10242011_G03.fcs
SUB120472	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at enrollment		23	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689577			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003882		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	578586	Flow cytometry result	Panel_L3_G9_L3_110270_PBMC_10242011_G09.578586.fcs	Panel_L3_G9_L3_110270_PBMC_10242011_G09.fcs
SUB120472	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at enrollment		23	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689577			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004330		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579038	Flow cytometry result	Panel_P1_G12_P1_110270_PBMC_10242011_G12.579038.fcs	Panel_P1_G12_P1_110270_PBMC_10242011_G12.fcs
SUB120472	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at enrollment		23	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689577			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004701		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579409	Flow cytometry result	Panel_L2_G6_L2_110270_PBMC_10242011_G06.579409.fcs	Panel_L2_G6_L2_110270_PBMC_10242011_G06.fcs
SUB120472	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at enrollment		23	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689577			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005037		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579745	Flow cytometry result	Panel_L1_G3_L1_110270_PBMC_10242011_G03.579745.fcs	Panel_L1_G3_L1_110270_PBMC_10242011_G03.fcs
SUB120472	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at enrollment		23	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689577			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005273		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579981	Flow cytometry result	Panel_L4_B_Cells_G3_L4_110270_PBMC_10242011_G03.579981.fcs	Panel_L4_B_Cells_G3_L4_110270_PBMC_10242011_G03.fcs
SUB120472	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at enrollment		23	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689577			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005306		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	580014	Flow cytometry result	Panel_P2_G9_P2_110270_PBMC_10242011_G09.580014.fcs	Panel_P2_G9_P2_110270_PBMC_10242011_G09.fcs
SUB120472	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at enrollment		23	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689577			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005323		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580031	Flow cytometry result	Panel_P10_G6_P10_110270_PBMC_10242011_G06.580031.fcs	Panel_P10_G6_P10_110270_PBMC_10242011_G06.fcs
SUB120472	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at enrollment		23	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689577			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005446		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	580154	Flow cytometry result	Panel_L5_MonoNKDC_G6_L5_110270_PBMC_10242011_G06.580154.fcs	Panel_L5_MonoNKDC_G6_L5_110270_PBMC_10242011_G06.fcs
SUB120472	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at enrollment		23	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752397			PBMC		17	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003742		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	578422	Flow cytometry result	Panel_P1_E12_P1_110270_PBMC_11032011_E12.578422.fcs	Panel_P1_E12_P1_110270_PBMC_11032011_E12.fcs
SUB120472	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at enrollment		23	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752397			PBMC		17	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003963		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	578671	Flow cytometry result	Panel_L2_E6_L2_110270_PBMC_11032011_E06.578671.fcs	Panel_L2_E6_L2_110270_PBMC_11032011_E06.fcs
SUB120472	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at enrollment		23	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752397			PBMC		17	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004064		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	578772	Flow cytometry result	Panel_L1_E3_L1_110270_PBMC_11032011_E03.578772.fcs	Panel_L1_E3_L1_110270_PBMC_11032011_E03.fcs
SUB120472	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at enrollment		23	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752398			PBMC		21	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004648		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579356	Flow cytometry result	Panel_P1_F12_P1_110270_PBMC_11072011_F12.579356.fcs	Panel_P1_F12_P1_110270_PBMC_11072011_F12.fcs
SUB120472	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at enrollment		23	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752398			PBMC		21	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005613		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	580321	Flow cytometry result	Panel_L1_F3_L1_110270_PBMC_11072011_F03.580321.fcs	Panel_L1_F3_L1_110270_PBMC_11072011_F03.fcs
SUB120472	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at enrollment		23	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752399			PBMC		24	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004032		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	578740	Flow cytometry result	Panel_P1_G12_P1_110270_PBMC_11102011_G12.578740.fcs	Panel_P1_G12_P1_110270_PBMC_11102011_G12.fcs
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689579			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004063		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	578771	Flow cytometry result	Panel_L5_MonoNKDC_A5_L5_110271_PBMC_10172011_A05.578771.fcs	Panel_L5_MonoNKDC_A5_L5_110271_PBMC_10172011_A05.fcs
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689579			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004550		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579258	Flow cytometry result	Panel_L1_A2_L1_110271_PBMC_10172011_A02.579258.fcs	Panel_L1_A2_L1_110271_PBMC_10172011_A02.fcs
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689579			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004859		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579567	Flow cytometry result	Panel_P13_A11_P13_110271_PBMC_10172011_A11.579567.fcs	Panel_P13_A11_P13_110271_PBMC_10172011_A11.fcs
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689579			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004864		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579572	Flow cytometry result	Panel_P1_A11_P1_110271_PBMC_10172011_A11.579572.fcs	Panel_P1_A11_P1_110271_PBMC_10172011_A11.fcs
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689579			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004995		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579703	Flow cytometry result	Panel_L3_A8_L3_110271_PBMC_10172011_A08.579703.fcs	Panel_L3_A8_L3_110271_PBMC_10172011_A08.fcs
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689579			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005040		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579748	Flow cytometry result	Panel_L2_A5_L2_110271_PBMC_10172011_A05.579748.fcs	Panel_L2_A5_L2_110271_PBMC_10172011_A05.fcs
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689579			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005288		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579996	Flow cytometry result	Panel_P10_A5_P10_110271_PBMC_10172011_A05.579996.fcs	Panel_P10_A5_P10_110271_PBMC_10172011_A05.fcs
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689579			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005313		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	580021	Flow cytometry result	Panel_P2_A8_P2_110271_PBMC_10172011_A08.580021.fcs	Panel_P2_A8_P2_110271_PBMC_10172011_A08.fcs
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689579			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005374		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	580082	Flow cytometry result	Panel_L4_B_Cells_A2_L4_110271_PBMC_10172011_A02.580082.fcs	Panel_L4_B_Cells_A2_L4_110271_PBMC_10172011_A02.fcs
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689579			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005377		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580085	Flow cytometry result	Panel_P9_A2_P9_110271_PBMC_10172011_A02.580085.fcs	Panel_P9_A2_P9_110271_PBMC_10172011_A02.fcs
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689580			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003648		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	578276	Flow cytometry result	Panel_L3_B8_L3_110271_PBMC_10192011_B08.578276.fcs	Panel_L3_B8_L3_110271_PBMC_10192011_B08.fcs
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689580			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003833		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	578531	Flow cytometry result	Panel_P13_B11_P13_110271_PBMC_10192011_B11.578531.fcs	Panel_P13_B11_P13_110271_PBMC_10192011_B11.fcs
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689580			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003979		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	578687	Flow cytometry result	Panel_P2_B8_P2_110271_PBMC_10192011_B08.578687.fcs	Panel_P2_B8_P2_110271_PBMC_10192011_B08.fcs
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689580			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003980		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	578688	Flow cytometry result	Panel_P1_B11_P1_110271_PBMC_10192011_B11.578688.fcs	Panel_P1_B11_P1_110271_PBMC_10192011_B11.fcs
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689580			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004052		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	578760	Flow cytometry result	Panel_L1_B2_L1_110271_PBMC_10192011_B02.578760.fcs	Panel_L1_B2_L1_110271_PBMC_10192011_B02.fcs
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689580			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004140		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	578848	Flow cytometry result	Panel_L4_B_Cells_B2_L4_110271_PBMC_10192011_B02.578848.fcs	Panel_L4_B_Cells_B2_L4_110271_PBMC_10192011_B02.fcs
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689580			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004691		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579399	Flow cytometry result	Panel_L2_B5_L2_110271_PBMC_10192011_B05.579399.fcs	Panel_L2_B5_L2_110271_PBMC_10192011_B05.fcs
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689580			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005359		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580067	Flow cytometry result	Panel_P9_B2_P9_110271_PBMC_10192011_B02.580067.fcs	Panel_P9_B2_P9_110271_PBMC_10192011_B02.fcs
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689580			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005526		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	580234	Flow cytometry result	Panel_L5_MonoNKDC_B5_L5_110271_PBMC_10192011_B05.580234.fcs	Panel_L5_MonoNKDC_B5_L5_110271_PBMC_10192011_B05.fcs
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689580			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005645		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580353	Flow cytometry result	Panel_P10_B5_P10_110271_PBMC_10192011_B05.580353.fcs	Panel_P10_B5_P10_110271_PBMC_10192011_B05.fcs
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689581			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003712		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578381	Flow cytometry result	Panel_P9_C2_P9_110271_PBMC_10242011_C02.578381.fcs	Panel_P9_C2_P9_110271_PBMC_10242011_C02.fcs
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689581			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003829		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	578527	Flow cytometry result	Panel_L2_C5_L2_110271_PBMC_10242011_C05.578527.fcs	Panel_L2_C5_L2_110271_PBMC_10242011_C05.fcs
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689581			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004071		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578779	Flow cytometry result	Panel_P10_C5_P10_110271_PBMC_10242011_C05.578779.fcs	Panel_P10_C5_P10_110271_PBMC_10242011_C05.fcs
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689581			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004128		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	578836	Flow cytometry result	Panel_L5_MonoNKDC_C5_L5_110271_PBMC_10242011_C05.578836.fcs	Panel_L5_MonoNKDC_C5_L5_110271_PBMC_10242011_C05.fcs
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689581			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004231		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	578939	Flow cytometry result	Panel_P2_C8_P2_110271_PBMC_10242011_C08.578939.fcs	Panel_P2_C8_P2_110271_PBMC_10242011_C08.fcs
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689581			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004413		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579121	Flow cytometry result	Panel_L3_C8_L3_110271_PBMC_10242011_C08.579121.fcs	Panel_L3_C8_L3_110271_PBMC_10242011_C08.fcs
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689581			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004434		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579142	Flow cytometry result	Panel_P1_C11_P1_110271_PBMC_10242011_C11.579142.fcs	Panel_P1_C11_P1_110271_PBMC_10242011_C11.fcs
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689581			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004683		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579391	Flow cytometry result	Panel_L4_B_Cells_C2_L4_110271_PBMC_10242011_C02.579391.fcs	Panel_L4_B_Cells_C2_L4_110271_PBMC_10242011_C02.fcs
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689581			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005330		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	580038	Flow cytometry result	Panel_P13_C11_P13_110271_PBMC_10242011_C11.580038.fcs	Panel_P13_C11_P13_110271_PBMC_10242011_C11.fcs
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689581			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005341		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	580049	Flow cytometry result	Panel_L1_C2_L1_110271_PBMC_10242011_C02.580049.fcs	Panel_L1_C2_L1_110271_PBMC_10242011_C02.fcs
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689582			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003639		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578258	Flow cytometry result	Panel_P10_D5_P10_110271_PBMC_11142011_D05.578258.fcs	Panel_P10_D5_P10_110271_PBMC_11142011_D05.fcs
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689582			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003655		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	578287	Flow cytometry result	Panel_P1_D11_P1_110271_PBMC_11142011_D11.578287.fcs	Panel_P1_D11_P1_110271_PBMC_11142011_D11.fcs
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689582			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003689		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	578343	Flow cytometry result	Panel_L4_B_Cells_D2_L4_110271_PBMC_11142011_D02.578343.fcs	Panel_L4_B_Cells_D2_L4_110271_PBMC_11142011_D02.fcs
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689582			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004380		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579088	Flow cytometry result	Panel_L5_MonoNKDC_D5_L5_110271_PBMC_11142011_D05.579088.fcs	Panel_L5_MonoNKDC_D5_L5_110271_PBMC_11142011_D05.fcs
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689582			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004444		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579152	Flow cytometry result	Panel_P2_D8_P2_110271_PBMC_11142011_D08.579152.fcs	Panel_P2_D8_P2_110271_PBMC_11142011_D08.fcs
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689582			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004723		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579431	Flow cytometry result	Panel_P13_D11_P13_110271_PBMC_11142011_D11.579431.fcs	Panel_P13_D11_P13_110271_PBMC_11142011_D11.fcs
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689582			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004997		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579705	Flow cytometry result	Panel_L3_D8_L3_110271_PBMC_11142011_D08.579705.fcs	Panel_L3_D8_L3_110271_PBMC_11142011_D08.fcs
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689582			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005031		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579739	Flow cytometry result	Panel_P9_D2_P9_110271_PBMC_11142011_D02.579739.fcs	Panel_P9_D2_P9_110271_PBMC_11142011_D02.fcs
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689582			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005435		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	580143	Flow cytometry result	Panel_L2_D5_L2_110271_PBMC_11142011_D05.580143.fcs	Panel_L2_D5_L2_110271_PBMC_11142011_D05.fcs
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689582			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005687		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	580395	Flow cytometry result	Panel_L1_D2_L1_110271_PBMC_11142011_D02.580395.fcs	Panel_L1_D2_L1_110271_PBMC_11142011_D02.fcs
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752400			PBMC		3	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004516		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579224	Flow cytometry result	Panel_L2_B5_L2_110271_PBMC_10202011_B05.579224.fcs	Panel_L2_B5_L2_110271_PBMC_10202011_B05.fcs
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689583			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003644		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	578268	Flow cytometry result	Panel_L3_E8_L3_110272_PBMC_10172011_E08.578268.fcs	Panel_L3_E8_L3_110272_PBMC_10172011_E08.fcs
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689583			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003806		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	578501	Flow cytometry result	Panel_L1_E2_L1_110272_PBMC_10172011_E02.578501.fcs	Panel_L1_E2_L1_110272_PBMC_10172011_E02.fcs
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689583			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003972		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	578680	Flow cytometry result	Panel_L4_B_Cells_E2_L4_110272_PBMC_10172011_E02.578680.fcs	Panel_L4_B_Cells_E2_L4_110272_PBMC_10172011_E02.fcs
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689583			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003973		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	578681	Flow cytometry result	Panel_P1_E11_P1_110272_PBMC_10172011_E11.578681.fcs	Panel_P1_E11_P1_110272_PBMC_10172011_E11.fcs
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689583			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004098		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	578806	Flow cytometry result	Panel_L2_E5_L2_110272_PBMC_10172011_E05.578806.fcs	Panel_L2_E5_L2_110272_PBMC_10172011_E05.fcs
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689583			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004190		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	578898	Flow cytometry result	Panel_P13_E11_P13_110272_PBMC_10172011_E11.578898.fcs	Panel_P13_E11_P13_110272_PBMC_10172011_E11.fcs
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689583			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004279		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578987	Flow cytometry result	Panel_P9_E2_P9_110272_PBMC_10172011_E02.578987.fcs	Panel_P9_E2_P9_110272_PBMC_10172011_E02.fcs
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689583			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004394		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579102	Flow cytometry result	Panel_L5_MonoNKDC_E5_L5_110272_PBMC_10172011_E05.579102.fcs	Panel_L5_MonoNKDC_E5_L5_110272_PBMC_10172011_E05.fcs
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689583			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004724		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579432	Flow cytometry result	Panel_P10_E5_P10_110272_PBMC_10172011_E05.579432.fcs	Panel_P10_E5_P10_110272_PBMC_10172011_E05.fcs
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689583			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004877		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579585	Flow cytometry result	Panel_P2_E8_P2_110272_PBMC_10172011_E08.579585.fcs	Panel_P2_E8_P2_110272_PBMC_10172011_E08.fcs
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689584			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004046		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	578754	Flow cytometry result	Panel_P1_F11_P1_110272_PBMC_10192011_F11.578754.fcs	Panel_P1_F11_P1_110272_PBMC_10192011_F11.fcs
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689584			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004677		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579385	Flow cytometry result	Panel_P13_F11_P13_110272_PBMC_10192011_F11.579385.fcs	Panel_P13_F11_P13_110272_PBMC_10192011_F11.fcs
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689584			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005160		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579868	Flow cytometry result	Panel_P9_F2_P9_110272_PBMC_10192011_F02.579868.fcs	Panel_P9_F2_P9_110272_PBMC_10192011_F02.fcs
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689584			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005168		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579876	Flow cytometry result	Panel_L3_F8_L3_110272_PBMC_10192011_F08.579876.fcs	Panel_L3_F8_L3_110272_PBMC_10192011_F08.fcs
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689584			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005247		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579955	Flow cytometry result	Panel_L1_F2_L1_110272_PBMC_10192011_F02.579955.fcs	Panel_L1_F2_L1_110272_PBMC_10192011_F02.fcs
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689584			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005350		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	580058	Flow cytometry result	Panel_L5_MonoNKDC_F5_L5_110272_PBMC_10192011_F05.580058.fcs	Panel_L5_MonoNKDC_F5_L5_110272_PBMC_10192011_F05.fcs
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689584			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005424		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	580132	Flow cytometry result	Panel_L4_B_Cells_F2_L4_110272_PBMC_10192011_F02.580132.fcs	Panel_L4_B_Cells_F2_L4_110272_PBMC_10192011_F02.fcs
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689584			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005429		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	580137	Flow cytometry result	Panel_L2_F5_L2_110272_PBMC_10192011_F05.580137.fcs	Panel_L2_F5_L2_110272_PBMC_10192011_F05.fcs
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689584			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005650		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580358	Flow cytometry result	Panel_P10_F5_P10_110272_PBMC_10192011_F05.580358.fcs	Panel_P10_F5_P10_110272_PBMC_10192011_F05.fcs
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689584			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005682		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	580390	Flow cytometry result	Panel_P2_F8_P2_110272_PBMC_10192011_F08.580390.fcs	Panel_P2_F8_P2_110272_PBMC_10192011_F08.fcs
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689585			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003933		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	578638	Flow cytometry result	Panel_L1_G2_L1_110272_PBMC_10242011_G02.578638.fcs	Panel_L1_G2_L1_110272_PBMC_10242011_G02.fcs
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689585			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004078		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578786	Flow cytometry result	Panel_P10_G5_P10_110272_PBMC_10242011_G05.578786.fcs	Panel_P10_G5_P10_110272_PBMC_10242011_G05.fcs
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689585			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004122		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	578830	Flow cytometry result	Panel_P1_G11_P1_110272_PBMC_10242011_G11.578830.fcs	Panel_P1_G11_P1_110272_PBMC_10242011_G11.fcs
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689585			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004183		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578891	Flow cytometry result	Panel_P9_G2_P9_110272_PBMC_10242011_G02.578891.fcs	Panel_P9_G2_P9_110272_PBMC_10242011_G02.fcs
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689585			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004474		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579182	Flow cytometry result	Panel_L4_B_Cells_G2_L4_110272_PBMC_10242011_G02.579182.fcs	Panel_L4_B_Cells_G2_L4_110272_PBMC_10242011_G02.fcs
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689585			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005060		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579768	Flow cytometry result	Panel_P2_G8_P2_110272_PBMC_10242011_G08.579768.fcs	Panel_P2_G8_P2_110272_PBMC_10242011_G08.fcs
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689585			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005314		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	580022	Flow cytometry result	Panel_L2_G5_L2_110272_PBMC_10242011_G05.580022.fcs	Panel_L2_G5_L2_110272_PBMC_10242011_G05.fcs
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689585			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005524		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	580232	Flow cytometry result	Panel_L3_G8_L3_110272_PBMC_10242011_G08.580232.fcs	Panel_L3_G8_L3_110272_PBMC_10242011_G08.fcs
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689585			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005658		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	580366	Flow cytometry result	Panel_L5_MonoNKDC_G5_L5_110272_PBMC_10242011_G05.580366.fcs	Panel_L5_MonoNKDC_G5_L5_110272_PBMC_10242011_G05.fcs
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689585			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005684		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	580392	Flow cytometry result	Panel_P13_G11_P13_110272_PBMC_10242011_G11.580392.fcs	Panel_P13_G11_P13_110272_PBMC_10242011_G11.fcs
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689586			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004113		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	578821	Flow cytometry result	Panel_P2_H8_P2_110272_PBMC_11142011_H08.578821.fcs	Panel_P2_H8_P2_110272_PBMC_11142011_H08.fcs
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689586			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004229		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578937	Flow cytometry result	Panel_P10_H5_P10_110272_PBMC_11142011_H05.578937.fcs	Panel_P10_H5_P10_110272_PBMC_11142011_H05.fcs
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689586			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004296		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579004	Flow cytometry result	Panel_P9_H2_P9_110272_PBMC_11142011_H02.579004.fcs	Panel_P9_H2_P9_110272_PBMC_11142011_H02.fcs
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689586			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004385		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579093	Flow cytometry result	Panel_L3_H8_L3_110272_PBMC_11142011_H08.579093.fcs	Panel_L3_H8_L3_110272_PBMC_11142011_H08.fcs
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689586			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004645		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579353	Flow cytometry result	Panel_L2_H5_L2_110272_PBMC_11142011_H05.579353.fcs	Panel_L2_H5_L2_110272_PBMC_11142011_H05.fcs
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689586			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004719		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579427	Flow cytometry result	Panel_L5_MonoNKDC_H5_L5_110272_PBMC_11142011_H05.579427.fcs	Panel_L5_MonoNKDC_H5_L5_110272_PBMC_11142011_H05.fcs
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689586			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004753		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579461	Flow cytometry result	Panel_P13_H11_P13_110272_PBMC_11142011_H11.579461.fcs	Panel_P13_H11_P13_110272_PBMC_11142011_H11.fcs
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689586			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004858		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579566	Flow cytometry result	Panel_P1_H11_P1_110272_PBMC_11142011_H11.579566.fcs	Panel_P1_H11_P1_110272_PBMC_11142011_H11.fcs
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689586			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005441		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	580149	Flow cytometry result	Panel_L1_H2_L1_110272_PBMC_11142011_H02.580149.fcs	Panel_L1_H2_L1_110272_PBMC_11142011_H02.fcs
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689586			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005564		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	580272	Flow cytometry result	Panel_L4_B_Cells_H2_L4_110272_PBMC_11142011_H02.580272.fcs	Panel_L4_B_Cells_H2_L4_110272_PBMC_11142011_H02.fcs
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752401			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003834		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578532	Flow cytometry result	Panel_P9_E3_P9_110276_PBMC_10182011_E03.578532.fcs	Panel_P9_E3_P9_110276_PBMC_10182011_E03.fcs
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752401			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004666		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579374	Flow cytometry result	Panel_L3_E9_L3_110276_PBMC_10182011_E09.579374.fcs	Panel_L3_E9_L3_110276_PBMC_10182011_E09.fcs
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752401			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004769		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579477	Flow cytometry result	Panel_L5_MonoNKDC_E6_L5_110276_PBMC_10182011_E06.579477.fcs	Panel_L5_MonoNKDC_E6_L5_110276_PBMC_10182011_E06.fcs
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752401			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004803		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579511	Flow cytometry result	Panel_L2_E6_L2_110276_PBMC_10182011_E06.579511.fcs	Panel_L2_E6_L2_110276_PBMC_10182011_E06.fcs
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752401			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004922		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579630	Flow cytometry result	Panel_L4_B_Cells_E3_L4_110276_PBMC_10182011_E03.579630.fcs	Panel_L4_B_Cells_E3_L4_110276_PBMC_10182011_E03.fcs
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752401			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005132		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579840	Flow cytometry result	Panel_P10_E6_P10_110276_PBMC_10182011_E06.579840.fcs	Panel_P10_E6_P10_110276_PBMC_10182011_E06.fcs
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752401			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005329		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	580037	Flow cytometry result	Panel_P1_E12_P1_110276_PBMC_10182011_E12.580037.fcs	Panel_P1_E12_P1_110276_PBMC_10182011_E12.fcs
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752401			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005382		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	580090	Flow cytometry result	Panel_P2_E9_P2_110276_PBMC_10182011_E09.580090.fcs	Panel_P2_E9_P2_110276_PBMC_10182011_E09.fcs
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752401			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005617		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	580325	Flow cytometry result	Panel_P13_E12_P13_110276_PBMC_10182011_E12.580325.fcs	Panel_P13_E12_P13_110276_PBMC_10182011_E12.fcs
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752401			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005681		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	580389	Flow cytometry result	Panel_L1_E3_L1_110276_PBMC_10182011_E03.580389.fcs	Panel_L1_E3_L1_110276_PBMC_10182011_E03.fcs
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752402			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003918		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	578623	Flow cytometry result	Panel_L2_F6_L2_110276_PBMC_10202011_F06.578623.fcs	Panel_L2_F6_L2_110276_PBMC_10202011_F06.fcs
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752402			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004115		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	578823	Flow cytometry result	Panel_P1_F12_P1_110276_PBMC_10202011_F12.578823.fcs	Panel_P1_F12_P1_110276_PBMC_10202011_F12.fcs
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752402			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004255		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	578963	Flow cytometry result	Panel_L1_F3_L1_110276_PBMC_10202011_F03.578963.fcs	Panel_L1_F3_L1_110276_PBMC_10202011_F03.fcs
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752402			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005025		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579733	Flow cytometry result	Panel_P13_F12_P13_110276_PBMC_10202011_F12.579733.fcs	Panel_P13_F12_P13_110276_PBMC_10202011_F12.fcs
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752402			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005228		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579936	Flow cytometry result	Panel_P2_F9_P2_110276_PBMC_10202011_F09.579936.fcs	Panel_P2_F9_P2_110276_PBMC_10202011_F09.fcs
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752402			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005264		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579972	Flow cytometry result	Panel_L4_B_Cells_F3_L4_110276_PBMC_10202011_F03.579972.fcs	Panel_L4_B_Cells_F3_L4_110276_PBMC_10202011_F03.fcs
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752402			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005279		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579987	Flow cytometry result	Panel_L5_MonoNKDC_F6_L5_110276_PBMC_10202011_F06.579987.fcs	Panel_L5_MonoNKDC_F6_L5_110276_PBMC_10202011_F06.fcs
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752402			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005297		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	580005	Flow cytometry result	Panel_L3_F9_L3_110276_PBMC_10202011_F09.580005.fcs	Panel_L3_F9_L3_110276_PBMC_10202011_F09.fcs
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752402			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005366		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580074	Flow cytometry result	Panel_P10_F6_P10_110276_PBMC_10202011_F06.580074.fcs	Panel_P10_F6_P10_110276_PBMC_10202011_F06.fcs
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752402			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005685		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580393	Flow cytometry result	Panel_P9_F3_P9_110276_PBMC_10202011_F03.580393.fcs	Panel_P9_F3_P9_110276_PBMC_10202011_F03.fcs
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752403			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004039		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578747	Flow cytometry result	Panel_P10_G6_P10_110276_PBMC_10252011_G06.578747.fcs	Panel_P10_G6_P10_110276_PBMC_10252011_G06.fcs
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752403			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004282		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	578990	Flow cytometry result	Panel_P1_G12_P1_110276_PBMC_10252011_G12.578990.fcs	Panel_P1_G12_P1_110276_PBMC_10252011_G12.fcs
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752403			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004334		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579042	Flow cytometry result	Panel_L1_G3_L1_110276_PBMC_10252011_G03.579042.fcs	Panel_L1_G3_L1_110276_PBMC_10252011_G03.fcs
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752403			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004335		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579043	Flow cytometry result	Panel_L5_MonoNKDC_G6_L5_110276_PBMC_10252011_G06.579043.fcs	Panel_L5_MonoNKDC_G6_L5_110276_PBMC_10252011_G06.fcs
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752403			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004437		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579145	Flow cytometry result	Panel_L3_G9_L3_110276_PBMC_10252011_G09.579145.fcs	Panel_L3_G9_L3_110276_PBMC_10252011_G09.fcs
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752403			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004717		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579425	Flow cytometry result	Panel_P13_G12_P13_110276_PBMC_10252011_G12.579425.fcs	Panel_P13_G12_P13_110276_PBMC_10252011_G12.fcs
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752403			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004830		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579538	Flow cytometry result	Panel_L2_G6_L2_110276_PBMC_10252011_G06.579538.fcs	Panel_L2_G6_L2_110276_PBMC_10252011_G06.fcs
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752403			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005164		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579872	Flow cytometry result	Panel_L4_B_Cells_G3_L4_110276_PBMC_10252011_G03.579872.fcs	Panel_L4_B_Cells_G3_L4_110276_PBMC_10252011_G03.fcs
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752403			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005243		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579951	Flow cytometry result	Panel_P2_G9_P2_110276_PBMC_10252011_G09.579951.fcs	Panel_P2_G9_P2_110276_PBMC_10252011_G09.fcs
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752403			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005547		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580255	Flow cytometry result	Panel_P9_G3_P9_110276_PBMC_10252011_G03.580255.fcs	Panel_P9_G3_P9_110276_PBMC_10252011_G03.fcs
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752404			PBMC		21	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004729		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579437	Flow cytometry result	Panel_P9_H3_P9_110276_PBMC_11082011_H03.579437.fcs	Panel_P9_H3_P9_110276_PBMC_11082011_H03.fcs
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752405			PBMC		35	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003962		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578670	Flow cytometry result	Panel_P9_H3_P9_110276_PBMC_11222011_H03.578670.fcs	Panel_P9_H3_P9_110276_PBMC_11222011_H03.fcs
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752405			PBMC		35	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004702		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579410	Flow cytometry result	Panel_P1_H12_P1_110276_PBMC_11222011_H12.579410.fcs	Panel_P1_H12_P1_110276_PBMC_11222011_H12.fcs
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752405			PBMC		35	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004961		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579669	Flow cytometry result	Panel_P2_H9_P2_110276_PBMC_11222011_H09.579669.fcs	Panel_P2_H9_P2_110276_PBMC_11222011_H09.fcs
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752405			PBMC		35	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005202		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579910	Flow cytometry result	Panel_P10_H6_P10_110276_PBMC_11222011_H06.579910.fcs	Panel_P10_H6_P10_110276_PBMC_11222011_H06.fcs
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752405			PBMC		35	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005220		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579928	Flow cytometry result	Panel_L5_MonoNKDC_H6_L5_110276_PBMC_11222011_H06.579928.fcs	Panel_L5_MonoNKDC_H6_L5_110276_PBMC_11222011_H06.fcs
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752405			PBMC		35	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005237		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579945	Flow cytometry result	Panel_L1_H3_L1_110276_PBMC_11222011_H03.579945.fcs	Panel_L1_H3_L1_110276_PBMC_11222011_H03.fcs
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752405			PBMC		35	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005240		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579948	Flow cytometry result	Panel_P13_H12_P13_110276_PBMC_11222011_H12.579948.fcs	Panel_P13_H12_P13_110276_PBMC_11222011_H12.fcs
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752405			PBMC		35	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005357		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	580065	Flow cytometry result	Panel_L2_H6_L2_110276_PBMC_11222011_H06.580065.fcs	Panel_L2_H6_L2_110276_PBMC_11222011_H06.fcs
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752405			PBMC		35	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005397		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	580105	Flow cytometry result	Panel_L4_B_Cells_H3_L4_110276_PBMC_11222011_H03.580105.fcs	Panel_L4_B_Cells_H3_L4_110276_PBMC_11222011_H03.fcs
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752405			PBMC		35	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005565		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	580273	Flow cytometry result	Panel_L3_H9_L3_110276_PBMC_11222011_H09.580273.fcs	Panel_L3_H9_L3_110276_PBMC_11222011_H09.fcs
SUB120479	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689587			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003692		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	578349	Flow cytometry result	Panel_L3_A9_L3_110277_PBMC_10182011_A09.578349.fcs	Panel_L3_A9_L3_110277_PBMC_10182011_A09.fcs
SUB120479	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689587			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003788		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578479	Flow cytometry result	Panel_P9_A3_P9_110277_PBMC_10182011_A03.578479.fcs	Panel_P9_A3_P9_110277_PBMC_10182011_A03.fcs
SUB120479	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689587			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004537		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579245	Flow cytometry result	Panel_P13_A12_P13_110277_PBMC_10182011_A12.579245.fcs	Panel_P13_A12_P13_110277_PBMC_10182011_A12.fcs
SUB120479	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689587			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004608		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579316	Flow cytometry result	Panel_L1_A3_L1_110277_PBMC_10182011_A03.579316.fcs	Panel_L1_A3_L1_110277_PBMC_10182011_A03.fcs
SUB120479	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689587			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004705		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579413	Flow cytometry result	Panel_L5_MonoNKDC_A6_L5_110277_PBMC_10182011_A06.579413.fcs	Panel_L5_MonoNKDC_A6_L5_110277_PBMC_10182011_A06.fcs
SUB120479	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689587			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004869		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579577	Flow cytometry result	Panel_L4_B_Cells_A3_L4_110277_PBMC_10182011_A03.579577.fcs	Panel_L4_B_Cells_A3_L4_110277_PBMC_10182011_A03.fcs
SUB120479	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689587			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004992		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579700	Flow cytometry result	Panel_L2_A6_L2_110277_PBMC_10182011_A06.579700.fcs	Panel_L2_A6_L2_110277_PBMC_10182011_A06.fcs
SUB120479	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689587			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005000		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579708	Flow cytometry result	Panel_P1_A12_P1_110277_PBMC_10182011_A12.579708.fcs	Panel_P1_A12_P1_110277_PBMC_10182011_A12.fcs
SUB120479	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689587			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005129		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579837	Flow cytometry result	Panel_P10_A6_P10_110277_PBMC_10182011_A06.579837.fcs	Panel_P10_A6_P10_110277_PBMC_10182011_A06.fcs
SUB120479	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689587			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005352		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	580060	Flow cytometry result	Panel_P2_A9_P2_110277_PBMC_10182011_A09.580060.fcs	Panel_P2_A9_P2_110277_PBMC_10182011_A09.fcs
SUB120479	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689588			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003715		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	578385	Flow cytometry result	Panel_L4_B_Cells_B3_L4_110277_PBMC_10202011_B03.578385.fcs	Panel_L4_B_Cells_B3_L4_110277_PBMC_10202011_B03.fcs
SUB120479	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689588			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003786		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	578475	Flow cytometry result	Panel_L2_B6_L2_110277_PBMC_10202011_B06.578475.fcs	Panel_L2_B6_L2_110277_PBMC_10202011_B06.fcs
SUB120479	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689588			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004069		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	578777	Flow cytometry result	Panel_L3_B9_L3_110277_PBMC_10202011_B09.578777.fcs	Panel_L3_B9_L3_110277_PBMC_10202011_B09.fcs
SUB120479	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689588			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004472		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579180	Flow cytometry result	Panel_P9_B3_P9_110277_PBMC_10202011_B03.579180.fcs	Panel_P9_B3_P9_110277_PBMC_10202011_B03.fcs
SUB120479	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689588			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004539		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579247	Flow cytometry result	Panel_P2_B9_P2_110277_PBMC_10202011_B09.579247.fcs	Panel_P2_B9_P2_110277_PBMC_10202011_B09.fcs
SUB120479	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689588			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004727		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579435	Flow cytometry result	Panel_P10_B6_P10_110277_PBMC_10202011_B06.579435.fcs	Panel_P10_B6_P10_110277_PBMC_10202011_B06.fcs
SUB120479	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689588			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004919		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579627	Flow cytometry result	Panel_L5_MonoNKDC_B6_L5_110277_PBMC_10202011_B06.579627.fcs	Panel_L5_MonoNKDC_B6_L5_110277_PBMC_10202011_B06.fcs
SUB120479	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689588			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004972		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579680	Flow cytometry result	Panel_P1_B12_P1_110277_PBMC_10202011_B12.579680.fcs	Panel_P1_B12_P1_110277_PBMC_10202011_B12.fcs
SUB120479	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689588			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005013		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579721	Flow cytometry result	Panel_L1_B3_L1_110277_PBMC_10202011_B03.579721.fcs	Panel_L1_B3_L1_110277_PBMC_10202011_B03.fcs
SUB120479	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689588			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005122		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579830	Flow cytometry result	Panel_P13_B12_P13_110277_PBMC_10202011_B12.579830.fcs	Panel_P13_B12_P13_110277_PBMC_10202011_B12.fcs
SUB120479	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689589			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003739		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	578418	Flow cytometry result	Panel_L1_C3_L1_110277_PBMC_10252011_C03.578418.fcs	Panel_L1_C3_L1_110277_PBMC_10252011_C03.fcs
SUB120479	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689589			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003822		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	578520	Flow cytometry result	Panel_P2_C9_P2_110277_PBMC_10252011_C09.578520.fcs	Panel_P2_C9_P2_110277_PBMC_10252011_C09.fcs
SUB120479	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689589			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004187		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	578895	Flow cytometry result	Panel_L5_MonoNKDC_C6_L5_110277_PBMC_10252011_C06.578895.fcs	Panel_L5_MonoNKDC_C6_L5_110277_PBMC_10252011_C06.fcs
SUB120479	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689589			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004725		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579433	Flow cytometry result	Panel_L2_C6_L2_110277_PBMC_10252011_C06.579433.fcs	Panel_L2_C6_L2_110277_PBMC_10252011_C06.fcs
SUB120479	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689589			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005007		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579715	Flow cytometry result	Panel_P13_C12_P13_110277_PBMC_10252011_C12.579715.fcs	Panel_P13_C12_P13_110277_PBMC_10252011_C12.fcs
SUB120479	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689589			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005312		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580020	Flow cytometry result	Panel_P10_C6_P10_110277_PBMC_10252011_C06.580020.fcs	Panel_P10_C6_P10_110277_PBMC_10252011_C06.fcs
SUB120479	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689589			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005469		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	580177	Flow cytometry result	Panel_P1_C12_P1_110277_PBMC_10252011_C12.580177.fcs	Panel_P1_C12_P1_110277_PBMC_10252011_C12.fcs
SUB120479	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689589			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005605		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580313	Flow cytometry result	Panel_P9_C3_P9_110277_PBMC_10252011_C03.580313.fcs	Panel_P9_C3_P9_110277_PBMC_10252011_C03.fcs
SUB120479	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689589			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005624		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	580332	Flow cytometry result	Panel_L4_B_Cells_C3_L4_110277_PBMC_10252011_C03.580332.fcs	Panel_L4_B_Cells_C3_L4_110277_PBMC_10252011_C03.fcs
SUB120479	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689589			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005698		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	580406	Flow cytometry result	Panel_L3_C9_L3_110277_PBMC_10252011_C09.580406.fcs	Panel_L3_C9_L3_110277_PBMC_10252011_C09.fcs
SUB120479	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752406			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005134		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579842	Flow cytometry result	Panel_L1_A3_L1_110277_PBMC_10172011_A03.579842.fcs	Panel_L1_A3_L1_110277_PBMC_10172011_A03.fcs
SUB120479	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752407			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004062		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	578770	Flow cytometry result	Panel_L1_B3_L1_110277_PBMC_10192011_B03.578770.fcs	Panel_L1_B3_L1_110277_PBMC_10192011_B03.fcs
SUB120479	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752408			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003750		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	578432	Flow cytometry result	Panel_L1_D3_L1_110277_PBMC_11182011_D03.578432.fcs	Panel_L1_D3_L1_110277_PBMC_11182011_D03.fcs
SUB120479	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752408			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004034		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578742	Flow cytometry result	Panel_P9_D3_P9_110277_PBMC_11182011_D03.578742.fcs	Panel_P9_D3_P9_110277_PBMC_11182011_D03.fcs
SUB120479	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752408			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004119		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	578827	Flow cytometry result	Panel_L2_D6_L2_110277_PBMC_11182011_D06.578827.fcs	Panel_L2_D6_L2_110277_PBMC_11182011_D06.fcs
SUB120479	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752408			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004306		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579014	Flow cytometry result	Panel_P1_D12_P1_110277_PBMC_11182011_D12.579014.fcs	Panel_P1_D12_P1_110277_PBMC_11182011_D12.fcs
SUB120479	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752408			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004482		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579190	Flow cytometry result	Panel_P2_D9_P2_110277_PBMC_11182011_D09.579190.fcs	Panel_P2_D9_P2_110277_PBMC_11182011_D09.fcs
SUB120479	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752408			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004680		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579388	Flow cytometry result	Panel_L5_MonoNKDC_D6_L5_110277_PBMC_11182011_D06.579388.fcs	Panel_L5_MonoNKDC_D6_L5_110277_PBMC_11182011_D06.fcs
SUB120479	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752408			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004710		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579418	Flow cytometry result	Panel_L3_D9_L3_110277_PBMC_11182011_D09.579418.fcs	Panel_L3_D9_L3_110277_PBMC_11182011_D09.fcs
SUB120479	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752408			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005158		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579866	Flow cytometry result	Panel_L4_B_Cells_D3_L4_110277_PBMC_11182011_D03.579866.fcs	Panel_L4_B_Cells_D3_L4_110277_PBMC_11182011_D03.fcs
SUB120479	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752408			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005204		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579912	Flow cytometry result	Panel_P10_D6_P10_110277_PBMC_11182011_D06.579912.fcs	Panel_P10_D6_P10_110277_PBMC_11182011_D06.fcs
SUB120479	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752408			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005271		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579979	Flow cytometry result	Panel_P13_D12_P13_110277_PBMC_11182011_D12.579979.fcs	Panel_P13_D12_P13_110277_PBMC_11182011_D12.fcs
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689591			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003695		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	578354	Flow cytometry result	Panel_L2_A4_L2_110278_PBMC_11032011_A04.578354.fcs	Panel_L2_A4_L2_110278_PBMC_11032011_A04.fcs
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689591			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003857		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	578558	Flow cytometry result	Panel_P13_A10_P13_110278_PBMC_11032011_A10.578558.fcs	Panel_P13_A10_P13_110278_PBMC_11032011_A10.fcs
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689591			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004201		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	578909	Flow cytometry result	Panel_P1_A10_P1_110278_PBMC_11032011_A10.578909.fcs	Panel_P1_A10_P1_110278_PBMC_11032011_A10.fcs
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689591			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004371		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579079	Flow cytometry result	Panel_L1_A1_L1_110278_PBMC_11032011_A01.579079.fcs	Panel_L1_A1_L1_110278_PBMC_11032011_A01.fcs
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689591			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004511		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579219	Flow cytometry result	Panel_L5_MonoNKDC_A4_L5_110278_PBMC_11032011_A04.579219.fcs	Panel_L5_MonoNKDC_A4_L5_110278_PBMC_11032011_A04.fcs
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689591			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004572		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579280	Flow cytometry result	Panel_P9_A1_P9_110278_PBMC_11032011_A01.579280.fcs	Panel_P9_A1_P9_110278_PBMC_11032011_A01.fcs
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689591			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005065		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579773	Flow cytometry result	Panel_L3_A7_L3_110278_PBMC_11032011_A07.579773.fcs	Panel_L3_A7_L3_110278_PBMC_11032011_A07.fcs
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689591			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005140		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579848	Flow cytometry result	Panel_L4_B_Cells_A1_L4_110278_PBMC_11032011_A01.579848.fcs	Panel_L4_B_Cells_A1_L4_110278_PBMC_11032011_A01.fcs
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689591			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005343		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580051	Flow cytometry result	Panel_P10_A4_P10_110278_PBMC_11032011_A04.580051.fcs	Panel_P10_A4_P10_110278_PBMC_11032011_A04.fcs
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689591			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005370		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	580078	Flow cytometry result	Panel_P2_A7_P2_110278_PBMC_11032011_A07.580078.fcs	Panel_P2_A7_P2_110278_PBMC_11032011_A07.fcs
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689592			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003672		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	578317	Flow cytometry result	Panel_P2_B7_P2_110278_PBMC_11072011_B07.578317.fcs	Panel_P2_B7_P2_110278_PBMC_11072011_B07.fcs
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689592			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003802		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578496	Flow cytometry result	Panel_P9_B1_P9_110278_PBMC_11072011_B01.578496.fcs	Panel_P9_B1_P9_110278_PBMC_11072011_B01.fcs
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689592			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004288		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	578996	Flow cytometry result	Panel_L5_MonoNKDC_B4_L5_110278_PBMC_11072011_B04.578996.fcs	Panel_L5_MonoNKDC_B4_L5_110278_PBMC_11072011_B04.fcs
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689592			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004407		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579115	Flow cytometry result	Panel_L1_B1_L1_110278_PBMC_11072011_B01.579115.fcs	Panel_L1_B1_L1_110278_PBMC_11072011_B01.fcs
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689592			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004606		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579314	Flow cytometry result	Panel_P10_B4_P10_110278_PBMC_11072011_B04.579314.fcs	Panel_P10_B4_P10_110278_PBMC_11072011_B04.fcs
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689592			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004786		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579494	Flow cytometry result	Panel_L4_B_Cells_B1_L4_110278_PBMC_11072011_B01.579494.fcs	Panel_L4_B_Cells_B1_L4_110278_PBMC_11072011_B01.fcs
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689592			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004788		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579496	Flow cytometry result	Panel_P13_B10_P13_110278_PBMC_11072011_B10.579496.fcs	Panel_P13_B10_P13_110278_PBMC_11072011_B10.fcs
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689592			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004854		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579562	Flow cytometry result	Panel_L3_B7_L3_110278_PBMC_11072011_B07.579562.fcs	Panel_L3_B7_L3_110278_PBMC_11072011_B07.fcs
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689592			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004994		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579702	Flow cytometry result	Panel_P1_B10_P1_110278_PBMC_11072011_B10.579702.fcs	Panel_P1_B10_P1_110278_PBMC_11072011_B10.fcs
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689592			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005049		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579757	Flow cytometry result	Panel_L2_B4_L2_110278_PBMC_11072011_B04.579757.fcs	Panel_L2_B4_L2_110278_PBMC_11072011_B04.fcs
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689593			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004089		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578797	Flow cytometry result	Panel_P10_C4_P10_110278_PBMC_11102011_C04.578797.fcs	Panel_P10_C4_P10_110278_PBMC_11102011_C04.fcs
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689593			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004110		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	578818	Flow cytometry result	Panel_L5_MonoNKDC_C4_L5_110278_PBMC_11102011_C04.578818.fcs	Panel_L5_MonoNKDC_C4_L5_110278_PBMC_11102011_C04.fcs
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689593			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004134		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	578842	Flow cytometry result	Panel_L4_B_Cells_C1_L4_110278_PBMC_11102011_C01.578842.fcs	Panel_L4_B_Cells_C1_L4_110278_PBMC_11102011_C01.fcs
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689593			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004386		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579094	Flow cytometry result	Panel_P1_C10_P1_110278_PBMC_11102011_C10.579094.fcs	Panel_P1_C10_P1_110278_PBMC_11102011_C10.fcs
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689593			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004502		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579210	Flow cytometry result	Panel_L1_C1_L1_110278_PBMC_11102011_C01.579210.fcs	Panel_L1_C1_L1_110278_PBMC_11102011_C01.fcs
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689593			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004588		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579296	Flow cytometry result	Panel_P2_C7_P2_110278_PBMC_11102011_C07.579296.fcs	Panel_P2_C7_P2_110278_PBMC_11102011_C07.fcs
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689593			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005006		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579714	Flow cytometry result	Panel_L2_C4_L2_110278_PBMC_11102011_C04.579714.fcs	Panel_L2_C4_L2_110278_PBMC_11102011_C04.fcs
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689593			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005056		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579764	Flow cytometry result	Panel_P9_C1_P9_110278_PBMC_11102011_C01.579764.fcs	Panel_P9_C1_P9_110278_PBMC_11102011_C01.fcs
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689593			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005523		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	580231	Flow cytometry result	Panel_P13_C10_P13_110278_PBMC_11102011_C10.580231.fcs	Panel_P13_C10_P13_110278_PBMC_11102011_C10.fcs
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689593			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005629		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	580337	Flow cytometry result	Panel_L3_C7_L3_110278_PBMC_11102011_C07.580337.fcs	Panel_L3_C7_L3_110278_PBMC_11102011_C07.fcs
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689594			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003717		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	578388	Flow cytometry result	Panel_L5_MonoNKDC_D4_L5_110278_PBMC_12012011_D04.578388.fcs	Panel_L5_MonoNKDC_D4_L5_110278_PBMC_12012011_D04.fcs
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689594			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004275		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	578983	Flow cytometry result	Panel_L1_D1_L1_110278_PBMC_12012011_D01.578983.fcs	Panel_L1_D1_L1_110278_PBMC_12012011_D01.fcs
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689594			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004478		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579186	Flow cytometry result	Panel_L4_B_Cells_D1_L4_110278_PBMC_12012011_D01.579186.fcs	Panel_L4_B_Cells_D1_L4_110278_PBMC_12012011_D01.fcs
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689594			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004483		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579191	Flow cytometry result	Panel_P13_D10_P13_110278_PBMC_12012011_D10.579191.fcs	Panel_P13_D10_P13_110278_PBMC_12012011_D10.fcs
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689594			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004611		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579319	Flow cytometry result	Panel_L2_D4_L2_110278_PBMC_12012011_D04.579319.fcs	Panel_L2_D4_L2_110278_PBMC_12012011_D04.fcs
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689594			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004778		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579486	Flow cytometry result	Panel_P1_D10_P1_110278_PBMC_12012011_D10.579486.fcs	Panel_P1_D10_P1_110278_PBMC_12012011_D10.fcs
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689594			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004809		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579517	Flow cytometry result	Panel_P2_D7_P2_110278_PBMC_12012011_D07.579517.fcs	Panel_P2_D7_P2_110278_PBMC_12012011_D07.fcs
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689594			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005495		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580203	Flow cytometry result	Panel_P9_D1_P9_110278_PBMC_12012011_D01.580203.fcs	Panel_P9_D1_P9_110278_PBMC_12012011_D01.fcs
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689594			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005496		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580204	Flow cytometry result	Panel_P10_D4_P10_110278_PBMC_12012011_D04.580204.fcs	Panel_P10_D4_P10_110278_PBMC_12012011_D04.fcs
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689594			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005616		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	580324	Flow cytometry result	Panel_L3_D7_L3_110278_PBMC_12012011_D07.580324.fcs	Panel_L3_D7_L3_110278_PBMC_12012011_D07.fcs
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689595			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004001		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	578709	Flow cytometry result	Panel_P1_E10_P1_110279_PBMC_11032011_E10.578709.fcs	Panel_P1_E10_P1_110279_PBMC_11032011_E10.fcs
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689595			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004091		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	578799	Flow cytometry result	Panel_P2_E7_P2_110279_PBMC_11032011_E07.578799.fcs	Panel_P2_E7_P2_110279_PBMC_11032011_E07.fcs
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689595			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004203		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	578911	Flow cytometry result	Panel_P13_E10_P13_110279_PBMC_11032011_E10.578911.fcs	Panel_P13_E10_P13_110279_PBMC_11032011_E10.fcs
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689595			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004285		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	578993	Flow cytometry result	Panel_L5_MonoNKDC_E4_L5_110279_PBMC_11032011_E04.578993.fcs	Panel_L5_MonoNKDC_E4_L5_110279_PBMC_11032011_E04.fcs
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689595			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005189		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579897	Flow cytometry result	Panel_P9_E1_P9_110279_PBMC_11032011_E01.579897.fcs	Panel_P9_E1_P9_110279_PBMC_11032011_E01.fcs
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689595			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005322		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580030	Flow cytometry result	Panel_P10_E4_P10_110279_PBMC_11032011_E04.580030.fcs	Panel_P10_E4_P10_110279_PBMC_11032011_E04.fcs
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689595			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005361		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	580069	Flow cytometry result	Panel_L1_E1_L1_110279_PBMC_11032011_E01.580069.fcs	Panel_L1_E1_L1_110279_PBMC_11032011_E01.fcs
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689595			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005383		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	580091	Flow cytometry result	Panel_L3_E7_L3_110279_PBMC_11032011_E07.580091.fcs	Panel_L3_E7_L3_110279_PBMC_11032011_E07.fcs
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689595			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005633		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	580341	Flow cytometry result	Panel_L4_B_Cells_E1_L4_110279_PBMC_11032011_E01.580341.fcs	Panel_L4_B_Cells_E1_L4_110279_PBMC_11032011_E01.fcs
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689595			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005665		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	580373	Flow cytometry result	Panel_L2_E4_L2_110279_PBMC_11032011_E04.580373.fcs	Panel_L2_E4_L2_110279_PBMC_11032011_E04.fcs
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689596			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004085		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	578793	Flow cytometry result	Panel_L1_F1_L1_110279_PBMC_11072011_F01.578793.fcs	Panel_L1_F1_L1_110279_PBMC_11072011_F01.fcs
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689596			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004087		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	578795	Flow cytometry result	Panel_L2_F4_L2_110279_PBMC_11072011_F04.578795.fcs	Panel_L2_F4_L2_110279_PBMC_11072011_F04.fcs
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689596			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004381		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579089	Flow cytometry result	Panel_L4_B_Cells_F1_L4_110279_PBMC_11072011_F01.579089.fcs	Panel_L4_B_Cells_F1_L4_110279_PBMC_11072011_F01.fcs
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689596			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004699		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579407	Flow cytometry result	Panel_P9_F1_P9_110279_PBMC_11072011_F01.579407.fcs	Panel_P9_F1_P9_110279_PBMC_11072011_F01.fcs
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689596			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004736		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579444	Flow cytometry result	Panel_L3_F7_L3_110279_PBMC_11072011_F07.579444.fcs	Panel_L3_F7_L3_110279_PBMC_11072011_F07.fcs
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689596			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005276		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579984	Flow cytometry result	Panel_L5_MonoNKDC_F4_L5_110279_PBMC_11072011_F04.579984.fcs	Panel_L5_MonoNKDC_F4_L5_110279_PBMC_11072011_F04.fcs
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689596			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005283		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579991	Flow cytometry result	Panel_P2_F7_P2_110279_PBMC_11072011_F07.579991.fcs	Panel_P2_F7_P2_110279_PBMC_11072011_F07.fcs
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689596			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005388		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	580096	Flow cytometry result	Panel_P13_F10_P13_110279_PBMC_11072011_F10.580096.fcs	Panel_P13_F10_P13_110279_PBMC_11072011_F10.fcs
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689596			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005548		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580256	Flow cytometry result	Panel_P10_F4_P10_110279_PBMC_11072011_F04.580256.fcs	Panel_P10_F4_P10_110279_PBMC_11072011_F04.fcs
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689596			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005655		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	580363	Flow cytometry result	Panel_P1_F10_P1_110279_PBMC_11072011_F10.580363.fcs	Panel_P1_F10_P1_110279_PBMC_11072011_F10.fcs
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689597			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003716		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	578386	Flow cytometry result	Panel_L1_G1_L1_110279_PBMC_11102011_G01.578386.fcs	Panel_L1_G1_L1_110279_PBMC_11102011_G01.fcs
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689597			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003817		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	578513	Flow cytometry result	Panel_L2_G4_L2_110279_PBMC_11102011_G04.578513.fcs	Panel_L2_G4_L2_110279_PBMC_11102011_G04.fcs
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689597			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003953		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	578660	Flow cytometry result	Panel_P1_G10_P1_110279_PBMC_11102011_G10.578660.fcs	Panel_P1_G10_P1_110279_PBMC_11102011_G10.fcs
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689597			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004206		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578914	Flow cytometry result	Panel_P10_G4_P10_110279_PBMC_11102011_G04.578914.fcs	Panel_P10_G4_P10_110279_PBMC_11102011_G04.fcs
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689597			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004754		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579462	Flow cytometry result	Panel_L3_G7_L3_110279_PBMC_11102011_G07.579462.fcs	Panel_L3_G7_L3_110279_PBMC_11102011_G07.fcs
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689597			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005141		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579849	Flow cytometry result	Panel_L5_MonoNKDC_G4_L5_110279_PBMC_11102011_G04.579849.fcs	Panel_L5_MonoNKDC_G4_L5_110279_PBMC_11102011_G04.fcs
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689597			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005244		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579952	Flow cytometry result	Panel_P2_G7_P2_110279_PBMC_11102011_G07.579952.fcs	Panel_P2_G7_P2_110279_PBMC_11102011_G07.fcs
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689597			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005250		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579958	Flow cytometry result	Panel_P9_G1_P9_110279_PBMC_11102011_G01.579958.fcs	Panel_P9_G1_P9_110279_PBMC_11102011_G01.fcs
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689597			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005464		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	580172	Flow cytometry result	Panel_P13_G10_P13_110279_PBMC_11102011_G10.580172.fcs	Panel_P13_G10_P13_110279_PBMC_11102011_G10.fcs
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689597			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005579		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	580287	Flow cytometry result	Panel_L4_B_Cells_G1_L4_110279_PBMC_11102011_G01.580287.fcs	Panel_L4_B_Cells_G1_L4_110279_PBMC_11102011_G01.fcs
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689598			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003764		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	578447	Flow cytometry result	Panel_P13_H10_P13_110279_PBMC_12012011_H10.578447.fcs	Panel_P13_H10_P13_110279_PBMC_12012011_H10.fcs
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689598			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004171		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	578879	Flow cytometry result	Panel_L3_H7_L3_110279_PBMC_12012011_H07.578879.fcs	Panel_L3_H7_L3_110279_PBMC_12012011_H07.fcs
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689598			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004198		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578906	Flow cytometry result	Panel_P10_H4_P10_110279_PBMC_12012011_H04.578906.fcs	Panel_P10_H4_P10_110279_PBMC_12012011_H04.fcs
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689598			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004326		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579034	Flow cytometry result	Panel_L2_H4_L2_110279_PBMC_12012011_H04.579034.fcs	Panel_L2_H4_L2_110279_PBMC_12012011_H04.fcs
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689598			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004730		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579438	Flow cytometry result	Panel_L1_H1_L1_110279_PBMC_12012011_H01.579438.fcs	Panel_L1_H1_L1_110279_PBMC_12012011_H01.fcs
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689598			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004825		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579533	Flow cytometry result	Panel_P9_H1_P9_110279_PBMC_12012011_H01.579533.fcs	Panel_P9_H1_P9_110279_PBMC_12012011_H01.fcs
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689598			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004881		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579589	Flow cytometry result	Panel_P2_H7_P2_110279_PBMC_12012011_H07.579589.fcs	Panel_P2_H7_P2_110279_PBMC_12012011_H07.fcs
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689598			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004952		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579660	Flow cytometry result	Panel_L4_B_Cells_H1_L4_110279_PBMC_12012011_H01.579660.fcs	Panel_L4_B_Cells_H1_L4_110279_PBMC_12012011_H01.fcs
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689598			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005085		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579793	Flow cytometry result	Panel_P1_H10_P1_110279_PBMC_12012011_H10.579793.fcs	Panel_P1_H10_P1_110279_PBMC_12012011_H10.fcs
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689598			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005525		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	580233	Flow cytometry result	Panel_L5_MonoNKDC_H4_L5_110279_PBMC_12012011_H04.580233.fcs	Panel_L5_MonoNKDC_H4_L5_110279_PBMC_12012011_H04.fcs
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752409			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003676		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	578324	Flow cytometry result	Panel_L4_B_Cells_E2_L4_110280_PBMC_11032011_E02.578324.fcs	Panel_L4_B_Cells_E2_L4_110280_PBMC_11032011_E02.fcs
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752409			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003704		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578369	Flow cytometry result	Panel_P10_E5_P10_110280_PBMC_11032011_E05.578369.fcs	Panel_P10_E5_P10_110280_PBMC_11032011_E05.fcs
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752409			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004013		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	578721	Flow cytometry result	Panel_P1_E11_P1_110280_PBMC_11032011_E11.578721.fcs	Panel_P1_E11_P1_110280_PBMC_11032011_E11.fcs
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752409			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004035		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578743	Flow cytometry result	Panel_P9_E2_P9_110280_PBMC_11032011_E02.578743.fcs	Panel_P9_E2_P9_110280_PBMC_11032011_E02.fcs
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752409			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004066		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	578774	Flow cytometry result	Panel_P2_E8_P2_110280_PBMC_11032011_E08.578774.fcs	Panel_P2_E8_P2_110280_PBMC_11032011_E08.fcs
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752409			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004549		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579257	Flow cytometry result	Panel_L3_E8_L3_110280_PBMC_11032011_E08.579257.fcs	Panel_L3_E8_L3_110280_PBMC_11032011_E08.fcs
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752409			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004966		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579674	Flow cytometry result	Panel_L1_E2_L1_110280_PBMC_11032011_E02.579674.fcs	Panel_L1_E2_L1_110280_PBMC_11032011_E02.fcs
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752409			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004971		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579679	Flow cytometry result	Panel_P13_E11_P13_110280_PBMC_11032011_E11.579679.fcs	Panel_P13_E11_P13_110280_PBMC_11032011_E11.fcs
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752409			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005177		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579885	Flow cytometry result	Panel_L5_MonoNKDC_E5_L5_110280_PBMC_11032011_E05.579885.fcs	Panel_L5_MonoNKDC_E5_L5_110280_PBMC_11032011_E05.fcs
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752409			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005324		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	580032	Flow cytometry result	Panel_L2_E5_L2_110280_PBMC_11032011_E05.580032.fcs	Panel_L2_E5_L2_110280_PBMC_11032011_E05.fcs
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752410			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003678		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578327	Flow cytometry result	Panel_P9_F2_P9_110280_PBMC_11072011_F02.578327.fcs	Panel_P9_F2_P9_110280_PBMC_11072011_F02.fcs
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752410			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003795		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578487	Flow cytometry result	Panel_P10_F5_P10_110280_PBMC_11072011_F05.578487.fcs	Panel_P10_F5_P10_110280_PBMC_11072011_F05.fcs
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752410			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004706		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579414	Flow cytometry result	Panel_L4_B_Cells_F2_L4_110280_PBMC_11072011_F02.579414.fcs	Panel_L4_B_Cells_F2_L4_110280_PBMC_11072011_F02.fcs
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752410			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005029		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579737	Flow cytometry result	Panel_L1_F2_L1_110280_PBMC_11072011_F02.579737.fcs	Panel_L1_F2_L1_110280_PBMC_11072011_F02.fcs
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752410			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005047		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579755	Flow cytometry result	Panel_P1_F11_P1_110280_PBMC_11072011_F11.579755.fcs	Panel_P1_F11_P1_110280_PBMC_11072011_F11.fcs
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752410			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005079		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579787	Flow cytometry result	Panel_L2_F5_L2_110280_PBMC_11072011_F05.579787.fcs	Panel_L2_F5_L2_110280_PBMC_11072011_F05.fcs
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752410			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005183		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579891	Flow cytometry result	Panel_L5_MonoNKDC_F5_L5_110280_PBMC_11072011_F05.579891.fcs	Panel_L5_MonoNKDC_F5_L5_110280_PBMC_11072011_F05.fcs
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752410			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005192		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579900	Flow cytometry result	Panel_P13_F11_P13_110280_PBMC_11072011_F11.579900.fcs	Panel_P13_F11_P13_110280_PBMC_11072011_F11.fcs
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752410			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005581		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	580289	Flow cytometry result	Panel_L3_F8_L3_110280_PBMC_11072011_F08.580289.fcs	Panel_L3_F8_L3_110280_PBMC_11072011_F08.fcs
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752410			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005606		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	580314	Flow cytometry result	Panel_P2_F8_P2_110280_PBMC_11072011_F08.580314.fcs	Panel_P2_F8_P2_110280_PBMC_11072011_F08.fcs
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752411			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003743		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	578423	Flow cytometry result	Panel_L4_B_Cells_G2_L4_110280_PBMC_11102011_G02.578423.fcs	Panel_L4_B_Cells_G2_L4_110280_PBMC_11102011_G02.fcs
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752411			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004029		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	578737	Flow cytometry result	Panel_L1_G2_L1_110280_PBMC_11102011_G02.578737.fcs	Panel_L1_G2_L1_110280_PBMC_11102011_G02.fcs
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752411			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004144		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578852	Flow cytometry result	Panel_P9_G2_P9_110280_PBMC_11102011_G02.578852.fcs	Panel_P9_G2_P9_110280_PBMC_11102011_G02.fcs
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752411			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004197		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	578905	Flow cytometry result	Panel_L5_MonoNKDC_G5_L5_110280_PBMC_11102011_G05.578905.fcs	Panel_L5_MonoNKDC_G5_L5_110280_PBMC_11102011_G05.fcs
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752411			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004200		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	578908	Flow cytometry result	Panel_P13_G11_P13_110280_PBMC_11102011_G11.578908.fcs	Panel_P13_G11_P13_110280_PBMC_11102011_G11.fcs
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752411			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004286		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	578994	Flow cytometry result	Panel_L2_G5_L2_110280_PBMC_11102011_G05.578994.fcs	Panel_L2_G5_L2_110280_PBMC_11102011_G05.fcs
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752411			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004620		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579328	Flow cytometry result	Panel_P1_G11_P1_110280_PBMC_11102011_G11.579328.fcs	Panel_P1_G11_P1_110280_PBMC_11102011_G11.fcs
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752411			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005480		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	580188	Flow cytometry result	Panel_L3_G8_L3_110280_PBMC_11102011_G08.580188.fcs	Panel_L3_G8_L3_110280_PBMC_11102011_G08.fcs
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752411			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005571		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	580279	Flow cytometry result	Panel_P2_G8_P2_110280_PBMC_11102011_G08.580279.fcs	Panel_P2_G8_P2_110280_PBMC_11102011_G08.fcs
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752411			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005601		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580309	Flow cytometry result	Panel_P10_G5_P10_110280_PBMC_11102011_G05.580309.fcs	Panel_P10_G5_P10_110280_PBMC_11102011_G05.fcs
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752412			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004031		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	578739	Flow cytometry result	Panel_P2_H8_P2_110280_PBMC_12012011_H08.578739.fcs	Panel_P2_H8_P2_110280_PBMC_12012011_H08.fcs
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752412			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004262		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578970	Flow cytometry result	Panel_P9_H2_P9_110280_PBMC_12012011_H02.578970.fcs	Panel_P9_H2_P9_110280_PBMC_12012011_H02.fcs
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752412			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004589		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579297	Flow cytometry result	Panel_L5_MonoNKDC_H5_L5_110280_PBMC_12012011_H05.579297.fcs	Panel_L5_MonoNKDC_H5_L5_110280_PBMC_12012011_H05.fcs
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752412			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004612		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579320	Flow cytometry result	Panel_P1_H11_P1_110280_PBMC_12012011_H11.579320.fcs	Panel_P1_H11_P1_110280_PBMC_12012011_H11.fcs
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752412			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004746		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579454	Flow cytometry result	Panel_P13_H11_P13_110280_PBMC_12012011_H11.579454.fcs	Panel_P13_H11_P13_110280_PBMC_12012011_H11.fcs
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752412			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004950		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579658	Flow cytometry result	Panel_L4_B_Cells_H2_L4_110280_PBMC_12012011_H02.579658.fcs	Panel_L4_B_Cells_H2_L4_110280_PBMC_12012011_H02.fcs
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752412			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005043		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579751	Flow cytometry result	Panel_L3_H8_L3_110280_PBMC_12012011_H08.579751.fcs	Panel_L3_H8_L3_110280_PBMC_12012011_H08.fcs
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752412			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005268		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579976	Flow cytometry result	Panel_P10_H5_P10_110280_PBMC_12012011_H05.579976.fcs	Panel_P10_H5_P10_110280_PBMC_12012011_H05.fcs
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752412			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005558		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	580266	Flow cytometry result	Panel_L2_H5_L2_110280_PBMC_12012011_H05.580266.fcs	Panel_L2_H5_L2_110280_PBMC_12012011_H05.fcs
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752412			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005647		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	580355	Flow cytometry result	Panel_L1_H2_L1_110280_PBMC_12012011_H02.580355.fcs	Panel_L1_H2_L1_110280_PBMC_12012011_H02.fcs
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689599			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003698		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	578359	Flow cytometry result	Panel_L4_B_Cells_A2_L4_110281_PBMC_11032011_A02.578359.fcs	Panel_L4_B_Cells_A2_L4_110281_PBMC_11032011_A02.fcs
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689599			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003727		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578402	Flow cytometry result	Panel_P10_A5_P10_110281_PBMC_11032011_A05.578402.fcs	Panel_P10_A5_P10_110281_PBMC_11032011_A05.fcs
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689599			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003948		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578654	Flow cytometry result	Panel_P9_A2_P9_110281_PBMC_11032011_A02.578654.fcs	Panel_P9_A2_P9_110281_PBMC_11032011_A02.fcs
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689599			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004137		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	578845	Flow cytometry result	Panel_L1_A2_L1_110281_PBMC_11032011_A02.578845.fcs	Panel_L1_A2_L1_110281_PBMC_11032011_A02.fcs
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689599			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004179		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	578887	Flow cytometry result	Panel_P2_A8_P2_110281_PBMC_11032011_A08.578887.fcs	Panel_P2_A8_P2_110281_PBMC_11032011_A08.fcs
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689599			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004332		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579040	Flow cytometry result	Panel_L2_A5_L2_110281_PBMC_11032011_A05.579040.fcs	Panel_L2_A5_L2_110281_PBMC_11032011_A05.fcs
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689599			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004370		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579078	Flow cytometry result	Panel_P1_A11_P1_110281_PBMC_11032011_A11.579078.fcs	Panel_P1_A11_P1_110281_PBMC_11032011_A11.fcs
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689599			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004569		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579277	Flow cytometry result	Panel_P13_A11_P13_110281_PBMC_11032011_A11.579277.fcs	Panel_P13_A11_P13_110281_PBMC_11032011_A11.fcs
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689599			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004805		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579513	Flow cytometry result	Panel_L5_MonoNKDC_A5_L5_110281_PBMC_11032011_A05.579513.fcs	Panel_L5_MonoNKDC_A5_L5_110281_PBMC_11032011_A05.fcs
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689599			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004889		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579597	Flow cytometry result	Panel_L3_A8_L3_110281_PBMC_11032011_A08.579597.fcs	Panel_L3_A8_L3_110281_PBMC_11032011_A08.fcs
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689600			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003789		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	578480	Flow cytometry result	Panel_L5_MonoNKDC_B5_L5_110281_PBMC_11072011_B05.578480.fcs	Panel_L5_MonoNKDC_B5_L5_110281_PBMC_11072011_B05.fcs
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689600			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004079		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	578787	Flow cytometry result	Panel_P13_B11_P13_110281_PBMC_11072011_B11.578787.fcs	Panel_P13_B11_P13_110281_PBMC_11072011_B11.fcs
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689600			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004430		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579138	Flow cytometry result	Panel_L4_B_Cells_B2_L4_110281_PBMC_11072011_B02.579138.fcs	Panel_L4_B_Cells_B2_L4_110281_PBMC_11072011_B02.fcs
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689600			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004765		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579473	Flow cytometry result	Panel_P2_B8_P2_110281_PBMC_11072011_B08.579473.fcs	Panel_P2_B8_P2_110281_PBMC_11072011_B08.fcs
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689600			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004838		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579546	Flow cytometry result	Panel_P1_B11_P1_110281_PBMC_11072011_B11.579546.fcs	Panel_P1_B11_P1_110281_PBMC_11072011_B11.fcs
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689600			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004982		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579690	Flow cytometry result	Panel_P9_B2_P9_110281_PBMC_11072011_B02.579690.fcs	Panel_P9_B2_P9_110281_PBMC_11072011_B02.fcs
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689600			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004991		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579699	Flow cytometry result	Panel_L1_B2_L1_110281_PBMC_11072011_B02.579699.fcs	Panel_L1_B2_L1_110281_PBMC_11072011_B02.fcs
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689600			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005142		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579850	Flow cytometry result	Panel_L3_B8_L3_110281_PBMC_11072011_B08.579850.fcs	Panel_L3_B8_L3_110281_PBMC_11072011_B08.fcs
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689600			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005385		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	580093	Flow cytometry result	Panel_L2_B5_L2_110281_PBMC_11072011_B05.580093.fcs	Panel_L2_B5_L2_110281_PBMC_11072011_B05.fcs
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689600			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005642		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580350	Flow cytometry result	Panel_P10_B5_P10_110281_PBMC_11072011_B05.580350.fcs	Panel_P10_B5_P10_110281_PBMC_11072011_B05.fcs
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689601			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003745		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	578425	Flow cytometry result	Panel_L1_C2_L1_110281_PBMC_11102011_C02.578425.fcs	Panel_L1_C2_L1_110281_PBMC_11102011_C02.fcs
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689601			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003770		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	578454	Flow cytometry result	Panel_P13_C11_P13_110281_PBMC_11102011_C11.578454.fcs	Panel_P13_C11_P13_110281_PBMC_11102011_C11.fcs
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689601			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003936		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	578641	Flow cytometry result	Panel_L3_C8_L3_110281_PBMC_11102011_C08.578641.fcs	Panel_L3_C8_L3_110281_PBMC_11102011_C08.fcs
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689601			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004106		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	578814	Flow cytometry result	Panel_P1_C11_P1_110281_PBMC_11102011_C11.578814.fcs	Panel_P1_C11_P1_110281_PBMC_11102011_C11.fcs
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689601			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004161		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578869	Flow cytometry result	Panel_P9_C2_P9_110281_PBMC_11102011_C02.578869.fcs	Panel_P9_C2_P9_110281_PBMC_11102011_C02.fcs
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689601			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004428		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579136	Flow cytometry result	Panel_L5_MonoNKDC_C5_L5_110281_PBMC_11102011_C05.579136.fcs	Panel_L5_MonoNKDC_C5_L5_110281_PBMC_11102011_C05.fcs
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689601			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004799		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579507	Flow cytometry result	Panel_L2_C5_L2_110281_PBMC_11102011_C05.579507.fcs	Panel_L2_C5_L2_110281_PBMC_11102011_C05.fcs
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689601			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004892		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579600	Flow cytometry result	Panel_P10_C5_P10_110281_PBMC_11102011_C05.579600.fcs	Panel_P10_C5_P10_110281_PBMC_11102011_C05.fcs
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689601			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005024		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579732	Flow cytometry result	Panel_P2_C8_P2_110281_PBMC_11102011_C08.579732.fcs	Panel_P2_C8_P2_110281_PBMC_11102011_C08.fcs
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689601			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005262		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579970	Flow cytometry result	Panel_L4_B_Cells_C2_L4_110281_PBMC_11102011_C02.579970.fcs	Panel_L4_B_Cells_C2_L4_110281_PBMC_11102011_C02.fcs
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689602			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003726		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	578400	Flow cytometry result	Panel_L3_D8_L3_110281_PBMC_12012011_D08.578400.fcs	Panel_L3_D8_L3_110281_PBMC_12012011_D08.fcs
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689602			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003757		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	578440	Flow cytometry result	Panel_L1_D2_L1_110281_PBMC_12012011_D02.578440.fcs	Panel_L1_D2_L1_110281_PBMC_12012011_D02.fcs
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689602			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004186		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	578894	Flow cytometry result	Panel_L4_B_Cells_D2_L4_110281_PBMC_12012011_D02.578894.fcs	Panel_L4_B_Cells_D2_L4_110281_PBMC_12012011_D02.fcs
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689602			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004409		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579117	Flow cytometry result	Panel_P10_D5_P10_110281_PBMC_12012011_D05.579117.fcs	Panel_P10_D5_P10_110281_PBMC_12012011_D05.fcs
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689602			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004494		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579202	Flow cytometry result	Panel_L2_D5_L2_110281_PBMC_12012011_D05.579202.fcs	Panel_L2_D5_L2_110281_PBMC_12012011_D05.fcs
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689602			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004532		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579240	Flow cytometry result	Panel_P9_D2_P9_110281_PBMC_12012011_D02.579240.fcs	Panel_P9_D2_P9_110281_PBMC_12012011_D02.fcs
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689602			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004880		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579588	Flow cytometry result	Panel_P1_D11_P1_110281_PBMC_12012011_D11.579588.fcs	Panel_P1_D11_P1_110281_PBMC_12012011_D11.fcs
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689602			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005232		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579940	Flow cytometry result	Panel_L5_MonoNKDC_D5_L5_110281_PBMC_12012011_D05.579940.fcs	Panel_L5_MonoNKDC_D5_L5_110281_PBMC_12012011_D05.fcs
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689602			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005263		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579971	Flow cytometry result	Panel_P2_D8_P2_110281_PBMC_12012011_D08.579971.fcs	Panel_P2_D8_P2_110281_PBMC_12012011_D08.fcs
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689602			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005453		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	580161	Flow cytometry result	Panel_P13_D11_P13_110281_PBMC_12012011_D11.580161.fcs	Panel_P13_D11_P13_110281_PBMC_12012011_D11.fcs
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752413			PBMC		11	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004759		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579467	Flow cytometry result	Panel_L3_D8_L3_110281_PBMC_11142011_D08.579467.fcs	Panel_L3_D8_L3_110281_PBMC_11142011_D08.fcs
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689603			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003732		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	578408	Flow cytometry result	Panel_P2_E8_P2_110282_PBMC_11032011_E08.578408.fcs	Panel_P2_E8_P2_110282_PBMC_11032011_E08.fcs
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689603			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004060		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	578768	Flow cytometry result	Panel_L3_E8_L3_110282_PBMC_11032011_E08.578768.fcs	Panel_L3_E8_L3_110282_PBMC_11032011_E08.fcs
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689603			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004109		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578817	Flow cytometry result	Panel_P9_E2_P9_110282_PBMC_11032011_E02.578817.fcs	Panel_P9_E2_P9_110282_PBMC_11032011_E02.fcs
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689603			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004212		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	578920	Flow cytometry result	Panel_P1_E11_P1_110282_PBMC_11032011_E11.578920.fcs	Panel_P1_E11_P1_110282_PBMC_11032011_E11.fcs
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689603			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004241		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	578949	Flow cytometry result	Panel_P13_E11_P13_110282_PBMC_11032011_E11.578949.fcs	Panel_P13_E11_P13_110282_PBMC_11032011_E11.fcs
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689603			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004267		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	578975	Flow cytometry result	Panel_L4_B_Cells_E2_L4_110282_PBMC_11032011_E02.578975.fcs	Panel_L4_B_Cells_E2_L4_110282_PBMC_11032011_E02.fcs
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689603			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004488		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579196	Flow cytometry result	Panel_L2_E5_L2_110282_PBMC_11032011_E05.579196.fcs	Panel_L2_E5_L2_110282_PBMC_11032011_E05.fcs
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689603			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004867		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579575	Flow cytometry result	Panel_L1_E2_L1_110282_PBMC_11032011_E02.579575.fcs	Panel_L1_E2_L1_110282_PBMC_11032011_E02.fcs
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689603			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005014		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579722	Flow cytometry result	Panel_L5_MonoNKDC_E5_L5_110282_PBMC_11032011_E05.579722.fcs	Panel_L5_MonoNKDC_E5_L5_110282_PBMC_11032011_E05.fcs
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689603			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005443		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580151	Flow cytometry result	Panel_P10_E5_P10_110282_PBMC_11032011_E05.580151.fcs	Panel_P10_E5_P10_110282_PBMC_11032011_E05.fcs
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689604			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003730		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	578406	Flow cytometry result	Panel_P13_F11_P13_110282_PBMC_11072011_F11.578406.fcs	Panel_P13_F11_P13_110282_PBMC_11072011_F11.fcs
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689604			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004421		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579129	Flow cytometry result	Panel_P2_F8_P2_110282_PBMC_11072011_F08.579129.fcs	Panel_P2_F8_P2_110282_PBMC_11072011_F08.fcs
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689604			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004534		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579242	Flow cytometry result	Panel_L5_MonoNKDC_F5_L5_110282_PBMC_11072011_F05.579242.fcs	Panel_L5_MonoNKDC_F5_L5_110282_PBMC_11072011_F05.fcs
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689604			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004638		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579346	Flow cytometry result	Panel_L4_B_Cells_F2_L4_110282_PBMC_11072011_F02.579346.fcs	Panel_L4_B_Cells_F2_L4_110282_PBMC_11072011_F02.fcs
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689604			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004939		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579647	Flow cytometry result	Panel_L3_F8_L3_110282_PBMC_11072011_F08.579647.fcs	Panel_L3_F8_L3_110282_PBMC_11072011_F08.fcs
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689604			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005003		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579711	Flow cytometry result	Panel_P9_F2_P9_110282_PBMC_11072011_F02.579711.fcs	Panel_P9_F2_P9_110282_PBMC_11072011_F02.fcs
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689604			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005484		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	580192	Flow cytometry result	Panel_L2_F5_L2_110282_PBMC_11072011_F05.580192.fcs	Panel_L2_F5_L2_110282_PBMC_11072011_F05.fcs
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689604			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005554		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	580262	Flow cytometry result	Panel_P1_F11_P1_110282_PBMC_11072011_F11.580262.fcs	Panel_P1_F11_P1_110282_PBMC_11072011_F11.fcs
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689604			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005661		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580369	Flow cytometry result	Panel_P10_F5_P10_110282_PBMC_11072011_F05.580369.fcs	Panel_P10_F5_P10_110282_PBMC_11072011_F05.fcs
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689604			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005689		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	580397	Flow cytometry result	Panel_L1_F2_L1_110282_PBMC_11072011_F02.580397.fcs	Panel_L1_F2_L1_110282_PBMC_11072011_F02.fcs
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689605			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004037		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	578745	Flow cytometry result	Panel_L1_G2_L1_110282_PBMC_11102011_G02.578745.fcs	Panel_L1_G2_L1_110282_PBMC_11102011_G02.fcs
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689605			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004133		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	578841	Flow cytometry result	Panel_L2_G5_L2_110282_PBMC_11102011_G05.578841.fcs	Panel_L2_G5_L2_110282_PBMC_11102011_G05.fcs
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689605			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004630		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579338	Flow cytometry result	Panel_P10_G5_P10_110282_PBMC_11102011_G05.579338.fcs	Panel_P10_G5_P10_110282_PBMC_11102011_G05.fcs
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689605			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004762		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579470	Flow cytometry result	Panel_P1_G11_P1_110282_PBMC_11102011_G11.579470.fcs	Panel_P1_G11_P1_110282_PBMC_11102011_G11.fcs
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689605			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004767		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579475	Flow cytometry result	Panel_P9_G2_P9_110282_PBMC_11102011_G02.579475.fcs	Panel_P9_G2_P9_110282_PBMC_11102011_G02.fcs
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689605			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005076		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579784	Flow cytometry result	Panel_L4_B_Cells_G2_L4_110282_PBMC_11102011_G02.579784.fcs	Panel_L4_B_Cells_G2_L4_110282_PBMC_11102011_G02.fcs
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689605			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005120		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579828	Flow cytometry result	Panel_L5_MonoNKDC_G5_L5_110282_PBMC_11102011_G05.579828.fcs	Panel_L5_MonoNKDC_G5_L5_110282_PBMC_11102011_G05.fcs
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689605			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005418		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	580126	Flow cytometry result	Panel_P13_G11_P13_110282_PBMC_11102011_G11.580126.fcs	Panel_P13_G11_P13_110282_PBMC_11102011_G11.fcs
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689605			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005509		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	580217	Flow cytometry result	Panel_P2_G8_P2_110282_PBMC_11102011_G08.580217.fcs	Panel_P2_G8_P2_110282_PBMC_11102011_G08.fcs
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689605			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005568		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	580276	Flow cytometry result	Panel_L3_G8_L3_110282_PBMC_11102011_G08.580276.fcs	Panel_L3_G8_L3_110282_PBMC_11102011_G08.fcs
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689606			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003860		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	578562	Flow cytometry result	Panel_P2_H8_P2_110282_PBMC_12012011_H08.578562.fcs	Panel_P2_H8_P2_110282_PBMC_12012011_H08.fcs
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689606			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003932		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	578637	Flow cytometry result	Panel_L2_H5_L2_110282_PBMC_12012011_H05.578637.fcs	Panel_L2_H5_L2_110282_PBMC_12012011_H05.fcs
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689606			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004148		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	578856	Flow cytometry result	Panel_P1_H11_P1_110282_PBMC_12012011_H11.578856.fcs	Panel_P1_H11_P1_110282_PBMC_12012011_H11.fcs
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689606			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004319		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579027	Flow cytometry result	Panel_P13_H11_P13_110282_PBMC_12012011_H11.579027.fcs	Panel_P13_H11_P13_110282_PBMC_12012011_H11.fcs
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689606			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004792		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579500	Flow cytometry result	Panel_L1_H2_L1_110282_PBMC_12012011_H02.579500.fcs	Panel_L1_H2_L1_110282_PBMC_12012011_H02.fcs
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689606			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004931		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579639	Flow cytometry result	Panel_L3_H8_L3_110282_PBMC_12012011_H08.579639.fcs	Panel_L3_H8_L3_110282_PBMC_12012011_H08.fcs
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689606			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005009		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579717	Flow cytometry result	Panel_P10_H5_P10_110282_PBMC_12012011_H05.579717.fcs	Panel_P10_H5_P10_110282_PBMC_12012011_H05.fcs
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689606			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005300		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	580008	Flow cytometry result	Panel_L4_B_Cells_H2_L4_110282_PBMC_12012011_H02.580008.fcs	Panel_L4_B_Cells_H2_L4_110282_PBMC_12012011_H02.fcs
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689606			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005344		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580052	Flow cytometry result	Panel_P9_H2_P9_110282_PBMC_12012011_H02.580052.fcs	Panel_P9_H2_P9_110282_PBMC_12012011_H02.fcs
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689606			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005557		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	580265	Flow cytometry result	Panel_L5_MonoNKDC_H5_L5_110282_PBMC_12012011_H05.580265.fcs	Panel_L5_MonoNKDC_H5_L5_110282_PBMC_12012011_H05.fcs
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752414			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003807		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	578502	Flow cytometry result	Panel_L5_MonoNKDC_F5_L5_110282_PBMC_10192011_F05.578502.fcs	Panel_L5_MonoNKDC_F5_L5_110282_PBMC_10192011_F05.fcs
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689607			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003680		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	578331	Flow cytometry result	Panel_P2_A9_P2_110283_PBMC_11032011_A09.578331.fcs	Panel_P2_A9_P2_110283_PBMC_11032011_A09.fcs
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689607			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003782		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	578469	Flow cytometry result	Panel_L4_B_Cells_A3_L4_110283_PBMC_11032011_A03.578469.fcs	Panel_L4_B_Cells_A3_L4_110283_PBMC_11032011_A03.fcs
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689607			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003984		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578692	Flow cytometry result	Panel_P9_A3_P9_110283_PBMC_11032011_A03.578692.fcs	Panel_P9_A3_P9_110283_PBMC_11032011_A03.fcs
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689607			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004022		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	578730	Flow cytometry result	Panel_L1_A3_L1_110283_PBMC_11032011_A03.578730.fcs	Panel_L1_A3_L1_110283_PBMC_11032011_A03.fcs
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689607			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004169		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	578877	Flow cytometry result	Panel_L5_MonoNKDC_A6_L5_110283_PBMC_11032011_A06.578877.fcs	Panel_L5_MonoNKDC_A6_L5_110283_PBMC_11032011_A06.fcs
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689607			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004205		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	578913	Flow cytometry result	Panel_L2_A6_L2_110283_PBMC_11032011_A06.578913.fcs	Panel_L2_A6_L2_110283_PBMC_11032011_A06.fcs
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689607			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004875		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579583	Flow cytometry result	Panel_P10_A6_P10_110283_PBMC_11032011_A06.579583.fcs	Panel_P10_A6_P10_110283_PBMC_11032011_A06.fcs
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689607			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005246		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579954	Flow cytometry result	Panel_L3_A9_L3_110283_PBMC_11032011_A09.579954.fcs	Panel_L3_A9_L3_110283_PBMC_11032011_A09.fcs
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689607			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005257		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579965	Flow cytometry result	Panel_P13_A12_P13_110283_PBMC_11032011_A12.579965.fcs	Panel_P13_A12_P13_110283_PBMC_11032011_A12.fcs
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689607			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005551		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	580259	Flow cytometry result	Panel_P1_A12_P1_110283_PBMC_11032011_A12.580259.fcs	Panel_P1_A12_P1_110283_PBMC_11032011_A12.fcs
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689608			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003729		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578405	Flow cytometry result	Panel_P10_B6_P10_110283_PBMC_11072011_B06.578405.fcs	Panel_P10_B6_P10_110283_PBMC_11072011_B06.fcs
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689608			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003886		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578590	Flow cytometry result	Panel_P9_B3_P9_110283_PBMC_11072011_B03.578590.fcs	Panel_P9_B3_P9_110283_PBMC_11072011_B03.fcs
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689608			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004166		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	578874	Flow cytometry result	Panel_P13_B12_P13_110283_PBMC_11072011_B12.578874.fcs	Panel_P13_B12_P13_110283_PBMC_11072011_B12.fcs
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689608			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004252		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	578960	Flow cytometry result	Panel_L3_B9_L3_110283_PBMC_11072011_B09.578960.fcs	Panel_L3_B9_L3_110283_PBMC_11072011_B09.fcs
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689608			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004484		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579192	Flow cytometry result	Panel_P2_B9_P2_110283_PBMC_11072011_B09.579192.fcs	Panel_P2_B9_P2_110283_PBMC_11072011_B09.fcs
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689608			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004555		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579263	Flow cytometry result	Panel_P1_B12_P1_110283_PBMC_11072011_B12.579263.fcs	Panel_P1_B12_P1_110283_PBMC_11072011_B12.fcs
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689608			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004640		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579348	Flow cytometry result	Panel_L1_B3_L1_110283_PBMC_11072011_B03.579348.fcs	Panel_L1_B3_L1_110283_PBMC_11072011_B03.fcs
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689608			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004812		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579520	Flow cytometry result	Panel_L4_B_Cells_B3_L4_110283_PBMC_11072011_B03.579520.fcs	Panel_L4_B_Cells_B3_L4_110283_PBMC_11072011_B03.fcs
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689608			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004886		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579594	Flow cytometry result	Panel_L2_B6_L2_110283_PBMC_11072011_B06.579594.fcs	Panel_L2_B6_L2_110283_PBMC_11072011_B06.fcs
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689608			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005101		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579809	Flow cytometry result	Panel_L5_MonoNKDC_B6_L5_110283_PBMC_11072011_B06.579809.fcs	Panel_L5_MonoNKDC_B6_L5_110283_PBMC_11072011_B06.fcs
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689609			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003777		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	578464	Flow cytometry result	Panel_L2_C6_L2_110283_PBMC_11102011_C06.578464.fcs	Panel_L2_C6_L2_110283_PBMC_11102011_C06.fcs
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689609			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004108		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	578816	Flow cytometry result	Panel_P1_C12_P1_110283_PBMC_11102011_C12.578816.fcs	Panel_P1_C12_P1_110283_PBMC_11102011_C12.fcs
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689609			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004329		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579037	Flow cytometry result	Panel_P9_C3_P9_110283_PBMC_11102011_C03.579037.fcs	Panel_P9_C3_P9_110283_PBMC_11102011_C03.fcs
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689609			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004489		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579197	Flow cytometry result	Panel_L1_C3_L1_110283_PBMC_11102011_C03.579197.fcs	Panel_L1_C3_L1_110283_PBMC_11102011_C03.fcs
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689609			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004568		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579276	Flow cytometry result	Panel_L3_C9_L3_110283_PBMC_11102011_C09.579276.fcs	Panel_L3_C9_L3_110283_PBMC_11102011_C09.fcs
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689609			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004813		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579521	Flow cytometry result	Panel_P2_C9_P2_110283_PBMC_11102011_C09.579521.fcs	Panel_P2_C9_P2_110283_PBMC_11102011_C09.fcs
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689609			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004965		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579673	Flow cytometry result	Panel_L5_MonoNKDC_C6_L5_110283_PBMC_11102011_C06.579673.fcs	Panel_L5_MonoNKDC_C6_L5_110283_PBMC_11102011_C06.fcs
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689609			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005112		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579820	Flow cytometry result	Panel_P10_C6_P10_110283_PBMC_11102011_C06.579820.fcs	Panel_P10_C6_P10_110283_PBMC_11102011_C06.fcs
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689609			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005470		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	580178	Flow cytometry result	Panel_L4_B_Cells_C3_L4_110283_PBMC_11102011_C03.580178.fcs	Panel_L4_B_Cells_C3_L4_110283_PBMC_11102011_C03.fcs
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689609			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005567		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	580275	Flow cytometry result	Panel_P13_C12_P13_110283_PBMC_11102011_C12.580275.fcs	Panel_P13_C12_P13_110283_PBMC_11102011_C12.fcs
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689610			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003638		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	578256	Flow cytometry result	Panel_P1_D12_P1_110283_PBMC_12012011_D12.578256.fcs	Panel_P1_D12_P1_110283_PBMC_12012011_D12.fcs
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689610			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003688		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	578341	Flow cytometry result	Panel_L5_MonoNKDC_D6_L5_110283_PBMC_12012011_D06.578341.fcs	Panel_L5_MonoNKDC_D6_L5_110283_PBMC_12012011_D06.fcs
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689610			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003746		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	578426	Flow cytometry result	Panel_P13_D12_P13_110283_PBMC_12012011_D12.578426.fcs	Panel_P13_D12_P13_110283_PBMC_12012011_D12.fcs
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689610			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003793		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	578485	Flow cytometry result	Panel_L4_B_Cells_D3_L4_110283_PBMC_12012011_D03.578485.fcs	Panel_L4_B_Cells_D3_L4_110283_PBMC_12012011_D03.fcs
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689610			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004020		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578728	Flow cytometry result	Panel_P9_D3_P9_110283_PBMC_12012011_D03.578728.fcs	Panel_P9_D3_P9_110283_PBMC_12012011_D03.fcs
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689610			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005209		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579917	Flow cytometry result	Panel_L1_D3_L1_110283_PBMC_12012011_D03.579917.fcs	Panel_L1_D3_L1_110283_PBMC_12012011_D03.fcs
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689610			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005211		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579919	Flow cytometry result	Panel_L2_D6_L2_110283_PBMC_12012011_D06.579919.fcs	Panel_L2_D6_L2_110283_PBMC_12012011_D06.fcs
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689610			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005416		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580124	Flow cytometry result	Panel_P10_D6_P10_110283_PBMC_12012011_D06.580124.fcs	Panel_P10_D6_P10_110283_PBMC_12012011_D06.fcs
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689610			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005465		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	580173	Flow cytometry result	Panel_L3_D9_L3_110283_PBMC_12012011_D09.580173.fcs	Panel_L3_D9_L3_110283_PBMC_12012011_D09.fcs
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689610			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005669		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	580377	Flow cytometry result	Panel_P2_D9_P2_110283_PBMC_12012011_D09.580377.fcs	Panel_P2_D9_P2_110283_PBMC_12012011_D09.fcs
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752415			PBMC		11	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004847		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579555	Flow cytometry result	Panel_L3_D9_L3_110283_PBMC_11142011_D09.579555.fcs	Panel_L3_D9_L3_110283_PBMC_11142011_D09.fcs
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752416			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003820		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	578517	Flow cytometry result	Panel_L2_A6_L2_110284_PBMC_11032011_A06.578517.fcs	Panel_L2_A6_L2_110284_PBMC_11032011_A06.fcs
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752416			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004054		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	578762	Flow cytometry result	Panel_P1_A12_P1_110284_PBMC_11032011_A12.578762.fcs	Panel_P1_A12_P1_110284_PBMC_11032011_A12.fcs
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752416			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004088		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	578796	Flow cytometry result	Panel_L1_A3_L1_110284_PBMC_11032011_A03.578796.fcs	Panel_L1_A3_L1_110284_PBMC_11032011_A03.fcs
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752416			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004420		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579128	Flow cytometry result	Panel_L3_A9_L3_110284_PBMC_11032011_A09.579128.fcs	Panel_L3_A9_L3_110284_PBMC_11032011_A09.fcs
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752416			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004481		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579189	Flow cytometry result	Panel_P10_A6_P10_110284_PBMC_11032011_A06.579189.fcs	Panel_P10_A6_P10_110284_PBMC_11032011_A06.fcs
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752416			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004629		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579337	Flow cytometry result	Panel_L4_B_Cells_A3_L4_110284_PBMC_11032011_A03.579337.fcs	Panel_L4_B_Cells_A3_L4_110284_PBMC_11032011_A03.fcs
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752416			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004744		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579452	Flow cytometry result	Panel_P13_A12_P13_110284_PBMC_11032011_A12.579452.fcs	Panel_P13_A12_P13_110284_PBMC_11032011_A12.fcs
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752416			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004853		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579561	Flow cytometry result	Panel_P2_A9_P2_110284_PBMC_11032011_A09.579561.fcs	Panel_P2_A9_P2_110284_PBMC_11032011_A09.fcs
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752416			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005301		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	580009	Flow cytometry result	Panel_L5_MonoNKDC_A6_L5_110284_PBMC_11032011_A06.580009.fcs	Panel_L5_MonoNKDC_A6_L5_110284_PBMC_11032011_A06.fcs
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752416			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005657		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580365	Flow cytometry result	Panel_P9_A3_P9_110284_PBMC_11032011_A03.580365.fcs	Panel_P9_A3_P9_110284_PBMC_11032011_A03.fcs
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752417			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003790		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	578481	Flow cytometry result	Panel_L3_B9_L3_110284_PBMC_11072011_B09.578481.fcs	Panel_L3_B9_L3_110284_PBMC_11072011_B09.fcs
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752417			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004126		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578834	Flow cytometry result	Panel_P9_B3_P9_110284_PBMC_11072011_B03.578834.fcs	Panel_P9_B3_P9_110284_PBMC_11072011_B03.fcs
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752417			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004185		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	578893	Flow cytometry result	Panel_L1_B3_L1_110284_PBMC_11072011_B03.578893.fcs	Panel_L1_B3_L1_110284_PBMC_11072011_B03.fcs
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752417			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004225		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	578933	Flow cytometry result	Panel_L5_MonoNKDC_B6_L5_110284_PBMC_11072011_B06.578933.fcs	Panel_L5_MonoNKDC_B6_L5_110284_PBMC_11072011_B06.fcs
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752417			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004245		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	578953	Flow cytometry result	Panel_P13_B12_P13_110284_PBMC_11072011_B12.578953.fcs	Panel_P13_B12_P13_110284_PBMC_11072011_B12.fcs
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752417			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004272		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	578980	Flow cytometry result	Panel_L4_B_Cells_B3_L4_110284_PBMC_11072011_B03.578980.fcs	Panel_L4_B_Cells_B3_L4_110284_PBMC_11072011_B03.fcs
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752417			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004538		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579246	Flow cytometry result	Panel_P10_B6_P10_110284_PBMC_11072011_B06.579246.fcs	Panel_P10_B6_P10_110284_PBMC_11072011_B06.fcs
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752417			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004689		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579397	Flow cytometry result	Panel_P1_B12_P1_110284_PBMC_11072011_B12.579397.fcs	Panel_P1_B12_P1_110284_PBMC_11072011_B12.fcs
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752417			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005039		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579747	Flow cytometry result	Panel_L2_B6_L2_110284_PBMC_11072011_B06.579747.fcs	Panel_L2_B6_L2_110284_PBMC_11072011_B06.fcs
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752417			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005238		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579946	Flow cytometry result	Panel_P2_B9_P2_110284_PBMC_11072011_B09.579946.fcs	Panel_P2_B9_P2_110284_PBMC_11072011_B09.fcs
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752418			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003681		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578332	Flow cytometry result	Panel_P9_C3_P9_110284_PBMC_11102011_C03.578332.fcs	Panel_P9_C3_P9_110284_PBMC_11102011_C03.fcs
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752418			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003767		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	578450	Flow cytometry result	Panel_P2_C9_P2_110284_PBMC_11102011_C09.578450.fcs	Panel_P2_C9_P2_110284_PBMC_11102011_C09.fcs
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752418			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004333		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579041	Flow cytometry result	Panel_L3_C9_L3_110284_PBMC_11102011_C09.579041.fcs	Panel_L3_C9_L3_110284_PBMC_11102011_C09.fcs
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752418			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004477		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579185	Flow cytometry result	Panel_L5_MonoNKDC_C6_L5_110284_PBMC_11102011_C06.579185.fcs	Panel_L5_MonoNKDC_C6_L5_110284_PBMC_11102011_C06.fcs
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752418			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004540		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579248	Flow cytometry result	Panel_P13_C12_P13_110284_PBMC_11102011_C12.579248.fcs	Panel_P13_C12_P13_110284_PBMC_11102011_C12.fcs
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752418			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004651		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579359	Flow cytometry result	Panel_L4_B_Cells_C3_L4_110284_PBMC_11102011_C03.579359.fcs	Panel_L4_B_Cells_C3_L4_110284_PBMC_11102011_C03.fcs
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752418			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004770		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579478	Flow cytometry result	Panel_P10_C6_P10_110284_PBMC_11102011_C06.579478.fcs	Panel_P10_C6_P10_110284_PBMC_11102011_C06.fcs
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752418			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004826		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579534	Flow cytometry result	Panel_L2_C6_L2_110284_PBMC_11102011_C06.579534.fcs	Panel_L2_C6_L2_110284_PBMC_11102011_C06.fcs
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752418			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005028		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579736	Flow cytometry result	Panel_L1_C3_L1_110284_PBMC_11102011_C03.579736.fcs	Panel_L1_C3_L1_110284_PBMC_11102011_C03.fcs
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752418			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005181		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579889	Flow cytometry result	Panel_P1_C12_P1_110284_PBMC_11102011_C12.579889.fcs	Panel_P1_C12_P1_110284_PBMC_11102011_C12.fcs
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752419			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003718		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578389	Flow cytometry result	Panel_P9_D3_P9_110284_PBMC_12012011_D03.578389.fcs	Panel_P9_D3_P9_110284_PBMC_12012011_D03.fcs
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752419			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003853		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	578554	Flow cytometry result	Panel_L1_D3_L1_110284_PBMC_12012011_D03.578554.fcs	Panel_L1_D3_L1_110284_PBMC_12012011_D03.fcs
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752419			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003864		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	578566	Flow cytometry result	Panel_P2_D9_P2_110284_PBMC_12012011_D09.578566.fcs	Panel_P2_D9_P2_110284_PBMC_12012011_D09.fcs
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752419			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003956		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	578663	Flow cytometry result	Panel_P1_D12_P1_110284_PBMC_12012011_D12.578663.fcs	Panel_P1_D12_P1_110284_PBMC_12012011_D12.fcs
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752419			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004438		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579146	Flow cytometry result	Panel_L5_MonoNKDC_D6_L5_110284_PBMC_12012011_D06.579146.fcs	Panel_L5_MonoNKDC_D6_L5_110284_PBMC_12012011_D06.fcs
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752419			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004493		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579201	Flow cytometry result	Panel_L3_D9_L3_110284_PBMC_12012011_D09.579201.fcs	Panel_L3_D9_L3_110284_PBMC_12012011_D09.fcs
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752419			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005068		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	579776	Flow cytometry result	Panel_P13_D12_P13_110284_PBMC_12012011_D12.579776.fcs	Panel_P13_D12_P13_110284_PBMC_12012011_D12.fcs
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752419			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005154		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579862	Flow cytometry result	Panel_L2_D6_L2_110284_PBMC_12012011_D06.579862.fcs	Panel_L2_D6_L2_110284_PBMC_12012011_D06.fcs
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752419			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005409		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580117	Flow cytometry result	Panel_P10_D6_P10_110284_PBMC_12012011_D06.580117.fcs	Panel_P10_D6_P10_110284_PBMC_12012011_D06.fcs
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752419			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005458		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	580166	Flow cytometry result	Panel_L4_B_Cells_D3_L4_110284_PBMC_12012011_D03.580166.fcs	Panel_L4_B_Cells_D3_L4_110284_PBMC_12012011_D03.fcs
SUB120487	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689611			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003766		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	578449	Flow cytometry result	Panel_P13_A10_P13_110285_PBMC_11032011_A10.578449.fcs	Panel_P13_A10_P13_110285_PBMC_11032011_A10.fcs
SUB120487	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689611			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004215		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578923	Flow cytometry result	Panel_P9_A1_P9_110285_PBMC_11032011_A01.578923.fcs	Panel_P9_A1_P9_110285_PBMC_11032011_A01.fcs
SUB120487	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689611			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004311		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579019	Flow cytometry result	Panel_P1_A10_P1_110285_PBMC_11032011_A10.579019.fcs	Panel_P1_A10_P1_110285_PBMC_11032011_A10.fcs
SUB120487	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689611			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004794		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579502	Flow cytometry result	Panel_L5_MonoNKDC_A4_L5_110285_PBMC_11032011_A04.579502.fcs	Panel_L5_MonoNKDC_A4_L5_110285_PBMC_11032011_A04.fcs
SUB120487	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689611			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004801		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579509	Flow cytometry result	Panel_L1_A1_L1_110285_PBMC_11032011_A01.579509.fcs	Panel_L1_A1_L1_110285_PBMC_11032011_A01.fcs
SUB120487	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689611			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004839		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579547	Flow cytometry result	Panel_L4_B_Cells_A1_L4_110285_PBMC_11032011_A01.579547.fcs	Panel_L4_B_Cells_A1_L4_110285_PBMC_11032011_A01.fcs
SUB120487	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689611			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004865		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579573	Flow cytometry result	Panel_L3_A7_L3_110285_PBMC_11032011_A07.579573.fcs	Panel_L3_A7_L3_110285_PBMC_11032011_A07.fcs
SUB120487	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689611			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004949		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579657	Flow cytometry result	Panel_P10_A4_P10_110285_PBMC_11032011_A04.579657.fcs	Panel_P10_A4_P10_110285_PBMC_11032011_A04.fcs
SUB120487	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689611			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005075		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579783	Flow cytometry result	Panel_L2_A4_L2_110285_PBMC_11032011_A04.579783.fcs	Panel_L2_A4_L2_110285_PBMC_11032011_A04.fcs
SUB120487	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689611			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005683		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	580391	Flow cytometry result	Panel_P2_A7_P2_110285_PBMC_11032011_A07.580391.fcs	Panel_P2_A7_P2_110285_PBMC_11032011_A07.fcs
SUB120487	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689612			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003657		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	578291	Flow cytometry result	Panel_L4_B_Cells_B1_L4_110285_PBMC_11072011_B01.578291.fcs	Panel_L4_B_Cells_B1_L4_110285_PBMC_11072011_B01.fcs
SUB120487	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689612			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003693		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	578350	Flow cytometry result	Panel_L1_B1_L1_110285_PBMC_11072011_B01.578350.fcs	Panel_L1_B1_L1_110285_PBMC_11072011_B01.fcs
SUB120487	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689612			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003901		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	578605	Flow cytometry result	Panel_L3_B7_L3_110285_PBMC_11072011_B07.578605.fcs	Panel_L3_B7_L3_110285_PBMC_11072011_B07.fcs
SUB120487	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689612			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004025		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	578733	Flow cytometry result	Panel_P13_B10_P13_110285_PBMC_11072011_B10.578733.fcs	Panel_P13_B10_P13_110285_PBMC_11072011_B10.fcs
SUB120487	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689612			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004234		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	578942	Flow cytometry result	Panel_P2_B7_P2_110285_PBMC_11072011_B07.578942.fcs	Panel_P2_B7_P2_110285_PBMC_11072011_B07.fcs
SUB120487	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689612			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004586		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579294	Flow cytometry result	Panel_P1_B10_P1_110285_PBMC_11072011_B10.579294.fcs	Panel_P1_B10_P1_110285_PBMC_11072011_B10.fcs
SUB120487	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689612			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004967		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579675	Flow cytometry result	Panel_P9_B1_P9_110285_PBMC_11072011_B01.579675.fcs	Panel_P9_B1_P9_110285_PBMC_11072011_B01.fcs
SUB120487	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689612			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005226		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579934	Flow cytometry result	Panel_L5_MonoNKDC_B4_L5_110285_PBMC_11072011_B04.579934.fcs	Panel_L5_MonoNKDC_B4_L5_110285_PBMC_11072011_B04.fcs
SUB120487	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689612			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005389		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	580097	Flow cytometry result	Panel_L2_B4_L2_110285_PBMC_11072011_B04.580097.fcs	Panel_L2_B4_L2_110285_PBMC_11072011_B04.fcs
SUB120487	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689612			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005510		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	580218	Flow cytometry result	Panel_P10_B4_P10_110285_PBMC_11072011_B04.580218.fcs	Panel_P10_B4_P10_110285_PBMC_11072011_B04.fcs
SUB120487	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689613			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003914		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	578618	Flow cytometry result	Panel_P1_C10_P1_110285_PBMC_11102011_C10.578618.fcs	Panel_P1_C10_P1_110285_PBMC_11102011_C10.fcs
SUB120487	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689613			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004165		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	578873	Flow cytometry result	Panel_L1_C1_L1_110285_PBMC_11102011_C01.578873.fcs	Panel_L1_C1_L1_110285_PBMC_11102011_C01.fcs
SUB120487	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689613			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004261		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	578969	Flow cytometry result	Panel_P13_C10_P13_110285_PBMC_11102011_C10.578969.fcs	Panel_P13_C10_P13_110285_PBMC_11102011_C10.fcs
SUB120487	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689613			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004321		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579029	Flow cytometry result	Panel_P9_C1_P9_110285_PBMC_11102011_C01.579029.fcs	Panel_P9_C1_P9_110285_PBMC_11102011_C01.fcs
SUB120487	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689613			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004561		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579269	Flow cytometry result	Panel_L2_C4_L2_110285_PBMC_11102011_C04.579269.fcs	Panel_L2_C4_L2_110285_PBMC_11102011_C04.fcs
SUB120487	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689613			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005015		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	579723	Flow cytometry result	Panel_L5_MonoNKDC_C4_L5_110285_PBMC_11102011_C04.579723.fcs	Panel_L5_MonoNKDC_C4_L5_110285_PBMC_11102011_C04.fcs
SUB120487	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689613			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005048		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579756	Flow cytometry result	Panel_P2_C7_P2_110285_PBMC_11102011_C07.579756.fcs	Panel_P2_C7_P2_110285_PBMC_11102011_C07.fcs
SUB120487	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689613			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005229		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579937	Flow cytometry result	Panel_L3_C7_L3_110285_PBMC_11102011_C07.579937.fcs	Panel_L3_C7_L3_110285_PBMC_11102011_C07.fcs
SUB120487	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689613			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005281		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579989	Flow cytometry result	Panel_P10_C4_P10_110285_PBMC_11102011_C04.579989.fcs	Panel_P10_C4_P10_110285_PBMC_11102011_C04.fcs
SUB120487	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689613			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005362		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	580070	Flow cytometry result	Panel_L4_B_Cells_C1_L4_110285_PBMC_11102011_C01.580070.fcs	Panel_L4_B_Cells_C1_L4_110285_PBMC_11102011_C01.fcs
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689615			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003904		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578608	Flow cytometry result	Panel_P9_E1_P9_110286_PBMC_11032011_E01.578608.fcs	Panel_P9_E1_P9_110286_PBMC_11032011_E01.fcs
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689615			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004112		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	578820	Flow cytometry result	Panel_P13_E10_P13_110286_PBMC_11032011_E10.578820.fcs	Panel_P13_E10_P13_110286_PBMC_11032011_E10.fcs
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689615			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004138		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	578846	Flow cytometry result	Panel_L1_E1_L1_110286_PBMC_11032011_E01.578846.fcs	Panel_L1_E1_L1_110286_PBMC_11032011_E01.fcs
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689615			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004327		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579035	Flow cytometry result	Panel_P10_E4_P10_110286_PBMC_11032011_E04.579035.fcs	Panel_P10_E4_P10_110286_PBMC_11032011_E04.fcs
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689615			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004498		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579206	Flow cytometry result	Panel_L4_B_Cells_E1_L4_110286_PBMC_11032011_E01.579206.fcs	Panel_L4_B_Cells_E1_L4_110286_PBMC_11032011_E01.fcs
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689615			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004623		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579331	Flow cytometry result	Panel_P1_E10_P1_110286_PBMC_11032011_E10.579331.fcs	Panel_P1_E10_P1_110286_PBMC_11032011_E10.fcs
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689615			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005213		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579921	Flow cytometry result	Panel_L3_E7_L3_110286_PBMC_11032011_E07.579921.fcs	Panel_L3_E7_L3_110286_PBMC_11032011_E07.fcs
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689615			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005287		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579995	Flow cytometry result	Panel_L2_E4_L2_110286_PBMC_11032011_E04.579995.fcs	Panel_L2_E4_L2_110286_PBMC_11032011_E04.fcs
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689615			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005587		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	580295	Flow cytometry result	Panel_P2_E7_P2_110286_PBMC_11032011_E07.580295.fcs	Panel_P2_E7_P2_110286_PBMC_11032011_E07.fcs
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689615			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005637		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	580345	Flow cytometry result	Panel_L5_MonoNKDC_E4_L5_110286_PBMC_11032011_E04.580345.fcs	Panel_L5_MonoNKDC_E4_L5_110286_PBMC_11032011_E04.fcs
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689616			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003709		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	578376	Flow cytometry result	Panel_P13_F10_P13_110286_PBMC_11072011_F10.578376.fcs	Panel_P13_F10_P13_110286_PBMC_11072011_F10.fcs
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689616			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004121		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	578829	Flow cytometry result	Panel_P2_F7_P2_110286_PBMC_11072011_F07.578829.fcs	Panel_P2_F7_P2_110286_PBMC_11072011_F07.fcs
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689616			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004227		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	578935	Flow cytometry result	Panel_L5_MonoNKDC_F4_L5_110286_PBMC_11072011_F04.578935.fcs	Panel_L5_MonoNKDC_F4_L5_110286_PBMC_11072011_F04.fcs
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689616			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004398		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579106	Flow cytometry result	Panel_P1_F10_P1_110286_PBMC_11072011_F10.579106.fcs	Panel_P1_F10_P1_110286_PBMC_11072011_F10.fcs
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689616			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004510		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579218	Flow cytometry result	Panel_L2_F4_L2_110286_PBMC_11072011_F04.579218.fcs	Panel_L2_F4_L2_110286_PBMC_11072011_F04.fcs
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689616			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004521		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579229	Flow cytometry result	Panel_P10_F4_P10_110286_PBMC_11072011_F04.579229.fcs	Panel_P10_F4_P10_110286_PBMC_11072011_F04.fcs
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689616			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004855		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579563	Flow cytometry result	Panel_L4_B_Cells_F1_L4_110286_PBMC_11072011_F01.579563.fcs	Panel_L4_B_Cells_F1_L4_110286_PBMC_11072011_F01.fcs
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689616			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004887		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579595	Flow cytometry result	Panel_L3_F7_L3_110286_PBMC_11072011_F07.579595.fcs	Panel_L3_F7_L3_110286_PBMC_11072011_F07.fcs
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689616			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005069		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579777	Flow cytometry result	Panel_P9_F1_P9_110286_PBMC_11072011_F01.579777.fcs	Panel_P9_F1_P9_110286_PBMC_11072011_F01.fcs
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689616			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005256		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579964	Flow cytometry result	Panel_L1_F1_L1_110286_PBMC_11072011_F01.579964.fcs	Panel_L1_F1_L1_110286_PBMC_11072011_F01.fcs
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689617			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003733		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	578409	Flow cytometry result	Panel_L5_MonoNKDC_G4_L5_110286_PBMC_11102011_G04.578409.fcs	Panel_L5_MonoNKDC_G4_L5_110286_PBMC_11102011_G04.fcs
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689617			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003949		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	578655	Flow cytometry result	Panel_P13_G10_P13_110286_PBMC_11102011_G10.578655.fcs	Panel_P13_G10_P13_110286_PBMC_11102011_G10.fcs
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689617			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003988		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	578696	Flow cytometry result	Panel_L2_G4_L2_110286_PBMC_11102011_G04.578696.fcs	Panel_L2_G4_L2_110286_PBMC_11102011_G04.fcs
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689617			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004331		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579039	Flow cytometry result	Panel_P9_G1_P9_110286_PBMC_11102011_G01.579039.fcs	Panel_P9_G1_P9_110286_PBMC_11102011_G01.fcs
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689617			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004336		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	579044	Flow cytometry result	Panel_P1_G10_P1_110286_PBMC_11102011_G10.579044.fcs	Panel_P1_G10_P1_110286_PBMC_11102011_G10.fcs
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689617			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004378		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	579086	Flow cytometry result	Panel_P2_G7_P2_110286_PBMC_11102011_G07.579086.fcs	Panel_P2_G7_P2_110286_PBMC_11102011_G07.fcs
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689617			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004440		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	579148	Flow cytometry result	Panel_L3_G7_L3_110286_PBMC_11102011_G07.579148.fcs	Panel_L3_G7_L3_110286_PBMC_11102011_G07.fcs
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689617			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004462		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	579170	Flow cytometry result	Panel_L1_G1_L1_110286_PBMC_11102011_G01.579170.fcs	Panel_L1_G1_L1_110286_PBMC_11102011_G01.fcs
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689617			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004732		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579440	Flow cytometry result	Panel_P10_G4_P10_110286_PBMC_11102011_G04.579440.fcs	Panel_P10_G4_P10_110286_PBMC_11102011_G04.fcs
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689617			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004836		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579544	Flow cytometry result	Panel_L4_B_Cells_G1_L4_110286_PBMC_11102011_G01.579544.fcs	Panel_L4_B_Cells_G1_L4_110286_PBMC_11102011_G01.fcs
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689618			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003645		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15675, ESR15678, ESR15679, ESR15680, ESR15709, ESR15710, ESR15711, ESR15732	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_Ki67_25956, RA_Flu_FCM_Y2_EOMES_E17333-101, RA_Flu_FCM_Y2_T-bet_4020916, P1	PETxR, PCP5.5, PC7, APC-H7, V450, V500, FITC, PE, APC, 	578270	Flow cytometry result	Panel_P1_H10_P1_110286_PBMC_12012011_H10.578270.fcs	Panel_P1_H10_P1_110286_PBMC_12012011_H10.fcs
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689618			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003728		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	578404	Flow cytometry result	Panel_P9_H1_P9_110286_PBMC_12012011_H01.578404.fcs	Panel_P9_H1_P9_110286_PBMC_12012011_H01.fcs
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689618			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003890		FCM	TR_NoTreatment	ESR15671, ESR15672, ESR15673, ESR15674, ESR15675, ESR15676, ESR15677, ESR15678, ESR15679, ESR15680, ESR15727	RA_Flu_FCM_Y2_CD27_3217964, RA_Flu_FCM_Y2_CCR7_3347736, RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD45RA_3288914, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD28_B161718, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, L1	FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, APC-H7, V450, V500, 	578594	Flow cytometry result	Panel_L1_H1_L1_110286_PBMC_12012011_H01.578594.fcs	Panel_L1_H1_L1_110286_PBMC_12012011_H01.fcs
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689618			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004065		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15679, ESR15680, ESR15718, ESR15719, ESR15720, ESR15726, ESR15735	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD16_23551, RA_Flu_FCM_Y2_2B4/CD244_4045874, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_iNKT_B173850, P13	PETxR, PCP5.5, APC-H7, V450, V500, FITC, PE, PC7, APC, 	578773	Flow cytometry result	Panel_P13_H10_P13_110286_PBMC_12012011_H10.578773.fcs	Panel_P13_H10_P13_110286_PBMC_12012011_H10.fcs
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689618			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004107		FCM	TR_NoTreatment	ESR15673, ESR15680, ESR15702, ESR15703, ESR15704, ESR15705, ESR15706, ESR15707, ESR15708, ESR15731	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_HLA-A2_3189744, RA_Flu_FCM_Y2_CD56_36544, RA_Flu_FCM_Y2_CD123_36158, RA_Flu_FCM_Y2_CD11c_2339584, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD3, CD19, CD20_04867, 3018732, 4008676, RA_Flu_FCM_Y2_CD14_2216643, L5	PETxR, V500, FITC, PE, PCP5.5, PC7, APC, APC-H7, V450, 	578815	Flow cytometry result	Panel_L5_MonoNKDC_H4_L5_110286_PBMC_12012011_H04.578815.fcs	Panel_L5_MonoNKDC_H4_L5_110286_PBMC_12012011_H04.fcs
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689618			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004192		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15676, ESR15678, ESR15679, ESR15680, ESR15714, ESR15715, ESR15716, ESR15717, ESR15734	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD127_NA, RA_Flu_FCM_Y2_CD57_2195928, RA_Flu_FCM_Y2_PD-1_3018889, RA_Flu_FCM_Y2_CD27_2320982, P2	PETxR, PCP5.5, APC, APC-H7, V450, V500, FITC, PE, PC7, AF-700, 	578900	Flow cytometry result	Panel_P2_H7_P2_110286_PBMC_12012011_H07.578900.fcs	Panel_P2_H7_P2_110286_PBMC_12012011_H07.fcs
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689618			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004969		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16852	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P10	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	579677	Flow cytometry result	Panel_P10_H4_P10_110286_PBMC_12012011_H04.579677.fcs	Panel_P10_H4_P10_110286_PBMC_12012011_H04.fcs
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689618			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005033		FCM	TR_NoTreatment	ESR15676, ESR15679, ESR15683, ESR15695, ESR15696, ESR15697, ESR15698, ESR15699, ESR15700, ESR15701, ESR15730	RA_Flu_FCM_Y2_CD38_2116750, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CD21_3340542, RA_Flu_FCM_Y2_CD24_2205927, RA_Flu_FCM_Y2_CD19_2167866, RA_Flu_FCM_Y2_CD27_3275654, RA_Flu_FCM_Y2_CD10_E18186-101, RA_Flu_FCM_Y2_CD20_4008676, RA_Flu_FCM_Y2_IgD_3350946, L4	APC, V450, PETxR, FITC, PE, PCP5.5, PC7, AF-700, APC-H7, V500, 	579741	Flow cytometry result	Panel_L4_B_Cells_H1_L4_110286_PBMC_12012011_H01.579741.fcs	Panel_L4_B_Cells_H1_L4_110286_PBMC_12012011_H01.fcs
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689618			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005222		FCM	TR_NoTreatment	ESR15678, ESR15679, ESR15681, ESR15682, ESR15683, ESR15684, ESR15685, ESR15686, ESR15687, ESR15688, ESR15728	RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_CXCR5_17606, RA_Flu_FCM_Y2_CXCR3_3186915, RA_Flu_FCM_Y2_Live-Dead Fixable Red_1252216, RA_Flu_FCM_Y2_CCR4_3007853, RA_Flu_FCM_Y2_CCR6_3231784, RA_Flu_FCM_Y2_PD1_2116750, RA_Flu_FCM_Y2_CD45RO_3242705, RA_Flu_FCM_Y2_CD4_2097508, L2	APC-H7, V450, FITC, PE, PETxR, PCP5.5, PC7, APC, AF-700, V500, 	579930	Flow cytometry result	Panel_L2_H4_L2_110286_PBMC_12012011_H04.579930.fcs	Panel_L2_H4_L2_110286_PBMC_12012011_H04.fcs
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689618			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005372		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15679, ESR15680, ESR15689, ESR15690, ESR15691, ESR15692, ESR15693, ESR15694, ESR15729	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD3_3249776, RA_Flu_FCM_Y2_HLA-DR_28507, RA_Flu_FCM_Y2_CD39_3277711, RA_Flu_FCM_Y2_CD25_3318962, RA_Flu_FCM_Y2_CCR4_3165621, RA_Flu_FCM_Y2_CD127 Alexa-647_3168701, RA_Flu_FCM_Y2_Fox P3_E10352-1632, RA_Flu_FCM_Y2_CD45RO_3281678, L3	PETxR, PCP5.5, V450, V500, FITC, PE, PC7, APC, AF-700, APC-H7, 	580080	Flow cytometry result	Panel_L3_H7_L3_110286_PBMC_12012011_H07.580080.fcs	Panel_L3_H7_L3_110286_PBMC_12012011_H07.fcs
